CHI,Ti,ASST,ASSTIS,ASTET,ASTY,CEI,ASI,ASSTI,TII,Descr,RELATITY,ASSUBCELFRA,CONSC,VAI,CUB,SI,BAFO,SASI,ASOR,DOI,ASSCATE,ASSCETY
CHEMBL618647,50597,,Kidney,In vivo,A,,7524,10116.0,2113.0,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618648,50597,,Kidney,In vivo,A,,7525,10116.0,2113.0,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618649,50597,,Kidney,In vivo,A,,7526,10116.0,2113.0,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618650,50597,,Liver,In vivo,A,,7527,10116.0,2107.0,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618651,50597,,Liver,In vivo,A,,7528,10116.0,2107.0,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876497,50597,,Liver,In vivo,A,,7529,10116.0,2107.0,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618652,50597,,Lung,In vivo,A,,7530,10116.0,2048.0,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618653,50597,,Lung,In vivo,A,,7531,10116.0,2048.0,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618654,50597,,Lung,In vivo,A,,7532,10116.0,2048.0,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618655,50597,,,,A,,7533,10116.0,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6351,,
CHEMBL618656,50597,,,,A,,7534,10116.0,,Compound was tested for solubility in water,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1465,,
CHEMBL618657,22229,,,,P,,7535,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),U,,0,,Intermediate,1,BAO_0000100,,,5182,,
CHEMBL618658,50597,,,,A,,7536,10116.0,,Solubility was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17847,,
CHEMBL618659,50597,,,,A,,7537,10116.0,,solubility in water (ug/mL) at 37 degree C.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15339,,
CHEMBL618660,50597,,,,A,,7538,10116.0,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5202,,
CHEMBL618661,50597,,,,A,,7539,10116.0,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1088,,
CHEMBL873807,50597,,,,A,,7540,10116.0,,Half life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL618662,50597,,,,A,,7541,10116.0,,Half life in Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5353,,
CHEMBL618663,50597,,,In vivo,A,,7542,10116.0,,Half life period after 3 mg/kg iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2864,,
CHEMBL618664,50597,,,In vivo,A,,7543,10116.0,,Half life period after 3 mg/kg iv administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2864,,
CHEMBL618665,50597,,,In vivo,A,,7544,10116.0,,Half life period after 3 mg/kg iv administration in the rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2864,,
CHEMBL876498,50597,,,,A,,7545,10116.0,,Half life period in female Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6362,,
CHEMBL618666,50597,,,,A,,7546,10116.0,,Half life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6249,,
CHEMBL620440,50597,,,,A,,7547,10116.0,,Half-life in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL620441,50597,,,,A,,7548,10116.0,,Half-life in rats with metabolic oxidation,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL620442,50597,,,,A,,7549,10116.0,,Half-life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL620443,50597,,,In vivo,A,,7550,10116.0,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL620444,50597,,,In vivo,A,,7551,10116.0,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL620445,50597,,,In vivo,A,,7552,10116.0,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL620446,50597,,,In vivo,A,,7553,10116.0,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL620447,50597,,Plasma,,A,,7554,10116.0,1969.0,Biological half-life measured in plasma of rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL621129,50597,,Plasma,,A,,7555,10116.0,1969.0,Biological half-life measured in plasma of rat; 22-25,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL621130,50597,,Plasma,,A,,7556,10116.0,1969.0,Biological half-life measured in plasma of rat; 9-16,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL873808,50597,,,In vivo,A,,7557,10116.0,,Compound was evaluated for its half life when administered intravenously in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3184,,
CHEMBL876598,50597,,,In vivo,A,,7558,10116.0,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4891,,
CHEMBL621131,50597,,,In vivo,A,,7559,10116.0,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL621132,50597,,,In vivo,A,,7560,10116.0,,Half life (T1/2) after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL621133,50597,,,In vivo,A,,7561,10116.0,,Half life of compound after iv administration of 20 mg/kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4413,,
CHEMBL621312,50597,,,In vivo,A,,7562,10116.0,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL621313,50597,,,,A,,7563,10116.0,,Half life of compound was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17267,,
CHEMBL621314,50597,,Blood,,A,,7564,10116.0,178.0,Half life of compound was determined in rat blood,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL621315,50597,,,In vivo,A,,7565,10116.0,,Half life at 1 mg/kg was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL621316,50597,,,In vivo,A,,7566,10116.0,,Half life at 10 mg/kg was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL621317,50597,,,,A,,7567,10116.0,,Half life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,401,,
CHEMBL621318,50597,,,,A,,7568,10116.0,,Half life in rats in hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4942,,
CHEMBL621319,50597,,,In vivo,A,,7569,10116.0,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17735,,
CHEMBL621377,50597,,,In vivo,A,,7570,10116.0,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6056,,
CHEMBL621378,50597,,,,A,,7571,10116.0,,Half life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5213,,
CHEMBL876599,50597,,,In vivo,A,,7572,10116.0,,Half life after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6616,,
CHEMBL621379,50597,,,In vivo,A,,7573,10116.0,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5937,,
CHEMBL621380,50597,,Plasma,,A,,7574,10116.0,1969.0,Half life in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5819,,
CHEMBL621381,50597,,Plasma,,A,,7575,10116.0,1969.0,Half life in rat plasma; Not detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5819,,
CHEMBL618515,50597,,,,A,,7576,10116.0,,Half life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6803,,
CHEMBL618516,50597,,,In vivo,A,,7577,10116.0,,Half life period of compound was determined after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL618517,50597,,,In vivo,A,,7578,10116.0,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL618518,50597,,,,A,,7579,10116.0,,Half life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5948,,
CHEMBL618519,50597,,,In vivo,A,,7580,10116.0,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL618698,50597,,,In vivo,A,,7581,10116.0,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL618862,50597,,,In vivo,A,,7582,10116.0,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL618863,50597,,,In vivo,A,,7583,10116.0,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL618864,50597,,,In vivo,A,,7584,10116.0,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL618865,50597,,,In vivo,A,,7585,10116.0,,Half life time in rat the dose of 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL618866,50597,,,In vivo,A,,7586,10116.0,,Half-life 24 hr after 10 mg/kg iv administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL618867,50597,,,In vivo,A,,7587,10116.0,,Half-life 24 hr after 2 mg/kg iv administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL875828,50597,,,,A,,7588,10116.0,,Half-life consistent with the observed metabolic steady state in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL618868,50597,,,In vivo,A,,7589,10116.0,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17735,,
CHEMBL618869,50597,,,,A,,7590,10116.0,,Half-life for oxidative metabolic stability was determined using male human,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL618870,50597,,,In vivo,A,,7591,10116.0,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17670,,
CHEMBL618871,50597,,Plasma,,A,,7592,10116.0,1969.0,Half-life in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1696,,
CHEMBL618872,50597,,Plasma,,A,,7593,10116.0,1969.0,Half-life in rat plasma was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1742,,
CHEMBL873816,50597,,,,A,,7594,10116.0,,Half-life in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17800,,
CHEMBL618873,22224,,,,A,,7595,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,U,,0,,Autocuration,1,BAO_0000218,,,12923,,
CHEMBL621602,22224,,,,A,,7596,,,Area under curve after oral dose of 0.1 mg//kg,U,,0,,Autocuration,1,BAO_0000019,,,11954,,
CHEMBL621603,22224,,,,A,,7597,,,Area under curve after oral dose of 0.3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL621604,22224,,,,A,,7598,,,Area under curve after oral dose of 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL621605,22224,,,,A,,7599,,,Area under curve after oral dose of 10 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL621606,22224,,,,A,,7600,,,Area under curve after oral dose of 23.4 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL621607,22224,,,,A,,7601,,,Area under curve after oral dose of 3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL621608,22224,,,,A,,7602,,,Area under curve after oral dose of 3.87 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL621609,22224,,,,A,,7603,,,Area under curve was determined,U,,0,,Autocuration,1,BAO_0000019,,,5237,,
CHEMBL621610,22224,,,,A,,7604,,,Area under curve at a dose of 10 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,4026,,
CHEMBL621611,50597,,,,A,,7605,10116.0,,Area under curve was determined; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5237,,
CHEMBL621612,50597,,,,A,,7606,10116.0,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622308,50597,,,,A,,7607,10116.0,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622309,50597,,,,A,,7608,10116.0,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622310,50597,,,,A,,7609,10116.0,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622311,50597,,,,A,,7610,10116.0,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622312,50597,,,,A,,7611,10116.0,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622931,50597,,,,A,,7612,10116.0,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622932,50597,,,,A,,7613,10116.0,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622736,50597,,Plasma,,A,,7614,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622737,50597,,Plasma,,A,,7615,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622738,50597,,Plasma,,A,,7616,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622739,50597,,Plasma,,A,,7617,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622740,50597,,Plasma,,A,,7618,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622741,50597,,Plasma,,A,,7619,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622742,50597,,Plasma,,A,,7620,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622743,50597,,Plasma,,A,,7621,10116.0,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL622744,50594,,Plasma,,A,,7622,10090.0,1969.0,AUC in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11637,,
CHEMBL624134,22224,,,,A,,7623,,,Area under curve was measured from the graph obtained from concentration Vs time,U,,0,,Autocuration,1,BAO_0000019,,,11149,,
CHEMBL624135,22224,,,,A,,7624,,,Area under curve value of compound per hour after oral administration,U,,0,,Autocuration,1,BAO_0000019,,,10016,,
CHEMBL624136,50597,,,,A,,7625,10116.0,,Area under curve was determined after oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL624137,50597,,,,A,,7626,10116.0,,Area under curve was determined after oral administration in rats; No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL624320,50597,,,,A,,7627,10116.0,,Area under curve was determined after oral administration in rats;No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL624321,50588,,,,A,,7628,9615.0,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12923,,
CHEMBL624322,50597,,,,A,,7629,10116.0,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL624323,50597,,,,A,,7630,10116.0,,Area under curve was determined for the compound after iv dose of 5.06 in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL624324,50597,,,,A,,7631,10116.0,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL624325,50597,,,,A,,7632,10116.0,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL624326,50597,,,,A,,7633,10116.0,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL624327,50597,,,,A,,7634,10116.0,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL624328,50597,,,,A,,7635,10116.0,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL627848,50588,,,,A,,7636,9615.0,,Area under curve was determined in Dogs after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14169,,
CHEMBL627849,50597,,,,A,,7637,10116.0,,Area under curve was determined in Rats after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14169,,
CHEMBL627850,50597,,,,A,,7638,10116.0,,Area under curve was determined in carotid blood of rat when administered intradermally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14258,,
CHEMBL627851,50597,,,,A,,7639,10116.0,,Area under curve was determined in portal blood of rat when administered intradermally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14258,,
CHEMBL627852,50594,,,,A,,7640,10090.0,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627853,50594,,,,A,,7641,10090.0,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627854,50594,,,,A,,7642,10090.0,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627855,50594,,,,A,,7643,10090.0,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627856,50594,,,,A,,7644,10090.0,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL875339,50594,,,,A,,7645,10090.0,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627857,50594,,,,A,,7646,10090.0,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627858,50597,,Spleen,In vivo,A,,7647,10116.0,2106.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL627859,50597,,Blood,,A,,7648,10116.0,178.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627860,50597,,Brain,,A,,7649,10116.0,955.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627019,50597,,Heart,,A,,7650,10116.0,948.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627020,50597,,Liver,,A,,7651,10116.0,2107.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627021,50597,,Lung,,A,,7652,10116.0,2048.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627022,50597,,Muscle tissue,,A,,7653,10116.0,2385.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627023,50597,,,,A,,7654,10116.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627024,50597,,Spleen,,A,,7655,10116.0,2106.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627025,50597,,Thyroid gland,,A,,7656,10116.0,2046.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627026,50597,,Kidney,,A,,7657,10116.0,2113.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627027,50597,,Blood,,A,,7658,10116.0,178.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627028,50597,,Brain,,A,,7659,10116.0,955.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627029,50597,,Heart,,A,,7660,10116.0,948.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627030,50597,,Kidney,,A,,7661,10116.0,2113.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627031,50597,,Liver,,A,,7662,10116.0,2107.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627032,50597,,Lung,,A,,7663,10116.0,2048.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627033,50597,,Muscle tissue,,A,,7664,10116.0,2385.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627034,50597,,,,A,,7665,10116.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627035,50597,,Spleen,,A,,7666,10116.0,2106.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627036,50597,,Thyroid gland,,A,,7667,10116.0,2046.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL875340,50597,,Blood,,A,,7668,10116.0,178.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627037,50597,,Heart,,A,,7669,10116.0,948.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627038,50597,,Kidney,,A,,7670,10116.0,2113.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627039,50597,,Liver,,A,,7671,10116.0,2107.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL627040,50597,,Muscle tissue,,A,,7672,10116.0,2385.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL624663,50597,,Spleen,,A,,7673,10116.0,2106.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL625963,50597,,Thyroid gland,,A,,7674,10116.0,2046.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL876799,50597,,Brain,,A,,7675,10116.0,955.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL626133,50597,,Lung,,A,,7676,10116.0,2048.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL626134,50597,,,,A,,7677,10116.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL626135,50597,,,,A,,7678,10116.0,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6295,,
CHEMBL626136,50597,,,,A,,7679,10116.0,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6296,,
CHEMBL626137,50597,,,,A,,7680,10116.0,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6296,,
CHEMBL626138,50597,,,,A,,7681,10116.0,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6295,,
CHEMBL626139,50597,,,,A,,7682,10116.0,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6296,,
CHEMBL626140,50597,,,In vivo,A,,7683,10116.0,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL626141,50597,,,In vivo,A,,7684,10116.0,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL626142,50597,,,,A,,7685,10116.0,,C24h in rat p.o. at 20 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL627930,50597,,Muscle tissue,In vivo,A,,7686,10116.0,2385.0,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627931,50597,,Muscle tissue,In vivo,A,,7687,10116.0,2385.0,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627932,50597,,Muscle tissue,In vivo,A,,7688,10116.0,2385.0,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627933,50597,,Spleen,In vivo,A,,7689,10116.0,2106.0,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627934,50597,,Spleen,In vivo,A,,7690,10116.0,2106.0,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627935,50597,,Spleen,In vivo,A,,7691,10116.0,2106.0,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627936,50597,,Blood,In vivo,A,,7692,10116.0,178.0,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627937,50597,,Blood,In vivo,A,,7693,10116.0,178.0,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627938,50597,,Blood,In vivo,A,,7694,10116.0,178.0,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627939,50597,,Blood,In vivo,A,,7695,10116.0,178.0,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627940,50597,,Blood,In vivo,A,,7696,10116.0,178.0,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627941,50597,,Blood,In vivo,A,,7697,10116.0,178.0,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876800,50597,,Blood,In vivo,A,,7698,10116.0,178.0,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627942,50597,,Blood,In vivo,A,,7699,10116.0,178.0,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627943,50597,,Blood,In vivo,A,,7700,10116.0,178.0,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627944,50597,,Blood,In vivo,A,,7701,10116.0,178.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627945,50597,,Blood,In vivo,A,,7702,10116.0,178.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL628584,50597,,Blood,In vivo,A,,7703,10116.0,178.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL628585,50597,,Blood,In vivo,A,,7704,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL628586,50597,,Blood,In vivo,A,,7705,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL628587,50597,,Blood,In vivo,A,,7706,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL628588,50597,,Blood,In vivo,A,,7707,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL628589,50597,,Blood,In vivo,A,,7708,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL625304,50597,,Blood,In vivo,A,,7709,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL625305,50597,,Blood,In vivo,A,,7710,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL625306,50597,,Blood,In vivo,A,,7711,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL625307,50597,,Blood,In vivo,A,,7712,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL625308,50597,,Blood,In vivo,A,,7713,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627740,50597,,Blood,In vivo,A,,7714,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627741,50597,,Blood,In vivo,A,,7715,10116.0,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627742,50597,,Blood,In vivo,A,,7716,10116.0,178.0,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627743,50597,,Blood,In vivo,A,,7717,10116.0,178.0,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627744,50597,,Blood,In vivo,A,,7718,10116.0,178.0,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627745,50597,,Bone,In vivo,A,,7719,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627746,50597,,Bone,In vivo,A,,7720,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627747,50597,,Bone,In vivo,A,,7721,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876810,50597,,Bone,In vivo,A,,7722,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627748,50597,,Bone,In vivo,A,,7723,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627749,50597,,Bone,In vivo,A,,7724,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL627750,50597,,Bone,In vivo,A,,7725,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618728,50597,,Bone,In vivo,A,,7726,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618729,50597,,Bone,In vivo,A,,7727,10116.0,10000001.0,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618730,50597,,Bone,In vivo,A,,7728,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618731,50597,,Bone,In vivo,A,,7729,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618732,50597,,Bone,In vivo,A,,7730,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618733,50597,,Bone,In vivo,A,,7731,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618734,50597,,Bone,In vivo,A,,7732,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618735,50597,,Bone,In vivo,A,,7733,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876602,50597,,Bone,In vivo,A,,7734,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618736,50597,,Bone,In vivo,A,,7735,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618737,50597,,Bone,In vivo,A,,7736,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618738,50597,,Bone,In vivo,A,,7737,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618739,50597,,Bone,In vivo,A,,7738,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618740,50597,,Bone,In vivo,A,,7739,10116.0,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618741,50597,,Bone,In vivo,A,,7740,10116.0,10000001.0,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618742,50597,,Bone,In vivo,A,,7741,10116.0,10000001.0,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618743,50597,,Bone,In vivo,A,,7742,10116.0,10000001.0,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL618744,50597,,Plasma,In vivo,A,,7743,10116.0,1969.0,Half-life from rat plasma at a single oral dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL618745,50597,,,,A,,7744,10116.0,,Half-life in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5610,,
CHEMBL620479,50597,,,In vivo,A,,7745,10116.0,,Half-life in rat after peroral administration at 10 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL620480,50597,,,In vivo,A,,7746,10116.0,,Half-life in rat after peroral administration at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL620481,50597,,,In vivo,A,,7747,10116.0,,Half-life in rat at a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17771,,
CHEMBL620482,50597,,,,A,,7748,10116.0,,Half-life was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1974,,
CHEMBL876603,50597,,,,A,,7749,10116.0,,Half-life was measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4239,,
CHEMBL620483,50597,,,In vivo,A,,7750,10116.0,,Half-life period for the compound was determined in rats at 50 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6681,,
CHEMBL620484,50597,,,In vivo,A,,7751,10116.0,,Half-life period in rats after intravenous administration at 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL620485,50597,,,In vivo,A,,7752,10116.0,,Half-life period in rat at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6046,,
CHEMBL620486,50597,,,In vivo,A,,7753,10116.0,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL620487,50597,,,In vivo,A,,7754,10116.0,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL620488,50597,,,In vivo,A,,7755,10116.0,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL620489,50597,,,In vivo,A,,7756,10116.0,,Half-life time in rat the dose of 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL620490,50597,,,In vivo,A,,7757,10116.0,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1088,,
CHEMBL620491,50597,,,In vivo,A,,7758,10116.0,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5610,,
CHEMBL876604,50597,,Plasma,In vivo,A,,7759,10116.0,1969.0,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3032,,
CHEMBL620492,50597,,,In vivo,A,,7760,10116.0,,Oral half life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL620493,50597,,,In vivo,A,,7761,10116.0,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL620494,50597,,,In vivo,A,,7762,10116.0,,Pharmacokinetic property (t1/2) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4408,,
CHEMBL620495,50597,,Plasma,,A,,7763,10116.0,1969.0,Plasma elimination half-life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2552,,
CHEMBL620496,50597,,Plasma,In vivo,A,,7764,10116.0,1969.0,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL620497,50597,,Plasma,In vivo,A,,7765,10116.0,1969.0,Plasma half life was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL620498,50597,,Plasma,,A,,7766,10116.0,1969.0,Plasma half-life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1465,,
CHEMBL620499,50597,,Plasma,In vivo,A,,7767,10116.0,1969.0,Plasma half-life following oral administration in Fisher rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1446,,
CHEMBL620500,50597,,Plasma,,A,,7768,10116.0,1969.0,Plasma half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6824,,
CHEMBL873809,50597,,Plasma,In vivo,A,,7769,10116.0,1969.0,Plasmatic Half-life after intravenous administration to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17533,,
CHEMBL620501,50597,,,In vivo,A,,7770,10116.0,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5979,,
CHEMBL620502,50597,,,In vivo,A,,7771,10116.0,,Terminal half life after intravenous administration (1 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL620503,50597,,,In vivo,A,,7772,10116.0,,Terminal half life in Rat at a oral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL620504,50597,,,In vivo,A,,7773,10116.0,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2463,,
CHEMBL876605,50597,,,In vivo,A,,7774,10116.0,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL620505,50597,,,In vivo,A,,7775,10116.0,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL873811,50597,,Plasma,In vivo,A,,7776,10116.0,1969.0,plasma half life was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL624016,50597,,,In vivo,A,,7777,10116.0,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL624017,50597,,,,A,,7778,10116.0,,Half life of compound determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL624018,50597,,,,A,,7779,10116.0,,Mean residence time determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL624019,50597,,,,A,,7780,10116.0,,Plasma half life determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL624020,50597,,Brain,In vivo,A,,7781,10116.0,955.0,Compound was evaluated for Tmax in brain after intravenous administration in male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL624201,50597,,,In vivo,A,,7782,10116.0,,Compound was evaluated for pharmacokinetic parameter maximum time period,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4891,,
CHEMBL872528,50597,,,In vivo,A,,7783,10116.0,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL624202,50597,,,In vivo,A,,7784,10116.0,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624203,50597,,,In vivo,A,,7785,10116.0,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624350,50597,,,In vivo,A,,7786,10116.0,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL621320,50597,,,In vivo,A,,7787,10116.0,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL621321,50597,,,In vivo,A,,7788,10116.0,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL621322,50597,,,,A,,7789,10116.0,,Maximum time (Tmax) required to reach Cmax in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL621323,50597,,,In vivo,A,,7790,10116.0,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL621324,50597,,,In vivo,A,,7791,10116.0,,Maximum time of clearance of compound in rats after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6571,,
CHEMBL621325,50597,,,,A,,7792,10116.0,,Maximum time at the dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL875837,50597,,Plasma,In vivo,A,,7793,10116.0,1969.0,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL621326,50597,,Plasma,In vivo,A,,7794,10116.0,1969.0,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL621327,50597,,,In vivo,A,,7795,10116.0,,Tmax in Guinea pig (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14465,,
CHEMBL621328,50597,,,In vivo,A,,7796,10116.0,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL621329,50597,,,In vivo,A,,7797,10116.0,,Pharmacokinetic parameter (Tmax) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5960,,
CHEMBL621330,50597,,,In vivo,A,,7798,10116.0,,Pharmacokinetic parameter (Tmax) was estimated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5022,,
CHEMBL621331,50597,,,In vivo,A,,7799,10116.0,,Pharmacokinetic property (Tmax) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4408,,
CHEMBL621332,50597,,,In vivo,A,,7800,10116.0,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5983,,
CHEMBL621333,50597,,,In vivo,A,,7801,10116.0,,T max in Rat at a oral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL621334,50597,,,In vivo,A,,7802,10116.0,,T max was determined at 10 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL621335,50594,,,,A,,7803,10090.0,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL621336,50588,,,,A,,7804,9615.0,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14180,,
CHEMBL621337,50597,,,,A,,7805,10116.0,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14180,,
CHEMBL621338,50588,,,,A,,7806,9615.0,,Area under curve was measured after i.v. administration into Beagle dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL875838,50588,,,,A,,7807,9615.0,,Area under curve was measured after iv administration into Beagle dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL621339,50588,,,,A,,7808,9615.0,,Area under curve was measured after po administration into Beagle dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL621340,50588,,,,A,,7809,9615.0,,Area under curve was measured after po administration into Beagle dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL621341,22224,,,,A,,7810,,,Area under curve was measured at peroral dose of 3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15675,,
CHEMBL621342,22224,,,,A,,7811,,,Area under curve was measured by using concentration Vs time,U,,0,,Autocuration,1,BAO_0000019,,,12706,,
CHEMBL621343,22224,,,,A,,7812,,,Area under curve was measured by using concentration Vs time; not tested,U,,0,,Autocuration,1,BAO_0000019,,,12706,,
CHEMBL621344,50594,,,,A,,7813,10090.0,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9750,,
CHEMBL621345,50594,,,,A,,7814,10090.0,,Area under curve(AUC) was measured in mice after oral administration.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9750,,
CHEMBL621346,22224,,,,A,,7815,,,Area under curve(AUC) value of the compound,U,,0,,Autocuration,1,BAO_0000019,,,14691,,
CHEMBL621347,22224,,,,A,,7816,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,U,,0,,Autocuration,1,BAO_0000218,,,14691,,
CHEMBL621348,50588,,,,A,,7817,9615.0,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14691,,
CHEMBL621349,22224,,Blood,,A,,7818,,178.0,Area under curve(carotid artery) was determined by the availability in blood,U,,0,,Autocuration,1,BAO_0000019,,,2939,,
CHEMBL621350,22224,,Blood,,A,,7819,,178.0,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,U,,0,,Autocuration,1,BAO_0000019,,,2939,,
CHEMBL875839,22224,,Blood,,A,,7820,,178.0,Area under curve(carotid artery) was determined by the availability in blood; No data,U,,0,,Autocuration,1,BAO_0000019,,,2939,,
CHEMBL620211,22224,,Blood,,A,,7821,,178.0,Area under curve(portal vein) was determined by the availability in blood,U,,0,,Autocuration,1,BAO_0000019,,,2939,,
CHEMBL620212,22224,,Blood,,A,,7822,,178.0,Area under curve(portal vein) was determined by the availability in blood; ND means no data,U,,0,,Autocuration,1,BAO_0000019,,,2939,,
CHEMBL620213,22224,,Blood,,A,,7823,,178.0,Area under curve(portal vein) was determined by the availability in blood; No data,U,,0,,Autocuration,1,BAO_0000019,,,2939,,
CHEMBL620214,50797,,Plasma,,A,,7824,9544.0,1969.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,9552,,
CHEMBL620215,50797,,Plasma,,A,,7825,9544.0,1969.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,9552,,
CHEMBL620216,50797,,Plasma,,A,,7826,9544.0,1969.0,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,9552,,
CHEMBL620888,50588,,Plasma,,A,,7827,9615.0,1969.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9552,,
CHEMBL620889,50588,,Plasma,,A,,7828,9615.0,1969.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9552,,
CHEMBL620890,22224,,Plasma,,A,,7829,,1969.0,Area under plasma concentration vs time curve observed in rats for 0-3 h,U,,0,,Autocuration,1,BAO_0000019,,,9552,,
CHEMBL620891,50597,,Plasma,,A,,7830,10116.0,1969.0,Area under plasma time curve determined in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11911,,
CHEMBL620892,22224,,,,A,,7831,,,Area under the MAP curve measured over 5 min.,U,,0,,Autocuration,1,BAO_0000019,,,16618,,
CHEMBL621079,50594,,,,A,,7832,10090.0,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14387,,
CHEMBL621080,50594,,,,A,,7833,10090.0,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14387,,
CHEMBL621081,50588,,,,A,,7834,9615.0,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12836,,
CHEMBL621082,100712,,,,A,,7835,10026.0,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,12836,,
CHEMBL621083,50597,,,,A,,7836,10116.0,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12836,,
CHEMBL621084,50588,,,,A,,7837,9615.0,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14339,,
CHEMBL621085,50588,,,,A,,7838,9615.0,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14339,,
CHEMBL621086,50588,,,,A,,7839,9615.0,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14339,,
CHEMBL621087,50588,,,,A,,7840,9615.0,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,10524,,
CHEMBL622607,50588,,,,A,,7841,9615.0,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9994,,
CHEMBL622608,50588,,,,A,,7842,9615.0,,Serum AUC in marmosets (IV dose),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,11325,,
CHEMBL624481,22224,,,,A,,7843,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,12536,,
CHEMBL624482,22224,,,,A,,7844,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,12536,,
CHEMBL624483,22224,,,,A,,7845,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,12536,,
CHEMBL624484,22224,,,,A,,7846,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,12536,,
CHEMBL624485,22224,,,,A,,7847,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,12536,,
CHEMBL624486,50597,,,,A,,7848,10116.0,,Area under the curve for fumarate salt was evaluated in F344 Rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15556,,
CHEMBL624487,22224,,,,A,,7849,,,Area under the curve for the compound was calculated.,U,,0,,Autocuration,1,BAO_0000019,,,2809,,
CHEMBL624488,22224,,,,A,,7850,,,Area under the curve in concentration/ time,U,,0,,Autocuration,1,BAO_0000019,,,9511,,
CHEMBL624489,50597,,,,A,,7851,10116.0,,Area under the curve administered intraintestinal in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12818,,
CHEMBL625184,50597,,,,A,,7852,10116.0,,Area under the curve administered intravenously in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12818,,
CHEMBL625185,22224,,,,A,,7853,,,Area under the curve during intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,15118,,
CHEMBL875954,22224,,,,A,,7854,,,Area under the curve during intravenous administration; Not determined,U,,0,,Autocuration,1,BAO_0000019,,,15118,,
CHEMBL625186,22224,,,,A,,7855,,,Area under the curve during systemic administration,U,,0,,Autocuration,1,BAO_0000019,,,15118,,
CHEMBL625187,22224,,,,A,,7856,,,Area under the curve during systemic administration; Not determined,U,,0,,Autocuration,1,BAO_0000019,,,15118,,
CHEMBL625188,22224,,,,A,,7857,,,Area under the curve was calculated for the compound.,U,,0,,Autocuration,1,BAO_0000019,,,2632,,
CHEMBL625189,50588,,,,A,,7858,9615.0,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14346,,
CHEMBL625190,50588,,,,A,,7859,9615.0,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14346,,
CHEMBL621733,50597,,,,A,,7860,10116.0,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL621734,50597,,,,A,,7861,10116.0,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL621735,50597,,,,A,,7862,10116.0,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11149,,
CHEMBL621736,50597,,Plasma,,A,,7863,10116.0,1969.0,Clearance of the drug was measured in the plasma of rat; No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL621737,50597,,Plasma,,A,,7864,10116.0,1969.0,The pharmacokinetic parameter plasma clearance in vivo in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5247,,
CHEMBL621738,50597,,,,A,,7865,10116.0,,Plasma clearance at the dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL622806,50597,,,In vivo,A,,7866,10116.0,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL623519,50597,,,In vivo,A,,7867,10116.0,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL623520,50597,,,In vivo,A,,7868,10116.0,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL623521,50597,,,In vivo,A,,7869,10116.0,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17065,,
CHEMBL623522,50597,,,In vivo,A,,7870,10116.0,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17671,,
CHEMBL623523,50597,,,In vivo,A,,7871,10116.0,,Clearance rate in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6672,,
CHEMBL623690,50597,,,In vivo,A,,7872,10116.0,,Clearance rate in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6673,,
CHEMBL623691,50597,,,In vivo,A,,7873,10116.0,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623692,50597,,,In vivo,A,,7874,10116.0,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623693,50597,,,In vivo,A,,7875,10116.0,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623694,50597,,,In vivo,A,,7876,10116.0,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623695,50597,,,In vivo,A,,7877,10116.0,,Clearance of compound after iv administration of 20 mg/kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4413,,
CHEMBL623696,50597,,,In vivo,A,,7878,10116.0,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL623697,50597,,,In vivo,A,,7879,10116.0,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL623698,22224,,Plasma,In vivo,A,,7880,9544.0,1969.0,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,,0,,Intermediate,1,BAO_0000218,,Macaca mulatta,5005,,
CHEMBL623699,22224,,Plasma,In vivo,A,,7881,10116.0,1969.0,Compound was tested for its plasma clearance rate in Sprague Dawley rats,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5005,,
CHEMBL623700,50597,,,In vivo,A,,7882,10116.0,,Mean (%CV) PK parameters for CL(mL/min/kg).,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL623701,50597,,,In vivo,A,,7883,10116.0,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3747,,
CHEMBL623702,50597,,Plasma,In vivo,A,,7884,10116.0,1969.0,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL623703,50597,,,In vivo,A,,7885,10116.0,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL623704,50597,,,In vivo,A,,7886,10116.0,,Plasma clearance in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17267,,
CHEMBL623705,50597,,,In vivo,A,,7887,10116.0,,Plasma clearance in rat after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL623706,50597,,,In vivo,A,,7888,10116.0,,Plasma clearance in rat after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL623707,50597,,,In vivo,A,,7889,10116.0,,Plasma clearance was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL623708,50597,,,In vivo,A,,7890,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5960,,
CHEMBL623709,50597,,,In vivo,A,,7891,10116.0,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5937,,
CHEMBL623710,50597,,,In vivo,A,,7892,10116.0,,Plasma clearance in rat by iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5871,,
CHEMBL623711,50597,,,In vivo,A,,7893,10116.0,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5874,,
CHEMBL623712,50597,,,In vivo,A,,7894,10116.0,,Plasma clearance in rat p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6504,,
CHEMBL623713,50597,,,In vivo,A,,7895,10116.0,,Plasma clearance in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6803,,
CHEMBL623714,50597,,,In vivo,A,,7896,10116.0,,Plasma clearance was determined; ND denotes no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL623715,50597,,,In vivo,A,,7897,10116.0,,Plasma clearance was determined; ND denotes not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL623716,50597,,,In vivo,A,,7898,10116.0,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL622980,50597,,,In vivo,A,,7899,10116.0,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL622981,50597,,,In vivo,A,,7900,10116.0,,Plasma administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL622982,50597,,,In vivo,A,,7901,10116.0,,Plasma clearance of the compound in female Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6362,,
CHEMBL622983,50597,,,In vivo,A,,7902,10116.0,,Plasma clearance was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL622984,50597,,,In vivo,A,,7903,10116.0,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6215,,
CHEMBL622985,50597,,,In vivo,A,,7904,10116.0,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL623631,50597,,Plasma,In vivo,A,,7905,10116.0,1969.0,plasma clearance was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL623632,50597,,,In vivo,A,,7906,10116.0,,In vivo CL/F determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL623633,50597,,Plasma,In vivo,A,,7907,10116.0,1969.0,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL623634,50597,,Plasma,In vivo,A,,7908,10116.0,1969.0,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL623635,50597,,,In vivo,A,,7909,10116.0,,Compound was tested for the lower blood clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5213,,
CHEMBL621195,50597,,,In vivo,A,,7910,10116.0,,Evaluated for the low clearance in rat (in vivo),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4687,,
CHEMBL621196,50597,,,In vivo,A,,7911,10116.0,,Pharmacokinetic property (CLb)of the compound was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3371,,
CHEMBL875287,50597,,,In vivo,A,,7912,10116.0,,Rapid clearance after intravenous administration in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4690,,
CHEMBL621197,50597,,,In vivo,A,,7913,10116.0,,Clearance measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5702,,
CHEMBL621198,50597,,Plasma,In vivo,A,,7914,10116.0,1969.0,Compound was evaluated for plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,740,,
CHEMBL621199,50597,,Plasma,In vivo,A,,7915,10116.0,1969.0,Low plasma clearance was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL621200,50597,,,In vivo,A,,7916,10116.0,,Pharmacokinetic property (Clp) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5789,,
CHEMBL621201,50597,,,In vivo,A,,7917,10116.0,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL621202,50597,,,In vivo,A,,7918,10116.0,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL621203,50597,,,In vivo,A,,7919,10116.0,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL621204,50597,,,In vivo,A,,7920,10116.0,,Plasma clearance after IV dosing at 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL621205,50597,,Heart,In vivo,A,,7921,10116.0,948.0,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621206,50597,,Heart,In vivo,A,,7922,10116.0,948.0,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621207,50597,,Heart,In vivo,A,,7923,10116.0,948.0,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621208,50597,,Heart,In vivo,A,,7924,10116.0,948.0,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621209,50597,,Heart,In vivo,A,,7925,10116.0,948.0,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876484,50597,,Heart,In vivo,A,,7926,10116.0,948.0,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621210,50597,,Heart,In vivo,A,,7927,10116.0,948.0,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621211,50597,,Heart,In vivo,A,,7928,10116.0,948.0,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621212,50597,,Heart,In vivo,A,,7929,10116.0,948.0,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621213,50597,,Heart,In vivo,A,,7930,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621214,50597,,Heart,In vivo,A,,7931,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621215,50597,,Heart,In vivo,A,,7932,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621216,50597,,Heart,In vivo,A,,7933,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621217,50597,,Heart,In vivo,A,,7934,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621218,50597,,Heart,In vivo,A,,7935,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621219,50597,,Heart,In vivo,A,,7936,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621220,50597,,Heart,In vivo,A,,7937,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621221,50597,,Heart,In vivo,A,,7938,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621222,50597,,Heart,In vivo,A,,7939,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621223,50597,,Heart,In vivo,A,,7940,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876485,50597,,Heart,In vivo,A,,7941,10116.0,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621224,50597,,Heart,In vivo,A,,7942,10116.0,948.0,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621225,50597,,Heart,In vivo,A,,7943,10116.0,948.0,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621226,50597,,Heart,In vivo,A,,7944,10116.0,948.0,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621227,50597,,Kidney,In vivo,A,,7945,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621228,50597,,Kidney,In vivo,A,,7946,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621229,50597,,Kidney,In vivo,A,,7947,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621230,50597,,Kidney,In vivo,A,,7948,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621231,50597,,Kidney,In vivo,A,,7949,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621232,50597,,Kidney,In vivo,A,,7950,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621233,50597,,Kidney,In vivo,A,,7951,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621234,50597,,Kidney,In vivo,A,,7952,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621235,50597,,Kidney,In vivo,A,,7953,10116.0,2113.0,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621236,50597,,Kidney,In vivo,A,,7954,10116.0,2113.0,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621237,50597,,Kidney,In vivo,A,,7955,10116.0,2113.0,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876486,50597,,Kidney,In vivo,A,,7956,10116.0,2113.0,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622436,50597,,Intestine,In vivo,A,,7957,10116.0,160.0,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622437,50597,,Intestine,In vivo,A,,7958,10116.0,160.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622438,50597,,Intestine,In vivo,A,,7959,10116.0,160.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622439,50597,,Liver,In vivo,A,,7960,10116.0,2107.0,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622440,50597,,Liver,In vivo,A,,7961,10116.0,2107.0,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622441,50597,,Liver,In vivo,A,,7962,10116.0,2107.0,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622442,50597,,Liver,In vivo,A,,7963,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622443,50597,,Liver,In vivo,A,,7964,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622444,50597,,Liver,In vivo,A,,7965,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622445,50597,,Liver,In vivo,A,,7966,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622446,50597,,Liver,In vivo,A,,7967,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622447,50597,,Liver,In vivo,A,,7968,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622448,50597,,Liver,In vivo,A,,7969,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622449,50597,,Liver,In vivo,A,,7970,10116.0,2107.0,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622450,50597,,Liver,In vivo,A,,7971,10116.0,2107.0,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622451,50597,,Liver,In vivo,A,,7972,10116.0,2107.0,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622452,50597,,Liver,In vivo,A,,7973,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622453,50597,,Liver,In vivo,A,,7974,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622454,50597,,Liver,In vivo,A,,7975,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622455,50597,,Liver,In vivo,A,,7976,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876024,50597,,Liver,In vivo,A,,7977,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL622456,50597,,,In vivo,A,,7978,10116.0,,T max was determined at 3 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL622457,50597,,,In vivo,A,,7979,10116.0,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL622458,50597,,,In vivo,A,,7980,10116.0,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL622459,50597,,,,A,,7981,10116.0,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL873343,50597,,,,A,,7982,10116.0,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL622460,50597,,,,A,,7983,10116.0,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL622461,50597,,Plasma,,A,,7984,10116.0,1969.0,Time for maximum plasma concentration determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL622462,50597,,Plasma,In vivo,A,,7985,10116.0,1969.0,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6681,,
CHEMBL622463,50597,,,In vivo,A,,7986,10116.0,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622464,50597,,,In vivo,A,,7987,10116.0,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622465,50597,,,In vivo,A,,7988,10116.0,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622466,50597,,,In vivo,A,,7989,10116.0,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622467,50597,,,In vivo,A,,7990,10116.0,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622468,50597,,Plasma,,A,,7991,10116.0,1969.0,Time of maximum plasma concentration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6824,,
CHEMBL876025,50597,,Plasma,,A,,7992,10116.0,1969.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622469,50597,,Plasma,,A,,7993,10116.0,1969.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622470,50597,,Plasma,,A,,7994,10116.0,1969.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622471,50597,,,In vivo,A,,7995,10116.0,,Time required to reach maximum concentration (Cmax) after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL622472,50597,,Plasma,,A,,7996,10116.0,1969.0,Time required to reach maximum concentration in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1742,,
CHEMBL622473,50597,,Plasma,In vivo,A,,7997,10116.0,1969.0,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2774,,
CHEMBL624282,50597,,Plasma,In vivo,A,,7998,10116.0,1969.0,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL624283,50597,,Plasma,In vivo,A,,7999,10116.0,1969.0,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL624284,50597,,Plasma,In vivo,A,,8000,10116.0,1969.0,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL624285,50597,,Plasma,In vivo,A,,8001,10116.0,1969.0,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL624286,50597,,,In vivo,A,,8002,10116.0,,Time to reach Cmax after oral administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL624287,50597,,,In vivo,A,,8003,10116.0,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL624288,50597,,,,A,,8004,10116.0,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,216,,
CHEMBL624289,50597,,Plasma,In vivo,A,,8005,10116.0,1969.0,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL873344,50597,,Plasma,In vivo,A,,8006,10116.0,1969.0,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL619623,50597,,,In vivo,A,,8007,10116.0,,Tmax after peroral administration (10 mg/kg) was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6215,,
CHEMBL621399,50597,,,In vivo,A,,8008,10116.0,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL621400,50597,,,In vivo,A,,8009,10116.0,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL621401,50597,,,In vivo,A,,8010,10116.0,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17670,,
CHEMBL621402,50597,,,,A,,8011,10116.0,,Tmax was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1465,,
CHEMBL621403,50597,,,,A,,8012,10116.0,,Tmax was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2552,,
CHEMBL621121,50597,,,In vivo,A,,8013,10116.0,,Tmax after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL872525,50597,,,In vivo,A,,8014,10116.0,,Tmax after peroral administration in rats at 2.4 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL621122,50597,,,,A,,8015,10116.0,,Tmax in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5610,,
CHEMBL621123,50597,,,In vivo,A,,8016,10116.0,,Tmax in rat at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6046,,
CHEMBL621124,50597,,,In vivo,A,,8017,10116.0,,Tmax in rat by po administration at a dose of 40 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5874,,
CHEMBL621125,50597,,,,A,,8018,10116.0,,Tmax in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL621126,50597,,,In vivo,A,,8019,10116.0,,Tmax was measured in rats after peroral administration at 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL621127,50597,,,In vivo,A,,8020,10116.0,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL621128,50597,,,In vivo,A,,8021,10116.0,,Tmax value after administration of 20 mg/Kg oral dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2959,,
CHEMBL618263,50597,,,In vivo,A,,8022,10116.0,,Tmax value at a dose of 10 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL618264,50597,,,In vivo,A,,8023,10116.0,,Tmax value at a dose of 100 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL618265,50597,,,In vivo,A,,8024,10116.0,,Tmax value at a dose of 50 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL618266,50597,,Plasma,In vivo,A,,8025,10116.0,1969.0,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4186,,
CHEMBL618267,50597,,,In vivo,A,,8026,10116.0,,time required to reach maximum concentration (Cmax) after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL618450,50597,,Urine,,A,,8027,10116.0,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL618451,50597,,Urine,,A,,8028,10116.0,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL618452,50597,,,,A,,8029,10116.0,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5546,,
CHEMBL618453,50597,,Urine,,A,,8030,10116.0,1088.0,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3173,,
CHEMBL618454,50597,,Urine,,A,,8031,10116.0,1088.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3173,,
CHEMBL618455,50597,,Urine,,A,,8032,10116.0,1088.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3173,,
CHEMBL618456,50597,,,In vivo,A,,8033,10116.0,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4257,,
CHEMBL618457,50597,,,In vivo,A,,8034,10116.0,,Compound distribution in rat tissues was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6011,,
CHEMBL618458,50597,,,In vivo,A,,8035,10116.0,,Volume of distribution was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL618459,50597,,,,A,,8036,10116.0,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL876733,50597,,,,A,,8037,10116.0,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618460,50588,,,,A,,8038,9615.0,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14346,,
CHEMBL618461,50597,,,,A,,8039,10116.0,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618462,22224,,,,A,,8040,,,Area under the curve was determined after oral administration (300 uM/Kg),U,,0,,Autocuration,1,BAO_0000019,,,15469,,
CHEMBL618463,50597,,,,A,,8041,10116.0,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618464,50597,,,,A,,8042,10116.0,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618465,50597,,,,A,,8043,10116.0,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618466,50597,,,,A,,8044,10116.0,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618467,50597,,,,A,,8045,10116.0,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL618468,50597,,,,A,,8046,10116.0,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL618469,50588,,Plasma,,A,,8047,9615.0,1969.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12935,,
CHEMBL618470,50588,,Plasma,,A,,8048,9615.0,1969.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12935,,
CHEMBL618471,22224,,,,A,,8049,,,Plasma drug AUC in rat (PO dose),U,,0,,Autocuration,1,BAO_0000218,,,14813,,
CHEMBL618472,50594,,,,A,,8050,10090.0,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15792,,
CHEMBL618473,22224,,,,A,,8051,,,Area under was determined at a dose of 30 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,3579,,
CHEMBL621699,50506,,,,A,,8052,9669.0,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,12487,,
CHEMBL621700,50597,,,,A,,8053,10116.0,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12487,,
CHEMBL621701,50597,,,,A,,8054,10116.0,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12487,,
CHEMBL621702,50506,,,,A,,8055,9669.0,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,12487,,
CHEMBL621703,50588,,,,A,,8056,9615.0,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12487,,
CHEMBL621704,50588,,,,A,,8057,9615.0,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12487,,
CHEMBL624259,50597,,,,A,,8058,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624260,50597,,,,A,,8059,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624430,50597,,,,A,,8060,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624431,50597,,,,A,,8061,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624432,50597,,,,A,,8062,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624433,50597,,,,A,,8063,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624434,50597,,,,A,,8064,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL624435,50597,,,,A,,8065,10116.0,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL618570,50594,,,,A,,8066,10090.0,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL618571,50594,,,,A,,8067,10090.0,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL618572,50594,,,,A,,8068,10090.0,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL618573,50594,,,,A,,8069,10090.0,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL619267,50594,,,,A,,8070,10090.0,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL619431,50594,,,,A,,8071,10090.0,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL619432,50594,,,,A,,8072,10090.0,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL619433,50594,,,,A,,8073,10090.0,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL619434,22224,,Plasma,,A,,8074,,1969.0,AUC in mice after oral dose (50 mg/kg),U,,0,,Autocuration,1,BAO_0000218,,,13298,,
CHEMBL619435,50594,,Serum,,A,,8075,10090.0,1977.0,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12226,,
CHEMBL619436,22224,,Plasma,,A,,8076,,1969.0,AUC (0-4 hr) ug/ml/h,U,,0,,Autocuration,1,BAO_0000019,,,12634,,
CHEMBL619437,50597,,,,A,,8077,10116.0,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14810,,
CHEMBL619438,22224,,,,A,,8078,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,U,,0,,Autocuration,1,BAO_0000218,,,13889,,
CHEMBL619439,50594,,,,A,,8079,10090.0,,Compound was evaluated for Area under curve in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10018,,
CHEMBL619440,50597,,,,A,,8080,10116.0,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8758,,
CHEMBL619441,22224,,,,F,,8081,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,U,,0,,Autocuration,1,BAO_0000218,,,8758,,
CHEMBL619442,50597,,,,A,,8082,10116.0,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8758,,
CHEMBL875156,22224,,,,A,,8083,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,U,,0,,Autocuration,1,BAO_0000019,,,2249,,
CHEMBL619443,22224,,,,A,,8084,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,U,,0,,Autocuration,1,BAO_0000019,,,2249,,
CHEMBL619444,22224,,,,A,,8085,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,U,,0,,Autocuration,1,BAO_0000019,,,2249,,
CHEMBL623464,22224,,,,A,,8086,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,U,,0,,Autocuration,1,BAO_0000019,,,2249,,
CHEMBL623465,50594,,,,A,,8087,10090.0,,Compound was evaluated for area under curve when administered through oral route in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15115,,
CHEMBL623466,50597,,,In vivo,A,,8088,10116.0,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL623467,50597,,,In vivo,A,,8089,10116.0,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL623468,50597,,,In vivo,A,,8090,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6249,,
CHEMBL622660,50597,,,In vivo,A,,8091,10116.0,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2463,,
CHEMBL622661,50597,,,In vivo,A,,8092,10116.0,,Plasma clearance rate in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4969,,
CHEMBL622662,50597,,,In vivo,F,,8093,10116.0,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL622663,50597,,,In vivo,A,,8094,10116.0,,Pharmacokinetic property (total body clearance) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3457,,
CHEMBL622664,50597,,,In vivo,A,,8095,10116.0,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5983,,
CHEMBL622665,50597,,,,A,,8096,10116.0,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6295,,
CHEMBL622666,50597,,,,A,,8097,10116.0,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6296,,
CHEMBL621615,50597,,,In vivo,A,,8098,10116.0,,Cl in rat i.v. at 2 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL621616,50597,,,In vivo,A,,8099,10116.0,,Clearance of compound after intravenous administration in rats at 24 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL621617,50597,,,In vivo,A,,8100,10116.0,,Clearance was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5503,,
CHEMBL621618,50597,,,In vivo,A,,8101,10116.0,,Clearance by intravenous administration of 3.4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4368,,
CHEMBL621619,50597,,,In vivo,A,,8102,10116.0,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6005,,
CHEMBL621620,50597,,,In vivo,A,,8103,10116.0,,Clearance rate after i.v. administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5031,,
CHEMBL621786,50597,,,In vivo,A,,8104,10116.0,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL621787,50597,,,In vivo,A,,8105,10116.0,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL621788,50597,,,In vivo,A,,8106,10116.0,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5979,,
CHEMBL621789,50597,,,In vivo,A,,8107,10116.0,,Clearance (Cl) after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL621790,50597,,,In vivo,A,,8108,10116.0,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL621791,50597,,Plasma,In vivo,A,,8109,10116.0,1969.0,Compound was tested for plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4839,,
CHEMBL621792,50597,,,In vitro,A,,8110,10116.0,,In vitro microsome metabolism clearance in rat was determined,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL621793,50597,,,In vitro,A,,8111,10116.0,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL621794,50597,,,In vivo,A,,8112,10116.0,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL621795,50597,,Plasma,In vivo,A,,8113,10116.0,1969.0,In vivo plasma clearance was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5496,,
CHEMBL621796,50597,,,In vivo,A,,8114,10116.0,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5739,,
CHEMBL621797,50597,,Liver,In vivo,A,401.0,8115,10116.0,2107.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5676,,Hepatocyte
CHEMBL621798,50597,,,In vivo,A,,8116,10116.0,,Pharmacokinetic property (Plasma clearance) was measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4239,,
CHEMBL621799,50597,,,In vivo,A,,8117,10116.0,,Pharmacokinetic property (clearance) in rat i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5676,,
CHEMBL621800,50597,,,In vivo,A,,8118,10116.0,,"Plasma Clearance was evaluated in rats, iv",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1918,,
CHEMBL621801,50597,,,In vivo,A,,8119,10116.0,,Plasma clearance (in vivo) in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17800,,
CHEMBL621802,50597,,,In vivo,A,,8120,10116.0,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6056,,
CHEMBL618596,50597,,,In vivo,A,,8121,10116.0,,Plasma clearance was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5496,,
CHEMBL618597,50597,,,In vivo,A,,8122,10116.0,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL618598,50597,,,In vivo,A,,8123,10116.0,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL618599,50597,,,In vivo,A,,8124,10116.0,,Plasma clearance in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL618600,50597,,,In vivo,A,,8125,10116.0,,Plasma clearance rate determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL618601,50597,,,In vivo,A,,8126,10116.0,,Plasma clearance was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6011,,
CHEMBL618602,50597,,,In vivo,A,,8127,10116.0,,Plasma clearance was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL618603,50597,,,In vivo,A,,8128,10116.0,,Plasma clearance value in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5948,,
CHEMBL618604,50597,,Liver,Ex vivo,A,,8129,10116.0,2107.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6125,,
CHEMBL618605,50597,,,In vivo,A,,8130,10116.0,,Clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4839,,
CHEMBL618606,50597,,,In vivo,A,,8131,10116.0,,Total body clearance in rat i.v. at 2 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL618607,50597,,,In vivo,A,,8132,10116.0,,Clearance of compound in rats after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6571,,
CHEMBL618608,50597,,,In vivo,A,,8133,10116.0,,Clearance after iv administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3364,,
CHEMBL618609,50597,,,In vivo,A,,8134,10116.0,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618610,50597,,,In vivo,A,,8135,10116.0,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618611,50597,,,In vivo,A,,8136,10116.0,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618612,50597,,,In vivo,A,,8137,10116.0,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618613,50597,,,In vivo,A,,8138,10116.0,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL621076,50597,,,In vivo,A,,8139,10116.0,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL621077,50597,,,In vivo,A,,8140,10116.0,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL621078,50597,,,In vivo,A,,8141,10116.0,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17670,,
CHEMBL621251,50597,,,In vivo,A,,8142,10116.0,,Clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5970,,
CHEMBL621252,50597,,,In vivo,A,,8143,10116.0,,Clearance in rat after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL621253,50597,,,In vivo,A,,8144,10116.0,,Clearance in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4590,,
CHEMBL621254,50597,,,In vivo,A,,8145,10116.0,,Clearance rate following an oral dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6193,,
CHEMBL621255,50597,,,In vivo,A,,8146,10116.0,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2832,,
CHEMBL621256,50597,,Plasma,In vivo,A,,8147,10116.0,1969.0,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1052,,
CHEMBL621257,50597,,Liver,In vivo,A,,8148,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621258,50597,,Liver,In vivo,A,,8149,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621259,50597,,Liver,In vivo,A,,8150,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621260,50597,,Liver,In vivo,A,,8151,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876494,50597,,Liver,In vivo,A,,8152,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621261,50597,,Liver,In vivo,A,,8153,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621262,50597,,Liver,In vivo,A,,8154,10116.0,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621263,50597,,Liver,In vivo,A,,8155,10116.0,2107.0,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621264,50597,,Liver,In vivo,A,,8156,10116.0,2107.0,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621265,50597,,Muscle tissue,In vivo,A,,8157,10116.0,2385.0,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621266,50597,,Muscle tissue,In vivo,A,,8158,10116.0,2385.0,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621267,50597,,Muscle tissue,In vivo,A,,8159,10116.0,2385.0,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621268,50597,,Muscle tissue,In vivo,A,,8160,10116.0,2385.0,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621269,50597,,Muscle tissue,In vivo,A,,8161,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621270,50597,,Muscle tissue,In vivo,A,,8162,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621271,50597,,Muscle tissue,In vivo,A,,8163,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621272,50597,,Muscle tissue,In vivo,A,,8164,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621273,50597,,Muscle tissue,In vivo,A,,8165,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621274,50597,,Muscle tissue,In vivo,A,,8166,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876495,50597,,Muscle tissue,In vivo,A,,8167,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621275,50597,,Muscle tissue,In vivo,A,,8168,10116.0,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621276,50597,,Muscle tissue,In vivo,A,,8169,10116.0,2385.0,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621277,50597,,Muscle tissue,In vivo,A,,8170,10116.0,2385.0,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621278,50597,,Intestine,In vivo,A,,8171,10116.0,160.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621279,50597,,Intestine,In vivo,A,,8172,10116.0,160.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621280,50597,,Intestine,In vivo,A,,8173,10116.0,160.0,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621281,50597,,Spleen,In vivo,A,,8174,10116.0,2106.0,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621282,50597,,Spleen,In vivo,A,,8175,10116.0,2106.0,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621283,50597,,Spleen,In vivo,A,,8176,10116.0,2106.0,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621284,50597,,Spleen,In vivo,A,,8177,10116.0,2106.0,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621285,50597,,Spleen,In vivo,A,,8178,10116.0,2106.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621286,50597,,Spleen,In vivo,A,,8179,10116.0,2106.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL623220,50597,,Spleen,In vivo,A,,8180,10116.0,2106.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL623221,50597,,Spleen,In vivo,A,,8181,10116.0,2106.0,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL876029,50597,,Spleen,In vivo,A,,8182,10116.0,2106.0,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL623222,50597,,Stomach,In vivo,A,,8183,10116.0,945.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL623223,50597,,Stomach,In vivo,A,,8184,10116.0,945.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621445,50597,,Stomach,In vivo,A,,8185,10116.0,945.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9866,,
CHEMBL621446,50597,,Blood,In vivo,A,,8186,10116.0,178.0,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621447,50597,,Blood,In vivo,A,,8187,10116.0,178.0,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619681,50597,,Blood,In vivo,A,,8188,10116.0,178.0,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619682,50597,,Blood,In vivo,A,,8189,10116.0,178.0,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619683,50597,,Blood,In vivo,A,,8190,10116.0,178.0,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619684,50597,,Brain,In vivo,A,,8191,10116.0,955.0,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619685,50597,,Brain,In vivo,A,,8192,10116.0,955.0,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619686,50597,,Brain,In vivo,A,,8193,10116.0,955.0,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619687,50597,,Brain,In vivo,A,,8194,10116.0,955.0,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619688,50597,,Brain,In vivo,A,,8195,10116.0,955.0,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619689,50597,,Heart,In vivo,A,,8196,10116.0,948.0,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619690,50597,,Heart,In vivo,A,,8197,10116.0,948.0,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619691,50597,,Heart,In vivo,A,,8198,10116.0,948.0,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619692,50597,,,In vivo,A,,8199,10116.0,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6062,,
CHEMBL619693,50597,,,,A,,8200,10116.0,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL619694,50597,,,In vivo,A,,8201,10116.0,,Vc value after IV dose at a dose of 5 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL619695,50597,,,In vivo,A,,8202,10116.0,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL619696,50597,,,In vivo,A,,8203,10116.0,,Compound was evaluated for pharmacokinetic parameter volume of distribution,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4891,,
CHEMBL619697,50597,,,In vivo,A,,8204,10116.0,,Compound was evaluated for volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,740,,
CHEMBL619698,50597,,,In vivo,A,,8205,10116.0,,Steady state volume distribution was determined; steady state(ss),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL619699,50597,,,In vivo,A,,8206,10116.0,,Steady state volume of distribution after iv administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3364,,
CHEMBL619700,50597,,,In vivo,A,,8207,10116.0,,Steady state volume of distribution dosing at 3 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2552,,
CHEMBL619701,50597,,,In vivo,A,,8208,10116.0,,The compound was evaluated for volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,406,,
CHEMBL619702,50597,,,In vivo,A,,8209,10116.0,,The compound was tested for volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12500,,
CHEMBL620335,50597,,,In vivo,A,,8210,10116.0,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12500,,
CHEMBL620336,50597,,,In vivo,A,,8211,10116.0,,Volume distribution (VD) after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL620337,50597,,,In vivo,A,,8212,10116.0,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17671,,
CHEMBL620520,50597,,,In vivo,A,,8213,10116.0,,Volume distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1094,,
CHEMBL620521,50597,,,In vivo,A,,8214,10116.0,,Volume distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5833,,
CHEMBL875825,50597,,,In vivo,A,,8215,10116.0,,Volume distribution in rat after peroral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL620522,50597,,,In vivo,A,,8216,10116.0,,Volume distribution in rat after peroral administration at 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL620523,50597,,,In vivo,A,,8217,10116.0,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6005,,
CHEMBL620524,50597,,,In vivo,A,,8218,10116.0,,Volume of distribution in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1696,,
CHEMBL620525,50597,,,In vivo,A,,8219,10116.0,,Volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6672,,
CHEMBL620526,50597,,,In vivo,A,,8220,10116.0,,Volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6673,,
CHEMBL620527,50597,,,In vivo,A,,8221,10116.0,,Volume of distribution in rat by iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5871,,
CHEMBL620528,50597,,,In vivo,A,,8222,10116.0,,Volume of distribution in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6803,,
CHEMBL620529,50597,,,In vivo,A,,8223,10116.0,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL620530,50597,,,,A,,8224,10116.0,,Volume distribution at the dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL620531,50597,,,In vivo,A,,8225,10116.0,,Steady state volume of distribution was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL620532,22224,,,In vivo,A,,8226,9544.0,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,,0,,Intermediate,1,BAO_0000218,,Macaca mulatta,5005,,
CHEMBL620533,22224,,,In vivo,A,,8227,10116.0,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5005,,
CHEMBL620534,22224,,,In vivo,A,,8228,10116.0,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5005,,
CHEMBL620535,50597,,,In vivo,A,,8229,10116.0,,Mean (%CV) PK parameters for Vdss(mL/kg).,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL875826,50597,,,In vivo,A,,8230,10116.0,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL620536,50597,,,In vivo,A,,8231,10116.0,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL620537,50597,,,In vivo,A,,8232,10116.0,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL618526,50597,,,In vivo,A,,8233,10116.0,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL618527,50597,,,In vivo,A,,8234,10116.0,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5739,,
CHEMBL618528,50597,,,In vivo,A,,8235,10116.0,,Pharmacokinetic property (Vdss) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5789,,
CHEMBL618529,50597,,,In vivo,A,,8236,10116.0,,Pharmacokinetic property (vdss) was measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4239,,
CHEMBL618530,50597,,,In vivo,A,,8237,10116.0,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4709,,
CHEMBL618531,50597,,,In vivo,A,,8238,10116.0,,Volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6642,,
CHEMBL618532,50597,,,In vivo,A,,8239,10116.0,,The pharmacokinetic parameter volume of distribution in vivo in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5247,,
CHEMBL618533,50597,,,In vivo,F,,8240,10116.0,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL618534,50597,,,In vivo,A,,8241,10116.0,,Vdss in rat i.v. at 2 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL618535,50597,,,In vivo,A,,8242,10116.0,,Volume distribution after intravenous administration (1 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL618536,50597,,,In vivo,A,,8243,10116.0,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL618537,50597,,,In vivo,A,,8244,10116.0,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL618538,50597,,,In vivo,A,,8245,10116.0,,Volume distribution at a dose of 10 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL618539,50597,,,In vivo,A,,8246,10116.0,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4521,,
CHEMBL618540,50597,,,In vivo,A,,8247,10116.0,,Volume distribution was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL618541,50597,,,In vivo,A,,8248,10116.0,,Volume distribution was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL618542,50597,,,In vivo,A,,8249,10116.0,,Volume of distribution after intravenous administration was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2938,,
CHEMBL622544,50597,,,In vivo,A,,8250,10116.0,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6679,,
CHEMBL622545,50597,,,In vivo,A,,8251,10116.0,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622546,50597,,,In vivo,A,,8252,10116.0,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622547,50597,,,In vivo,A,,8253,10116.0,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622548,50597,,,In vivo,A,,8254,10116.0,,Volume of distribution in steady state was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5145,,
CHEMBL622549,50597,,,In vivo,A,,8255,10116.0,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6467,,
CHEMBL622550,50597,,,In vivo,A,,8256,10116.0,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6467,,
CHEMBL622551,50594,,,,A,,8257,10090.0,,Compound was evaluated for area under curve when administered through oral route to mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15115,,
CHEMBL622552,50597,,,,A,,8258,10116.0,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8758,,
CHEMBL622553,50597,,,,A,,8259,10116.0,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8758,,
CHEMBL622554,22224,,,In vivo,F,,8260,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,U,,0,,Autocuration,1,BAO_0000218,,,8267,,
CHEMBL622555,50588,,,,A,,8261,9615.0,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8267,,
CHEMBL622556,50594,,,,A,,8262,10090.0,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14239,,
CHEMBL622557,50594,,,,A,,8263,10090.0,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14239,,
CHEMBL622558,50594,,Blood,,A,,8264,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL622559,50594,,Blood,,A,,8265,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL622560,50588,,,,A,,8266,9615.0,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,10754,,
CHEMBL622561,50597,,,,A,,8267,10116.0,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14681,,
CHEMBL622562,50597,,,,A,,8268,10116.0,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14681,,
CHEMBL622563,50597,,,,A,,8269,10116.0,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14681,,
CHEMBL622564,22224,,,,A,,8270,,,Concentration of compound in Central nervous system,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622565,22224,,,,A,,8271,,,Concentration of compound in Central nervous system; Not detectable,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622566,50594,,,,A,,8272,10090.0,,"Concentration of diester in the blood, following oral administration in mice",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13318,,
CHEMBL624515,50594,,,,A,,8273,10090.0,,"Concentration of monoester in the blood, following oral administration in mice",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13318,,
CHEMBL624516,50594,,,,A,,8274,10090.0,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13318,,
CHEMBL624517,22224,,,,A,,8275,,,Evaluated for Pharmacokinetic property: Area under the curve,U,,0,,Autocuration,1,BAO_0000019,,,15692,,
CHEMBL624518,50594,,,,A,,8276,10090.0,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL624519,100710,,,,A,,8277,9541.0,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624520,100710,,,,A,,8278,9541.0,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624521,100710,,,,A,,8279,9541.0,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624522,100710,,,,A,,8280,9541.0,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624523,100710,,,,A,,8281,9541.0,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624409,100710,,,,A,,8282,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624410,100710,,,,A,,8283,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL624411,100710,,,,A,,8284,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL623531,100710,,,,A,,8285,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL623532,100710,,,,A,,8286,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL623533,100710,,,,A,,8287,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL623534,100710,,,,A,,8288,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL623535,50594,,,,A,,8289,10090.0,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623536,50594,,,,A,,8290,10090.0,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623537,50594,,,,A,,8291,10090.0,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623538,50594,,,,A,,8292,10090.0,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623539,50594,,,,A,,8293,10090.0,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623540,50594,,,,A,,8294,10090.0,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623541,50594,,,,A,,8295,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623542,50594,,,,A,,8296,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623543,50594,,,,A,,8297,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623544,50594,,,,A,,8298,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623545,50594,,,,A,,8299,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623546,50594,,,,A,,8300,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623547,50597,,Plasma,In vivo,A,,8301,10116.0,1969.0,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL623548,50597,,,In vivo,A,,8302,10116.0,,High i.v. clearance in Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6827,,
CHEMBL623549,50597,,Liver,In vitro,A,,8303,10116.0,2107.0,In vitro clearance in rat liver microsomes,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL623550,50597,,Liver,In vitro,A,,8304,10116.0,2107.0,Intrinsic clearance in rat liver microsomes was determined,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6331,,
CHEMBL875276,50597,,Liver,In vitro,A,401.0,8305,10116.0,2107.0,Intrinsic clearance in rat hepatocytes was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5948,,Hepatocyte
CHEMBL621872,50597,,,In vivo,A,,8306,10116.0,,Plasma Clearance was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL621873,50597,,,In vivo,A,,8307,10116.0,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6647,,
CHEMBL621874,50597,,,In vivo,A,,8308,10116.0,,Plasma clearance in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1696,,
CHEMBL621875,50597,,,In vivo,A,,8309,10116.0,,Plasma clearance in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL621876,50597,,,In vivo,A,,8310,10116.0,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,347,,
CHEMBL621877,50597,,,In vivo,A,,8311,10116.0,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL621878,50597,,,In vivo,A,,8312,10116.0,,Plasma clearance was measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL621879,50597,,,In vivo,A,,8313,10116.0,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL621880,50597,,Plasma,In vivo,A,,8314,10116.0,1969.0,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5328,,
CHEMBL621881,50597,,,In vivo,A,,8315,10116.0,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5160,,
CHEMBL621882,50597,,,In vivo,A,,8316,10116.0,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL875283,50597,,,In vivo,A,,8317,10116.0,,Total clearance at 1 mg/kg was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL621883,50597,,,In vivo,A,,8318,10116.0,,Total clearance at 10 mg/kg was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL621884,50597,,,In vivo,A,,8319,10116.0,,Clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6596,,
CHEMBL621885,50597,,,In vivo,A,,8320,10116.0,,Plasma clearance rate determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4796,,
CHEMBL621886,50597,,,In vivo,A,,8321,10116.0,,Clearance of compound in rat was evaluated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6850,,
CHEMBL621887,50597,,Plasma,In vivo,A,,8322,10116.0,1969.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5932,,
CHEMBL621888,50597,,,In vivo,A,,8323,10116.0,,Pharmacokinetic property (blood clearance) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3371,,
CHEMBL621889,50597,,,In vivo,A,,8324,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2083,,
CHEMBL621890,50597,,,In vivo,A,,8325,10116.0,,Plasma clearance in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4942,,
CHEMBL621891,50597,,Liver,In vitro,A,,8326,10116.0,2107.0,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6838,,
CHEMBL621892,50597,,,In vivo,A,,8327,10116.0,,Clearance in Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5353,,
CHEMBL621893,50597,,,In vivo,A,,8328,10116.0,,Clearance rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL621894,50597,,,In vivo,A,,8329,10116.0,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL621895,50597,,,In vivo,A,,8330,10116.0,,Clearance rat; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL875284,50597,,,In vivo,A,,8331,10116.0,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL618699,50597,,,In vivo,A,,8332,10116.0,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL618700,50597,,,In vivo,A,,8333,10116.0,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL618701,50597,,,In vivo,A,,8334,10116.0,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6211,,
CHEMBL876600,50597,,Plasma,In vivo,A,,8335,10116.0,1969.0,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL618702,50597,,,In vivo,A,,8336,10116.0,,Clearance of compound in rat after 1 mg/kg i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL618703,50597,,,In vivo,A,,8337,10116.0,,Compound was evaluated for Hepatic clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3341,,
CHEMBL618704,50597,,,In vivo,A,,8338,10116.0,,In vivo clearance after 5 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4891,,
CHEMBL618705,50597,,Plasma,In vivo,A,,8339,10116.0,1969.0,Compound was tested for plasma clearance in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1094,,
CHEMBL618706,50597,,,In vivo,A,,8340,10116.0,,Hepatic clearance after intravenous administration was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2938,,
CHEMBL618707,50597,,,In vivo,A,,8341,10116.0,,Lower clearance in rat (i.v.) at 0.5 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17853,,
CHEMBL618708,50597,,Plasma,In vivo,A,,8342,10116.0,1969.0,Pharmacokinetic parameter expressed as plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6049,,
CHEMBL618709,50597,,,In vivo,A,,8343,10116.0,,Pharmacokinetic property (Clp) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5789,,
CHEMBL618710,50597,,,In vivo,A,,8344,10116.0,,Plasma clearance in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL618711,50597,,,In vivo,A,,8345,10116.0,,Plasma clearance (Clp) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6448,,
CHEMBL618712,50597,,,In vivo,A,,8346,10116.0,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6062,,
CHEMBL618713,50597,,,In vivo,A,,8347,10116.0,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5710,,
CHEMBL618714,50597,,,In vivo,A,,8348,10116.0,,Plasma clearance after intravenous administration of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4709,,
CHEMBL618715,50597,,,In vivo,A,,8349,10116.0,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4521,,
CHEMBL618716,50597,,,In vivo,A,,8350,10116.0,,Plasma clearance in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1742,,
CHEMBL876601,50597,,,In vivo,A,,8351,10116.0,,Plasma clearance measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL618717,50597,,,In vivo,A,,8352,10116.0,,Plasma clearance was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL618718,50597,,,In vivo,A,,8353,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5145,,
CHEMBL618719,50597,,,In vivo,A,,8354,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5833,,
CHEMBL618720,50597,,,In vivo,A,,8355,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6453,,
CHEMBL618721,50597,,,In vivo,A,,8356,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL621477,50597,,,In vivo,A,,8357,10116.0,,Plasma clearance in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6305,,
CHEMBL621478,50597,,,In vivo,A,,8358,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6642,,
CHEMBL621479,50597,,,In vivo,A,,8359,10116.0,,Plasma clearance was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL621480,50597,,,In vivo,A,,8360,10116.0,,Plasma clearance was evaluated in rat; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL621481,50597,,,In vivo,A,,8361,10116.0,,Plasma clearance rate was determined for the compound in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5144,,
CHEMBL621482,50597,,,In vivo,A,,8362,10116.0,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL621483,50597,,,In vivo,A,,8363,10116.0,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL621484,50597,,,In vivo,A,,8364,10116.0,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL621485,50597,,Heart,In vivo,A,,8365,10116.0,948.0,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621486,50597,,Heart,In vivo,A,,8366,10116.0,948.0,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621487,50597,,Intestine,In vivo,A,,8367,10116.0,160.0,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621488,50597,,Intestine,In vivo,A,,8368,10116.0,160.0,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621489,50597,,Intestine,In vivo,A,,8369,10116.0,160.0,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621490,50597,,Intestine,In vivo,A,,8370,10116.0,160.0,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621491,50597,,Intestine,In vivo,A,,8371,10116.0,160.0,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621492,50597,,Kidney,In vivo,A,,8372,10116.0,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621493,50597,,Kidney,In vivo,A,,8373,10116.0,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621494,50597,,Kidney,In vivo,A,,8374,10116.0,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621495,50597,,Kidney,In vivo,A,,8375,10116.0,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621496,50597,,Kidney,In vivo,A,,8376,10116.0,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621497,50597,,Liver,In vivo,A,,8377,10116.0,2107.0,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621498,50597,,Liver,In vivo,A,,8378,10116.0,2107.0,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621499,50597,,Liver,In vivo,A,,8379,10116.0,2107.0,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL618634,50597,,Liver,In vivo,A,,8380,10116.0,2107.0,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL618635,50597,,Liver,In vivo,A,,8381,10116.0,2107.0,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL618636,50597,,Lung,In vivo,A,,8382,10116.0,2048.0,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619737,50597,,Lung,In vivo,A,,8383,10116.0,2048.0,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL619738,50597,,Lung,In vivo,A,,8384,10116.0,2048.0,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624329,50597,,Lung,In vivo,A,,8385,10116.0,2048.0,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624330,50597,,Lung,In vivo,A,,8386,10116.0,2048.0,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624331,50597,,Muscle tissue,In vivo,A,,8387,10116.0,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624332,50597,,Muscle tissue,In vivo,A,,8388,10116.0,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624333,50597,,Muscle tissue,In vivo,A,,8389,10116.0,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624334,50597,,Muscle tissue,In vivo,A,,8390,10116.0,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL624335,50597,,Muscle tissue,In vivo,A,,8391,10116.0,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620016,50597,,Spleen,In vivo,A,,8392,10116.0,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620169,50597,,Spleen,In vivo,A,,8393,10116.0,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620170,50597,,Spleen,In vivo,A,,8394,10116.0,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620171,50597,,Spleen,In vivo,A,,8395,10116.0,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620172,50597,,Spleen,In vivo,A,,8396,10116.0,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620173,50597,,Stomach,In vivo,A,,8397,10116.0,945.0,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620174,50597,,Stomach,In vivo,A,,8398,10116.0,945.0,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620175,50597,,Stomach,In vivo,A,,8399,10116.0,945.0,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620176,50597,,Stomach,In vivo,A,,8400,10116.0,945.0,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620177,50597,,Stomach,In vivo,A,,8401,10116.0,945.0,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620178,50597,,Cerebellum,,A,,8402,10116.0,2037.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620179,50597,,Cerebellum,,A,,8403,10116.0,2037.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620180,50597,,,,A,,8404,10116.0,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620181,50597,,,In vivo,A,,8405,10116.0,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL620182,50597,,,In vivo,A,,8406,10116.0,,Volume of distribution of compound in rats after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6571,,
CHEMBL620183,50597,,,In vivo,A,,8407,10116.0,,Volume of distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6453,,
CHEMBL620184,50597,,,In vivo,A,,8408,10116.0,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL620185,50597,,,In vivo,A,,8409,10116.0,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL620186,50597,,,In vivo,A,,8410,10116.0,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL620187,50597,,,In vivo,A,,8411,10116.0,,Volume of distribution was determined in Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5353,,
CHEMBL620188,50597,,,In vivo,A,,8412,10116.0,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL620189,50597,,,In vivo,A,,8413,10116.0,,Volume of distribution was reported in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL620190,50597,,,In vivo,A,,8414,10116.0,,Volumes of distribution in rat after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL620191,50597,,,In vivo,A,,8415,10116.0,,Volumes of distribution in rat after po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL620192,50597,,,In vivo,A,,8416,10116.0,,Volumes of distribution in rat after po administration; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL620193,50597,,,In vivo,A,,8417,10116.0,,Pharmacokinetic property (Volume) in rat i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5676,,
CHEMBL620194,50597,,,In vivo,A,,8418,10116.0,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL876730,50597,,,In vivo,A,,8419,10116.0,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17670,,
CHEMBL620195,50597,,,In vivo,A,,8420,10116.0,,Volume distribution in rat after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL620196,50597,,,In vivo,A,,8421,10116.0,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL620197,50597,,,In vivo,A,,8422,10116.0,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL620198,50597,,,In vivo,A,,8423,10116.0,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6647,,
CHEMBL620199,50597,,,In vivo,A,,8424,10116.0,,Volume of distribution in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL620200,50597,,,In vivo,A,,8425,10116.0,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL620201,50597,,,In vivo,A,,8426,10116.0,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL620202,50597,,,In vivo,A,,8427,10116.0,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL620203,50597,,,In vivo,A,,8428,10116.0,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL620204,50597,,,In vivo,A,,8429,10116.0,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL620205,50597,,,In vivo,A,,8430,10116.0,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624664,50597,,,In vivo,A,,8431,10116.0,,Pharmacokinetic parameter (Vss) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5960,,
CHEMBL624665,50597,,,In vivo,A,,8432,10116.0,,Pharmacokinetic property (Volume) in rat i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5676,,
CHEMBL624666,50597,,,,A,,8433,10116.0,,Pharmacokinetic property (Vss) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5948,,
CHEMBL624667,50597,,,In vivo,A,,8434,10116.0,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5979,,
CHEMBL624668,50597,,,In vivo,A,,8435,10116.0,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL624669,50597,,,In vivo,A,,8436,10116.0,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL624670,50597,,,In vivo,A,,8437,10116.0,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL624671,50597,,,In vivo,A,,8438,10116.0,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL624672,50597,,,In vivo,A,,8439,10116.0,,Steady state volume distribution in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6448,,
CHEMBL624673,50597,,Plasma,In vivo,A,,8440,10116.0,1969.0,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL624674,50597,,,In vivo,A,,8441,10116.0,,Steady state volume of distribution determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL624675,50597,,,In vivo,A,,8442,10116.0,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL621728,50597,,,In vivo,A,,8443,10116.0,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL621729,50597,,,,A,,8444,10116.0,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL621730,50597,,,,A,,8445,10116.0,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL621731,50597,,,In vivo,A,,8446,10116.0,,Volume distribution in rat after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL621732,50597,,,In vivo,A,,8447,10116.0,,Volume distribution in rat after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL621908,50597,,,In vivo,A,,8448,10116.0,,Volume in steady state distribution value was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL875347,50597,,,In vivo,A,,8449,10116.0,,Volume in steady state distribution value was determined; ND denotes no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL621909,50597,,,In vivo,A,,8450,10116.0,,Volume in steady state distribution value was determined; ND denotes not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL621910,50597,,,In vivo,A,,8451,10116.0,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17065,,
CHEMBL621911,50597,,,In vivo,A,,8452,10116.0,,Volume of distribution at steady state was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL621912,50597,,,In vivo,A,,8453,10116.0,,Volume of distribution at steady state was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL621913,50597,,,In vivo,A,,8454,10116.0,,Volume of distribution in steady state was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6485,,
CHEMBL621914,50597,,,In vivo,A,,8455,10116.0,,Volume of distribution in steady state was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL621915,50597,,,In vivo,A,,8456,10116.0,,Volume of distribution after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6616,,
CHEMBL621916,50597,,,In vivo,A,,8457,10116.0,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL621917,50594,,Liver,In vivo,A,,8458,10090.0,2107.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL621918,50594,,Liver,In vivo,A,,8459,10090.0,2107.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL621919,50594,,Spleen,In vivo,A,,8460,10090.0,2106.0,Biodistribution of compound (oxidized form) in spleen tissue,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL621920,50594,,Spleen,In vivo,A,,8461,10090.0,2106.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL621921,50594,,Spleen,In vivo,A,,8462,10090.0,2106.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622401,50594,,Spleen,In vivo,A,,8463,10090.0,2106.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL875348,50594,,Spleen,In vivo,A,,8464,10090.0,2106.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622402,50594,,Spleen,In vivo,A,,8465,10090.0,2106.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622403,50594,,Blood,In vivo,A,,8466,10090.0,178.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622404,50594,,Blood,In vivo,A,,8467,10090.0,178.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622405,50594,,Brain,In vivo,A,,8468,10090.0,955.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622406,50594,,Brain,In vivo,A,,8469,10090.0,955.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622407,50594,,Brain,In vivo,A,,8470,10090.0,955.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622408,50594,,Heart,In vivo,A,,8471,10090.0,948.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622409,50594,,Heart,In vivo,A,,8472,10090.0,948.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622410,50594,,Heart,In vivo,A,,8473,10090.0,948.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL622411,50594,,Kidney,In vivo,A,,8474,10090.0,2113.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627864,50594,,Kidney,In vivo,A,,8475,10090.0,2113.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627865,50594,,Kidney,In vivo,A,,8476,10090.0,2113.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627866,50594,,Liver,In vivo,A,,8477,10090.0,2107.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627751,50594,,Liver,In vivo,A,,8478,10090.0,2107.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627752,50594,,Spleen,In vivo,A,,8479,10090.0,2106.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627753,50594,,Spleen,In vivo,A,,8480,10090.0,2106.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627754,50594,,Spleen,In vivo,A,,8481,10090.0,2106.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16438,,
CHEMBL627755,50594,,,,A,,8482,10090.0,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12467,,
CHEMBL627756,50594,,Brain,In vivo,A,,8483,10090.0,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627757,50594,,Brain,In vivo,A,,8484,10090.0,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627758,50594,,Brain,In vivo,A,,8485,10090.0,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627759,50594,,Brain,In vivo,A,,8486,10090.0,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627760,50594,,Brain,In vivo,A,,8487,10090.0,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627761,50594,,Brain,In vivo,A,,8488,10090.0,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL876811,50594,,Heart,In vivo,A,,8489,10090.0,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627762,50594,,Heart,In vivo,A,,8490,10090.0,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627763,50594,,Heart,In vivo,A,,8491,10090.0,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627764,50594,,Heart,In vivo,A,,8492,10090.0,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627765,50594,,Heart,In vivo,A,,8493,10090.0,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627766,50594,,Heart,In vivo,A,,8494,10090.0,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627767,50594,,Kidney,In vivo,A,,8495,10090.0,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627768,50594,,Kidney,In vivo,A,,8496,10090.0,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL628422,50594,,Kidney,In vivo,A,,8497,10090.0,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL628423,50594,,Kidney,In vivo,A,,8498,10090.0,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL628424,50597,,,In vivo,A,,8499,10116.0,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5089,,
CHEMBL628425,50597,,,In vivo,A,,8500,10116.0,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5089,,
CHEMBL628426,50597,,,In vivo,A,,8501,10116.0,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4257,,
CHEMBL628427,50597,,,In vivo,A,,8502,10116.0,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6679,,
CHEMBL626938,50597,,,In vivo,A,,8503,10116.0,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5546,,
CHEMBL626939,50597,,,In vivo,A,,8504,10116.0,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6141,,
CHEMBL626940,50597,,,In vivo,A,,8505,10116.0,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL626941,50597,,,In vivo,A,,8506,10116.0,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL626942,50597,,,In vivo,A,,8507,10116.0,,Plasma clearance was reported in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL876812,50597,,,In vivo,A,,8508,10116.0,,Plasma clearance after intravenous administration (1 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL626943,50597,,,In vivo,A,,8509,10116.0,,Plasma clearance of compound in rats was evaluated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6848,,
CHEMBL626944,50597,,,In vivo,A,,8510,10116.0,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6848,,
CHEMBL626945,50597,,,In vivo,A,,8511,10116.0,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6467,,
CHEMBL626946,50597,,,In vivo,A,,8512,10116.0,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6467,,
CHEMBL626856,50597,,,In vivo,A,,8513,10116.0,,Plasma clearance rate in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4956,,
CHEMBL626857,50597,,,In vivo,A,,8514,10116.0,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5529,,
CHEMBL626858,50597,,Plasma,In vivo,A,,8515,10116.0,1969.0,The compound was evaluated for plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,406,,
CHEMBL627018,50597,,Plasma,In vivo,A,,8516,10116.0,1969.0,Total plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL625331,50597,,Blood,In vivo,A,,8517,10116.0,178.0,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3293,,
CHEMBL625332,50597,,Blood,In vivo,A,,8518,10116.0,178.0,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4075,,
CHEMBL877590,50597,,,In vivo,A,,8519,10116.0,,C max was determined at 10 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL625333,50597,,,In vivo,A,,8520,10116.0,,C max was determined at 3 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL625334,50597,,,In vivo,A,,8521,10116.0,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL625335,50597,,,In vivo,A,,8522,10116.0,,Cmax after single intravenous bolus of 1 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL625336,50597,,,In vivo,A,,8523,10116.0,,Cmax of compound at 5 mg/kg after po administration was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4762,,
CHEMBL625337,50597,,,In vivo,A,,8524,10116.0,,Cmax 24 hr after 10 mg/kg oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL625338,50597,,,In vivo,A,,8525,10116.0,,Cmax 24 hr after 2 mg/kg oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL625339,50597,,Plasma,In vivo,A,,8526,10116.0,1969.0,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL625340,50597,,,In vivo,A,,8527,10116.0,,Cmax in rat after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL625341,50597,,,In vivo,A,,8528,10116.0,,Cmax in rat after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL622687,50597,,,In vivo,A,,8529,10116.0,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL622688,50597,,Plasma,In vivo,A,,8530,10116.0,1969.0,Cmax wa determined in rat plasma at 30 mg/kg after po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6515,,
CHEMBL622689,50597,,Blood,In vivo,A,,8531,10116.0,178.0,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11149,,
CHEMBL620295,50597,,Blood,In vivo,A,,8532,10116.0,178.0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11149,,
CHEMBL620296,50597,,,In vivo,A,,8533,10116.0,,Cmax after 10 mg/kg oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17858,,
CHEMBL620297,50597,,,In vivo,A,,8534,10116.0,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL620298,50597,,,In vivo,A,,8535,10116.0,,Cmax after IV dosing at 1 mg/kg in rat; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL620299,50597,,,In vivo,A,,8536,10116.0,,Cmax after oral administration at 20 mpk in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL620300,50597,,,In vivo,A,,8537,10116.0,,Cmax after oral administration at 20 mpk in rats; Not performed.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL620301,50597,,,In vivo,A,,8538,10116.0,,Cmax after oral administration at 20 mpk in rats d; Not performed.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL620302,50597,,,In vivo,A,,8539,10116.0,,Cmax after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL620303,50597,,,In vivo,A,,8540,10116.0,,Cmax after oral administration at a dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL620304,50597,,,In vivo,A,,8541,10116.0,,Cmax after oral administration at a dose of 4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL620305,50597,,,In vivo,A,,8542,10116.0,,Cmax in rats after 20 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6113,,
CHEMBL620306,50597,,,In vivo,A,,8543,10116.0,,Cmax after peroral administration in rats at 2.4 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL620307,50597,,,In vivo,A,,8544,10116.0,,Cmax at the dose of 2 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL620308,50597,,,In vivo,A,,8545,10116.0,,Cmax at the dose of 5 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL620309,50597,,,In vivo,A,,8546,10116.0,,Cmax by administering at 20 mg/kg p.o. in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6402,,
CHEMBL620310,50597,,,In vivo,A,,8547,10116.0,,Cmax in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5610,,
CHEMBL620311,50597,,,In vivo,A,,8548,10116.0,,Cmax in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5207,,
CHEMBL620312,50597,,,In vivo,A,,8549,10116.0,,Cmax in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6011,,
CHEMBL620313,50597,,,In vivo,A,,8550,10116.0,,Cmax in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6504,,
CHEMBL620314,50597,,,In vivo,A,,8551,10116.0,,Cmax in rat at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6046,,
CHEMBL620315,50597,,,In vivo,A,,8552,10116.0,,Cmax in rat at the dose of 1 mg/kg i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6504,,
CHEMBL620316,50597,,,In vivo,A,,8553,10116.0,,Cmax in rat by po administration at a dose of 40 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5874,,
CHEMBL620317,50597,,,In vivo,A,,8554,10116.0,,Cmax in rat p.o. at 20 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL620318,50597,,,In vivo,A,,8555,10116.0,,Cmax in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5836,,
CHEMBL620319,50597,,,In vivo,A,,8556,10116.0,,Cmax in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL620320,50597,,,In vivo,A,,8557,10116.0,,Cmax was evaluated after 20 uM/kg of peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL620321,50597,,,In vivo,A,,8558,10116.0,,Cmax was measured in rats after peroral administration at 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL620322,50597,,,In vivo,A,,8559,10116.0,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL620323,50597,,,,A,,8560,10116.0,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620324,50597,,Frontal cortex,,A,,8561,10116.0,1870.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620325,50597,,Frontal cortex,,A,,8562,10116.0,1870.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620326,50597,,Hippocampus,,A,,8563,10116.0,10000000.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620327,50597,,Hippocampus,,A,,8564,10116.0,10000000.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620328,50597,,,,A,,8565,10116.0,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620329,50597,,,,A,,8566,10116.0,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620330,50597,,Midbrain,,A,,8567,10116.0,1891.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL875286,50597,,Midbrain,,A,,8568,10116.0,1891.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620331,50597,,,,A,,8569,10116.0,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620332,50597,,,,A,,8570,10116.0,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620333,50597,,Striatum,,A,,8571,10116.0,2435.0,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL620334,50597,,Striatum,,A,,8572,10116.0,2435.0,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13950,,
CHEMBL621015,50597,,Blood,,A,,8573,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621016,50597,,Blood,,A,,8574,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621191,50597,,Blood,,A,,8575,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621192,50597,,Blood,,A,,8576,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621193,50597,,Blood,,A,,8577,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621194,50597,,Blood,,A,,8578,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624204,50597,,Blood,,A,,8579,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624205,50597,,Blood,,A,,8580,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624206,50597,,Blood,,A,,8581,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624207,50597,,Blood,,A,,8582,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624208,50597,,Blood,,A,,8583,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624209,50597,,Blood,,A,,8584,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624210,50597,,Blood,,A,,8585,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624211,50597,,Blood,,A,,8586,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624212,50597,,Blood,,A,,8587,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624213,50597,,Blood,,A,,8588,10116.0,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL876611,50597,,Blood,,A,,8589,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624214,50597,,Blood,,A,,8590,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624215,50597,,Blood,,A,,8591,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624216,50597,,Blood,,A,,8592,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624217,50597,,Blood,,A,,8593,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624218,50597,,Blood,,A,,8594,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624219,50597,,Blood,,A,,8595,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624220,50597,,Blood,,A,,8596,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624221,50597,,Blood,,A,,8597,10116.0,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624222,50597,,,,A,,8598,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624223,50597,,,,A,,8599,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624224,50597,,,,A,,8600,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624225,50597,,,,A,,8601,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622420,50597,,,In vivo,A,,8602,10116.0,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL622421,50597,,,In vivo,A,,8603,10116.0,,Volume of steady state distribution after i.v. administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5031,,
CHEMBL622422,50597,,,In vivo,A,,8604,10116.0,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6215,,
CHEMBL622423,50597,,,In vivo,A,,8605,10116.0,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17671,,
CHEMBL622424,50597,,,In vivo,A,,8606,10116.0,,Vss was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL622425,50597,,,In vivo,A,,8607,10116.0,,Vss in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6596,,
CHEMBL876612,50597,,,In vivo,A,,8608,10116.0,,Vss was evaluated after 10 uM/kg of intra arterial administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL622426,50597,,,In vivo,A,,8609,10116.0,,volume of distribution at steady state was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL622427,50597,,,In vivo,A,,8610,10116.0,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6062,,
CHEMBL622428,50597,,,In vivo,A,,8611,10116.0,,Pharmacokinetic (PK) parameter Vz in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5874,,
CHEMBL622429,50597,,,In vivo,A,,8612,10116.0,,Volume distribution in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4942,,
CHEMBL622430,50597,,,In vivo,A,,8613,10116.0,,Volume of distribution in rat; No data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL622431,50597,,,In vivo,A,,8614,10116.0,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL622432,50597,,Ileum,,A,,8615,10116.0,2116.0,% absorption predicted from in vitro rat ileum transport studies,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL622433,50597,,,In vivo,A,,8616,10116.0,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL622434,50597,,,In vivo,A,,8617,10116.0,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL622435,50597,,,In vivo,A,,8618,10116.0,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618748,50597,,,In vivo,A,,8619,10116.0,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618749,50597,,,In vivo,A,,8620,10116.0,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618750,50597,,,In vivo,A,,8621,10116.0,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618751,50597,,,In vivo,A,,8622,10116.0,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618752,50597,,,In vivo,A,,8623,10116.0,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13569,,
CHEMBL618753,50597,,,In vivo,A,,8624,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL618754,50597,,Plasma,In vivo,A,,8625,10116.0,1969.0,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,750,,
CHEMBL618755,50597,,,In vivo,A,,8626,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,750,,
CHEMBL618756,50597,,,In vivo,A,,8627,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4590,,
CHEMBL618757,50597,,,In vivo,A,,8628,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1716,,
CHEMBL618758,50597,,,In vivo,A,,8629,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1974,,
CHEMBL621088,50597,,,In vivo,A,,8630,10116.0,,Oral bioavailability in rat (dose 30 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4502,,
CHEMBL621089,50597,,,,A,,8631,10116.0,,Pharmacokinetic property (cLogP) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3371,,
CHEMBL621090,50597,,Blood,,F,,8632,10116.0,178.0,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9099,,
CHEMBL621091,50597,,Blood,,F,,8633,10116.0,178.0,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9099,,
CHEMBL876731,50597,,,In vivo,A,,8634,10116.0,,Clearance in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4590,,
CHEMBL621092,50597,,,In vivo,A,,8635,10116.0,,Compound was evaluated for its clearance when administered intravenously in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3184,,
CHEMBL621093,50597,,,In vivo,A,,8636,10116.0,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16456,,
CHEMBL621094,50597,,,,A,,8637,10116.0,,Blood: Brain distribution ratio is determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL621095,50597,,,,A,,8638,10116.0,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL621096,50597,,,,A,,8639,10116.0,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL621097,50597,,Kidney,In vivo,A,,8640,10116.0,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL621098,50597,,,,F,,8641,10116.0,,Percent dose excreted in 0-48 hours administered ip to male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL621099,50597,,Cerebellum,,A,,8642,10116.0,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621100,50597,,Cerebellum,,A,,8643,10116.0,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621101,50597,,Cerebellum,,A,,8644,10116.0,2037.0,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621102,50597,,Cerebellum,,A,,8645,10116.0,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL876732,50597,,Cerebellum,,A,,8646,10116.0,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621103,50597,,,,A,,8647,10116.0,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621104,50597,,,,A,,8648,10116.0,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621105,50597,,,,A,,8649,10116.0,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621106,50597,,,,A,,8650,10116.0,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621107,50597,,,,A,,8651,10116.0,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621108,50597,,,,A,,8652,10116.0,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621109,50597,,,,A,,8653,10116.0,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621110,50594,,Kidney,In vivo,A,,8654,10090.0,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL621111,50594,,Kidney,In vivo,A,,8655,10090.0,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL622541,50594,,Liver,In vivo,A,,8656,10090.0,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL622542,50594,,Liver,In vivo,A,,8657,10090.0,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL622543,50594,,Liver,In vivo,A,,8658,10090.0,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624412,50594,,Liver,In vivo,A,,8659,10090.0,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624413,50594,,Liver,In vivo,A,,8660,10090.0,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624414,50594,,Liver,In vivo,A,,8661,10090.0,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624415,50594,,Lung,In vivo,A,,8662,10090.0,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624416,50594,,Lung,In vivo,A,,8663,10090.0,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624417,50594,,Lung,In vivo,A,,8664,10090.0,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624418,50594,,Lung,In vivo,A,,8665,10090.0,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624419,50594,,Lung,In vivo,A,,8666,10090.0,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624420,50594,,Lung,In vivo,A,,8667,10090.0,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624421,50594,,Muscle tissue,In vivo,A,,8668,10090.0,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624422,50594,,Muscle tissue,In vivo,A,,8669,10090.0,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL624423,50594,,Muscle tissue,In vivo,A,,8670,10090.0,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL625123,50594,,Muscle tissue,In vivo,A,,8671,10090.0,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL625124,50594,,Muscle tissue,In vivo,A,,8672,10090.0,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL625125,50594,,Muscle tissue,In vivo,A,,8673,10090.0,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL625126,50594,,Zone of skin,In vivo,A,,8674,10090.0,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626947,50594,,Zone of skin,In vivo,A,,8675,10090.0,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626948,50594,,Zone of skin,In vivo,A,,8676,10090.0,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626949,50594,,Zone of skin,In vivo,A,,8677,10090.0,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626950,50594,,Zone of skin,In vivo,A,,8678,10090.0,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626951,50594,,Zone of skin,In vivo,A,,8679,10090.0,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626952,50594,,Spleen,In vivo,A,,8680,10090.0,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626953,50594,,Spleen,In vivo,A,,8681,10090.0,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626954,50594,,Spleen,In vivo,A,,8682,10090.0,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626955,50594,,Spleen,In vivo,A,,8683,10090.0,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626956,50594,,Spleen,In vivo,A,,8684,10090.0,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626957,50594,,Spleen,In vivo,A,,8685,10090.0,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626958,50594,,Blood,In vivo,A,,8686,10090.0,178.0,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626959,50594,,Blood,In vivo,A,,8687,10090.0,178.0,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626960,50594,,Blood,In vivo,A,,8688,10090.0,178.0,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL626961,50594,,Blood,In vivo,A,,8689,10090.0,178.0,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627589,50594,,Blood,In vivo,A,,8690,10090.0,178.0,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627590,50594,,Blood,In vivo,A,,8691,10090.0,178.0,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17208,,
CHEMBL627591,50594,,,,A,,8692,10090.0,,Time taken for EC90 was determined when tested in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3132,,
CHEMBL627592,50594,,,,A,,8693,10090.0,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3132,,
CHEMBL627593,50594,,,In vivo,A,,8694,10090.0,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,16597,,
CHEMBL627594,50594,,,,A,,8695,10090.0,,Half life in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5727,,
CHEMBL876813,50594,,,In vivo,A,,8696,10090.0,,Half life period in mouse after 10 mg/Kg dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5302,,
CHEMBL627595,50594,,,In vivo,A,,8697,10090.0,,Half life period in mouse after 10 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5302,,
CHEMBL627596,50594,,,In vivo,A,,8698,10090.0,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,6348,,
CHEMBL627597,50597,,,In vivo,A,,8699,10116.0,,Cmax value at 5 mg/kg po was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5964,,
CHEMBL627598,50597,,,In vivo,A,,8700,10116.0,,Cmax value evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL627599,50597,,Brain,In vivo,A,,8701,10116.0,955.0,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5206,,
CHEMBL627600,50597,,,In vivo,A,,8702,10116.0,,Cmax value after administration of 20 mg/Kg oral dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2959,,
CHEMBL627601,50597,,,In vivo,A,,8703,10116.0,,Cmax value at 1 mg/kg po in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5964,,
CHEMBL627776,50597,,,In vivo,A,,8704,10116.0,,Cmax value at 5 mg/kg po in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5964,,
CHEMBL627777,50597,,,In vivo,A,,8705,10116.0,,Cmax value at a dose of 10 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL627778,50597,,,In vivo,A,,8706,10116.0,,Cmax value at a dose of 100 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL627779,50597,,,In vivo,A,,8707,10116.0,,Cmax value at a dose of 50 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL876814,50597,,,In vivo,A,,8708,10116.0,,Cmax value in rats at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17617,,
CHEMBL627780,50597,,,In vivo,A,,8709,10116.0,,Cmax value was evaluated in rats at a dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1445,,
CHEMBL627781,50597,,,In vivo,A,,8710,10116.0,,Cmax value was determined after peroral administration of 20 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6082,,
CHEMBL627782,50597,,,In vivo,A,,8711,10116.0,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1446,,
CHEMBL627783,50597,,Plasma,In vivo,A,,8712,10116.0,1969.0,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5407,,
CHEMBL627784,50597,,Plasma,In vivo,A,,8713,10116.0,1969.0,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2690,,
CHEMBL627785,50597,,,In vivo,A,,8714,10116.0,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL627786,50597,,,In vivo,A,,8715,10116.0,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL627787,50597,,Plasma,In vivo,A,,8716,10116.0,1969.0,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4891,,
CHEMBL627788,50597,,Plasma,In vivo,A,,8717,10116.0,1969.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2807,,
CHEMBL626579,50597,,Plasma,In vivo,A,,8718,10116.0,1969.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2807,,
CHEMBL626580,50597,,Plasma,In vivo,A,,8719,10116.0,1969.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2807,,
CHEMBL876815,50597,,,In vivo,A,,8720,10116.0,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3634,,
CHEMBL626581,50597,,Plasma,In vivo,A,,8721,10116.0,1969.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1881,,
CHEMBL626582,50597,,Plasma,In vivo,A,,8722,10116.0,1969.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1881,,
CHEMBL626583,50597,,,In vivo,A,,8723,10116.0,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL626205,50597,,,In vivo,A,,8724,10116.0,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL626206,50597,,,In vivo,A,,8725,10116.0,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL626207,50597,,,In vivo,A,,8726,10116.0,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL623882,50597,,,In vivo,A,,8727,10116.0,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL623883,50597,,,In vivo,A,,8728,10116.0,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL623884,50597,,,In vivo,A,,8729,10116.0,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL623885,50597,,Plasma,In vivo,A,,8730,10116.0,1969.0,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3032,,
CHEMBL623886,50597,,Plasma,In vivo,A,,8731,10116.0,1969.0,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6295,,
CHEMBL623887,50597,,,In vivo,A,,8732,10116.0,,Maximal concentration in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6619,,
CHEMBL623888,50597,,,In vivo,A,,8733,10116.0,,Maximal concentration after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6616,,
CHEMBL623889,50597,,Plasma,In vivo,A,,8734,10116.0,1969.0,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3249,,
CHEMBL623890,50597,,Plasma,In vivo,A,,8735,10116.0,1969.0,Maximal plasma concentration in rat after oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL623891,50597,,Plasma,In vivo,A,,8736,10116.0,1969.0,Cmax in rat plasma after oral dose (50 mg/Kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL623892,50597,,Plasma,In vivo,A,,8737,10116.0,1969.0,Maximal plasma concentration was determined.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1360,,
CHEMBL623893,50597,,Plasma,In vivo,A,,8738,10116.0,1969.0,Maximal plasma drug concentration was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2552,,
CHEMBL877616,50597,,,In vivo,A,,8739,10116.0,,Maximal concentration in rats after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6571,,
CHEMBL623894,50597,,,In vivo,A,,8740,10116.0,,Maximum concentration in rat after 2 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL623895,50597,,Plasma,In vivo,A,,8741,10116.0,1969.0,Maximum concentration in rat plasma after 5 mg/kg oral gavage,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6567,,
CHEMBL623896,50597,,,In vivo,A,,8742,10116.0,,Maximum concentration of compound in rat was evaluated.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3031,,
CHEMBL623897,50597,,,In vivo,A,,8743,10116.0,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3436,,
CHEMBL623898,50597,,,In vivo,A,,8744,10116.0,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3436,,
CHEMBL623899,50597,,,In vivo,A,,8745,10116.0,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2083,,
CHEMBL623900,50597,,,In vivo,A,,8746,10116.0,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3436,,
CHEMBL623901,50597,,,In vivo,A,,8747,10116.0,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL623902,50597,,,In vivo,A,,8748,10116.0,,Maximum concentration was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1974,,
CHEMBL623903,50597,,Cerebrospinal fluid,In vivo,A,,8749,10116.0,1359.0,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3307,,
CHEMBL623904,50597,,Plasma,In vivo,A,,8750,10116.0,1969.0,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3307,,
CHEMBL877617,50597,,Plasma,In vivo,A,,8751,10116.0,1969.0,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL623905,50597,,,In vivo,A,,8752,10116.0,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1500,,
CHEMBL623906,50597,,,In vivo,A,,8753,10116.0,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1500,,
CHEMBL623907,50597,,Plasma,In vivo,A,,8754,10116.0,1969.0,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4186,,
CHEMBL623908,50597,,,,A,,8755,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623909,50597,,,,A,,8756,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623910,50597,,,,A,,8757,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623911,50597,,,,A,,8758,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623912,50597,,,,A,,8759,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624616,50597,,,,A,,8760,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624617,50597,,,,A,,8761,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624618,50597,,,,A,,8762,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624619,50597,,,,A,,8763,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624794,50597,,,,A,,8764,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624795,50597,,,,A,,8765,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623921,50597,,,,A,,8766,10116.0,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623922,50597,,,,A,,8767,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623923,50597,,,,A,,8768,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623924,50597,,,,A,,8769,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623925,50597,,,,A,,8770,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623926,50597,,,,A,,8771,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623927,50597,,,,A,,8772,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623928,50597,,,,A,,8773,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623929,50597,,,,A,,8774,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623930,50597,,,,A,,8775,10116.0,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623931,50597,,Brain,,A,,8776,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622165,50597,,Brain,,A,,8777,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621249,50597,,Brain,,A,,8778,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621250,50597,,Brain,,A,,8779,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621448,50597,,Brain,,A,,8780,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621449,50597,,Brain,,A,,8781,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621450,50597,,Brain,,A,,8782,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621451,50597,,Brain,,A,,8783,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621452,50597,,Brain,,A,,8784,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621453,50597,,Brain,,A,,8785,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621454,50597,,Brain,,A,,8786,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621455,50597,,Brain,,A,,8787,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621456,50597,,Brain,,A,,8788,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625145,50597,,Brain,,A,,8789,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL875847,50597,,Brain,,A,,8790,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625146,50597,,Brain,,A,,8791,10116.0,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625147,50597,,Brain,,A,,8792,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625148,50597,,Brain,,A,,8793,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625149,50597,,Brain,,A,,8794,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625150,50597,,Brain,,A,,8795,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625151,50597,,Brain,,A,,8796,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625152,50597,,Brain,,A,,8797,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625153,50597,,Brain,,A,,8798,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625154,50597,,Brain,,A,,8799,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625155,50597,,Brain,,A,,8800,10116.0,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625156,50597,,,,A,,8801,10116.0,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624354,50597,,,,A,,8802,10116.0,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624355,50597,,Hippocampus,,A,,8803,10116.0,10000000.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624356,50597,,Hippocampus,,A,,8804,10116.0,10000000.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624357,50597,,Hippocampus,,A,,8805,10116.0,10000000.0,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624358,50597,,Hippocampus,,A,,8806,10116.0,10000000.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624359,50597,,Striatum,,A,,8807,10116.0,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624360,50597,,Striatum,,A,,8808,10116.0,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624361,50597,,Striatum,,A,,8809,10116.0,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624362,50597,,Striatum,,A,,8810,10116.0,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624363,50597,,Striatum,,A,,8811,10116.0,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624364,50597,,Blood,In vivo,A,,8812,10116.0,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624365,50597,,Blood,In vivo,A,,8813,10116.0,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624366,50597,,Blood,In vivo,A,,8814,10116.0,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624367,50597,,Blood,In vivo,A,,8815,10116.0,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624368,50597,,Brain,In vivo,A,,8816,10116.0,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624369,50597,,Brain,In vivo,A,,8817,10116.0,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624370,50597,,Brain,In vivo,A,,8818,10116.0,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625069,50597,,Brain,In vivo,A,,8819,10116.0,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625070,50597,,Brain,In vivo,A,,8820,10116.0,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626051,50597,,Heart,In vivo,A,,8821,10116.0,948.0,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626052,50597,,Heart,In vivo,A,,8822,10116.0,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626053,50597,,Heart,In vivo,A,,8823,10116.0,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626054,50597,,Heart,In vivo,A,,8824,10116.0,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626055,50597,,Heart,In vivo,A,,8825,10116.0,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626056,50597,,Kidney,In vivo,A,,8826,10116.0,2113.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626057,50597,,Kidney,In vivo,A,,8827,10116.0,2113.0,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625193,50597,,Kidney,In vivo,A,,8828,10116.0,2113.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625194,50597,,Kidney,In vivo,A,,8829,10116.0,2113.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625195,50597,,Liver,In vivo,A,,8830,10116.0,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625196,50597,,Liver,In vivo,A,,8831,10116.0,2107.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625197,50597,,Liver,In vivo,A,,8832,10116.0,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625198,50597,,Liver,In vivo,A,,8833,10116.0,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627929,50597,,Liver,In vivo,A,,8834,10116.0,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627074,50597,,Lung,In vivo,A,,8835,10116.0,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627075,50597,,Lung,In vivo,A,,8836,10116.0,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627076,50597,,Lung,In vivo,A,,8837,10116.0,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627077,50597,,Lung,In vivo,A,,8838,10116.0,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627078,50597,,Lung,In vivo,A,,8839,10116.0,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL627079,50597,,Muscle tissue,In vivo,A,,8840,10116.0,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL873824,50594,,,In vivo,A,,8841,10090.0,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,4573,,
CHEMBL627080,50594,,Plasma,In vivo,A,,8842,10090.0,1969.0,Half life in mouse plasma was determined at dose 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3132,,
CHEMBL627081,50594,,,,A,,8843,10090.0,,Half life was determined,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17718,,
CHEMBL627082,50594,,,In vivo,A,,8844,10090.0,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17728,,
CHEMBL627083,50594,,,In vivo,A,,8845,10090.0,,Half-life in male mice after 1 mg/kg intravenous dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5961,,
CHEMBL627085,50594,,Plasma,,A,,8847,10090.0,1969.0,Half life in mice plasma,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17731,,
CHEMBL627086,50594,,,,A,,8848,10090.0,,Half life in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17592,,
CHEMBL627087,50594,,Plasma,In vivo,A,,8849,10090.0,1969.0,Half life in mouse plasma at dose 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3132,,
CHEMBL627088,50594,,,In vivo,A,,8850,10090.0,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17729,,
CHEMBL627089,50594,,,In vivo,A,,8851,10090.0,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17729,,
CHEMBL627090,50594,,,In vivo,A,,8852,10090.0,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17729,,
CHEMBL627091,50594,,,In vivo,A,,8853,10090.0,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3277,,
CHEMBL627092,50594,,,In vivo,A,,8854,10090.0,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3760,,
CHEMBL876785,50594,,,In vivo,A,,8855,10090.0,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,3760,,
CHEMBL627093,50594,,,In vivo,A,,8856,10090.0,,Half-life by iv administration in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,2862,,
CHEMBL627094,50594,,,In vivo,A,,8857,10090.0,,Half-life by oral administration in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,2862,,
CHEMBL627095,50594,,,,A,,8858,10090.0,,Half-life in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5980,,
CHEMBL627096,50594,,Brain,,A,,8859,10090.0,955.0,Half-life using mouse brain homogenate,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,6159,,
CHEMBL627097,50594,,,,A,,8860,10090.0,,Half-life was measured in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,6254,,
CHEMBL627098,50594,,,In vivo,A,,8861,10090.0,,Half-life was measured in mouse after an iv dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,6062,,
CHEMBL627099,50594,,Blood,,A,,8862,10090.0,178.0,Half-life period was determined in mouse blood,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,1574,,
CHEMBL627100,50594,,Brain,,A,,8863,10090.0,955.0,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,56,,
CHEMBL627101,50594,,Plasma,,A,,8864,10090.0,1969.0,Plasma half life in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,993,,
CHEMBL627102,50594,,,,A,,8865,10090.0,,Stability of the peptide in the presence of mouse serum,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,6652,,
CHEMBL627103,50594,,,,A,,8866,10090.0,,Terminal half life of compound was determined in mouse,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17852,,
CHEMBL627104,50594,,,In vivo,A,,8867,10090.0,,Terminal half life was evaluated in mice after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,2675,,
CHEMBL627105,50594,,,In vivo,A,,8868,10090.0,,Terminal half life was evaluated in mice after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,2675,,
CHEMBL876786,50594,,,,A,,8869,10090.0,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,499,,
CHEMBL873825,50594,,,,A,,8870,10090.0,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,499,,
CHEMBL627106,50594,,,,A,,8871,10090.0,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,499,,
CHEMBL626336,50594,,,In vivo,A,,8872,10090.0,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14239,,
CHEMBL877462,50594,,,In vivo,A,,8873,10090.0,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5506,,
CHEMBL626337,50594,,,In vivo,A,,8874,10090.0,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,5506,,
CHEMBL626338,50594,,,,A,,8875,10090.0,,Half life after intraperitoneal administration of 100 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17734,,
CHEMBL626339,50594,,,In vivo,A,,8876,10090.0,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17728,,
CHEMBL626340,50594,,,In vivo,A,,8877,10090.0,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17728,,
CHEMBL625377,50594,,,In vivo,A,,8878,10090.0,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17728,,
CHEMBL625378,50594,,,In vivo,A,,8879,10090.0,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17728,,
CHEMBL625379,50594,,,In vivo,A,,8880,10090.0,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,17728,,
CHEMBL625380,22224,,,,A,,8881,9823.0,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),U,Microsomes,0,,Autocuration,1,BAO_0000251,,Sus scrofa,14294,,
CHEMBL625381,22224,,,,A,,8882,9823.0,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),U,Microsomes,0,,Autocuration,1,BAO_0000251,,Sus scrofa,14294,,
CHEMBL625382,22224,,,,A,,8883,9823.0,,Stability to porcine renal DHP-I,U,,0,,Autocuration,1,BAO_0000019,,Sus scrofa,6056,,
CHEMBL873828,22224,,,In vivo,A,,8884,9823.0,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,U,,0,,Autocuration,1,BAO_0000218,,Sus scrofa,1317,,
CHEMBL625383,22224,,,In vivo,A,,8885,9823.0,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,U,,0,,Autocuration,1,BAO_0000218,,Sus scrofa,1317,,
CHEMBL625384,22224,,,,A,,8886,9823.0,,Half-life of the parent prodrug in porcine esterase solution,U,,0,,Autocuration,1,BAO_0000019,,Sus scrofa,5229,,
CHEMBL625385,22224,,,,A,,8887,9823.0,,"First order rate constant, k was determined in in pig liver Esterase",U,,0,,Autocuration,1,BAO_0000019,,Sus scrofa,4231,,
CHEMBL625386,22224,,Liver,,A,,8888,9823.0,2107.0,Half life of the in pig liver Esterase,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,4231,,
CHEMBL623571,22224,,Liver,,A,,8889,9823.0,2107.0,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,5318,,
CHEMBL623572,22224,,Liver,,A,,8890,9823.0,2107.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,5318,,
CHEMBL623573,22224,,Liver,,A,,8891,9823.0,2107.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,5318,,
CHEMBL623574,22224,,Liver,,A,,8892,9823.0,2107.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,3305,,
CHEMBL623575,22224,,Liver,,A,,8893,9823.0,2107.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,3305,,
CHEMBL623749,22224,,Liver,,A,,8894,9823.0,2107.0,Half-life in the presence of pig liver esterase(PLE) was evaluated.,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,2842,,
CHEMBL623750,22224,,Liver,,A,,8895,9823.0,2107.0,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,2842,,
CHEMBL623751,22224,,Liver,In vitro,A,,8896,9823.0,2107.0,Half-life in vitro in pig liver,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,889,,
CHEMBL623752,22224,,Liver,,A,,8897,9823.0,2107.0,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,U,,0,,Autocuration,1,BAO_0000221,,Sus scrofa,1904,,
CHEMBL623753,50597,,Plasma,In vivo,A,,8898,10116.0,1969.0,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4186,,
CHEMBL623754,50597,,Plasma,In vivo,A,,8899,10116.0,1969.0,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2774,,
CHEMBL623755,50597,,Plasma,In vivo,A,,8900,10116.0,1969.0,Maximum concentration in rat plasma was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1742,,
CHEMBL623756,50597,,,In vivo,A,,8901,10116.0,,Maximum concentration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL623757,50597,,,In vivo,A,,8902,10116.0,,Maximum concentration in rats at 1-2 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL623758,50597,,,In vivo,A,,8903,10116.0,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2081,,
CHEMBL623759,50597,,Brain,In vivo,A,,8904,10116.0,955.0,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3307,,
CHEMBL623760,50597,,,In vivo,A,,8905,10116.0,,Maximum concentration at the dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL623761,50597,,,In vivo,A,,8906,10116.0,,Maximum concentration was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL623762,50597,,Plasma,In vivo,A,,8907,10116.0,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL877594,50597,,Plasma,In vivo,A,,8908,10116.0,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL623763,50597,,Plasma,In vivo,A,,8909,10116.0,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL623764,50597,,Plasma,In vivo,A,,8910,10116.0,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL623765,50597,,Plasma,In vivo,A,,8911,10116.0,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL623766,50597,,Blood,In vivo,A,,8912,10116.0,178.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2591,,
CHEMBL623767,50597,,Blood,In vivo,A,,8913,10116.0,178.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2591,,
CHEMBL623768,50597,,Blood,In vivo,A,,8914,10116.0,178.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2591,,
CHEMBL623769,50597,,Plasma,In vivo,A,,8915,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623770,50597,,Plasma,In vivo,A,,8916,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623771,50597,,Plasma,In vivo,A,,8917,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623772,50597,,Plasma,In vivo,A,,8918,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623773,50597,,Plasma,In vivo,A,,8919,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623774,50597,,Plasma,In vivo,A,,8920,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623775,50597,,Plasma,In vivo,A,,8921,10116.0,1969.0,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL623776,50597,,,In vivo,A,,8922,10116.0,,Cmax in rat (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14465,,
CHEMBL622191,50597,,Plasma,In vivo,A,,8923,10116.0,1969.0,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL622192,50597,,Plasma,In vivo,A,,8924,10116.0,1969.0,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL622193,50597,,Plasma,In vivo,A,,8925,10116.0,1969.0,Maximum plasma concentration determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL622194,50597,,Plasma,In vivo,A,,8926,10116.0,1969.0,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL622195,50597,,Plasma,In vivo,A,,8927,10116.0,1969.0,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL622196,50597,,Plasma,In vivo,A,,8928,10116.0,1969.0,Maximum plasma concentration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6824,,
CHEMBL622197,50597,,Plasma,In vivo,A,,8929,10116.0,1969.0,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17065,,
CHEMBL622198,50597,,Plasma,In vivo,A,,8930,10116.0,1969.0,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2932,,
CHEMBL622199,50597,,Plasma,In vivo,A,,8931,10116.0,1969.0,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2932,,
CHEMBL622200,50597,,Plasma,In vivo,A,,8932,10116.0,1969.0,Maximum plasma concentration of compound was measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL622201,50597,,Plasma,In vivo,A,,8933,10116.0,1969.0,Maximum plasma concentration after 20 mg/kg oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2864,,
CHEMBL623990,50597,,Plasma,In vivo,A,,8934,10116.0,1969.0,Maximum plasma concentration after oral administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL623991,50597,,Plasma,In vivo,A,,8935,10116.0,1969.0,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623992,50597,,Plasma,In vivo,A,,8936,10116.0,1969.0,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623993,50597,,Plasma,In vivo,A,,8937,10116.0,1969.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623994,50597,,Plasma,In vivo,A,,8938,10116.0,1969.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623995,50597,,Plasma,In vivo,F,,8939,10116.0,1969.0,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL623996,50597,,Plasma,In vivo,F,,8940,10116.0,1969.0,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL623997,50597,,Plasma,In vivo,F,,8941,10116.0,1969.0,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL623998,50597,,Plasma,In vivo,A,,8942,10116.0,1969.0,Maximum plasma concentration dosed orally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4516,,
CHEMBL623999,50597,,Plasma,In vivo,A,,8943,10116.0,1969.0,Maximum plasma concentration dosed orally in rats after 6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4516,,
CHEMBL624000,50597,,Plasma,In vivo,A,,8944,10116.0,1969.0,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4516,,
CHEMBL624001,50597,,Plasma,In vivo,A,,8945,10116.0,1969.0,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL624002,50597,,Plasma,In vivo,A,,8946,10116.0,1969.0,Maximum plasma concentration in rat after po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL624003,50597,,Plasma,In vivo,A,,8947,10116.0,1969.0,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL624004,50597,,Plasma,In vivo,A,,8948,10116.0,1969.0,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL624005,50597,,Heart,,A,,8949,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624006,50597,,Heart,,A,,8950,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624007,50597,,Heart,,A,,8951,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624008,50597,,Heart,,A,,8952,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624009,50597,,Heart,,A,,8953,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL874387,50597,,Heart,,A,,8954,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624010,50597,,Heart,,A,,8955,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624011,50597,,Heart,,A,,8956,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624012,50597,,Heart,,A,,8957,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624013,50597,,Heart,,A,,8958,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624736,50597,,Heart,,A,,8959,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624737,50597,,Heart,,A,,8960,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624738,50597,,Heart,,A,,8961,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624739,50597,,Heart,,A,,8962,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624740,50597,,Heart,,A,,8963,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL624896,50597,,Heart,,A,,8964,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624897,50597,,Heart,,A,,8965,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624108,50597,,Heart,,A,,8966,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624109,50597,,Heart,,A,,8967,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624110,50597,,Heart,,A,,8968,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624111,50597,,Heart,,A,,8969,10116.0,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624112,50597,,Heart,,A,,8970,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL624113,50597,,Heart,,A,,8971,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619709,50597,,Heart,,A,,8972,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619710,50597,,Heart,,A,,8973,10116.0,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619711,50597,,Kidney,,A,,8974,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619712,50597,,Kidney,,A,,8975,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619713,50597,,Kidney,,A,,8976,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619714,50597,,Kidney,,A,,8977,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619715,50597,,Kidney,,A,,8978,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619716,50597,,Kidney,,A,,8979,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619717,50597,,Kidney,,A,,8980,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619718,50597,,Kidney,,A,,8981,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619719,50597,,Kidney,,A,,8982,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL875329,50597,,Kidney,,A,,8983,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619720,50597,,Kidney,,A,,8984,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619721,50597,,Kidney,,A,,8985,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619722,50597,,Kidney,,A,,8986,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619723,50597,,Kidney,,A,,8987,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619724,50597,,Kidney,,A,,8988,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619725,50597,,Kidney,,A,,8989,10116.0,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619726,50597,,Kidney,,A,,8990,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619727,50597,,Kidney,,A,,8991,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619728,50597,,Kidney,,A,,8992,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL619729,50597,,Kidney,,A,,8993,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL619730,50597,,Muscle tissue,In vivo,A,,8994,10116.0,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL619731,50597,,Muscle tissue,In vivo,A,,8995,10116.0,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL619732,50597,,Muscle tissue,In vivo,A,,8996,10116.0,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL619733,50597,,Muscle tissue,In vivo,A,,8997,10116.0,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL619734,50597,,Muscle tissue,In vivo,A,,8998,10116.0,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL619735,50597,,Zone of skin,In vivo,A,,8999,10116.0,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL875330,50597,,Zone of skin,In vivo,A,,9000,10116.0,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628465,50597,,Zone of skin,In vivo,A,,9001,10116.0,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628466,50597,,Zone of skin,In vivo,A,,9002,10116.0,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628467,50597,,Zone of skin,In vivo,A,,9003,10116.0,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628468,50597,,Spleen,In vivo,A,,9004,10116.0,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628469,50597,,Spleen,In vivo,A,,9005,10116.0,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628470,50597,,Spleen,In vivo,A,,9006,10116.0,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628471,50597,,Spleen,In vivo,A,,9007,10116.0,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL628472,50597,,Spleen,In vivo,A,,9008,10116.0,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625191,50597,,Thyroid gland,In vivo,A,,9009,10116.0,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL625192,50597,,Thyroid gland,In vivo,A,,9010,10116.0,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL875337,50597,,Thyroid gland,In vivo,A,,9011,10116.0,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626341,50597,,Thyroid gland,In vivo,A,,9012,10116.0,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL626342,50597,,Thyroid gland,In vivo,A,,9013,10116.0,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621943,50597,,Liver,In vivo,A,,9014,10116.0,2107.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL621944,50597,,,,A,,9015,10116.0,,Half life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3748,,
CHEMBL621945,50597,,,,A,,9016,10116.0,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL621946,50597,,,,A,,9017,10116.0,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4871,,
CHEMBL621947,50597,,,,A,,9018,10116.0,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4871,,
CHEMBL621948,50597,,,,A,,9019,10116.0,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4872,,
CHEMBL621949,50597,,,,A,,9020,10116.0,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4872,,
CHEMBL621950,50597,,,,A,,9021,10116.0,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5413,,
CHEMBL621951,50597,,,,A,,9022,10116.0,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5413,,
CHEMBL621952,50597,,Blood,In vivo,A,,9023,10116.0,178.0,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15272,,
CHEMBL621953,50597,,Liver,,A,,9024,10116.0,2107.0,Stability (%) in rat liver microsomes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL621954,50597,,,,A,,9025,10116.0,,Area under curve was calculated after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL621955,50597,,,,A,,9026,10116.0,,Area under the curve was calculated after iv administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL621956,50597,,,,A,,9027,10116.0,,Area under the curve was calculated in rat after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL621957,50597,,,,A,,9028,10116.0,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6211,,
CHEMBL621958,50597,,,,A,,9029,10116.0,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5710,,
CHEMBL621959,50597,,,,A,,9030,10116.0,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5710,,
CHEMBL621960,50597,,,,A,,9031,10116.0,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17853,,
CHEMBL621961,50597,,,,A,,9032,10116.0,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17853,,
CHEMBL621962,50597,,,,A,,9033,10116.0,,p value of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL876787,50597,,,,F,,9034,10116.0,,p value of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL621963,50597,,,,A,,9035,10116.0,,p value of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL622637,50597,,Stomach,,A,,9036,10116.0,945.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL622638,50597,,Stomach,,A,,9037,10116.0,945.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL626561,50597,,Stomach,,A,,9038,10116.0,945.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL626562,22224,,,,F,,9039,9986.0,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),U,,0,,Autocuration,1,BAO_0000019,,Oryctolagus cuniculus,7991,,
CHEMBL626563,22224,,,,A,,9040,9986.0,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL626564,22224,,,,A,,9041,9986.0,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL626565,22224,,,In vivo,A,,9042,9986.0,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,6253,,
CHEMBL626566,22224,,,In vivo,A,,9043,9986.0,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,6253,,
CHEMBL626567,22224,,,In vivo,A,,9044,9986.0,,Clearance rate in rabbits,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,3615,,
CHEMBL626568,22224,,,In vivo,A,,9045,9986.0,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,4059,,
CHEMBL626569,22224,,,In vivo,A,,9046,9986.0,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL626570,22224,,,In vivo,A,,9047,9986.0,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL626571,22224,,,In vivo,A,,9048,9986.0,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL626572,22224,,,In vivo,A,,9049,9986.0,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL626573,22224,,Plasma,In vivo,A,,9050,9986.0,1969.0,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,4059,,
CHEMBL626574,22224,,Liver,,A,,9051,9986.0,2107.0,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,U,Microsomes,0,,Autocuration,1,BAO_0000251,,Oryctolagus cuniculus,9659,,
CHEMBL626575,22224,,Liver,,A,,9052,9986.0,2107.0,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,U,Microsomes,0,,Autocuration,1,BAO_0000251,,Oryctolagus cuniculus,9659,,
CHEMBL626576,22224,,,,A,,9053,9986.0,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,3639,,
CHEMBL626577,22224,,,,A,,9054,9986.0,,Dose at which bioavailability of perorally administered compound was tested in rabbit,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,3639,,
CHEMBL626578,22224,,,In vivo,A,,9055,9986.0,,The compound was tested for its bioavailability in rabbit (by oral dosage).,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,3639,,
CHEMBL625263,22224,,,In vivo,A,,9056,9986.0,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL625264,22224,,,In vivo,A,,9057,9986.0,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL625265,22224,,,In vivo,A,,9058,9986.0,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL625266,22224,,,,A,,9059,9986.0,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),U,Microsomes,0,,Autocuration,1,BAO_0000251,,Oryctolagus cuniculus,14294,,
CHEMBL876796,22224,,,,A,,9060,9986.0,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),U,Microsomes,0,,Autocuration,1,BAO_0000251,,Oryctolagus cuniculus,14294,,
CHEMBL625267,22224,,,In vivo,A,,9061,9986.0,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL625268,22224,,Plasma,In vivo,A,,9062,9986.0,1969.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL625269,22224,,Plasma,In vivo,A,,9063,9986.0,1969.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL624689,22224,,Plasma,In vivo,A,,9064,9986.0,1969.0,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,5124,,
CHEMBL624690,22224,,,In vivo,A,,9065,9986.0,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL624691,22224,,Urine,,A,,9066,9986.0,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL624692,22224,,Urine,,A,,9067,9986.0,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,429,,
CHEMBL624693,22224,,,In vivo,A,,9068,9986.0,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,4059,,
CHEMBL624694,22224,,,In vivo,A,,9069,9986.0,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,4137,,
CHEMBL877596,22224,,,In vitro,A,,9070,9986.0,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,U,,0,,Autocuration,1,BAO_0000221,,Oryctolagus cuniculus,11672,,
CHEMBL624695,22224,,,,A,,9071,9986.0,,Time within which only 10% of the drug was degraded,U,,0,,Autocuration,1,BAO_0000019,,Oryctolagus cuniculus,12886,,
CHEMBL624696,22224,,Liver,,A,,9072,9986.0,2107.0,Half life period in rabbit liver homogenate,U,,0,,Autocuration,1,BAO_0000221,,Oryctolagus cuniculus,3853,,
CHEMBL624697,22224,,,,A,,9073,9986.0,,Half life value in rabbits,U,,0,,Autocuration,1,BAO_0000019,,Oryctolagus cuniculus,3615,,
CHEMBL624698,22224,,Blood,In vivo,A,,9074,9986.0,178.0,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,6253,,
CHEMBL624699,22224,,Blood,In vivo,A,,9075,9986.0,178.0,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,6253,,
CHEMBL624700,22224,,,In vivo,A,,9076,9986.0,,Half-life period in rabbits following intravenous administration at 2 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Oryctolagus cuniculus,6077,,
CHEMBL622903,50597,,Plasma,,A,,9077,10116.0,1969.0,AUC 0-8 hr value in rats at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17617,,
CHEMBL622904,50597,,Plasma,,A,,9078,10116.0,1969.0,AUC after administration at 2000 mg/kg/day in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL622905,50597,,Plasma,,A,,9079,10116.0,1969.0,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6149,,
CHEMBL622906,50597,,Plasma,,A,,9080,10116.0,1969.0,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL622907,50597,,Plasma,,A,,9081,10116.0,1969.0,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL622908,50597,,Plasma,,A,,9082,10116.0,1969.0,AUC in rat after oral administration at 10.5 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL622909,50597,,Plasma,,A,,9083,10116.0,1969.0,AUC in rat after oral administration at 11.2 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL622910,50597,,Plasma,,A,,9084,10116.0,1969.0,AUC in rat after oral administration at 9.7 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL622911,50597,,Brain,,A,,9085,10116.0,955.0,AUC in rat brain after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL622912,50597,,Plasma,,A,,9086,10116.0,1969.0,AUC in rat p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6504,,
CHEMBL622913,50597,,Plasma,,A,,9087,10116.0,1969.0,AUC in rat p.o. at 20 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL622914,50597,,Plasma,,A,,9088,10116.0,1969.0,AUC in rat plasma after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL622915,50597,,Plasma,,A,,9089,10116.0,1969.0,AUC in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,216,,
CHEMBL622916,50597,,Plasma,,A,,9090,10116.0,1969.0,AUC value after IV dose at a dose of 5 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL622917,50597,,Plasma,,A,,9091,10116.0,1969.0,AUC value after oral dose at a dose of 10 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL622918,50597,,Plasma,In vivo,A,,9092,10116.0,1969.0,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622919,50597,,Plasma,In vivo,A,,9093,10116.0,1969.0,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,216,,
CHEMBL622920,50597,,Plasma,In vivo,A,,9094,10116.0,1969.0,Maximum plasma concentration was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6049,,
CHEMBL622921,50597,,Plasma,In vivo,A,,9095,10116.0,1969.0,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2463,,
CHEMBL622922,50597,,Plasma,In vivo,A,,9096,10116.0,1969.0,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6679,,
CHEMBL622923,50597,,Plasma,In vivo,A,,9097,10116.0,1969.0,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6681,,
CHEMBL877604,50597,,Plasma,In vivo,A,,9098,10116.0,1969.0,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL622924,50597,,Plasma,In vivo,A,,9099,10116.0,1969.0,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL622925,50597,,Plasma,In vivo,A,,9100,10116.0,1969.0,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL622926,50597,,Plasma,In vivo,A,,9101,10116.0,1969.0,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL623625,50597,,Plasma,In vivo,A,,9102,10116.0,1969.0,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6227,,
CHEMBL623626,50597,,Plasma,In vivo,A,,9103,10116.0,1969.0,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL623627,50597,,Plasma,In vivo,A,,9104,10116.0,1969.0,Maximum plasma drug concentration was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1465,,
CHEMBL623628,50597,,,In vivo,A,,9105,10116.0,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4368,,
CHEMBL623629,50597,,Plasma,In vivo,A,,9106,10116.0,1969.0,Mean peak plasma concentration was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL623630,50597,,Plasma,In vivo,A,,9107,10116.0,1969.0,Mean peak plasma concentration was observed after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL623804,50597,,,In vivo,A,,9108,10116.0,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL623805,50597,,,In vivo,A,,9109,10116.0,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL623806,50597,,Plasma,In vivo,A,,9110,10116.0,1969.0,Peak oral plasma concentration was determined in rats by oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1567,,
CHEMBL623807,50597,,Plasma,In vivo,A,,9111,10116.0,1969.0,Peak plasma concentration (Cmax) was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL623808,50597,,Plasma,In vivo,A,,9112,10116.0,1969.0,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6193,,
CHEMBL623809,50597,,Plasma,In vivo,A,,9113,10116.0,1969.0,Peak plasma concentration (Cmax) in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL623810,50597,,Plasma,In vivo,A,,9114,10116.0,1969.0,Peak plasma concentration at 1 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6485,,
CHEMBL623811,50597,,Plasma,In vivo,A,,9115,10116.0,1969.0,Peak plasma concentration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL623812,50597,,Plasma,In vivo,A,,9116,10116.0,1969.0,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL877605,50597,,,In vivo,A,,9117,10116.0,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5394,,
CHEMBL623813,50597,,,In vivo,A,,9118,10116.0,,Pharmacokinetic property (Cmax) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4408,,
CHEMBL623814,50597,,,In vivo,A,,9119,10116.0,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5983,,
CHEMBL623815,50597,,,In vivo,A,,9120,10116.0,,Cmax in rat after 3mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4878,,
CHEMBL623816,50597,Sprague-Dawley,,In vivo,A,,9121,10116.0,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5862,,
CHEMBL623145,50597,,,In vivo,A,,9122,10116.0,,Cmax in rats after 20 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4517,,
CHEMBL623146,50597,,Plasma,In vivo,A,,9123,10116.0,1969.0,Cmax in rat plasma after 30mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5932,,
CHEMBL623147,50597,,Plasma,In vivo,A,,9124,10116.0,1969.0,Plasma concentration after oral administration of 100 mg/kg to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5436,,
CHEMBL623042,50597,,Brain,In vivo,A,,9125,10116.0,955.0,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL623043,50597,,,In vivo,A,,9126,10116.0,,Tested for the Cmax in rat at 10 mg/kg per orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4950,,
CHEMBL623044,50597,,,In vivo,A,,9127,10116.0,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL623045,50597,,,In vivo,A,,9128,10116.0,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL623046,50597,,,In vivo,A,,9129,10116.0,,Bioavailability as oral Cmax in rats at 30 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3360,,
CHEMBL623226,50597,,,In vivo,A,,9130,10116.0,,Bioavailability as oral Cmax in rats at 6hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3360,,
CHEMBL623227,50597,,,In vivo,A,,9131,10116.0,,The maximum concentration of compound was measured at the dose of 100 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL623228,50597,,,In vivo,A,,9132,10116.0,,The maximum concentration of compound was measured at the dose of 300 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL623229,50597,,,In vivo,A,,9133,10116.0,,The maximum concentration of compound was measured at the dose of 30 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL623230,50597,,Plasma,In vivo,A,,9134,10116.0,1969.0,The maximum plasma levels for the compounds were determined by LC-MS.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5160,,
CHEMBL623231,50597,,Plasma,In vivo,A,,9135,10116.0,1969.0,mean peak plasma concentration was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL623232,50597,,Plasma,In vivo,A,,9136,10116.0,1969.0,mean peak plasma concentration was observed after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL623233,50597,,,,A,,9137,10116.0,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4709,,
CHEMBL623234,50597,,,,A,,9138,10116.0,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3535,,
CHEMBL623235,50597,,,,A,,9139,10116.0,,Concentration in plasma (portal) following oral dose in rats at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3535,,
CHEMBL623236,50597,,,,A,,9140,10116.0,,Concentration in plasma (portal) following oral dose in rats at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3535,,
CHEMBL623237,50597,,,,A,,9141,10116.0,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3535,,
CHEMBL623238,50597,,,,A,,9142,10116.0,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3535,,
CHEMBL623239,50597,,,,A,,9143,10116.0,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3535,,
CHEMBL623240,22224,,Plasma,In vivo,A,,9144,10116.0,1969.0,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5005,,
CHEMBL623241,50597,,Hypothalamus,,A,,9145,10116.0,1898.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6326,,
CHEMBL623242,50597,,Hypothalamus,,A,,9146,10116.0,1898.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6326,,
CHEMBL874394,50597,,,,A,,9147,10116.0,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6326,,
CHEMBL623243,50597,,,,A,,9148,10116.0,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6326,,
CHEMBL623244,50597,,,,A,,9149,10116.0,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL623245,50597,,Kidney,,A,,9150,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623246,50597,,Kidney,,A,,9151,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623247,50597,,Kidney,,A,,9152,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623248,50597,,Kidney,,A,,9153,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623249,50597,,Kidney,,A,,9154,10116.0,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625072,50597,,Liver,,A,,9155,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625073,50597,,Liver,,A,,9156,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625074,50597,,Liver,,A,,9157,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625075,50597,,Liver,,A,,9158,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625076,50597,,Liver,,A,,9159,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625077,50597,,Liver,,A,,9160,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625078,50597,,Liver,,A,,9161,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL874395,50597,,Liver,,A,,9162,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625079,50597,,Liver,,A,,9163,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625080,50597,,Liver,,A,,9164,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625081,50597,,Liver,,A,,9165,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625082,50597,,Liver,,A,,9166,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625083,50597,,Liver,,A,,9167,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625084,50597,,Liver,,A,,9168,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625085,50597,,Liver,,A,,9169,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625086,50597,,Liver,,A,,9170,10116.0,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL625087,50597,,Liver,,A,,9171,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625088,50597,,Liver,,A,,9172,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622205,50597,,Liver,,A,,9173,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622206,50597,,Liver,,A,,9174,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622207,50597,,Liver,,A,,9175,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622366,50597,,Liver,,A,,9176,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622367,50597,,Liver,,A,,9177,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL875331,50597,,Liver,,A,,9178,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622368,50597,,Liver,,A,,9179,10116.0,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622369,50597,,Lung,,A,,9180,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622370,50597,,Lung,,A,,9181,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622371,50597,,Lung,,A,,9182,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622372,50597,,Lung,,A,,9183,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622373,50597,,Lung,,A,,9184,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622374,50597,,Lung,,A,,9185,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622375,50597,,Lung,,A,,9186,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622376,50597,,Lung,,A,,9187,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622377,50597,,Lung,,A,,9188,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622378,50597,,Lung,,A,,9189,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622379,50597,,Lung,,A,,9190,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622380,50597,,Lung,,A,,9191,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622381,50597,,Lung,,A,,9192,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622382,50597,,Lung,,A,,9193,10116.0,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622383,50597,,Lung,,A,,9194,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL875332,50597,,Stomach,,A,,9195,10116.0,945.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL622384,50597,,Stomach,,A,,9196,10116.0,945.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL622385,50597,,Stomach,,A,,9197,10116.0,945.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL622386,50597,,Stomach,,A,,9198,10116.0,945.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6175,,
CHEMBL622387,50597,,,,A,,9199,10116.0,,The compound was tested for the plasma binding in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL622388,50597,,,,A,,9200,10116.0,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16459,,
CHEMBL622389,50597,,,,A,,9201,10116.0,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16459,,
CHEMBL622390,50597,,,,A,,9202,10116.0,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16459,,
CHEMBL622391,50597,,,,A,,9203,10116.0,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16459,,
CHEMBL622392,50597,,,,A,,9204,10116.0,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16459,,
CHEMBL622393,50597,,,,A,,9205,10116.0,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16459,,
CHEMBL622394,50597,,,,A,,9206,10116.0,,Plasma level at 2 hr after administration of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3278,,
CHEMBL622395,50597,,,,A,,9207,10116.0,,plasma level at 2 hr after administration of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3278,,
CHEMBL622396,50597,,Serum,,A,,9208,10116.0,1977.0,Stability in rat serum measured as % recovery at 1 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624894,50597,,Serum,,A,,9209,10116.0,1977.0,Stability in rat serum measured as % recovery at 10 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624895,50597,,Serum,,A,,9210,10116.0,1977.0,Stability in rat serum measured as % recovery at 10 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624058,50597,,Serum,,A,,9211,10116.0,1977.0,Stability in rat serum measured as % recovery at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624059,50597,,Serum,,A,,9212,10116.0,1977.0,Stability in rat serum measured as % recovery at 3 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624060,50597,,Serum,,A,,9213,10116.0,1977.0,Stability in rat serum measured as % recovery at 3 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624061,50597,,Serum,,A,,9214,10116.0,1977.0,Stability in rat serum measured as % recovery at 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624062,50597,,Serum,,A,,9215,10116.0,1977.0,Stability in rat serum measured as % recovery at 5 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4684,,
CHEMBL624063,50597,,,In vivo,A,,9216,10116.0,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16456,,
CHEMBL624064,50597,,,In vivo,A,,9217,10116.0,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16456,,
CHEMBL624065,50597,,Plasma,,A,,9218,10116.0,1969.0,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,723,,
CHEMBL624066,50597,,Plasma,,A,,9219,10116.0,1969.0,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,723,,
CHEMBL877490,50597,,,In vivo,A,,9220,10116.0,,Half life tested in mature male rat at a dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5160,,
CHEMBL874442,50597,,,In vivo,A,,9221,10116.0,,Half life after intravenous administration of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4709,,
CHEMBL626890,50597,,,In vivo,A,,9222,10116.0,,Half life period after administration (30 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5633,,
CHEMBL626891,50597,,,In vivo,A,,9223,10116.0,,Half life period in rat after 5 mg/Kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5302,,
CHEMBL626892,50597,,,In vivo,A,,9224,10116.0,,Half life period in rat after 5 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5302,,
CHEMBL626893,50597,,,,A,,9225,10116.0,,Half life period was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL626894,50597,,,,A,,9226,10116.0,,Half life period was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL626895,50597,,,,A,,9227,10116.0,,Half life period was evaluated in rat; 0.5-1.0,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL626896,50597,,,,A,,9228,10116.0,,Half life period was evaluated in rat; 5.9-7.5,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL626897,50597,,Plasma,,A,,9229,10116.0,1969.0,Half-life in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14512,,
CHEMBL626898,50597,,,,A,,9230,10116.0,,Half-life time in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6230,,
CHEMBL626899,50597,,,In vivo,A,,9231,10116.0,,Terminal half-life after iv administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3364,,
CHEMBL626900,50597,,,In vivo,A,,9232,10116.0,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6874,,
CHEMBL626901,50597,,,,A,,9233,10116.0,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,857,,
CHEMBL626902,50597,,,In vivo,A,,9234,10116.0,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,858,,
CHEMBL626903,50597,,,In vivo,A,,9235,10116.0,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,858,,
CHEMBL874443,50597,,,In vivo,A,,9236,10116.0,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL626904,50597,,,In vivo,A,,9237,10116.0,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL626905,50597,,,,A,,9238,10116.0,,Half life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6305,,
CHEMBL873830,50597,,Plasma,In vivo,A,,9239,10116.0,1969.0,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13501,,
CHEMBL626906,50597,,,In vivo,A,,9240,10116.0,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL631076,50597,,Plasma,In vivo,A,,9241,10116.0,1969.0,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4186,,
CHEMBL631077,50597,,Plasma,,A,,9242,10116.0,1969.0,Biological half-life was measured in plasma of rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2932,,
CHEMBL631078,50597,,,In vivo,A,,9243,10116.0,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17065,,
CHEMBL631079,50597,,,In vivo,A,,9244,10116.0,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL631080,50597,,,In vivo,A,,9245,10116.0,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2713,,
CHEMBL631081,50597,,,In vivo,A,,9246,10116.0,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL631239,50597,,,In vivo,A,,9247,10116.0,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL631240,50597,,Plasma,,A,,9248,10116.0,1969.0,Compound was evaluated for plasma half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,740,,
CHEMBL631241,50597,,Plasma,,A,,9249,10116.0,1969.0,AUC value at a dose of 5 mg/kg (p.o.) in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL631242,50597,,Plasma,,A,,9250,10116.0,1969.0,AUC value after administration of 20 mg/Kg oral dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2959,,
CHEMBL631243,50597,,Plasma,,A,,9251,10116.0,1969.0,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL874444,50597,,Plasma,,A,,9252,10116.0,1969.0,AUC0-96 after administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL631244,50597,,Plasma,,A,,9253,10116.0,1969.0,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL631245,50597,,,,A,,9254,10116.0,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3293,,
CHEMBL627162,50597,,,,A,,9255,10116.0,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL627163,50597,,,,A,,9256,10116.0,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL627164,50597,,,,A,,9257,10116.0,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6757,,
CHEMBL627165,50597,,Kidney,,A,,9258,10116.0,2113.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5979,,
CHEMBL627166,50597,,,,A,,9259,10116.0,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5979,,
CHEMBL627167,50597,,,,A,,9260,10116.0,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5979,,
CHEMBL627822,50597,,,,A,,9261,10116.0,,Area under curve (AUC) at a dose of 30 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL627823,50597,,,,A,,9262,10116.0,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL627824,50597,,,,A,,9263,10116.0,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL627825,50597,,,,A,,9264,10116.0,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5355,,
CHEMBL627826,50597,,,,A,,9265,10116.0,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5633,,
CHEMBL627827,50597,,,,A,,9266,10116.0,,Area under curve (Pharmacokinetic property) was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1716,,
CHEMBL627828,50597,,,,A,,9267,10116.0,,Area under curve (Pharmacokinetic property) of the compound; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1716,,
CHEMBL627829,50597,,,,A,,9268,10116.0,,Area under curve after intravenous administration (1 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL627830,50597,,,,A,,9269,10116.0,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL627831,50597,,,,A,,9270,10116.0,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL627832,50597,,,,A,,9271,10116.0,,Area under curve in male SD rats was observed after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL627833,50597,,,,A,,9272,10116.0,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4413,,
CHEMBL627834,50597,,,,A,,9273,10116.0,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL628004,50597,,,,A,,9274,10116.0,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL628005,50597,,,,A,,9275,10116.0,,Area under curve at 5 mg/kg po was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5964,,
CHEMBL628006,50597,,,,A,,9276,10116.0,,Area under curve in Rat at a oral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL628007,50597,,,,A,,9277,10116.0,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4186,,
CHEMBL625676,50597,,,,A,,9278,10116.0,,Area under curve was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL631309,50597,,,,A,,9279,10116.0,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17858,,
CHEMBL631310,50597,,,,A,,9280,10116.0,,Area under curve after intravenous administration at 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL631311,50597,,,,A,,9281,10116.0,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6106,,
CHEMBL631312,50597,,,,A,,9282,10116.0,,Area under curve at 4 hr in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5964,,
CHEMBL631313,50597,,,,A,,9283,10116.0,,Area under curve at a dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL631314,50597,,,,A,,9284,10116.0,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL631315,50597,,,,A,,9285,10116.0,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL631316,50597,,,,A,,9286,10116.0,,Area under curve for a 2-mpk po dose in SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5862,,
CHEMBL631317,50597,,,,A,,9287,10116.0,,Area under curve in SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5862,,
CHEMBL874471,50597,,,,A,,9288,10116.0,,Area under curve in rat after oral administration at 13 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL631318,50597,,,,A,,9289,10116.0,,Area under curve in rat by po administration at 0-24 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5871,,
CHEMBL631319,50597,,Plasma,,A,,9290,10116.0,1969.0,Area under curve in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5919,,
CHEMBL631320,50597,,,,A,,9291,10116.0,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL631321,50597,,,,A,,9292,10116.0,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL631322,50597,,,,A,,9293,10116.0,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10,,
CHEMBL631323,50597,,,,A,,9294,10116.0,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11149,,
CHEMBL631324,50597,,,,A,,9295,10116.0,,Area under curve value in rat at a dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5302,,
CHEMBL631325,50597,,,,A,,9296,10116.0,,Area under curve was determined after oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL631326,50597,,,,A,,9297,10116.0,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL631327,50597,,,,A,,9298,10116.0,,Area under curve was determined after peroral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6011,,
CHEMBL631328,50597,,,,A,,9299,10116.0,,Area under curve was determined at a dose 30 mpk administered orally.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5375,,
CHEMBL631329,50597,,,,A,,9300,10116.0,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL627217,50597,,,,A,,9301,10116.0,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4368,,
CHEMBL626352,50597,,,,A,,9302,10116.0,,Area under curve was determined in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5610,,
CHEMBL626353,50597,,,,A,,9303,10116.0,,Area under curve was determined in rat after PO administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5833,,
CHEMBL626354,50597,,,,A,,9304,10116.0,,Area under curve was determined in rat after a 3 mg/kg of oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4257,,
CHEMBL626355,50597,,,,A,,9305,10116.0,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5937,,
CHEMBL626356,50597,,,,A,,9306,10116.0,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5932,,
CHEMBL626357,50597,,,,A,,9307,10116.0,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5932,,
CHEMBL626358,50597,,,,A,,9308,10116.0,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL626359,50597,,,,A,,9309,10116.0,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL626360,50597,,Plasma,,A,,9310,10116.0,1969.0,Peak plasma concentration in rat at a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17771,,
CHEMBL626361,50597,,,,A,,9311,10116.0,,Plasma concentration at 2 hr in rats was evaluated.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1628,,
CHEMBL626362,50597,,,,A,,9312,10116.0,,Plasma concentration at 2 hr in rats was evaluated; Not available,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1628,,
CHEMBL626363,50597,,,,A,,9313,10116.0,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL626970,50597,,,,A,,9314,10116.0,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL626971,50597,,,,A,,9315,10116.0,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL626972,50597,,Plasma,,A,,9316,10116.0,1969.0,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL626973,50597,,Plasma,,A,,9317,10116.0,1969.0,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL626974,50597,,Plasma,,A,,9318,10116.0,1969.0,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL874592,50597,,Plasma,,A,,9319,10116.0,1969.0,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL626975,50597,,,,A,,9320,10116.0,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626976,50597,,,,A,,9321,10116.0,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626977,50597,,,,A,,9322,10116.0,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626978,50597,,,,A,,9323,10116.0,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626979,50597,,,,A,,9324,10116.0,,PK study was carried to determine the relative absorption ranking in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16427,,
CHEMBL626980,50597,,Plasma,In vivo,A,,9325,10116.0,1969.0,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL626981,50597,,Blood,,A,,9326,10116.0,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL626982,50597,,Blood,,A,,9327,10116.0,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL626983,50597,,Blood,,A,,9328,10116.0,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622522,50597,,Blood,,A,,9329,10116.0,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622523,50597,,Blood,,A,,9330,10116.0,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622524,50597,,Blood,,A,,9331,10116.0,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622525,50597,,Brain,,A,,9332,10116.0,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622526,50597,,Brain,,A,,9333,10116.0,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL619849,50597,,Brain,,A,,9334,10116.0,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL619850,50597,,Brain,,A,,9335,10116.0,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623864,50597,,Brain,,A,,9336,10116.0,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623865,50597,,Brain,,A,,9337,10116.0,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623866,50597,,Heart,,A,,9338,10116.0,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623867,50597,,Heart,,A,,9339,10116.0,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL877615,50597,,Heart,,A,,9340,10116.0,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623868,50597,,Heart,,A,,9341,10116.0,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623869,50597,,Heart,,A,,9342,10116.0,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623870,50597,,Heart,,A,,9343,10116.0,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL623871,50597,,Lung,,A,,9344,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623872,50597,,Lung,,A,,9345,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622129,50597,,Lung,,A,,9346,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622130,50597,,Lung,,A,,9347,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622131,50597,,Lung,,A,,9348,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622132,50597,,Lung,,A,,9349,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622133,50597,,Lung,,A,,9350,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622134,50597,,Lung,,A,,9351,10116.0,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622135,50597,,Lung,,A,,9352,10116.0,2048.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622136,50597,,Lung,,A,,9353,10116.0,2048.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622137,50597,,Muscle tissue,,A,,9354,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622138,50597,,Muscle tissue,,A,,9355,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623017,50597,,Muscle tissue,,A,,9356,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623018,50597,,Muscle tissue,,A,,9357,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623019,50597,,Muscle tissue,,A,,9358,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623020,50597,,Muscle tissue,,A,,9359,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623021,50597,,Muscle tissue,,A,,9360,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623022,50597,,Muscle tissue,,A,,9361,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623023,50597,,Muscle tissue,,A,,9362,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623024,50597,,Muscle tissue,,A,,9363,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623025,50597,,Muscle tissue,,A,,9364,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620545,50597,,Muscle tissue,,A,,9365,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620546,50597,,Muscle tissue,,A,,9366,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620547,50597,,Muscle tissue,,A,,9367,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620548,50597,,Muscle tissue,,A,,9368,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620549,50597,,Muscle tissue,,A,,9369,10116.0,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620550,50597,,Muscle tissue,,A,,9370,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL620551,50597,,Muscle tissue,,A,,9371,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL620552,50597,,Muscle tissue,,A,,9372,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL620553,50597,,Muscle tissue,,A,,9373,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620554,50597,,Muscle tissue,,A,,9374,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL875845,50597,,Muscle tissue,,A,,9375,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620555,50597,,Muscle tissue,,A,,9376,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620556,50597,,Muscle tissue,,A,,9377,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620557,50597,,Muscle tissue,,A,,9378,10116.0,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL620558,50597,,,,A,,9379,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL620559,50597,,,,A,,9380,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622939,50597,,,,A,,9381,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622940,50597,,,,A,,9382,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622941,50597,,,,A,,9383,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622942,50597,,,,A,,9384,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622943,50597,,,,A,,9385,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622944,50597,,,,A,,9386,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622945,50597,,,,A,,9387,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622946,50597,,,,A,,9388,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622947,50597,,,,A,,9389,10116.0,,Compound was evaluated for terminal half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3341,,
CHEMBL622948,50597,,Plasma,In vivo,A,,9390,10116.0,1969.0,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3634,,
CHEMBL622949,50597,,Plasma,In vivo,A,,9391,10116.0,1969.0,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3634,,
CHEMBL622950,50597,,,,A,,9392,10116.0,,Compound was tested for its half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4839,,
CHEMBL622951,22224,,Plasma,In vivo,A,,9393,9544.0,1969.0,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,U,,0,,Intermediate,1,BAO_0000218,,Macaca mulatta,5005,,
CHEMBL622952,22224,,Plasma,,A,,9394,10116.0,1969.0,Compound was tested for its plasma half life in Sprague Dawley rats,U,,0,,Intermediate,1,BAO_0000366,,Rattus norvegicus,5005,,
CHEMBL622953,22224,,Plasma,,A,,9395,10116.0,1969.0,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,U,,0,,Intermediate,1,BAO_0000366,,Rattus norvegicus,5005,,
CHEMBL873818,50597,,Plasma,,A,,9396,10116.0,1969.0,Compound was tested for plasma half-life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1094,,
CHEMBL622954,50597,,,In vivo,A,,9397,10116.0,,Elimination half life after i.v. administration of compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5031,,
CHEMBL622955,50597,,,In vivo,A,,9398,10116.0,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL875229,50597,,,In vivo,A,,9399,10116.0,,Elimination half-life after IV dosing at 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL622956,50597,,,In vivo,A,,9400,10116.0,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL622957,50597,,,In vivo,A,,9401,10116.0,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL622958,50597,,Brain,In vivo,A,,9402,10116.0,955.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL622959,50597,,Plasma,In vivo,A,,9403,10116.0,1969.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL622960,50597,,Brain,In vivo,A,,9404,10116.0,955.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL622961,50597,,Plasma,In vivo,A,,9405,10116.0,1969.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL622962,50597,,,In vivo,A,,9406,10116.0,,Evaluated for the half life in rat (in vivo),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4687,,
CHEMBL622963,50597,,,,A,,9407,10116.0,,Hafl life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL622964,50597,,,,A,,9408,10116.0,,Hafl life rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL622965,50597,,,,A,,9409,10116.0,,Hafl life rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL622966,50597,,,,A,,9410,10116.0,,Hafl life rat; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL622967,50597,,,,A,,9411,10116.0,,Hafl life rat; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL622968,50597,,Kidney,In vivo,A,,9412,10116.0,2113.0,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL622969,50597,,Liver,In vivo,A,,9413,10116.0,2107.0,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL875327,50597,,Lung,In vivo,A,,9414,10116.0,2048.0,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL628638,50597,,,In vivo,A,,9415,10116.0,,Half life in rat after 1 mg/kg i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL628639,50597,,,In vivo,A,,9416,10116.0,,Half life in rat after 2 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL625840,50597,,,In vivo,A,,9417,10116.0,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL625841,50597,,,In vivo,A,,9418,10116.0,,Half life of 10 mg/kg oral dose determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4722,,
CHEMBL625842,50597,,,In vivo,A,,9419,10116.0,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL625843,50597,,,In vivo,A,,9420,10116.0,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL625844,50597,,,In vivo,A,,9421,10116.0,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL873822,50597,,,In vivo,A,,9422,10116.0,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL625845,50597,,,In vivo,A,,9423,10116.0,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL627059,50597,,,In vivo,A,,9424,10116.0,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL627060,50597,,,In vivo,A,,9425,10116.0,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL627061,50597,,,In vivo,A,,9426,10116.0,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL627709,50597,,,In vivo,A,,9427,10116.0,,Half life of compound at 5 mg/kg after po administration was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4762,,
CHEMBL627710,50597,,,In vivo,A,,9428,10116.0,,Half life of compound determined after intravenous administration to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5327,,
CHEMBL627711,50597,,,,A,,9429,10116.0,,Half life of compound was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4847,,
CHEMBL627712,50597,,Plasma,In vivo,A,,9430,10116.0,1969.0,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL627713,50597,,,In vivo,A,,9431,10116.0,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL627714,50597,,,In vivo,A,,9432,10116.0,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL627889,22224,,,In vivo,A,,9433,9541.0,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,U,,0,,Intermediate,1,BAO_0000218,,Macaca fascicularis,4256,,
CHEMBL627890,22224,,,In vivo,A,,9434,10116.0,,Half life determined in rat by intravenous administration,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4256,,
CHEMBL627891,50597,,,In vivo,A,,9435,10116.0,,Half life determined in rats after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4722,,
CHEMBL627892,50597,,Plasma,In vivo,A,,9436,10116.0,1969.0,Half life in rat plasma after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL627893,50597,,Plasma,In vivo,A,,9437,10116.0,1969.0,Half life in rat plasma after administration of 2 mg/kg iv,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL627894,50597,,Plasma,,A,,9438,10116.0,1969.0,Half life in rat plasma was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1435,,
CHEMBL627895,50597,,Plasma,,A,,9439,10116.0,1969.0,Half life in rat plasma was determined; NA means not applicable,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1435,,
CHEMBL627896,50597,,,,A,,9440,10116.0,,Half life in rat was tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5206,,
CHEMBL627897,50597,,Plasma,,A,,9441,10116.0,1969.0,Half life measured in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6080,,
CHEMBL627898,50597,,,,A,,9442,10116.0,,Half life recorded in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4449,,
CHEMBL627899,50597,,,,A,,9443,10116.0,,Half life was calculated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL873823,50597,,,,A,,9444,10116.0,,Half life was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL627900,50597,,,,A,,9445,10116.0,,Half life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3747,,
CHEMBL627901,50597,,,In vivo,A,,9446,10116.0,,Half life after 10 mg/kg oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17858,,
CHEMBL627902,50597,,,In vivo,A,,9447,10116.0,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL627903,50597,,,In vivo,A,,9448,10116.0,,Half life after administering orally a dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL627904,50597,,,,A,,9449,10116.0,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5031,,
CHEMBL627905,50597,,,,A,,9450,10116.0,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4722,,
CHEMBL627906,50597,,,,A,,9451,10116.0,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL627907,50597,,,,A,,9452,10116.0,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL876783,50597,,,,A,,9453,10116.0,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL627908,50597,,,,A,,9454,10116.0,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL627909,50597,,,,A,,9455,10116.0,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17065,,
CHEMBL627910,50597,,,,A,,9456,10116.0,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1353,,
CHEMBL627911,50597,,,,A,,9457,10116.0,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1353,,
CHEMBL627912,50597,,,,A,,9458,10116.0,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1353,,
CHEMBL627913,50597,,,,A,,9459,10116.0,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1353,,
CHEMBL627914,50597,,,,A,,9460,10116.0,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1353,,
CHEMBL627915,50597,,,,A,,9461,10116.0,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL627916,50597,,,,A,,9462,10116.0,,Area under the curve was evaluated after 20 uM/kg of peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL627917,50597,,,,A,,9463,10116.0,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6062,,
CHEMBL627918,50597,,,,A,,9464,10116.0,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6056,,
CHEMBL627919,50597,,,,A,,9465,10116.0,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL627920,50597,,,,A,,9466,10116.0,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL627921,50597,,,,A,,9467,10116.0,,Area under the curve was evaluated at an oral dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL627922,50597,,,,A,,9468,10116.0,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL876784,50597,,,,A,,9469,10116.0,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL627923,50597,,,,A,,9470,10116.0,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL626208,50597,,,,A,,9471,10116.0,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL626209,50597,,,,A,,9472,10116.0,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL626210,50597,,,,A,,9473,10116.0,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL627994,50597,,Plasma,,A,,9474,10116.0,1969.0,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2463,,
CHEMBL627995,50597,,,,A,,9475,10116.0,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4709,,
CHEMBL627996,50597,,,,A,,9476,10116.0,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4075,,
CHEMBL627997,50597,,,,A,,9477,10116.0,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5394,,
CHEMBL627998,50597,,,,A,,9478,10116.0,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL628640,50597,,,,A,,9479,10116.0,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL628641,50597,,,,A,,9480,10116.0,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL628642,50597,,,,A,,9481,10116.0,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL628643,50597,,,,A,,9482,10116.0,,Compound was evaluated for area under the curve expressed as (h*ug/ml),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL628644,50597,,,,A,,9483,10116.0,,Compound was tested for area under curve in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2591,,
CHEMBL628645,50597,,,,A,,9484,10116.0,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6567,,
CHEMBL628646,50597,,,,A,,9485,10116.0,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6211,,
CHEMBL628647,50597,,,,A,,9486,10116.0,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5529,,
CHEMBL628648,50597,,,,A,,9487,10116.0,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL625358,50597,,,,A,,9488,10116.0,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL625359,50597,,,,A,,9489,10116.0,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL625360,50597,,,,A,,9490,10116.0,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5408,,
CHEMBL625361,50597,,,,A,,9491,10116.0,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL625362,50597,,,,A,,9492,10116.0,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL625363,50597,,,,A,,9493,10116.0,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL625364,50597,,,,A,,9494,10116.0,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4796,,
CHEMBL625365,50597,,,,A,,9495,10116.0,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625366,50597,,,,A,,9496,10116.0,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625367,50597,,,,A,,9497,10116.0,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625368,50597,,Kidney,,A,,9498,10116.0,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625369,50597,,Kidney,,A,,9499,10116.0,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625370,50597,,Kidney,,A,,9500,10116.0,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625371,50597,,Kidney,,A,,9501,10116.0,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625372,50597,,Kidney,,A,,9502,10116.0,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625373,50597,,Kidney,,A,,9503,10116.0,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625374,50597,,Liver,,A,,9504,10116.0,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL877593,50597,,Liver,,A,,9505,10116.0,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625375,50597,,Liver,,A,,9506,10116.0,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL625376,50597,,Liver,,A,,9507,10116.0,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL621973,50597,,Liver,,A,,9508,10116.0,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL621974,50597,,Liver,,A,,9509,10116.0,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL621975,50597,,Lung,,A,,9510,10116.0,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622166,50597,,Lung,,A,,9511,10116.0,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622167,50597,,Lung,,A,,9512,10116.0,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622168,50597,,Lung,,A,,9513,10116.0,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622169,50597,,Lung,,A,,9514,10116.0,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622170,50597,,Lung,,A,,9515,10116.0,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622171,50597,,Thyroid gland,,A,,9516,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622172,50597,,Thyroid gland,,A,,9517,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622173,50597,,Thyroid gland,,A,,9518,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622174,50597,,Thyroid gland,,A,,9519,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622175,50597,,Thyroid gland,,A,,9520,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622176,50597,,Thyroid gland,,A,,9521,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622177,50597,,Thyroid gland,,A,,9522,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622178,50597,,Thyroid gland,,A,,9523,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622179,50597,,Thyroid gland,,A,,9524,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622180,50597,,Thyroid gland,,A,,9525,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622181,50597,,,,A,,9526,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622182,50597,,,,A,,9527,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622183,50597,,,,A,,9528,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622184,50597,,,,A,,9529,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622185,50597,,,,A,,9530,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622186,50597,,,,A,,9531,10116.0,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622187,50597,,,,A,,9532,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625002,50597,,,,A,,9533,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622090,50597,,,,A,,9534,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622091,50597,,,,A,,9535,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622092,50597,,,,A,,9536,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622093,50597,,,,A,,9537,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622094,50597,,,,A,,9538,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622095,50597,,,,A,,9539,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622264,50597,,,,A,,9540,10116.0,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622265,50597,,Spleen,,A,,9541,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622266,50597,,Spleen,,A,,9542,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622267,50597,,Spleen,,A,,9543,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622268,50597,,Spleen,,A,,9544,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622269,50597,,Spleen,,A,,9545,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL625071,50597,,Spleen,,A,,9546,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621621,50597,,Spleen,,A,,9547,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621622,50597,,Spleen,,A,,9548,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621623,50597,,Spleen,,A,,9549,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621624,50597,,Spleen,,A,,9550,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621625,50597,,Spleen,,A,,9551,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621626,50597,,Spleen,,A,,9552,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621627,50597,,Spleen,,A,,9553,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621628,50597,,Spleen,,A,,9554,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL875328,50597,,Spleen,,A,,9555,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621629,50597,,Spleen,,A,,9556,10116.0,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621630,50597,,Spleen,,A,,9557,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621631,50597,,Spleen,,A,,9558,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621632,50597,,Spleen,,A,,9559,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL621633,50597,,Spleen,,A,,9560,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621634,50597,,Spleen,,A,,9561,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621635,50597,,Spleen,,A,,9562,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621636,50597,,Spleen,,A,,9563,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621637,50597,,Spleen,,A,,9564,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL621638,50597,,Spleen,,A,,9565,10116.0,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL618883,50597,,,,A,,9566,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL618884,50597,,,,A,,9567,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL628627,50597,,,,A,,9568,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL628628,50597,,,,A,,9569,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL628629,50597,,,,A,,9570,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL628630,50597,,,In vivo,A,,9571,10116.0,,Half life after administering orally a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL628631,50597,,,In vivo,A,,9572,10116.0,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL628632,50597,,,In vivo,A,,9573,10116.0,,Half life after administering intravenously a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL628633,50597,,,In vivo,A,,9574,10116.0,,Half life after oral dosing in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,526,,
CHEMBL628634,50597,,,In vivo,A,,9575,10116.0,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL627789,50597,,,In vivo,A,,9576,10116.0,,Half life by intravenous administration of 3.4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4368,,
CHEMBL627790,50597,,,,A,,9577,10116.0,,Half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3371,,
CHEMBL627791,50597,,,,A,,9578,10116.0,,Half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6448,,
CHEMBL627792,50597,,,,A,,9579,10116.0,,Half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6453,,
CHEMBL627793,50597,,,In vivo,A,,9580,10116.0,,Half life in rat after intravenous administration of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL627794,50597,,Plasma,In vivo,A,,9581,10116.0,1969.0,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL627795,50597,,,In vivo,A,,9582,10116.0,,Half life in rat after po administration of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL627796,50597,,,In vivo,A,,9583,10116.0,,Half life in rat after po administration of the compound; ND means Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL875335,50597,,Plasma,In vivo,A,,9584,10116.0,1969.0,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL627797,50597,,Plasma,In vivo,A,,9585,10116.0,1969.0,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL627798,50597,,,In vivo,A,,9586,10116.0,,Half life in rat i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5789,,
CHEMBL627799,50597,,,In vivo,A,,9587,10116.0,,Half life in rat i.v. at 2 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL627800,50597,,,,A,,9588,10116.0,,Half life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL627801,50597,,,In vivo,A,,9589,10116.0,,Half life in rats after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,484,,
CHEMBL627802,50597,,,In vivo,A,,9590,10116.0,,Half life in rats at the dose of 1.0 mpk by i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6467,,
CHEMBL627803,50597,,,,A,,9591,10116.0,,Half life in rat,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,6642,,
CHEMBL873820,50597,,,In vivo,A,,9592,10116.0,,Half life was evaluated after intravenous administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL627804,50597,,,,A,,9593,10116.0,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1369,,
CHEMBL627805,50597,,,,A,,9594,10116.0,,Half life was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL627806,50597,,,,A,,9595,10116.0,,Half life was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6049,,
CHEMBL627107,50597,,,,A,,9596,10116.0,,Half life was evaluated in rat; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL627108,50597,,,In vivo,A,,9597,10116.0,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL627109,50597,,,In vivo,A,,9598,10116.0,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11149,,
CHEMBL627110,50597,,Blood,In vivo,A,,9599,10116.0,178.0,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11149,,
CHEMBL627111,22224,,,In vivo,A,,9600,9443.0,,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,,0,,Intermediate,1,BAO_0000218,,Primates,2891,,
CHEMBL627112,22224,,,In vivo,A,,9601,9443.0,,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,,0,,Intermediate,1,BAO_0000218,,Primates,2891,,
CHEMBL627113,22224,,,In vivo,A,,9602,10116.0,,Half life was measured in rat at dose of 30 mg/kg by iv administration,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2891,,
CHEMBL627114,22224,,,In vivo,A,,9603,10116.0,,Half life was measured in rat at dose of 30 mg/kg by po administration,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2891,,
CHEMBL627115,50597,,,,A,,9604,10116.0,,Half life (t1/2) was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL627116,50597,,,,A,,9605,10116.0,,Half life period at a dose of 10 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL627117,50597,,,In vivo,A,,9606,10116.0,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL627118,50597,,,,A,,9607,10116.0,,Half life period was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5503,,
CHEMBL627119,50597,,,In vivo,A,,9608,10116.0,,Half life period after intravenous administration at 20 mpk in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL627120,50597,,,In vivo,A,,9609,10116.0,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL626922,50597,,,In vivo,A,,9610,10116.0,,Half life period after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6109,,
CHEMBL626923,50597,,,In vivo,A,,9611,10116.0,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL626924,50597,,,In vivo,A,,9612,10116.0,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL626925,50597,,Plasma,,A,,9613,10116.0,1969.0,Half life period in 80% rat plasma at 37 degree Centigrade,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4755,,
CHEMBL626926,50597,,,,A,,9614,10116.0,,Half life period in SD rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5862,,
CHEMBL626927,50597,,Plasma,,A,,9615,10116.0,1969.0,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626928,50597,,Plasma,,A,,9616,10116.0,1969.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626929,50597,,Plasma,,A,,9617,10116.0,1969.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626930,50597,,Plasma,,A,,9618,10116.0,1969.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626931,50597,,,,A,,9619,10116.0,,Half life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5960,,
CHEMBL626932,50597,,,,A,,9620,10116.0,,Half life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6103,,
CHEMBL626933,50597,,,,A,,9621,10116.0,,Half life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6317,,
CHEMBL873826,50597,,,In vivo,A,,9622,10116.0,,Half life period in rat after oral administration at 10.5 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL626934,50597,,,In vivo,A,,9623,10116.0,,Half life period in rat after oral administration at 11.2 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL626935,50597,,,In vivo,A,,9624,10116.0,,Half life period in rat after oral administration at 13 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL626936,50597,,,In vivo,A,,9625,10116.0,,Half life period in rat after oral administration at 9.7 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL626937,50597,,,,A,,9626,10116.0,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625906,50597,,,,A,,9627,10116.0,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6295,,
CHEMBL625907,50597,,,,A,,9628,10116.0,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6296,,
CHEMBL625908,50597,,,,A,,9629,10116.0,,PK study was carried to determine AUC (area under curve) value in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16427,,
CHEMBL625909,50597,,,,A,,9630,10116.0,,Pharmacokinetic parameter AUC after intravenous administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL625910,50597,,,,A,,9631,10116.0,,Pharmacokinetic parameter AUC after oral administration to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL625911,50597,,,,A,,9632,10116.0,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL625912,50597,,,,A,,9633,10116.0,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL626538,50597,,,,A,,9634,10116.0,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL876794,50597,,,,A,,9635,10116.0,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL626539,50597,,,,A,,9636,10116.0,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL626540,50597,,,,A,,9637,10116.0,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL626541,50597,,,,A,,9638,10116.0,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5394,,
CHEMBL626542,50597,,,,A,,9639,10116.0,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5394,,
CHEMBL626543,50597,,,,A,,9640,10116.0,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL626544,50597,,,,A,,9641,10116.0,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL626545,50597,,,,A,,9642,10116.0,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL626546,50597,,,,A,,9643,10116.0,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL626547,50597,,,,A,,9644,10116.0,,Pharmacokinetic parameter area under curve was reported,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL626548,50597,,,,A,,9645,10116.0,,Pharmacokinetic property (AUC) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4408,,
CHEMBL626549,50597,,,,A,,9646,10116.0,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5983,,
CHEMBL626550,50597,,,,A,,9647,10116.0,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4397,,
CHEMBL626551,50597,,,,A,,9648,10116.0,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4397,,
CHEMBL623777,50597,,,,A,,9649,10116.0,,Pharmacokinetic property was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5491,,
CHEMBL623778,50597,,,,A,,9650,10116.0,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5491,,
CHEMBL623779,50597,,,,A,,9651,10116.0,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5491,,
CHEMBL623780,50597,,Plasma,,A,,9652,10116.0,1969.0,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL622015,50597,,Plasma,,A,,9653,10116.0,1969.0,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL622016,50597,,Plasma,,A,,9654,10116.0,1969.0,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL622017,50597,,,,A,,9655,10116.0,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5173,,
CHEMBL622018,50597,,,,A,,9656,10116.0,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5173,,
CHEMBL622019,50597,,,,A,,9657,10116.0,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5173,,
CHEMBL622020,50597,,,,A,,9658,10116.0,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5173,,
CHEMBL622021,50597,,,,A,,9659,10116.0,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL622022,50597,,,,A,,9660,10116.0,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL622023,50597,,,,A,,9661,10116.0,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5327,,
CHEMBL622024,50597,,,,A,,9662,10116.0,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6681,,
CHEMBL622693,50597,,,,A,,9663,10116.0,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL622694,50597,,,,A,,9664,10116.0,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL622695,50597,,,,A,,9665,10116.0,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622696,50597,,,,A,,9666,10116.0,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622697,50597,,,,A,,9667,10116.0,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL622874,50597,,,,A,,9668,10116.0,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6619,,
CHEMBL622875,50597,,,,A,,9669,10116.0,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6619,,
CHEMBL622876,50597,,,,A,,9670,10116.0,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10363,,
CHEMBL622877,50597,,,,A,,9671,10116.0,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4796,,
CHEMBL622878,50597,,,,A,,9672,10116.0,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL622879,50597,,Plasma,,A,,9673,10116.0,1969.0,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL877602,50597,,,,A,,9674,10116.0,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4839,,
CHEMBL622880,50597,,,,A,,9675,10116.0,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL622881,50597,,,,A,,9676,10116.0,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL622882,50597,,,,A,,9677,10116.0,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL622883,50597,,,,A,,9678,10116.0,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL622884,50597,,Thyroid gland,,A,,9679,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622885,50597,,Thyroid gland,,A,,9680,10116.0,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11450,,
CHEMBL622886,50597,,,,A,,9681,10116.0,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL622887,50597,,,,A,,9682,10116.0,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL622888,50597,,Urine,,A,,9683,10116.0,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL622889,50597,,Blood,In vivo,A,,9684,10116.0,178.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622890,50597,,Blood,In vivo,A,,9685,10116.0,178.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622891,50597,,Blood,In vivo,A,,9686,10116.0,178.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL877603,50597,,Blood,In vivo,A,,9687,10116.0,178.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622892,50597,,Brain,In vivo,A,,9688,10116.0,955.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622893,50597,,Brain,In vivo,A,,9689,10116.0,955.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622894,50597,,Brain,In vivo,A,,9690,10116.0,955.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622895,50597,,Brain,In vivo,A,,9691,10116.0,955.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622896,50597,,Brain,In vivo,A,,9692,10116.0,955.0,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622897,50597,,Heart,In vivo,A,,9693,10116.0,948.0,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622898,50597,,Heart,In vivo,A,,9694,10116.0,948.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622899,50597,,Heart,In vivo,A,,9695,10116.0,948.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622900,50597,,Kidney,In vivo,A,,9696,10116.0,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624114,50597,,Kidney,In vivo,A,,9697,10116.0,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624115,50597,,Kidney,In vivo,A,,9698,10116.0,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624116,50597,,Kidney,In vivo,A,,9699,10116.0,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624117,50597,,Liver,In vivo,A,,9700,10116.0,2107.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624118,50597,,Liver,In vivo,A,,9701,10116.0,2107.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624119,50597,,Liver,In vivo,A,,9702,10116.0,2107.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624120,50597,,Liver,In vivo,A,,9703,10116.0,2107.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624121,50597,,Lung,In vivo,A,,9704,10116.0,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624122,50597,,Lung,In vivo,A,,9705,10116.0,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624123,50597,,Lung,In vivo,A,,9706,10116.0,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624124,50597,,Lung,In vivo,A,,9707,10116.0,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624125,50597,,Muscle tissue,In vivo,A,,9708,10116.0,2385.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624126,50597,,Muscle tissue,In vivo,A,,9709,10116.0,2385.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624127,50597,,Muscle tissue,In vivo,A,,9710,10116.0,2385.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624128,50597,,Muscle tissue,In vivo,A,,9711,10116.0,2385.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624129,50597,,Zone of skin,In vivo,A,,9712,10116.0,14.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL624130,50597,,Zone of skin,In vivo,A,,9713,10116.0,14.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622340,50597,,Zone of skin,In vivo,A,,9714,10116.0,14.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622341,50597,,Zone of skin,In vivo,A,,9715,10116.0,14.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622342,50597,,Intestine,In vivo,A,,9716,10116.0,160.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622343,50597,,Intestine,In vivo,A,,9717,10116.0,160.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622344,50597,,Intestine,In vivo,A,,9718,10116.0,160.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622345,50597,,Intestine,In vivo,A,,9719,10116.0,160.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622346,50597,,Spleen,In vivo,A,,9720,10116.0,2106.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622347,50597,,Spleen,In vivo,A,,9721,10116.0,2106.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622348,50597,,Spleen,In vivo,A,,9722,10116.0,2106.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622349,50597,,Spleen,In vivo,A,,9723,10116.0,2106.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622350,50597,,,,A,,9724,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622351,50597,,,,A,,9725,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622352,50597,,,,A,,9726,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622353,50597,,,,A,,9727,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622354,50597,,,,A,,9728,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622355,50597,,,,A,,9729,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622356,50597,,,,A,,9730,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622357,50597,,,,A,,9731,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622358,50597,,,,A,,9732,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622359,50597,,,,A,,9733,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL874393,50597,,,,A,,9734,10116.0,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL622872,50597,,,,A,,9735,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL622873,50597,,,,A,,9736,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623047,50597,,,,A,,9737,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL623048,50597,,,,A,,9738,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623049,50597,,,,A,,9739,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623050,50597,,,,A,,9740,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623051,50597,,,,A,,9741,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL623052,50597,,,,A,,9742,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL626343,50597,,,,A,,9743,10116.0,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL626344,50597,,,,A,,9744,10116.0,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL626345,50597,,,,A,,9745,10116.0,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL626346,50597,,,,A,,9746,10116.0,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL626347,50597,,,,A,,9747,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL626348,50597,,,,A,,9748,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL626349,50597,,,,A,,9749,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16434,,
CHEMBL626350,50597,,,,F,,9750,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL626351,50597,,,,A,,9751,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL627650,50597,,,,A,,9752,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL627651,50597,,,,F,,9753,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL627652,50597,,,,A,,9754,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL627653,50597,,,,A,,9755,10116.0,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16435,,
CHEMBL627654,50597,,,,A,,9756,10116.0,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627835,50597,,,,A,,9757,10116.0,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627836,50597,,,,A,,9758,10116.0,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627837,50597,,,,A,,9759,10116.0,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627838,50597,,,,A,,9760,10116.0,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL875338,50597,,,,A,,9761,10116.0,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627839,50597,,,,A,,9762,10116.0,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627840,50597,,,,A,,9763,10116.0,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627841,50597,,,,A,,9764,10116.0,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627842,50597,,,,A,,9765,10116.0,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627843,50597,,,,A,,9766,10116.0,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627844,50597,,,,A,,9767,10116.0,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627845,50597,,,,A,,9768,10116.0,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL627846,50597,,,In vivo,A,,9769,10116.0,,Half life period in rat by iv administration at a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5874,,
CHEMBL627847,50597,,Plasma,,A,,9770,10116.0,1969.0,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL873821,50597,,Plasma,,A,,9771,10116.0,1969.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626079,50597,,Plasma,,A,,9772,10116.0,1969.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626080,50597,,Plasma,,A,,9773,10116.0,1969.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1515,,
CHEMBL626081,50597,,Plasma,,A,,9774,10116.0,1969.0,Half life period was evaluated in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5491,,
CHEMBL875344,50597,,Plasma,,A,,9775,10116.0,1969.0,Half life period was evaluated in rat plasma; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5491,,
CHEMBL626082,50597,,,,A,,9776,10116.0,,Half life period was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1918,,
CHEMBL626250,50597,,,In vivo,A,,9777,10116.0,,"Half life period was evaluated in rats, iv",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1918,,
CHEMBL626251,50597,,,In vivo,A,,9778,10116.0,,Half life period after intravenous administration at 5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6113,,
CHEMBL626252,50597,,,In vivo,A,,9779,10116.0,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5546,,
CHEMBL626253,50597,,,In vivo,A,,9780,10116.0,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5553,,
CHEMBL626254,50597,,Plasma,,A,,9781,10116.0,1969.0,Half life stability of compound was evaluated in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4188,,
CHEMBL626255,50597,,,In vivo,A,,9782,10116.0,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6215,,
CHEMBL626256,50597,,,In vivo,A,,9783,10116.0,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6141,,
CHEMBL626257,50597,,,In vivo,A,,9784,10116.0,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL626258,50597,,,In vivo,A,,9785,10116.0,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL626259,50597,,,In vivo,A,,9786,10116.0,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5710,,
CHEMBL626260,50597,,,In vivo,A,,9787,10116.0,,Half in rat i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5789,,
CHEMBL875345,50597,,,In vivo,A,,9788,10116.0,,Half period in rat after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6011,,
CHEMBL626261,50597,,,In vivo,A,,9789,10116.0,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17594,,
CHEMBL626262,50597,,Liver,In vitro,A,,9790,10116.0,2107.0,Half-life measured in in vitro Cathepsin B assay in rat liver,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12357,,
CHEMBL626263,50597,,,,A,,9791,10116.0,,Half-life of compound was determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5210,,
CHEMBL625270,50597,,,In vivo,A,,9792,10116.0,,Half-life at 10 mg/kg in rat upon intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL625271,50597,,,,A,,9793,10116.0,,Half-life determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6672,,
CHEMBL625272,50597,,,,A,,9794,10116.0,,Half-life determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6673,,
CHEMBL625273,50597,,Brain,In vivo,A,,9795,10116.0,955.0,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL625274,50597,,Plasma,,A,,9796,10116.0,1969.0,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3741,,
CHEMBL625275,50597,,,In vivo,A,,9797,10116.0,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17671,,
CHEMBL625276,50597,,Plasma,In vivo,A,,9798,10116.0,1969.0,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL625277,50597,,Plasma,,A,,9799,10116.0,1969.0,Half-life in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17537,,
CHEMBL625278,50597,,Plasma,,A,,9800,10116.0,1969.0,Half-life in rat plasma was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4965,,
CHEMBL625279,50597,,Plasma,,A,,9801,10116.0,1969.0,Half-life in rat plasma; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17537,,
CHEMBL625280,50597,,Serum,,A,,9802,10116.0,1977.0,Half-life in rat serum,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6124,,
CHEMBL876797,50597,,Serum,,A,,9803,10116.0,1977.0,Half-life in rat serum; na is not available,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6124,,
CHEMBL625281,50597,,,,A,,9804,10116.0,,Half-life was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL873827,50597,,Plasma,,A,,9805,10116.0,1969.0,Half-life was calculated in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17668,,
CHEMBL625282,50597,,,,A,,9806,10116.0,,Half-life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3185,,
CHEMBL625283,50597,,,,A,,9807,10116.0,,Half-life was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL625284,50597,,,In vivo,A,,9808,10116.0,,Half-life after administration of 20 mg/Kg oral dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2959,,
CHEMBL625285,50597,,,In vivo,A,,9809,10116.0,,Half-life after administration of 3.2 mg/kg intravenously in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4029,,
CHEMBL625286,50597,,,In vivo,A,,9810,10116.0,,Half-life after intravenous administration in female rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4029,,
CHEMBL625287,50597,,,In vivo,A,,9811,10116.0,,Half-life after intravenous administration in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4029,,
CHEMBL625288,50597,,,In vivo,A,,9812,10116.0,,Half-life after intravenous dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6180,,
CHEMBL625289,50597,,Liver,,A,,9813,10116.0,2107.0,Half-life in a rat liver homogenate preparation,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1557,,
CHEMBL625290,50597,,Plasma,,A,,9814,10116.0,1969.0,Half-life in plasma of rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12500,,
CHEMBL876798,50597,,Plasma,,A,,9815,10116.0,1969.0,Half-life in plasma of rat at dose of 3-10 mgkg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12500,,
CHEMBL625291,50597,,,,A,,9816,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5064,,
CHEMBL625292,50597,,,,A,,9817,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5145,,
CHEMBL625293,50597,,,,A,,9818,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5147,,
CHEMBL622832,50597,,,,A,,9819,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5833,,
CHEMBL622833,50597,,,,A,,9820,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6596,,
CHEMBL622834,50597,,,,A,,9821,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL622835,50597,,,In vivo,A,,9822,10116.0,,Half-life in rat after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL622836,50597,,,In vivo,A,,9823,10116.0,,Half-life in rat after po administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL622837,50597,,,In vivo,A,,9824,10116.0,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL622838,50597,,,In vivo,A,,9825,10116.0,,Half-life in rat at 3 mg/kg dose administered intravenously,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10,,
CHEMBL622839,50597,,Brain,,A,,9826,10116.0,955.0,Half-life in rat brain homogenate,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17669,,
CHEMBL622840,50597,,Plasma,,A,,9827,10116.0,1969.0,Half-life in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17065,,
CHEMBL622841,50597,,,,A,,9828,10116.0,,Half-life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4333,,
CHEMBL622842,50597,,,,A,,9829,10116.0,,Half-life in Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6827,,
CHEMBL622843,50597,,Plasma,In vitro,A,,9830,10116.0,1969.0,Half-life in vitro in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,889,,
CHEMBL622844,50597,,Plasma,In vitro,A,,9831,10116.0,1969.0,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,889,,
CHEMBL622845,50597,,,,A,,9832,10116.0,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3747,,
CHEMBL622846,50597,,,,A,,9833,10116.0,,The area under the curve of compound was measured at the dose of 100 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL622847,50597,,,,A,,9834,10116.0,,The area under the curve of compound was measured at the dose of 300 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL622848,50597,,,,A,,9835,10116.0,,The area under the curve of compound was measured at the dose of 30 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL622849,50597,,,In vivo,A,,9836,10116.0,,Bioavailability as oral AUC in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3360,,
CHEMBL622850,50597,,Plasma,,A,,9837,10116.0,1969.0,The plasma concentration versus time curve (AUC) was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL876807,50597,,,,A,,9838,10116.0,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL622851,50597,,,,A,,9839,10116.0,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL622852,50597,,,,A,,9840,10116.0,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL622853,50597,,,,A,,9841,10116.0,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL622854,50597,,,,A,,9842,10116.0,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL622855,50597,,,,A,,9843,10116.0,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17411,,
CHEMBL622856,50597,,Plasma,,A,,9844,10116.0,1969.0,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL622857,50597,,Plasma,,A,,9845,10116.0,1969.0,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL622858,50597,,Plasma,,A,,9846,10116.0,1969.0,AUC in rat after po administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL622859,50597,,Plasma,,A,,9847,10116.0,1969.0,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL622860,50597,,,,A,,9848,10116.0,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL622861,50597,,,,A,,9849,10116.0,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL622862,50597,,,,A,,9850,10116.0,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL622863,50597,,,,A,,9851,10116.0,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL623817,50597,,,,A,,9852,10116.0,,Area under curve value 6 hr after po administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL623818,50597,,,,A,,9853,10116.0,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623819,50597,,,,A,,9854,10116.0,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623820,50597,,,,A,,9855,10116.0,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623821,50597,,,,A,,9856,10116.0,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL623822,50597,,Plasma,,A,,9857,10116.0,1969.0,AUC normalized for dose (AUCN) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6642,,
CHEMBL623823,50597,,,,A,,9858,10116.0,,Area under curve in rat after p.o. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL623824,50597,,,,A,,9859,10116.0,,Area under curve in rat after p.o. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL623825,50597,,,,A,,9860,10116.0,,Area under curve in rat after p.o. administration; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL622070,50597,,,,A,,9861,10116.0,,Area under curve in rat after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL622071,50597,,,,A,,9862,10116.0,,Area under curve (carotid artery) value of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3603,,
CHEMBL622072,50597,,,,A,,9863,10116.0,,Bioavailability expressed as the area under curve of rat carotid artery,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3550,,
CHEMBL622073,50597,,,,A,,9864,10116.0,,Area under curve in male SD rats was observed after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL622074,50597,,,,A,,9865,10116.0,,Area under curve of the compound was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL622075,50597,,,,A,,9866,10116.0,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5407,,
CHEMBL622076,50597,,Plasma,,A,,9867,10116.0,1969.0,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL622077,50597,,Plasma,,A,,9868,10116.0,1969.0,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL622078,50597,,,,A,,9869,10116.0,,Area under curve (portal vein) value of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3603,,
CHEMBL622079,50597,,,,A,,9870,10116.0,,Bioavailability expressed as the area under curve of rat portal vein,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3550,,
CHEMBL622080,50597,,Plasma,,A,,9871,10116.0,1969.0,Area Under plasma concentration time curve in rat upon peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL877612,50597,,,,A,,9872,10116.0,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL622081,50597,,,,A,,9873,10116.0,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL622082,50597,,,,A,,9874,10116.0,,Compound was evaluated for oral bioavailability in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL622083,50597,,,,A,,9875,10116.0,,Compound was evaluated for oral bioavailability in rats after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL622084,50597,,,,A,,9876,10116.0,,Compound was evaluated for oral bioavailability in rats; 30-80,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL622085,50597,,,,A,,9877,10116.0,,Compound was evaluated for oral bioavailability in rats; 50-60,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL622086,50597,,,,A,,9878,10116.0,,Compound was evaluated for oral bioavailability in rats; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL622087,50597,,,,A,,9879,10116.0,,Compound was evaluated for oral bioavailability in rats; peptide,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17791,,
CHEMBL622088,50597,,Blood,,A,,9880,10116.0,178.0,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL622089,50597,,Blood,,A,,9881,10116.0,178.0,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL623685,50597,,Blood,,A,,9882,10116.0,178.0,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL623686,50597,,Blood,,A,,9883,10116.0,178.0,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL623687,50597,,Stomach,In vivo,A,,9884,10116.0,945.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL623688,50597,,Stomach,In vivo,A,,9885,10116.0,945.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL623689,50597,,Stomach,In vivo,A,,9886,10116.0,945.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622485,50597,,Stomach,In vivo,A,,9887,10116.0,945.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622486,50597,,Thyroid gland,In vivo,A,,9888,10116.0,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL877613,50597,,Thyroid gland,In vivo,A,,9889,10116.0,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622487,50597,,Thyroid gland,In vivo,A,,9890,10116.0,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622488,50597,,Thyroid gland,In vivo,A,,9891,10116.0,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622489,50597,,Heart,In vivo,A,,9892,10116.0,948.0,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622490,50597,,Urine,,A,,9893,10116.0,1088.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622491,50597,,Urine,,A,,9894,10116.0,1088.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622492,50597,,Liver,,A,,9895,10116.0,2107.0,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622493,50597,,Urine,,A,,9896,10116.0,1088.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622494,50597,,Urine,,A,,9897,10116.0,1088.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622495,50597,,Muscle tissue,,A,,9898,10116.0,2385.0,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8677,,
CHEMBL622496,50597,,,,A,,9899,10116.0,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622497,50597,,Urine,,A,,9900,10116.0,1088.0,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6899,,
CHEMBL622498,50597,,,,A,,9901,10116.0,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2189,,
CHEMBL624918,50597,,Urine,,A,,9902,10116.0,1088.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2189,,
CHEMBL624919,50597,,Urine,,A,,9903,10116.0,1088.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2189,,
CHEMBL624920,50597,,Blood,In vivo,A,,9904,10116.0,178.0,Biodistribution of compound in rat blood after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624921,50597,,Blood,In vivo,A,,9905,10116.0,178.0,Biodistribution of compound in rat blood after 5 min of administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624922,50597,,Brain,In vivo,A,,9906,10116.0,955.0,Biodistribution of compound in rat brain after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624923,50597,,Heart,In vivo,A,,9907,10116.0,948.0,Biodistribution of compound in rat heart after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624924,50597,,Heart,In vivo,A,,9908,10116.0,948.0,Biodistribution of compound in rat heart after 5 min of administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624925,50597,,Kidney,In vivo,A,,9909,10116.0,2113.0,Biodistribution of compound in rat kidney after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624926,50597,,Kidney,In vivo,A,,9910,10116.0,2113.0,Biodistribution of compound in rat kidney after 5 min of administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624927,50597,,Liver,In vivo,A,,9911,10116.0,2107.0,Biodistribution of compound in rat liver after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL874402,50597,,Liver,In vivo,A,,9912,10116.0,2107.0,Biodistribution of compound in rat liver after 5 min of administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624928,50597,,Lung,In vivo,A,,9913,10116.0,2048.0,Biodistribution of compound in rat lung after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624929,50597,,Lung,In vivo,A,,9914,10116.0,2048.0,Biodistribution of compound in rat lung after 5 min of administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624930,50597,,Muscle tissue,In vivo,A,,9915,10116.0,2385.0,Biodistribution of compound in rat muscle after 5 min of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624931,50597,,Muscle tissue,In vivo,A,,9916,10116.0,2385.0,Biodistribution of compound in rat muscle after 5 min of administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10839,,
CHEMBL624932,50597,,Heart,,A,,9917,10116.0,948.0,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624933,50597,,Heart,,A,,9918,10116.0,948.0,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624934,50597,,Liver,,A,,9919,10116.0,2107.0,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624935,50597,,Liver,,A,,9920,10116.0,2107.0,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624936,50597,,,,A,,9921,10116.0,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624937,50597,,,,A,,9922,10116.0,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624938,50597,,Spleen,,A,,9923,10116.0,2106.0,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624939,50597,,Spleen,,A,,9924,10116.0,2106.0,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624940,50597,,,,A,,9925,10116.0,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL874403,50597,,,,A,,9926,10116.0,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4043,,
CHEMBL624941,50597,,,,A,,9927,10116.0,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1446,,
CHEMBL624942,50597,,Urine,,A,,9928,10116.0,1088.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9971,,
CHEMBL624943,50597,,Urine,,A,,9929,10116.0,1088.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9971,,
CHEMBL624944,50597,,,In vivo,A,,9930,10116.0,,% Bioavailability after 1 day of the drug administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5765,,
CHEMBL624945,50597,,,In vivo,A,,9931,10116.0,,% Bioavailability after 4 day of the drug administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5765,,
CHEMBL624946,50597,,,In vivo,A,,9932,10116.0,,Absolute bioavailability was evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4257,,
CHEMBL624947,50597,,,,A,,9933,10116.0,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624948,50597,,,,A,,9934,10116.0,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624949,50597,,,,A,,9935,10116.0,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622025,50597,,Kidney,,A,,9936,10116.0,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622026,50597,,Kidney,,A,,9937,10116.0,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622027,50597,,Kidney,,A,,9938,10116.0,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622028,50597,,Kidney,,A,,9939,10116.0,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622029,50597,,Liver,,A,,9940,10116.0,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622208,50597,,Liver,,A,,9941,10116.0,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622209,50597,,Liver,,A,,9942,10116.0,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622210,50597,,Liver,,A,,9943,10116.0,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622211,50597,,,,A,,9944,10116.0,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622212,50597,,,,A,,9945,10116.0,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL622213,50597,,,,A,,9946,10116.0,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL874404,50597,,,,A,,9947,10116.0,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL620452,50597,,Muscle tissue,,A,,9948,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL620453,50597,,Muscle tissue,,A,,9949,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL620454,50597,,Muscle tissue,,A,,9950,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624067,50597,,Muscle tissue,,A,,9951,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624068,50597,,,,A,,9952,10116.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624069,50597,,Female gonad,,A,,9953,10116.0,992.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624070,50597,,Female gonad,,A,,9954,10116.0,992.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624071,50597,,Female gonad,,A,,9955,10116.0,992.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624072,50597,,Uterus,,A,,9956,10116.0,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624073,50597,,Uterus,,A,,9957,10116.0,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624788,50597,,Uterus,,A,,9958,10116.0,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624789,50597,,Uterus,,A,,9959,10116.0,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624790,50597,,,,A,,9960,10116.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624791,50597,,,,A,,9961,10116.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624792,50597,,,,A,,9962,10116.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624793,50597,,,,A,,9963,10116.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL877491,50597,,Muscle tissue,,A,,9964,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624957,50597,,Muscle tissue,,A,,9965,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624958,50597,,Muscle tissue,,A,,9966,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624959,50597,,Muscle tissue,,A,,9967,10116.0,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13091,,
CHEMBL624960,50597,,,,A,,9968,10116.0,,Dissociation constant was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11977,,
CHEMBL624961,50597,,,,A,,9969,10116.0,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL624962,50597,,,,A,,9970,10116.0,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL624963,50597,,,,A,,9971,10116.0,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL624964,50597,,,,A,,9972,10116.0,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4755,,
CHEMBL624965,50597,,,,A,,9973,10116.0,,LogP value was evaluated in the in situ rat gut perfusion assay,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,589,,
CHEMBL624966,50597,,,In vivo,A,,9974,10116.0,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL624967,50597,,,In vivo,A,,9975,10116.0,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5031,,
CHEMBL624968,50597,,,In vivo,A,,9976,10116.0,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL624969,50597,,,,A,,9977,10116.0,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL624970,50597,,,,F,,9978,10116.0,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,2862,,
CHEMBL624971,50597,,,,A,,9979,10116.0,,Half-life was evaluated after 10 uM/kg of intra arterial administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL624972,50597,,,In vivo,A,,9980,10116.0,,Half-life was evaluated after 20 uM/kg of peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL624973,50597,,,In vivo,A,,9981,10116.0,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6005,,
CHEMBL624974,50597,,Plasma,,A,,9982,10116.0,1969.0,Half-life was evaluated in plasma of rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2938,,
CHEMBL624975,50597,,,In vivo,A,,9983,10116.0,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL877492,50597,,,In vivo,A,,9984,10116.0,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL624976,50597,,,In vivo,A,,9985,10116.0,,Half-life was measured in rat after an iv dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6062,,
CHEMBL624977,50597,,,In vivo,A,,9986,10116.0,,Half-life period of compound in rats after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6571,,
CHEMBL626848,50597,,Plasma,,A,,9987,10116.0,1969.0,Half-life period of compound was measured in rat plasma.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3136,,
CHEMBL626849,50597,,Plasma,,A,,9988,10116.0,1969.0,Half-life period of compound was measured in rat plasma; ND is not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3136,,
CHEMBL626850,50597,,Plasma,,A,,9989,10116.0,1969.0,Half-life period of compound was measured in rat plasma; not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3136,,
CHEMBL626851,50597,,,In vivo,A,,9990,10116.0,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4521,,
CHEMBL626852,50597,,,In vivo,A,,9991,10116.0,,Half-life period in rat by iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5871,,
CHEMBL626853,50597,,,In vivo,A,,9992,10116.0,,Half-life period in rats following intravenous administration at 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6077,,
CHEMBL626854,50597,,,In vivo,A,,9993,10116.0,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6679,,
CHEMBL627486,50597,,,,A,,9994,10116.0,,Half-life period was determined for the compound in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5144,,
CHEMBL627487,50597,,,In vivo,A,,9995,10116.0,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4498,,
CHEMBL627488,50597,,,In vivo,A,,9996,10116.0,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4498,,
CHEMBL627489,50597,,,In vivo,A,,9997,10116.0,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL627490,50597,,,In vivo,A,,9998,10116.0,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6211,,
CHEMBL873829,50597,,,In vivo,A,,9999,10116.0,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5529,,
CHEMBL627655,50597,,,In vivo,A,,10000,10116.0,,Half-life was determined in rat at a dose of 1 mpk i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL625994,50597,,,In vivo,A,,10001,10116.0,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL625995,50597,,,In vivo,A,,10002,10116.0,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6444,,
CHEMBL625996,50597,,,,A,,10003,10116.0,,Half-life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5207,,
CHEMBL625850,50597,,Plasma,In vitro,A,,10004,10116.0,1969.0,In vitro half life in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,530,,
CHEMBL625851,50597,,Plasma,In vitro,A,,10005,10116.0,1969.0,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1116,,
CHEMBL625852,50597,,,In vitro,A,,10006,10116.0,,In vitro half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3219,,
CHEMBL625853,50597,,,In vivo,A,,10007,10116.0,,In vivo half life period after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6109,,
CHEMBL625854,50597,,,In vivo,A,,10008,10116.0,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL874450,50597,,,In vivo,A,,10009,10116.0,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL625855,50597,,,In vivo,A,,10010,10116.0,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625856,50597,,,In vivo,A,,10011,10116.0,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625857,50597,,,In vivo,A,,10012,10116.0,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL873831,50597,,,In vivo,A,,10013,10116.0,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL625858,50597,,,In vivo,A,,10014,10116.0,,Longer half-life in rat (i.v.) at 0.5 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17853,,
CHEMBL625859,50597,,,In vivo,A,,10015,10116.0,,Longer half-life in rat (p.o.) at 2.0 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17853,,
CHEMBL625860,50597,,,,A,,10016,10116.0,,Pharmacokinetic property (half life) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3457,,
CHEMBL625861,50597,,,In vivo,A,,10017,10116.0,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL625862,50597,,,In vivo,A,,10018,10116.0,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL625863,50597,,,In vivo,A,,10019,10116.0,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL625864,50597,,,In vivo,A,,10020,10116.0,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL625865,50597,,,In vivo,A,,10021,10116.0,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5739,,
CHEMBL625866,50597,,,In vivo,A,,10022,10116.0,,Pharmacokinetic half time was determined intravenously in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL625867,50597,,Plasma,In vivo,A,,10023,10116.0,1969.0,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6567,,
CHEMBL625868,50597,,Plasma,,A,,10024,10116.0,1969.0,Plasma half life of hydrolysis of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2448,,
CHEMBL625869,50597,,Plasma,In vivo,A,,10025,10116.0,1969.0,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5423,,
CHEMBL874451,50597,,Plasma,,A,,10026,10116.0,1969.0,Plasma half life period was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL625870,50597,,Plasma,,A,,10027,10116.0,1969.0,Plasma half-life in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL625871,50597,,Plasma,,A,,10028,10116.0,1969.0,Plasma half-life in Sprague-Dawley rats; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL625872,50597,,Plasma,,A,,10029,10116.0,1969.0,Plasma half-life in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1500,,
CHEMBL625873,50597,,Plasma,,A,,10030,10116.0,1969.0,Plasma half-life in rats; <MQL,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1500,,
CHEMBL625874,50597,,Plasma,,A,,10031,10116.0,1969.0,Plasma half-life period (0-8 h) was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL625875,50597,,Plasma,,A,,10032,10116.0,1969.0,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL625876,50597,,Plasma,In vivo,A,,10033,10116.0,1969.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL631258,50597,,Plasma,In vivo,A,,10034,10116.0,1969.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL631259,50597,,Plasma,,A,,10035,10116.0,1969.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4956,,
CHEMBL631260,50597,,Plasma,,A,,10036,10116.0,1969.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4956,,
CHEMBL631261,50597,,Blood,,A,,10037,10116.0,178.0,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631262,50597,,Blood,,A,,10038,10116.0,178.0,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631263,50597,,Blood,,A,,10039,10116.0,178.0,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631264,50597,,,,A,,10040,10116.0,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631265,50597,,,,A,,10041,10116.0,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631266,50597,,,,A,,10042,10116.0,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631267,50597,,,,A,,10043,10116.0,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631268,50597,,,,A,,10044,10116.0,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631269,50597,,,,A,,10045,10116.0,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631270,50597,,,,A,,10046,10116.0,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631271,50597,,Heart,,A,,10047,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631272,50597,,Heart,,A,,10048,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631273,50597,,Heart,,A,,10049,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631274,50597,,Heart,,A,,10050,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL631275,50597,,Heart,,A,,10051,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626984,50597,,Heart,,A,,10052,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626985,50597,,Heart,,A,,10053,10116.0,948.0,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626986,50597,,Liver,,A,,10054,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626987,50597,,Liver,,A,,10055,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626988,50597,,Liver,,A,,10056,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626989,50597,,Liver,,A,,10057,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626990,50597,,Liver,,A,,10058,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626991,50597,,Liver,,A,,10059,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626992,50597,,Liver,,A,,10060,10116.0,2107.0,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626993,50597,,Lung,,A,,10061,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL874593,50597,,Lung,,A,,10062,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626994,50597,,Lung,,A,,10063,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626995,50597,,Lung,,A,,10064,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626190,50597,,Lung,,A,,10065,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626191,50597,,Lung,,A,,10066,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626364,50597,,Lung,,A,,10067,10116.0,2048.0,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626365,50597,,Thyroid gland,,A,,10068,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626366,50597,,Thyroid gland,,A,,10069,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626367,50597,,Thyroid gland,,A,,10070,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626368,50597,,Thyroid gland,,A,,10071,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626369,50597,,Thyroid gland,,A,,10072,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626370,50597,,Thyroid gland,,A,,10073,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626371,50597,,,In vivo,A,,10074,10116.0,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4498,,
CHEMBL626372,50597,,,In vivo,A,,10075,10116.0,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4498,,
CHEMBL626373,50597,,,In vivo,A,,10076,10116.0,,Bioavailability after a dose of 10 mg/kg p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3603,,
CHEMBL626374,50597,,,In vivo,A,,10077,10116.0,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6215,,
CHEMBL626375,50597,,,In vivo,A,,10078,10116.0,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5710,,
CHEMBL626376,50597,,,In vivo,A,,10079,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5710,,
CHEMBL626377,50597,,,In vivo,A,,10080,10116.0,,Bioavailability in rat po was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5676,,
CHEMBL626378,50597,,,In vivo,A,,10081,10116.0,,Bioavailability of compound at 10 mg/kg in rat after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17667,,
CHEMBL626379,50597,,,In vivo,A,,10082,10116.0,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17667,,
CHEMBL626380,50597,,,In vivo,A,,10083,10116.0,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6848,,
CHEMBL626381,50597,,,In vivo,A,,10084,10116.0,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6848,,
CHEMBL626382,50597,,,In vivo,A,,10085,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17267,,
CHEMBL626383,50597,,,In vivo,A,,10086,10116.0,,Bioavailability in rat (Sprague-Dawley) (female),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6362,,
CHEMBL874652,50597,,,In vivo,A,,10087,10116.0,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17671,,
CHEMBL626384,50597,,,In vivo,A,,10088,10116.0,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17671,,
CHEMBL626385,50597,,,In vivo,A,,10089,10116.0,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4333,,
CHEMBL626386,50597,,,In vivo,A,,10090,10116.0,,Bioavailability in rat at an oral dose of 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6077,,
CHEMBL626387,50597,,,In vivo,A,,10091,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3278,,
CHEMBL626388,50597,,,In vivo,A,,10092,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5964,,
CHEMBL626389,50597,,,In vivo,A,,10093,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4884,,
CHEMBL626390,50597,,,In vivo,A,,10094,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4905,,
CHEMBL626391,50597,,,In vivo,A,,10095,10116.0,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4884,,
CHEMBL626392,50597,,,In vivo,A,,10096,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6850,,
CHEMBL626393,50597,,,In vivo,A,,10097,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2864,,
CHEMBL623026,50597,,,In vivo,A,,10098,10116.0,,Bioavailability was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5780,,
CHEMBL623027,50597,,,In vivo,A,,10099,10116.0,,Bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1465,,
CHEMBL623028,50597,,,In vivo,A,,10100,10116.0,,Bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5199,,
CHEMBL623029,50597,,,In vivo,A,,10101,10116.0,,Bioavailability in rat after 1 day dosing,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5765,,
CHEMBL623030,50597,,,In vivo,A,,10102,10116.0,,Bioavailability in rat after 4 day dosing,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5765,,
CHEMBL623031,50597,,,In vivo,A,,10103,10116.0,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL623032,50597,,,In vivo,A,,10104,10116.0,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL623033,50597,,,In vivo,A,,10105,10116.0,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL623034,50597,,,In vivo,A,,10106,10116.0,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6518,,
CHEMBL623035,50597,,,In vivo,A,,10107,10116.0,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2083,,
CHEMBL623036,50597,,,In vivo,A,,10108,10116.0,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17260,,
CHEMBL623037,50597,,,In vivo,A,,10109,10116.0,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4956,,
CHEMBL623038,50597,,,In vivo,A,,10110,10116.0,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4368,,
CHEMBL874385,50597,,Plasma,In vivo,A,,10111,10116.0,1969.0,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17752,,
CHEMBL623039,50597,,,In vivo,A,,10112,10116.0,,Bioavailability in rat (Fisher) (fasted),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1446,,
CHEMBL623040,22224,,,In vivo,A,,10113,9443.0,,Bioavailability in monkey after po administration of 10 mg/kg dose,U,,0,,Intermediate,1,BAO_0000218,,Primates,2891,,
CHEMBL623041,22224,,,In vivo,A,,10114,9443.0,,Oral bioavailability in monkey (dose 10 mg/kg),U,,0,,Intermediate,1,BAO_0000218,,Primates,2891,,
CHEMBL623741,50597,,,In vivo,A,,10115,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6672,,
CHEMBL623742,50597,,,In vivo,A,,10116,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6673,,
CHEMBL623743,50597,,,In vivo,A,,10117,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL623744,50597,,,In vivo,A,,10118,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL623745,50597,,,In vivo,A,,10119,10116.0,,Bioavailability in rat (dose 2.0 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17853,,
CHEMBL623746,50597,,,In vivo,A,,10120,10116.0,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4521,,
CHEMBL623747,50597,,,In vivo,A,,10121,10116.0,,Oral bioavailability in rat (dose 5 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4940,,
CHEMBL623748,22224,,,In vivo,A,,10122,10116.0,,Bioavailability in rat after po administration of 30 mg/kg dose,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2891,,
CHEMBL623916,22224,,,In vivo,A,,10123,10116.0,,Bioavailability in rat after po administration of 30 mg/kg dose,U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2891,,
CHEMBL623917,50597,,,In vivo,A,,10124,10116.0,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4521,,
CHEMBL623918,50597,,,In vivo,A,,10125,10116.0,,Bioavailability in rat (dose 2 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17686,,
CHEMBL874386,50597,,,In vivo,A,,10126,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL623919,50597,,Plasma,In vivo,A,,10127,10116.0,1969.0,Bioavailability in rat; Only traces detected in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL623920,50597,,,In vivo,A,,10128,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5064,,
CHEMBL623148,50597,,,In vivo,A,,10129,10116.0,,Bioavailability upon oral administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5147,,
CHEMBL623149,50597,,,In vivo,A,,10130,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1916,,
CHEMBL623150,50597,,,In vivo,A,,10131,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6049,,
CHEMBL623151,50597,,,In vivo,A,,10132,10116.0,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1445,,
CHEMBL623152,50597,,,In vivo,A,,10133,10116.0,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1445,,
CHEMBL623153,50597,,,,F,,10134,10116.0,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,2862,,
CHEMBL623154,50597,,,,F,,10135,10116.0,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,2862,,
CHEMBL623155,50597,,,,A,,10136,10116.0,,In vitro and metabolic stability was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4194,,
CHEMBL623156,50597,,,,A,,10137,10116.0,,In vitro metabolic stability in rat hepatocytes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4194,,
CHEMBL623157,50597,,,,A,,10138,10116.0,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5486,,
CHEMBL623158,50597,,Liver,In vitro,A,401.0,10139,10116.0,2107.0,Metabolic rate for compound was observed in rat hepatocytes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,Hepatocyte
CHEMBL623159,50597,,,,A,,10140,10116.0,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5600,,
CHEMBL874390,50597,,,,A,,10141,10116.0,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14294,,
CHEMBL623160,50597,,,,A,,10142,10116.0,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14294,,
CHEMBL623161,50597,,,,A,,10143,10116.0,,Metabolism of compound in rat S9 microsomes; Trace,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14294,,
CHEMBL623162,50597,,,,A,,10144,10116.0,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17847,,
CHEMBL623163,50597,,,,A,,10145,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623164,50597,,,,A,,10146,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623165,50597,,,,A,,10147,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623166,50597,,,,A,,10148,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL624983,50597,,,,A,,10149,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL624984,50597,,,,A,,10150,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL624985,50597,,,,A,,10151,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622970,50597,,,,A,,10152,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622971,50597,,,,A,,10153,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622972,50597,,,,A,,10154,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622973,50597,,,,A,,10155,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622974,50597,,,,A,,10156,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622975,50597,,,,A,,10157,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622976,50597,,,,A,,10158,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622977,50597,,,,A,,10159,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL624351,50597,,,,A,,10160,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL624352,50597,,,,A,,10161,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL624353,50597,,,,A,,10162,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622397,50597,,,,A,,10163,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622398,50597,,,,A,,10164,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622399,50597,,,,A,,10165,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL622400,50597,,,,A,,10166,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628428,50597,,,,A,,10167,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628590,50597,,,,A,,10168,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628591,50597,,,,A,,10169,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628592,50597,,,,A,,10170,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628593,50597,,,,A,,10171,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL875333,50597,,,,A,,10172,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628594,50597,,,,A,,10173,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628595,50597,,Plasma,,A,,10174,10116.0,1969.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4969,,
CHEMBL628596,50597,,Plasma,,A,,10175,10116.0,1969.0,Stability in rat plasma was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6737,,
CHEMBL628597,50597,,Plasma,,A,,10176,10116.0,1969.0,Stability in rat plasma was determined; ND= no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6737,,
CHEMBL628598,50597,,Plasma,,A,,10177,10116.0,1969.0,Tested for plasma half life period in rat (0-8 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5089,,
CHEMBL628599,50597,,Plasma,,A,,10178,10116.0,1969.0,Tested for plasma half life period in rat (0-8 hr); Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5089,,
CHEMBL628600,50597,,,In vivo,A,,10179,10116.0,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL628601,50597,,,In vivo,A,,10180,10116.0,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL628602,50597,,,,A,,10181,10116.0,,Tested for the half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4950,,
CHEMBL628603,50597,,,In vitro,A,,10182,10116.0,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2412,,
CHEMBL628604,50597,,,In vitro,A,,10183,10116.0,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2412,,
CHEMBL628605,50597,,,In vitro,A,,10184,10116.0,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2412,,
CHEMBL628606,50597,,,In vitro,A,,10185,10116.0,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2412,,
CHEMBL628607,50597,,,In vitro,A,,10186,10116.0,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2412,,
CHEMBL628608,50597,,,,A,,10187,10116.0,,The biological half life the compound was measured at the dose of 100 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL628609,50597,,,,A,,10188,10116.0,,The biological half life the compound was measured at the dose of 30 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15022,,
CHEMBL628610,50597,,Plasma,,A,,10189,10116.0,1969.0,The compound was evaluated for plasma half life period in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,406,,
CHEMBL873819,50597,,,In vivo,A,,10190,10116.0,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL628611,50597,,,In vivo,A,,10191,10116.0,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL628612,50597,,,In vivo,A,,10192,10116.0,,The pharmacokinetic parameter half-life period in vivo in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5247,,
CHEMBL628613,50597,,,In vivo,A,,10193,10116.0,,"The pharmacokinetic property, Half-life was determined",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL628614,50597,,,In vivo,A,,10194,10116.0,,"The pharmacokinetic property, Half-life in rat in vivo",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL628615,50597,,,In vivo,A,,10195,10116.0,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL628616,50597,,,In vivo,A,,10196,10116.0,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL627924,50597,,Plasma,,A,,10197,10116.0,1969.0,The plasma half life period in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3918,,
CHEMBL627925,50597,,Liver,,A,,10198,10116.0,2107.0,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2906,,
CHEMBL627926,50597,,,In vivo,A,,10199,10116.0,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6467,,
CHEMBL627927,50597,,,,A,,10200,10116.0,,t1/2 (apparent elimination)of the compound was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL627928,50597,,,,A,,10201,10116.0,,t1/2 value in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3788,,
CHEMBL627539,50597,,,,A,,10202,10116.0,,Half life in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17796,,
CHEMBL876790,50597,,Plasma,In vivo,A,,10203,10116.0,1969.0,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL858186,50597,,,In vivo,A,,10204,10116.0,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5983,,
CHEMBL627540,50597,,,,A,,10205,10116.0,,Half-life period in fasted rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL627541,50597,,,In vivo,A,,10206,10116.0,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL627715,50597,,,In vivo,A,,10207,10116.0,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL627716,50597,,,In vivo,A,,10208,10116.0,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,429,,
CHEMBL627717,50597,,,,A,,10209,10116.0,,Maximum time required to achieve Cmax was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL627718,50597,,,In vivo,A,,10210,10116.0,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL627719,50597,,,In vivo,A,,10211,10116.0,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL627720,50597,,,In vivo,A,,10212,10116.0,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL627721,50597,,,In vivo,A,,10213,10116.0,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL627722,50597,,,In vivo,A,,10214,10116.0,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL627723,50597,,,In vivo,A,,10215,10116.0,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL626058,50597,,,In vivo,A,,10216,10116.0,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL626059,50597,,,In vivo,A,,10217,10116.0,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL626060,50597,,,In vivo,A,,10218,10116.0,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL626061,50597,,Plasma,In vivo,A,,10219,10116.0,1969.0,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL876791,50597,,,In vivo,A,,10220,10116.0,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL626062,50597,,,In vivo,A,,10221,10116.0,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4723,,
CHEMBL626063,50597,,,In vivo,A,,10222,10116.0,,Tmax at the dose of 2 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL626064,50597,,,In vivo,A,,10223,10116.0,,Tmax at the dose of 5 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL626065,50597,,Plasma,In vivo,A,,10224,10116.0,1969.0,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL626066,50597,,Plasma,In vivo,A,,10225,10116.0,1969.0,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17720,,
CHEMBL626067,50597,,,In vivo,A,,10226,10116.0,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL626068,50597,,,,F,,10227,10116.0,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626069,50597,,,,F,,10228,10116.0,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626070,50597,,,,F,,10229,10116.0,,Percent total excretion of 3-methoxyacetaminophen glucuronide,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626071,50597,,,,F,,10230,10116.0,,Percent total excretion of N-methoxyacetaminophen glucuronide,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626072,50597,,,,F,,10231,10116.0,,Percent total excretion of N-methoxyacetaminophen sulfate,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626073,50597,,,,F,,10232,10116.0,,Percent total excretion of acetaminophen,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626741,50597,,Thyroid gland,,A,,10233,10116.0,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7768,,
CHEMBL626742,50597,,,,A,,10234,10116.0,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17655,,
CHEMBL626743,50597,,,,A,,10235,10116.0,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17735,,
CHEMBL876792,50597,,,,A,,10236,10116.0,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5960,,
CHEMBL626744,50597,,,,A,,10237,10116.0,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17735,,
CHEMBL626745,50597,,,,A,,10238,10116.0,,Compound was tested for antidiuretic activity in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7116,,
CHEMBL626746,50597,,Plasma,In vivo,A,,10239,10116.0,1969.0,AUC in rat after 3mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4878,,
CHEMBL626747,50597,,,,A,,10240,10116.0,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL626748,50597,,,,A,,10241,10116.0,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL626749,50597,,,,A,,10242,10116.0,,Bioavailability administered orally at a dose of 10 mg/kg to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16367,,
CHEMBL626750,50597,,,,A,,10243,10116.0,,Oral Bioavailability was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16366,,
CHEMBL626751,50597,,,,A,,10244,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL626913,50597,,,,A,,10245,10116.0,,Oral bioavailability in rat; Not performed.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4426,,
CHEMBL626914,50597,,,,A,,10246,10116.0,,Bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL626915,50597,,,,A,,10247,10116.0,,Bioavailability was determined; ND denotes no data,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5041,,
CHEMBL626916,50597,,,,A,,10248,10116.0,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1500,,
CHEMBL626917,50597,,,,A,,10249,10116.0,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1500,,
CHEMBL626918,50597,,,,A,,10250,10116.0,,Binding towards rat plasma protein at 10 uM,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17409,,
CHEMBL626919,50597,,,,A,,10251,10116.0,,Binding towards rat plasma protein at 100 uM,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17409,,
CHEMBL626920,50597,,,In vivo,A,,10252,10116.0,,Bioavailability in rat (dose 20 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2959,,
CHEMBL621976,50597,,,In vivo,A,,10253,10116.0,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13501,,
CHEMBL877599,50597,,,In vivo,A,,10254,10116.0,,Bioavailability in rat after 5 mg/kg oral gavage,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6567,,
CHEMBL621977,50597,,,In vivo,A,,10255,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6571,,
CHEMBL621978,50597,,,In vivo,A,,10256,10116.0,,Bioavailability in rat (dose 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6715,,
CHEMBL621979,50597,,,In vivo,A,,10257,10116.0,,Bioavailability in rat (dose 3 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6715,,
CHEMBL621980,50597,,,In vivo,A,,10258,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2932,,
CHEMBL621981,50597,,,In vivo,A,,10259,10116.0,,Bioavailability of the compound in rats after administration of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4171,,
CHEMBL621982,50597,,,In vivo,A,,10260,10116.0,,Bioavailability after administration of 10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL882953,50597,,,In vivo,A,,10261,10116.0,,Bioavailability after administration of 2 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17509,,
CHEMBL621983,50597,,,In vivo,A,,10262,10116.0,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4527,,
CHEMBL621984,50597,,,In vivo,A,,10263,10116.0,,Bioavailability in dogs was determined; high,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL621985,50597,,,In vivo,A,,10264,10116.0,,Bioavailability in monkey after intravenous administration at 1 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6659,,
CHEMBL621986,50597,,,In vivo,A,,10265,10116.0,,Bioavailability in monkey after peroral administration at 10 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6659,,
CHEMBL621987,50597,,,In vivo,A,,10266,10116.0,,Bioavailability in rat after intravenous administration at 1 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6659,,
CHEMBL877600,50597,,,In vivo,F,,10267,10116.0,,Bioavailability in rat after intravenous administration at 2 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6659,,
CHEMBL621988,50597,,,In vivo,A,,10268,10116.0,,Bioavailability in rat after peroral administration at 30 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6659,,
CHEMBL621989,50597,,,In vivo,F,,10269,10116.0,,Bioavailability in rat after peroral administration at at 100 mpk,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6659,,
CHEMBL621990,50597,,,In vivo,A,,10270,10116.0,,Bioavailability in rats was evaluated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6597,,
CHEMBL621991,50597,,,In vivo,A,,10271,10116.0,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1202,,
CHEMBL621992,50597,,,In vivo,A,,10272,10116.0,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1202,,
CHEMBL621993,50597,,,In vivo,A,,10273,10116.0,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1202,,
CHEMBL621994,50597,,,In vivo,A,,10274,10116.0,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1202,,
CHEMBL621995,50597,,,In vivo,A,,10275,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5207,,
CHEMBL621996,50597,,,In vivo,A,,10276,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5970,,
CHEMBL621997,50597,,,In vivo,A,,10277,10116.0,,Oral bioavailability in rat (dose 10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL621998,50597,,,In vivo,A,,10278,10116.0,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17538,,
CHEMBL621999,50597,,,In vivo,A,,10279,10116.0,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1466,,
CHEMBL622000,50597,,,In vivo,A,,10280,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL622001,50597,,,In vivo,A,,10281,10116.0,,Bioavailability was measured in rat after oral administration; 2-4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL622002,50597,,,In vivo,A,,10282,10116.0,,Bioavailability was measured in rat after oral administration; 3-7,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2879,,
CHEMBL622003,50597,,,In vivo,A,,10283,10116.0,,Bioavailability in rat (intraduodenal administration),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3777,,
CHEMBL877601,50597,,,In vivo,A,,10284,10116.0,,Bioavailability in rat (intraduodenal administration),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3777,,
CHEMBL624871,50597,,,In vivo,A,,10285,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3777,,
CHEMBL622004,50597,,,In vivo,A,,10286,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3777,,
CHEMBL882954,50597,,,In vivo,A,,10287,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5423,,
CHEMBL622005,50597,,,In vivo,A,,10288,10116.0,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622006,50597,,,In vivo,A,,10289,10116.0,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16365,,
CHEMBL622007,50597,,,In vivo,A,,10290,10116.0,,Bioavailability was measured in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4239,,
CHEMBL622008,50597,,,In vivo,A,,10291,10116.0,,Bioavailability was reported,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5438,,
CHEMBL622009,50597,,,In vivo,A,,10292,10116.0,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL622010,50597,,,In vivo,A,,10293,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL622011,50597,,,In vivo,A,,10294,10116.0,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL622012,50597,,,In vivo,A,,10295,10116.0,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL622013,50597,,,In vivo,A,,10296,10116.0,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4199,,
CHEMBL622014,50597,,,In vivo,A,,10297,10116.0,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4890,,
CHEMBL624749,50597,,,In vivo,A,,10298,10116.0,,Bioavailability was determined at 3 mg/kg po dose in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2792,,
CHEMBL624750,50597,,,In vivo,A,,10299,10116.0,,Oral bioavailability in rat (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5529,,
CHEMBL624751,50597,,,In vivo,A,,10300,10116.0,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL624752,50597,,,In vivo,A,,10301,10116.0,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL624753,50597,,,In vivo,A,,10302,10116.0,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6685,,
CHEMBL624754,50597,,,In vivo,A,,10303,10116.0,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6005,,
CHEMBL624755,50597,,,In vivo,A,,10304,10116.0,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL624756,50597,,,In vivo,A,,10305,10116.0,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL624757,50597,,,In vivo,A,,10306,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6103,,
CHEMBL624758,50597,,,In vivo,A,,10307,10116.0,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL622270,50597,,,In vivo,A,,10308,10116.0,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6410,,
CHEMBL622271,50597,,,In vivo,A,,10309,10116.0,,Bioavailability in rat (Sprague-Dawley),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5353,,
CHEMBL622272,50597,,,In vivo,A,,10310,10116.0,,Bioavailability in rat at the dose of 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL622273,50597,,,In vivo,A,,10311,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL622274,50597,,,In vivo,A,,10312,10116.0,,Bioavailability in rat (cannulated) (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5809,,
CHEMBL622275,50597,,,In vivo,A,,10313,10116.0,,Bioavailability value of compound in rats was determined after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL622276,50597,,,In vivo,A,,10314,10116.0,,Oral bioavailability in rat (dose 20 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3634,,
CHEMBL622277,50597,,,In vivo,A,,10315,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3341,,
CHEMBL622278,50597,,,In vivo,A,,10316,10116.0,,Oral bioavailability in rat (dose 5 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2690,,
CHEMBL622279,50597,,,In vivo,A,,10317,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3184,,
CHEMBL622280,50597,,,In vivo,A,,10318,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,740,,
CHEMBL624083,50597,,,In vivo,A,,10319,10116.0,,Compound was evaluated for oral bioavailability in rats; 15-27 %,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1806,,
CHEMBL624084,50597,,,In vivo,A,,10320,10116.0,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4891,,
CHEMBL624085,50597,,,In vivo,A,,10321,10116.0,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3634,,
CHEMBL624086,50597,,,In vivo,A,,10322,10116.0,,Compound was tested for bioavailability in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,64,,
CHEMBL624087,50597,,,In vivo,A,,10323,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4839,,
CHEMBL624088,50597,,,In vivo,A,,10324,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1094,,
CHEMBL624089,22224,,,In vivo,A,,10325,9544.0,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,U,,0,,Intermediate,1,BAO_0000218,,Macaca mulatta,5005,,
CHEMBL624090,22224,,,In vivo,A,,10326,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),U,,0,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5005,,
CHEMBL624091,50597,,,In vivo,A,,10327,10116.0,,Evaluated for the bioavailability in rat (in vivo),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4687,,
CHEMBL624092,50597,,,In vivo,A,,10328,10116.0,,F value of compound in rats was determined after peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17804,,
CHEMBL624093,50597,,,In vivo,A,,10329,10116.0,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624094,50597,,,In vivo,A,,10330,10116.0,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624095,50597,,,In vivo,A,,10331,10116.0,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624096,50597,,,In vivo,A,,10332,10116.0,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5974,,
CHEMBL624097,50597,,,In vivo,A,,10333,10116.0,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1088,,
CHEMBL624098,50597,,,In vivo,A,,10334,10116.0,,Maximum fall in carotid flow in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1742,,
CHEMBL874392,50597,,,In vivo,A,,10335,10116.0,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4689,,
CHEMBL624099,50597,,,In vivo,A,,10336,10116.0,,Oral bioavailability in rat (dose 5 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2463,,
CHEMBL624100,50597,,,In vivo,A,,10337,10116.0,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL624101,50597,,,In vivo,A,,10338,10116.0,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5654,,
CHEMBL624102,50597,,,In vivo,A,,10339,10116.0,,Oral bioavailability in rat (male Wistar),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6874,,
CHEMBL624103,50597,,,In vivo,A,,10340,10116.0,,Oral bioavailability after administration (30 mg/kg) in rat; good,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5633,,
CHEMBL624104,50597,,,In vivo,A,,10341,10116.0,,Oral bioavailability at the dose of 2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5496,,
CHEMBL624105,50597,,,In vivo,A,,10342,10116.0,,Oral bioavailability determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2358,,
CHEMBL624106,50597,,,In vivo,A,,10343,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16456,,
CHEMBL624107,50597,,,In vivo,A,,10344,10116.0,,Oral bioavailability in rat (dose single 10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5302,,
CHEMBL623943,50597,,,In vivo,A,,10345,10116.0,,Oral bioavailability in rat (dose single 10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5302,,
CHEMBL623944,50597,,,In vivo,A,,10346,10116.0,,Oral bioavailability in rat (dose 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5302,,
CHEMBL623945,50597,,,,A,,10347,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623946,50597,,,,A,,10348,10116.0,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623947,50597,,,,A,,10349,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623948,50597,,,,A,,10350,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623949,50597,,,,A,,10351,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623950,50597,,,,A,,10352,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL874398,50597,,,,A,,10353,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623951,50597,,,,A,,10354,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623952,50597,,,,A,,10355,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623953,50597,,,,A,,10356,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623954,50597,,,,A,,10357,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623955,50597,,,,A,,10358,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL623956,50597,,,,A,,10359,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627807,50597,,,,A,,10360,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627808,50597,,,,A,,10361,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627809,50597,,,,A,,10362,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627810,50597,,,,A,,10363,10116.0,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627811,50597,,,,A,,10364,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627812,50597,,,,A,,10365,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627813,50597,,,,A,,10366,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627814,50597,,,,A,,10367,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL875336,50597,,,,A,,10368,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627815,50597,,,,A,,10369,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627816,50597,,,,A,,10370,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627817,50597,,,,A,,10371,10116.0,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627818,50597,,,,A,,10372,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627819,50597,,,,A,,10373,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627820,50597,,,,A,,10374,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL627821,50597,,,,A,,10375,10116.0,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL628464,50597,,,,A,,10376,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626239,50597,,,,A,,10377,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626240,50597,,,,A,,10378,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626241,50597,,,,A,,10379,10116.0,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626242,50597,,,,A,,10380,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626243,50597,,,,A,,10381,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626244,50597,,,,A,,10382,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626907,50597,,,,A,,10383,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626908,50597,,,,A,,10384,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626909,50597,,,,A,,10385,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL626910,50597,,,,A,,10386,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL875342,50597,,,,F,,10387,10116.0,,Percent total excretion of acetaminophen cysteine conjugate,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626911,50597,,,,F,,10388,10116.0,,Percent total excretion of acetaminophen glucuronide,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL626912,50597,,,,F,,10389,10116.0,,Percent total excretion of acetaminophen sulfate,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL627065,50597,,,,F,,10390,10116.0,,Percent total excretion of acetaminophen-mercapturic acid,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7449,,
CHEMBL627066,50597,,Urine,,A,,10391,10116.0,1088.0,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3172,,
CHEMBL627067,50597,,,In vivo,A,,10392,10116.0,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16456,,
CHEMBL627068,22224,,Muscle tissue,In vivo,A,,10393,8656.0,2385.0,Biodistribution of compound in rat muscle after 5 min of administration,U,,0,,Autocuration,1,BAO_0000218,,ratrat,10839,,
CHEMBL627069,22224,,Muscle tissue,In vivo,A,,10394,8656.0,2385.0,Biodistribution of compound in rat muscle after 5 min of administration.,U,,0,,Autocuration,1,BAO_0000218,,ratrat,10839,,
CHEMBL627070,22224,,,In vivo,A,,10395,9940.0,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL627071,22224,,,In vivo,A,,10396,9940.0,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL627072,22224,,,In vivo,A,,10397,9940.0,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL627073,22224,,,In vivo,A,,10398,9940.0,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL625387,22224,,,In vivo,A,,10399,9940.0,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL625388,22224,,,In vivo,A,,10400,9940.0,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL625389,22224,,Plasma,In vivo,A,,10401,9940.0,1969.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL875343,22224,,Plasma,In vivo,A,,10402,9940.0,1969.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,0,,Autocuration,1,BAO_0000218,,Ovis aries,5334,,
CHEMBL876795,50497,,,,A,,10403,8570.0,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),N,,1,,Intermediate,1,BAO_0000218,,Serpentes,1735,,
CHEMBL626552,50497,,,,A,,10404,8570.0,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,N,,1,,Intermediate,1,BAO_0000218,,Serpentes,1469,,
CHEMBL626553,50497,,,,A,,10405,8570.0,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,N,,1,,Intermediate,1,BAO_0000218,,Serpentes,1336,,
CHEMBL626554,22224,,Plasma,,A,,10406,9606.0,1969.0,The human biological plasma half life of the compound,U,,0,,Autocuration,1,BAO_0000366,,Homo sapiens,12403,,
CHEMBL626555,50597,,Urine,,A,,10407,10116.0,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL626556,50597,,,,A,,10408,10116.0,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL626557,50597,,,,A,,10409,10116.0,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL626558,50597,,,,A,,10410,10116.0,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL626559,50597,,,,A,,10411,10116.0,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL626560,50597,,,,A,,10412,10116.0,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL876803,50597,,,,A,,10413,10116.0,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627964,50597,,,,A,,10414,10116.0,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627965,50597,,,,A,,10415,10116.0,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627966,50597,,,,A,,10416,10116.0,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627967,50597,,,,A,,10417,10116.0,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627968,50597,,,,A,,10418,10116.0,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627969,50597,,,,A,,10419,10116.0,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627970,50597,,,,A,,10420,10116.0,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627971,50597,,Blood,,A,,10421,10116.0,178.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL627972,50597,,Blood,,A,,10422,10116.0,178.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8004,,
CHEMBL856029,180,,,,B,,10423,9606.0,,Dissociation constant against binding to human cyclophilin A,D,,9,,Expert,1,BAO_0000357,,Homo sapiens,15917,,
CHEMBL627973,11591,,,,B,,10424,9913.0,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,H,,8,,Expert,1,BAO_0000019,,Bos taurus,12396,,
CHEMBL627974,22224,,,,A,,10425,,,-Log C was determined by performing the electroshock minimum test,U,,0,,Autocuration,1,BAO_0000019,,,7065,,
CHEMBL627975,22224,,,,A,,10426,,,-Log C was determined by performing the foot shock test,U,,0,,Autocuration,1,BAO_0000019,,,7065,,
CHEMBL627976,22224,,,,A,,10427,,,-Log C was determined by performing the incl screen test,U,,0,,Autocuration,1,BAO_0000019,,,7065,,
CHEMBL627977,22224,,,,A,,10428,,,-Log C was determined by performing the maximum electroshock test,U,,0,,Autocuration,1,BAO_0000019,,,7065,,
CHEMBL627978,22224,,,,A,,10429,,,-Log C was determined by performing the pentylenetetrazole test,U,,0,,Autocuration,1,BAO_0000019,,,7065,,
CHEMBL627979,22224,,,,A,,10430,,,Tested for experimental arotinoid inhibitory dose,U,,0,,Autocuration,1,BAO_0000019,,,12415,,
CHEMBL876804,22224,,,,A,,10431,,,Negative log transformed activity,U,,0,,Autocuration,1,BAO_0000019,,,10256,,
CHEMBL627980,22224,,,,A,,10432,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",U,,0,,Autocuration,1,BAO_0000019,,,7991,,
CHEMBL627981,50512,,,,A,,10433,10141.0,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14342,,
CHEMBL627982,50512,,,,A,,10434,10141.0,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14342,,
CHEMBL627983,50512,,,,A,,10435,10141.0,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14342,,
CHEMBL627984,50512,,Ileum,,A,,10436,10141.0,2116.0,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14342,,
CHEMBL627985,22229,,,,P,,10437,,,Solubility in water was determined; values expressed as -log,U,,0,,Autocuration,1,BAO_0000100,,,6047,,
CHEMBL627986,22224,,,,A,,10438,,,Ratio of Kcat to that of Km was determined,U,,0,,Autocuration,1,BAO_0000019,,,17269,,
CHEMBL627987,22224,,,,A,,10439,,,Observed first order rate constant,U,,0,,Autocuration,1,BAO_0000019,,,10026,,
CHEMBL627988,22224,,,,A,,10440,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,U,,0,,Autocuration,1,BAO_0000019,,,14583,,
CHEMBL627989,50597,,,In vivo,A,,10441,10116.0,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL627990,50597,,,In vivo,A,,10442,10116.0,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2661,,
CHEMBL876805,50597,,,In vivo,A,,10443,10116.0,,Oral Bioavailability after administration of 10 mg/kg in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4029,,
CHEMBL627991,50597,,,In vivo,A,,10444,10116.0,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17735,,
CHEMBL627992,50597,,,In vivo,A,,10445,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4576,,
CHEMBL627993,50597,,,In vivo,A,,10446,10116.0,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17582,,
CHEMBL622817,50597,,,In vivo,A,,10447,10116.0,,Oral bioavailability at 1 mg/kg was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL622818,50597,,,In vivo,A,,10448,10116.0,,Oral bioavailability at 10 mg/kg was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17651,,
CHEMBL622819,50597,,,In vivo,A,,10449,10116.0,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17670,,
CHEMBL872267,50597,,,In vivo,A,,10450,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5045,,
CHEMBL622820,50597,,,In vivo,A,,10451,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1696,,
CHEMBL622821,50597,,,In vivo,A,,10452,10116.0,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17764,,
CHEMBL622822,50597,,,In vivo,A,,10453,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6448,,
CHEMBL622823,50597,,,In vivo,A,,10454,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6596,,
CHEMBL622824,50597,,,In vivo,A,,10455,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17547,,
CHEMBL622825,50597,,,In vivo,A,,10456,10116.0,,Oral bioavailability in rat at a dose of 3 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17771,,
CHEMBL622901,50597,,,In vivo,A,,10457,10116.0,,Oral bioavailability in rat after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL622902,50597,,,In vivo,A,,10458,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4558,,
CHEMBL621844,50597,,,In vivo,A,,10459,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL621845,50597,,,In vivo,A,,10460,10116.0,,Oral bioavailability in Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6827,,
CHEMBL621846,50597,,,In vivo,A,,10461,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4026,,
CHEMBL621847,50597,,,In vivo,A,,10462,10116.0,,Oral bioavailability in rat (dose 30 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10,,
CHEMBL877609,50597,,,In vivo,A,,10463,10116.0,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL621848,50597,,,In vivo,A,,10464,10116.0,,Bioavailability in rat (dose 3 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL621849,50597,,,In vivo,A,,10465,10116.0,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL622030,50597,,,In vivo,A,,10466,10116.0,,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL622031,50597,,,In vivo,A,,10467,10116.0,,Percent oral bioavailability determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4796,,
CHEMBL622032,50597,,,In vivo,A,,10468,10116.0,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL622033,50597,,,In vivo,A,,10469,10116.0,,The compound was evaluated for bioavailability in rats; 32-51,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2137,,
CHEMBL622034,50597,,,In vivo,A,,10470,10116.0,,Bioavailability in rat (dose 20 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2959,,
CHEMBL622035,50597,,,In vivo,A,,10471,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1361,,
CHEMBL882966,50597,,,In vivo,A,,10472,10116.0,,Bioavailability percent in rat at the dose of 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4727,,
CHEMBL622036,50597,,,In vivo,A,,10473,10116.0,,Bioavailability was evaluated after 20 uM/kg of peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16423,,
CHEMBL622037,50597,,,In vivo,A,,10474,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5206,,
CHEMBL622038,50597,,,In vivo,A,,10475,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6448,,
CHEMBL622039,50597,,,In vivo,A,,10476,10116.0,,Bioavailability in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17723,,
CHEMBL622040,50597,,Blood,In vivo,A,,10477,10116.0,178.0,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622041,50597,,Blood,In vivo,A,,10478,10116.0,178.0,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622042,50597,,Blood,In vivo,A,,10479,10116.0,178.0,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622043,50597,,Blood,In vivo,A,,10480,10116.0,178.0,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622044,50597,,Blood,In vivo,A,,10481,10116.0,178.0,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622045,50597,,Bone,In vivo,A,,10482,10116.0,10000001.0,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622046,50597,,Bone,In vivo,A,,10483,10116.0,10000001.0,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622047,50597,,Bone,In vivo,A,,10484,10116.0,10000001.0,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL877610,50597,,Bone,In vivo,A,,10485,10116.0,10000001.0,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622048,50597,,Brain,In vivo,A,,10486,10116.0,955.0,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622049,50597,,Brain,In vivo,A,,10487,10116.0,955.0,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622050,50597,,Brain,In vivo,A,,10488,10116.0,955.0,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622051,50597,,Brain,In vivo,A,,10489,10116.0,955.0,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622052,50597,,,In vivo,A,,10490,10116.0,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622053,50597,,,In vivo,A,,10491,10116.0,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622054,50597,,,In vivo,A,,10492,10116.0,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622055,50597,,,In vivo,A,,10493,10116.0,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622056,50597,,,In vivo,A,,10494,10116.0,,Oral bioavailability in rats was determined; High,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5237,,
CHEMBL622057,50597,,,In vivo,A,,10495,10116.0,,Oral bioavailability in the rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5503,,
CHEMBL628008,50597,,,In vivo,A,,10496,10116.0,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15765,,
CHEMBL622058,50597,,,In vivo,A,,10497,10116.0,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15660,,
CHEMBL622059,50597,,,In vivo,A,,10498,10116.0,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL622060,50597,,,In vivo,A,,10499,10116.0,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL622061,50597,,,In vivo,A,,10500,10116.0,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL622062,50597,,,In vivo,A,,10501,10116.0,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5978,,
CHEMBL622063,50597,,,In vivo,A,,10502,10116.0,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL877611,50597,,,In vivo,A,,10503,10116.0,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,3598,,
CHEMBL622064,50597,,,In vivo,A,,10504,10116.0,,Oral bioavailability of compound in Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4216,,
CHEMBL622065,50597,,,In vivo,A,,10505,10116.0,,Oral bioavailability of compound in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17839,,
CHEMBL622066,50597,,,In vivo,A,,10506,10116.0,,Oral bioavailability in rat (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6570,,
CHEMBL622067,50597,,,In vivo,A,,10507,10116.0,,Oral bioavailability of compound in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5334,,
CHEMBL622068,50597,,,In vivo,A,,10508,10116.0,,Oral bioavailability of compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6886,,
CHEMBL622069,50597,,,In vivo,A,,10509,10116.0,,Oral bioavailability of compound was determined in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5210,,
CHEMBL624796,50597,,,In vivo,A,,10510,10116.0,,Oral bioavailability at a dose of 30 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4170,,
CHEMBL624797,50597,,,In vivo,A,,10511,10116.0,,Oral bioavailability in rat (dose 10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6028,,
CHEMBL623053,50597,,,In vivo,A,,10512,10116.0,,Oral bioavailability in rat (dose 10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6028,,
CHEMBL623054,50597,,,In vivo,A,,10513,10116.0,,Oral bioavailability evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL623055,50597,,,In vivo,A,,10514,10116.0,,Oral bioavailability in fasted rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6168,,
CHEMBL623056,50597,,,In vivo,A,,10515,10116.0,,Oral bioavailability in fed rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6168,,
CHEMBL623057,50597,,,In vivo,A,,10516,10116.0,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5160,,
CHEMBL623058,50597,,,In vivo,A,,10517,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL623059,50597,,,In vivo,A,,10518,10116.0,,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL623060,50597,,,In vivo,A,,10519,10116.0,,Oral bioavailability in rat after administration of 10 mg/kg po,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6535,,
CHEMBL623061,50597,,,In vivo,A,,10520,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4194,,
CHEMBL623062,50597,,,In vivo,A,,10521,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6230,,
CHEMBL623063,50597,,,In vivo,A,,10522,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6619,,
CHEMBL623064,50597,,,In vivo,A,,10523,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17607,,
CHEMBL623065,50597,,,In vivo,A,,10524,10116.0,,Oral bioavailability in ratrs,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4942,,
CHEMBL623066,50597,,,In vivo,A,,10525,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4942,,
CHEMBL623067,50597,,,In vivo,A,,10526,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6646,,
CHEMBL623068,50597,,,In vivo,A,,10527,10116.0,,Oral bioavailability in rats was determined; High,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5237,,
CHEMBL623069,50597,,,In vivo,A,,10528,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6646,,
CHEMBL623070,50597,,,In vivo,A,,10529,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4449,,
CHEMBL623071,50597,,,In vivo,A,,10530,10116.0,,Oral bioavailability was calculated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6057,,
CHEMBL623072,50597,,,In vivo,A,,10531,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2552,,
CHEMBL623073,50597,,,In vivo,A,,10532,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5496,,
CHEMBL623074,50597,,,In vivo,A,,10533,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6484,,
CHEMBL623075,50597,,,In vivo,A,,10534,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6485,,
CHEMBL623076,50597,,,In vivo,A,,10535,10116.0,,Oral bioavailability after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6616,,
CHEMBL623077,50597,,,In vivo,A,,10536,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4969,,
CHEMBL623078,50597,,,In vivo,A,,10537,10116.0,,Oral bioavailability in rat (Sprague-Dawley),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5862,,
CHEMBL623079,50597,,,In vivo,A,,10538,10116.0,,Oral bioavailability in Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL623080,50597,,,In vivo,A,,10539,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL623081,50597,,,In vivo,A,,10540,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL623082,50597,,,In vivo,A,,10541,10116.0,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5546,,
CHEMBL874400,50597,,,In vivo,A,,10542,10116.0,,Oral bioavailability in fasted rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6168,,
CHEMBL623083,50597,,,In vivo,A,,10543,10116.0,,Oral bioavailability in fed rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6168,,
CHEMBL623084,50597,,,In vivo,A,,10544,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3624,,
CHEMBL623085,50597,,,In vivo,A,,10545,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5213,,
CHEMBL623086,50597,,,In vivo,A,,10546,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5496,,
CHEMBL623087,50597,,,In vivo,A,,10547,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5553,,
CHEMBL623088,50597,,,In vivo,A,,10548,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5833,,
CHEMBL623089,50597,,,In vivo,A,,10549,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5836,,
CHEMBL623090,50597,,,In vivo,A,,10550,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5865,,
CHEMBL623091,50597,,,In vivo,A,,10551,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5960,,
CHEMBL623092,50597,,,In vivo,A,,10552,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6249,,
CHEMBL623093,50597,,,In vivo,A,,10553,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6448,,
CHEMBL874401,50597,,,In vivo,A,,10554,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6453,,
CHEMBL623094,50597,,,In vivo,A,,10555,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL623095,50597,,,In vivo,A,,10556,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17607,,
CHEMBL623096,50597,,,In vivo,A,,10557,10116.0,,Oral bioavailability in rat after peroral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL624913,50597,,,In vivo,A,,10558,10116.0,,Oral bioavailability in rat after peroral administration at 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5939,,
CHEMBL624914,50597,,,In vivo,A,,10559,10116.0,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6281,,
CHEMBL624915,50597,,,In vivo,A,,10560,10116.0,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5874,,
CHEMBL624916,50597,,,In vivo,A,,10561,10116.0,,Oral bioavailability in rat; Not measured,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5213,,
CHEMBL624917,50597,,,In vivo,A,,10562,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4964,,
CHEMBL625157,50597,,,,A,,10563,10116.0,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11020,,
CHEMBL625158,50597,,Liver,,A,,10564,10116.0,2107.0,In vitro metabolic potential in rat liver microsomes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6251,,
CHEMBL625159,50597,,,In vivo,A,,10565,10116.0,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1568,,
CHEMBL625160,50597,,,In vivo,A,,10566,10116.0,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3032,,
CHEMBL625161,50597,,,In vivo,A,,10567,10116.0,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3748,,
CHEMBL625162,50597,,,In vivo,A,,10568,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,401,,
CHEMBL625163,50597,,,In vivo,A,,10569,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6512,,
CHEMBL625164,50597,,,In vivo,A,,10570,10116.0,,Oral bioavailability in rats at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17617,,
CHEMBL625165,50597,,,In vivo,A,,10571,10116.0,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6679,,
CHEMBL625166,50597,,,In vivo,A,,10572,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6742,,
CHEMBL625167,50597,,,,A,,10573,10116.0,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,589,,
CHEMBL625168,50597,,,,A,,10574,10116.0,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,589,,
CHEMBL625169,50597,,,In vivo,A,,10575,10116.0,,Plasma clearance of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3185,,
CHEMBL626264,50597,,,In vivo,A,,10576,10116.0,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17596,,
CHEMBL626265,50597,,,In vivo,A,,10577,10116.0,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2713,,
CHEMBL626266,50597,,Plasma,In vivo,A,,10578,10116.0,1969.0,The compound was tested for plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12500,,
CHEMBL626267,50597,,Plasma,In vivo,A,,10579,10116.0,1969.0,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12500,,
CHEMBL626268,50597,,,,A,,10580,10116.0,,Plasma concentration upon oral administration of 1 mg/Kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2713,,
CHEMBL626269,50597,,,,A,,10581,10116.0,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1446,,
CHEMBL626270,50597,,,,A,,10582,10116.0,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6227,,
CHEMBL626271,50597,,,,A,,10583,10116.0,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4709,,
CHEMBL626272,50597,,,,A,,10584,10116.0,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626273,50597,,,,A,,10585,10116.0,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL875346,50597,,,,A,,10586,10116.0,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626274,50597,,,,A,,10587,10116.0,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5510,,
CHEMBL626275,50597,,,,A,,10588,10116.0,,Compound was tested for protein binding in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4514,,
CHEMBL624646,50597,,,,A,,10589,10116.0,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2713,,
CHEMBL624647,50597,,,,A,,10590,10116.0,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2713,,
CHEMBL624648,50597,,Liver,,A,,10591,10116.0,2107.0,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5340,,
CHEMBL624649,50597,,,,A,,10592,10116.0,,Area under curve ratio was determined (po/iv) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12058,,
CHEMBL624650,50597,,,,A,,10593,10116.0,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL624651,50597,,,,A,,10594,10116.0,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL624652,50597,,,,A,,10595,10116.0,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL624653,50597,,,,A,,10596,10116.0,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6495,,
CHEMBL624654,50597,,,,A,,10597,10116.0,,Ratio of AUCbrain to AUCplasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6078,,
CHEMBL624655,50597,,,,A,,10598,10116.0,,Ratio of brain to plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5656,,
CHEMBL624656,50597,,,,A,,10599,10116.0,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL624657,50597,,,,A,,10600,10116.0,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL624658,50597,,,,A,,10601,10116.0,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL624659,50597,,,,A,,10602,10116.0,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL624660,50597,,,,A,,10603,10116.0,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL624661,50597,,,,A,,10604,10116.0,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10130,,
CHEMBL624662,50597,,,,A,,10605,10116.0,,Steady state brain :blood ratio was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5213,,
CHEMBL625199,50597,,,,A,,10606,10116.0,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL625200,50597,,,,A,,10607,10116.0,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL625201,50597,,,,A,,10608,10116.0,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL625202,50597,,,,A,,10609,10116.0,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4910,,
CHEMBL625203,50597,,,,A,,10610,10116.0,,Percentage recovery after 3h incubation with rat hapatocytes was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2083,,
CHEMBL625204,50597,,,,A,,10611,10116.0,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2082,,
CHEMBL625205,50597,,,,A,,10612,10116.0,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2082,,
CHEMBL625206,50597,,,,A,,10613,10116.0,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6351,,
CHEMBL625207,22224,,,,A,,10614,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",U,,0,,Autocuration,1,BAO_0000019,,,14583,,
CHEMBL625208,22224,,,,A,,10615,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,U,,0,,Autocuration,1,BAO_0000019,,,14583,,
CHEMBL625209,50587,,,,A,495.0,10616,9606.0,,In vivo absorption in Caco-2 cell line monolayers was determined,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,4608,,Caco-2
CHEMBL625210,22229,,,,P,,10617,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13668,,
CHEMBL625211,50597,,,,A,,10618,10116.0,,Area under curve was determine after peroral administration at 10 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL625212,50797,,,,A,,10619,9544.0,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,5669,,
CHEMBL625213,50597,,,,A,,10620,10116.0,,Area under curve was determine after peroral administration at 160 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL625214,50597,,,,A,,10621,10116.0,,Area under curve was determine after peroral administration at 20 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL874542,50597,,,,A,,10622,10116.0,,Area under curve was determine after peroral administration at 50 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL625215,22229,,,,P,,10623,,,Calculated partition coefficient (clogP) (AlogP),U,,0,,Autocuration,1,BAO_0000100,,,6472,,
CHEMBL625216,22224,,,,A,,10624,,,Activated partial thromboplastin time measured,U,,0,,Autocuration,1,BAO_0000019,,,15106,,
CHEMBL625217,22224,,,,P,,10625,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),U,,0,,Autocuration,1,BAO_0000100,,,15207,,
CHEMBL625218,22224,,,,P,,10626,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),U,,0,,Autocuration,1,BAO_0000100,,,15207,,
CHEMBL622864,50588,,Plasma,,A,,10627,9615.0,1969.0,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13941,,
CHEMBL622865,50597,,Plasma,,A,,10628,10116.0,1969.0,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13941,,
CHEMBL622866,50597,,Plasma,,A,,10629,10116.0,1969.0,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13941,,
CHEMBL622867,50588,,Plasma,,A,,10630,9615.0,1969.0,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13941,,
CHEMBL876808,50512,,Plasma,,A,,10631,10141.0,1969.0,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,15240,,
CHEMBL627725,22224,,Brain,,A,,10632,,955.0,AUC in brain,U,,0,,Autocuration,1,BAO_0000019,,,10655,,
CHEMBL627726,22224,,Serum,,A,,10633,,1977.0,AUC in serum,U,,0,,Autocuration,1,BAO_0000019,,,10655,,
CHEMBL627727,22224,,Plasma,,A,,10634,,1969.0,AUC was determined,U,,0,,Autocuration,1,BAO_0000019,,,6504,,
CHEMBL627728,22224,,Plasma,,A,,10635,,1969.0,AUC of the compound.,U,,0,,Autocuration,1,BAO_0000019,,,10615,,
CHEMBL627729,22224,,Plasma,,A,,10636,,1969.0,AUC value (0-4 hr),U,,0,,Autocuration,1,BAO_0000019,,,10353,,
CHEMBL627730,22224,,Plasma,,A,,10637,,1969.0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",U,,0,,Autocuration,1,BAO_0000019,,,14907,,
CHEMBL627731,22224,,Plasma,,A,,10638,,1969.0,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,U,,0,,Autocuration,1,BAO_0000019,,,14907,,
CHEMBL627732,22224,,Plasma,,A,,10639,,1969.0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",U,,0,,Autocuration,1,BAO_0000019,,,14907,,
CHEMBL627733,22224,,Plasma,,A,,10640,,1969.0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",U,,0,,Autocuration,1,BAO_0000019,,,14907,,
CHEMBL627734,50597,,Plasma,,A,,10641,10116.0,1969.0,AUC(area under curve) was determined after intravenous administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16359,,
CHEMBL627735,50597,,Plasma,,A,,10642,10116.0,1969.0,AUC(area under curve) was determined after oral administration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16359,,
CHEMBL627736,50512,,Plasma,,A,,10643,10141.0,1969.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,15240,,
CHEMBL876809,50597,,Plasma,,A,,10644,10116.0,1969.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15240,,
CHEMBL627737,22224,,,,A,,10645,,,Area Under Curve after oral dosing of 100 uM/Kg,U,,0,,Autocuration,1,BAO_0000019,,,15469,,
CHEMBL627738,22224,,,,A,,10646,,,Area Under Curve after oral dosing of 30 uM/Kg,U,,0,,Autocuration,1,BAO_0000019,,,15469,,
CHEMBL627739,22224,,,,A,,10647,,,Area Under Curve was measured by ploting the graph between concentration verses time,U,,0,,Autocuration,1,BAO_0000019,,,13520,,
CHEMBL626143,50588,,,,A,,10648,9615.0,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17025,,
CHEMBL626144,22224,,,,A,,10649,314293.0,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17025,,
CHEMBL626145,50592,,,,A,,10650,9986.0,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL626146,50597,,,,A,,10651,10116.0,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17025,,
CHEMBL626147,50597,,Blood,,A,,10652,10116.0,178.0,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12032,,
CHEMBL626148,22224,,,,A,,10653,,,Area under curve (AUC) was determined,U,,0,,Autocuration,1,BAO_0000019,,,10291,,
CHEMBL626149,22224,,,,A,,10654,,,Area under curve (AUC) following ip administration at 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,5767,,
CHEMBL626150,22224,,,,A,,10655,,,Area under curve (AUC) was determined; ND is Not determined,U,,0,,Autocuration,1,BAO_0000019,,,1434,,
CHEMBL626151,50588,,,,A,,10656,9615.0,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14925,,
CHEMBL626152,50588,,,,A,,10657,9615.0,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14925,,
CHEMBL626153,50588,,,,A,,10658,9615.0,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14925,,
CHEMBL626154,22224,,,,A,,10659,,,Area under curve (AUR) was determined,U,,0,,Autocuration,1,BAO_0000019,,,1434,,
CHEMBL626155,22224,,,,A,,10660,,,Area under curve at 1 uM/dg administered intravenously,U,,0,,Autocuration,1,BAO_0000019,,,11883,,
CHEMBL626156,22224,,,,A,,10661,,,Area under curve at 10 uM/dg administered perorally,U,,0,,Autocuration,1,BAO_0000019,,,11883,,
CHEMBL626157,22224,,,,A,,10662,,,Area under curve at 2 uM/dg administered intravenously,U,,0,,Autocuration,1,BAO_0000019,,,11883,,
CHEMBL626158,22224,,,,A,,10663,,,Area under curve at 20 uM/dg administered perorally,U,,0,,Autocuration,1,BAO_0000019,,,11883,,
CHEMBL626159,50588,,,,A,,10664,9615.0,,Area under curve at a peroral dose of 3 mg/kg in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15233,,
CHEMBL626160,50597,,,,A,,10665,10116.0,,Area under curve at a peroral dose of 3 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15233,,
CHEMBL626161,50588,,,,A,,10666,9615.0,,Area under curve at an iv dose of 1 mg/kg in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15233,,
CHEMBL626162,50597,,,,A,,10667,10116.0,,Area under curve at an iv dose of 1 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15233,,
CHEMBL626163,22224,,,,A,,10668,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,U,,0,,Autocuration,1,BAO_0000019,,,12978,,
CHEMBL626164,22224,,,,A,,10669,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,U,,0,,Autocuration,1,BAO_0000019,,,12978,,
CHEMBL626165,50594,,,,A,,10670,10090.0,,Area under curve measured as conc vs time after intravenous administration to mice.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11355,,
CHEMBL626166,50594,,,,A,,10671,10090.0,,Area under curve measured as conc vs time after peroral administration to mice.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11355,,
CHEMBL626167,50588,,,,A,,10672,9615.0,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12923,,
CHEMBL626168,50588,,,,A,,10673,9615.0,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12923,,
CHEMBL877463,50588,,,,A,,10674,9615.0,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12923,,
CHEMBL626169,50588,,,,A,,10675,9615.0,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12923,,
CHEMBL626170,50597,,Heart,In vivo,A,,10676,10116.0,948.0,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626171,50597,,Heart,In vivo,A,,10677,10116.0,948.0,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626172,50597,,Heart,In vivo,A,,10678,10116.0,948.0,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626173,50597,,Heart,In vivo,A,,10679,10116.0,948.0,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626174,50597,,Kidney,In vivo,A,,10680,10116.0,2113.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626175,50597,,Kidney,In vivo,A,,10681,10116.0,2113.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626176,50597,,Kidney,In vivo,A,,10682,10116.0,2113.0,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL626177,50597,,Kidney,In vivo,A,,10683,10116.0,2113.0,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622499,50597,,Kidney,In vivo,A,,10684,10116.0,2113.0,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622500,50597,,Liver,In vivo,A,,10685,10116.0,2107.0,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622501,50597,,Liver,In vivo,A,,10686,10116.0,2107.0,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622502,50597,,Liver,In vivo,A,,10687,10116.0,2107.0,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL622503,50597,,Liver,In vivo,A,,10688,10116.0,2107.0,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL877614,50597,,Liver,In vivo,A,,10689,10116.0,2107.0,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624839,50597,,Lung,In vivo,A,,10690,10116.0,2048.0,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624840,50597,,Lung,In vivo,A,,10691,10116.0,2048.0,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624841,50597,,Lung,In vivo,A,,10692,10116.0,2048.0,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624842,50597,,Lung,In vivo,A,,10693,10116.0,2048.0,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624843,50597,,Muscle tissue,In vivo,A,,10694,10116.0,2385.0,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624844,50597,,Muscle tissue,In vivo,A,,10695,10116.0,2385.0,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL624845,50597,,Muscle tissue,In vivo,A,,10696,10116.0,2385.0,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL621904,50597,,Muscle tissue,In vivo,A,,10697,10116.0,2385.0,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17738,,
CHEMBL621905,50597,,Blood,In vivo,A,,10698,10116.0,178.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL874382,50597,,Blood,In vivo,A,,10699,10116.0,178.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL621906,50597,,Blood,In vivo,A,,10700,10116.0,178.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL621907,50597,,Brain,In vivo,A,,10701,10116.0,955.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622096,50597,,Brain,In vivo,A,,10702,10116.0,955.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622097,50597,,Brain,In vivo,A,,10703,10116.0,955.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622098,50597,,Heart,In vivo,A,,10704,10116.0,948.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622099,50597,,Heart,In vivo,A,,10705,10116.0,948.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622100,50597,,Heart,In vivo,A,,10706,10116.0,948.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622101,50597,,Kidney,In vivo,A,,10707,10116.0,2113.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622102,50597,,Kidney,In vivo,A,,10708,10116.0,2113.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622103,50597,,Kidney,In vivo,A,,10709,10116.0,2113.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622104,50597,,Liver,In vivo,A,,10710,10116.0,2107.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622105,50597,,Liver,In vivo,A,,10711,10116.0,2107.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622106,50597,,Liver,In vivo,A,,10712,10116.0,2107.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622107,50597,,Lung,In vivo,A,,10713,10116.0,2048.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622108,50597,,Lung,In vivo,A,,10714,10116.0,2048.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622109,50597,,Lung,In vivo,A,,10715,10116.0,2048.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622110,50597,,Muscle tissue,In vivo,A,,10716,10116.0,2385.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622111,50597,,Muscle tissue,In vivo,A,,10717,10116.0,2385.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL874383,50597,,Muscle tissue,In vivo,A,,10718,10116.0,2385.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622112,50597,,Zone of skin,In vivo,A,,10719,10116.0,14.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622113,50597,,Zone of skin,In vivo,A,,10720,10116.0,14.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622114,50597,,Zone of skin,In vivo,A,,10721,10116.0,14.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622115,50597,,Spleen,In vivo,A,,10722,10116.0,2106.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622116,50597,,Spleen,In vivo,A,,10723,10116.0,2106.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11195,,
CHEMBL622117,50597,,,In vivo,A,,10724,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6193,,
CHEMBL622118,50597,,,In vivo,A,,10725,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6803,,
CHEMBL622119,50597,,,In vivo,A,,10726,10116.0,,Oral bioavailability in rats at 6 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6647,,
CHEMBL622120,50597,,,In vivo,A,,10727,10116.0,,Oral bioavailability in rat (dose 6 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6647,,
CHEMBL622121,50597,,,In vivo,A,,10728,10116.0,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6647,,
CHEMBL622122,50597,,,In vivo,A,,10729,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6640,,
CHEMBL622123,50597,,,In vivo,A,,10730,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL622124,50597,,,In vivo,A,,10731,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6641,,
CHEMBL622125,50597,,,In vivo,A,,10732,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6642,,
CHEMBL622126,50597,,,In vivo,A,,10733,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL620455,50597,,,In vivo,A,,10734,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6141,,
CHEMBL620456,50597,,,In vivo,A,,10735,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4390,,
CHEMBL620457,50597,,,In vivo,A,,10736,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL620458,50597,,,In vivo,A,,10737,10116.0,,Oral bioavailability was evaluated; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5472,,
CHEMBL620459,50597,,,In vivo,A,,10738,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5438,,
CHEMBL620460,50597,,,In vivo,A,,10739,10116.0,,Oral bioavailability in rat by oral dosing,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4883,,
CHEMBL620461,50597,,,In vivo,A,,10740,10116.0,,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1908,,
CHEMBL620462,50597,,,In vivo,A,,10741,10116.0,,Oral bioavailability in rat (Sprague-Dawley),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620463,50597,,,In vivo,A,,10742,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620464,50597,,,In vivo,A,,10743,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620465,50597,,,In vivo,A,,10744,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620466,50597,,,In vivo,A,,10745,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620467,50597,,,In vivo,A,,10746,10116.0,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620468,50597,,,In vivo,A,,10747,10116.0,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4853,,
CHEMBL620469,50597,,,In vivo,A,,10748,10116.0,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL620470,50597,,,In vivo,A,,10749,10116.0,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12873,,
CHEMBL620471,50597,,,In vivo,A,,10750,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3169,,
CHEMBL620472,50597,,,In vivo,A,,10751,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6305,,
CHEMBL620473,50597,,,In vivo,A,,10752,10116.0,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4762,,
CHEMBL620474,50597,,,In vivo,A,,10753,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17847,,
CHEMBL620475,50597,,,In vivo,A,,10754,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6211,,
CHEMBL620476,50597,,,In vivo,A,,10755,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6011,,
CHEMBL620477,50597,,,In vivo,A,,10756,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6317,,
CHEMBL620478,50597,,,In vivo,A,,10757,10116.0,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL618768,50597,,,In vivo,A,,10758,10116.0,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL618769,50597,,,In vivo,A,,10759,10116.0,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL618770,50597,,,In vivo,A,,10760,10116.0,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6644,,
CHEMBL618771,50597,,,In vivo,A,,10761,10116.0,,Oral bioavailability (dose 20 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6113,,
CHEMBL618772,50597,,,In vivo,A,,10762,10116.0,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5937,,
CHEMBL618773,50597,,,In vivo,A,,10763,10116.0,,Oral bioavailability in rat at 10 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5711,,
CHEMBL875842,50597,,,In vivo,A,,10764,10116.0,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL618774,50597,,,In vivo,A,,10765,10116.0,,Bioavailability in rat (dose 3 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL618775,50597,,,In vivo,A,,10766,10116.0,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL618776,50597,,,In vivo,A,,10767,10116.0,,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17717,,
CHEMBL618777,50597,,,In vivo,A,,10768,10116.0,,Percent bioavailability (F) in rats after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4722,,
CHEMBL618778,50597,,,In vivo,A,,10769,10116.0,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4722,,
CHEMBL618779,50597,,,In vivo,A,,10770,10116.0,,Bioavailability in rat (dose 5 uM/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4353,,
CHEMBL618780,50597,,,In vivo,A,,10771,10116.0,,Oral bioavailability,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15662,,
CHEMBL618781,50597,,,In vivo,A,,10772,10116.0,,Bioavailability in rat (dose 2 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL618782,50597,,,In vivo,A,,10773,10116.0,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,4756,,
CHEMBL618783,50597,,,In vivo,A,,10774,10116.0,,Oral bioavailability in rat (dose 20 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3436,,
CHEMBL618784,50597,,,In vivo,A,,10775,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17800,,
CHEMBL618785,50597,,,In vivo,A,,10776,10116.0,,Percent oral bioavailability evaluated in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15762,,
CHEMBL618786,50597,,,In vivo,A,,10777,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5089,,
CHEMBL618787,50597,,,In vivo,A,,10778,10116.0,,Percent oral bioavailability in rat; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5089,,
CHEMBL618788,50597,,,In vivo,A,,10779,10116.0,,Oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3185,,
CHEMBL618789,50597,,,In vivo,A,,10780,10116.0,,Bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5145,,
CHEMBL618790,50597,,,In vivo,A,,10781,10116.0,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3457,,
CHEMBL618791,50597,,,In vivo,A,,10782,10116.0,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3457,,
CHEMBL875843,50597,,,In vivo,A,,10783,10116.0,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5983,,
CHEMBL618792,50597,,,In vivo,A,,10784,10116.0,,Oral bioavailability in rat (dose 20 mg/kg p.o.),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5739,,
CHEMBL623395,50597,,,In vivo,A,,10785,10116.0,,Cmax at a dose of 30 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,3579,,
CHEMBL623396,22224,,,In vivo,A,,10786,314293.0,,Cmax in monkeys at a dose of 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17788,,
CHEMBL623397,50597,,,In vivo,A,,10787,10116.0,,Cmax in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14956,,
CHEMBL623398,50597,,,In vivo,A,,10788,10116.0,,Cmax in rats at a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17788,,
CHEMBL623399,50594,,,In vivo,A,,10789,10090.0,,Cmax was measured in mice after an oral dose of 50 mg/kg.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9750,,
CHEMBL623400,22224,,,In vivo,A,,10790,,,"Cmax value at a dose of 12.7 uM/kg, po",U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL623401,22224,,,In vivo,A,,10791,,,"Cmax value at a dose of 6.3 uM/kg, iv",U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL623402,22224,,,In vivo,A,,10792,,,"Cmax value at a dose of 7.1 uM/kg, iv",U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL623403,22224,,,In vivo,A,,10793,,,Cmax value of compound was determined after 1 hr,U,,0,,Autocuration,1,BAO_0000218,,,12703,,
CHEMBL623404,22224,,,In vivo,A,,10794,,,Cmax value of the compound,U,,0,,Autocuration,1,BAO_0000218,,,15778,,
CHEMBL625997,50597,,,In vivo,A,,10795,10116.0,,Cmax value administered intraintestinal in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12818,,
CHEMBL625998,50597,,,In vivo,A,,10796,10116.0,,Cmax value administered perorally was determined in rat; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14964,,
CHEMBL625999,22224,,,In vivo,A,,10797,,,Cmax value at the dose of 2.3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15808,,
CHEMBL626000,22224,,,In vivo,A,,10798,,,Cmax value at the dose of 5 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15808,,
CHEMBL626001,22224,,,In vivo,A,,10799,,,Cmax value in the period of 8 hr after dosing. ,U,,0,,Autocuration,1,BAO_0000218,,,15778,,
CHEMBL626002,22224,,,In vivo,A,,10800,,,Cmax value at a oral dose of 20 mg/kg; Not tested,U,,0,,Autocuration,1,BAO_0000218,,,3715,,
CHEMBL626003,22224,,,In vivo,A,,10801,,,Cmax value at a oral dose of 20 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,3715,,
CHEMBL626004,50597,,,In vivo,A,,10802,10116.0,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,1446,,
CHEMBL626005,50512,,,In vivo,A,,10803,10141.0,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,15240,,
CHEMBL626006,50597,,,In vivo,A,,10804,10116.0,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15240,,
CHEMBL626007,50597,,Plasma,In vivo,A,,10805,10116.0,1969.0,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14810,,
CHEMBL626008,50594,,Plasma,In vivo,A,,10806,10090.0,1969.0,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14239,,
CHEMBL626009,50588,,Liver,In vivo,A,,10807,9615.0,2107.0,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12555,,
CHEMBL626010,50588,,,In vivo,A,,10808,9615.0,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,10754,,
CHEMBL626011,50594,,Blood,In vivo,A,,10809,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL626012,50594,,Blood,In vivo,A,,10810,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL626013,50594,,Blood,In vivo,A,,10811,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL626014,50594,,Blood,In vivo,A,,10812,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL877496,50594,,Blood,In vivo,A,,10813,10090.0,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10754,,
CHEMBL626015,50588,,,In vivo,F,,10814,9615.0,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626016,50588,,,In vivo,F,,10815,9615.0,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626017,50588,,,In vivo,F,,10816,9615.0,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626018,50588,,Plasma,In vivo,A,,10817,9615.0,1969.0,Bioavailability as maximal plasma concentration in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13543,,
CHEMBL626692,50588,,Plasma,In vivo,A,,10818,9615.0,1969.0,Bioavailability as maximal plasma concentration in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13543,,
CHEMBL626693,50597,,Plasma,In vivo,A,,10819,10116.0,1969.0,Bioavailability as maximal plasma concentration in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13543,,
CHEMBL626694,22224,,Plasma,In vivo,A,,10820,10116.0,1969.0,Bioavailability as maximal plasma concentration in rats,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,13543,,
CHEMBL626695,50588,,Blood,In vivo,A,,10821,9615.0,178.0,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626696,50588,,Blood,In vivo,A,,10822,9615.0,178.0,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626697,50588,,Blood,In vivo,A,,10823,9615.0,178.0,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626859,50588,,Blood,In vivo,A,,10824,9615.0,178.0,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626860,50588,,Blood,In vivo,A,,10825,9615.0,178.0,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626861,50588,,Blood,In vivo,A,,10826,9615.0,178.0,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14600,,
CHEMBL626296,50597,,,In vivo,A,,10827,10116.0,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14681,,
CHEMBL626297,22224,,,In vivo,A,,10828,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15905,,
CHEMBL626298,22224,,Plasma,In vivo,A,,10829,,1969.0,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,U,,0,,Autocuration,1,BAO_0000218,,,15905,,
CHEMBL626299,50597,,Plasma,In vivo,A,,10830,10116.0,1969.0,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13304,,
CHEMBL626300,50597,,Plasma,In vivo,A,,10831,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL626301,50597,,Plasma,In vivo,A,,10832,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL626962,50597,,Plasma,In vivo,A,,10833,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL626963,50597,,Plasma,In vivo,A,,10834,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL626964,50597,,Plasma,In vivo,A,,10835,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL626965,100710,,Plasma,In vivo,A,,10836,9541.0,1969.0,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL626966,50594,,Plasma,In vivo,A,,10837,10090.0,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL626967,50594,,Plasma,In vivo,A,,10838,10090.0,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL626968,100710,,Plasma,In vivo,A,,10839,9541.0,1969.0,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL626969,50597,,Heart,,A,,10840,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627126,50597,,Heart,,A,,10841,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631276,50597,,Heart,,A,,10842,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631277,50597,,Heart,,A,,10843,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631278,50597,,Heart,,A,,10844,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL874457,50597,,Heart,,A,,10845,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631279,50597,,Heart,,A,,10846,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631280,50597,,Heart,,A,,10847,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631281,50597,,Heart,,A,,10848,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631968,50597,,Heart,,A,,10849,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631969,50597,,Heart,,A,,10850,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631970,50597,,Heart,,A,,10851,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631971,50597,,Heart,,A,,10852,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631972,50597,,Heart,,A,,10853,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630435,50597,,Heart,,A,,10854,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630436,50597,,Heart,,A,,10855,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630437,50597,,Heart,,A,,10856,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630438,50597,,Heart,,A,,10857,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630439,50597,,Heart,,A,,10858,10116.0,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630440,50597,,Kidney,,A,,10859,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630441,50597,,Kidney,,A,,10860,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630442,50597,,Kidney,,A,,10861,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625234,50597,,Kidney,,A,,10862,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625235,50597,,Kidney,,A,,10863,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625236,50597,,Kidney,,A,,10864,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625237,50597,,Kidney,,A,,10865,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626125,50597,,Kidney,,A,,10866,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626126,50597,,Kidney,,A,,10867,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626127,50597,,Kidney,,A,,10868,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626128,50597,,Kidney,,A,,10869,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626129,50597,,Kidney,,A,,10870,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626130,50597,,Kidney,,A,,10871,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626131,50597,,Kidney,,A,,10872,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626132,50597,,Kidney,,A,,10873,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626752,50597,,Kidney,,A,,10874,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626753,50597,,Kidney,,A,,10875,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626754,50597,,Kidney,,A,,10876,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626755,50597,,Kidney,,A,,10877,10116.0,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626756,50597,,Liver,,A,,10878,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626757,50597,,Liver,,A,,10879,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626758,50597,,Liver,,A,,10880,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626759,50597,,Liver,,A,,10881,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626760,50597,,Liver,,A,,10882,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL626394,50588,,,,A,,10883,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL626395,50588,,,,A,,10884,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL626396,50588,,,,A,,10885,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL626397,50588,,,,A,,10886,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL626398,50588,,,,A,,10887,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL626399,50588,,,,A,,10888,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL874653,50597,,,,A,,10889,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL626400,50597,,,,A,,10890,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL626401,50597,,,,A,,10891,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL626402,50597,,,,A,,10892,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL626403,50597,,,,A,,10893,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL626404,50597,,,,A,,10894,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL626405,50597,,,,A,,10895,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625529,50597,,,,A,,10896,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625530,50597,,,,A,,10897,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625531,50597,,,,A,,10898,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625532,50597,,,,A,,10899,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625533,50597,,,,A,,10900,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL875474,50597,,,,A,,10901,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625534,50597,,,,A,,10902,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625535,50597,,,,A,,10903,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625536,50597,,,,A,,10904,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625537,50597,,,,A,,10905,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625538,50597,,,,A,,10906,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625539,50597,,,,A,,10907,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625540,50597,,,,A,,10908,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625541,50597,,,,A,,10909,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625542,50597,,,,A,,10910,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625543,50597,,,,A,,10911,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625544,50597,,,,A,,10912,10116.0,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625545,50588,,,,A,,10913,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625546,50588,,,,A,,10914,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625547,50588,,,,A,,10915,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625548,50588,,,,A,,10916,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625549,50588,,,,A,,10917,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625550,50588,,,,A,,10918,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625551,50588,,,,A,,10919,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL875475,50588,,,,A,,10920,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625552,50588,,,,A,,10921,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625553,50588,,,,A,,10922,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625554,50588,,,,A,,10923,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625555,50588,,,,A,,10924,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625556,50588,,,,A,,10925,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624986,50588,,,,A,,10926,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624987,50588,,,,A,,10927,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624988,50588,,,,A,,10928,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624989,50588,,Artery,In vivo,A,,10929,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624990,50588,,Artery,In vivo,A,,10930,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL874391,50588,,Artery,In vivo,A,,10931,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624991,50588,,Artery,In vivo,A,,10932,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624992,50588,,Artery,In vivo,A,,10933,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624993,50588,,Artery,In vivo,A,,10934,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624994,50588,,Artery,In vivo,A,,10935,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624995,50588,,Artery,In vivo,A,,10936,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624996,50588,,Artery,In vivo,A,,10937,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624997,50588,,Artery,In vivo,A,,10938,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624998,50588,,Artery,In vivo,A,,10939,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624999,50588,,Artery,In vivo,A,,10940,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL882955,50588,,Artery,In vivo,A,,10941,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625000,50588,,Artery,In vivo,A,,10942,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625001,50588,,Artery,In vivo,A,,10943,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625089,50588,,Artery,In vivo,A,,10944,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625090,50588,,Artery,In vivo,A,,10945,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625091,50588,,Artery,In vivo,A,,10946,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625092,50588,,Artery,In vivo,A,,10947,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625093,50588,,Artery,In vivo,A,,10948,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625094,50588,,Artery,In vivo,A,,10949,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625095,50588,,Artery,In vivo,A,,10950,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625096,50588,,,In vivo,A,,10951,9615.0,,Compound was evaluated for its bioavailability in the dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,2249,,
CHEMBL625097,50597,,,In vivo,A,,10952,10116.0,,Compound was evaluated for its bioavailability in the rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2249,,
CHEMBL882956,22224,,,In vivo,A,,10953,,,Compound was evaluated for oral bioavailability,U,,0,,Autocuration,1,BAO_0000218,,,17515,,
CHEMBL625098,50597,,,In vivo,A,,10954,10116.0,,Compound was evaluated for percentage of Oral bioavailability in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14541,,
CHEMBL625099,22224,,,In vivo,A,,10955,10141.0,,Bioavailability in guinea pig,U,,0,,Autocuration,1,BAO_0000218,,Cavia porcellus,12797,,
CHEMBL625100,50597,,,In vivo,A,,10956,10116.0,,Compound was evaluated for the oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12797,,
CHEMBL625101,50588,,,In vivo,A,,10957,9615.0,,Compound was evaluated for the oral bioavailability in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12797,,
CHEMBL874396,50597,,,In vivo,A,,10958,10116.0,,Compound was evaluated for the oral bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12797,,
CHEMBL625102,22224,,,In vivo,F,,10959,9615.0,,Bioavailability in dog (dosed i.v.),U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,11727,,
CHEMBL625103,50588,,,In vivo,A,,10960,9615.0,,Compound was tested for in vivo bioavailability in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13249,,
CHEMBL625104,100712,,,In vivo,A,,10961,10026.0,,Compound was tested for in vivo bioavailability in hamsters,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,13249,,
CHEMBL625105,22224,,,In vivo,A,,10962,314293.0,,Compound was tested for in vivo bioavailability in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,13249,,
CHEMBL625106,50597,,,In vivo,A,,10963,10116.0,,Compound was tested for in vivo bioavailability in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13249,,
CHEMBL625107,22224,,,In vivo,A,,10964,10090.0,,Oral bioavailability in mouse,U,,0,,Autocuration,1,BAO_0000218,,Mus musculus,9552,,
CHEMBL625108,50594,,,In vivo,A,,10965,10090.0,,Compound was tested for percent of oral bioavailability in mice; 56-74,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9552,,
CHEMBL625109,22224,,,In vivo,A,,10966,10090.0,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),U,,0,,Autocuration,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL625110,22224,,,In vivo,A,,10967,9541.0,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),U,,0,,Autocuration,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL625111,22224,,,In vivo,A,,10968,9541.0,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),U,,0,,Autocuration,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL625112,50594,,,In vivo,A,,10969,10090.0,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL875334,50594,,,In vivo,A,,10970,10090.0,,Oral bioavailability in nude mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL628617,22224,,,In vivo,A,,10971,9443.0,,Bioavailability in monkey (i.d. dosing),U,,0,,Autocuration,1,BAO_0000218,,Primates,11219,,
CHEMBL628618,22224,,,In vivo,A,,10972,10116.0,,Bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,9552,,
CHEMBL628619,22224,,,In vivo,A,,10973,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL628620,22224,,,In vivo,A,,10974,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL628621,100710,,,In vivo,A,,10975,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL628622,100710,,,In vivo,A,,10976,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL628623,100710,,,In vivo,A,,10977,9541.0,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL628624,100710,,Plasma,In vivo,A,,10978,9541.0,1969.0,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL628625,50594,,Plasma,In vivo,A,,10979,10090.0,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL628626,100710,,Plasma,In vivo,A,,10980,9541.0,1969.0,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14839,,
CHEMBL627041,50594,,Plasma,In vivo,A,,10981,10090.0,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL627042,50594,,Plasma,In vivo,A,,10982,10090.0,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL627043,50594,,Plasma,In vivo,A,,10983,10090.0,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL627044,22224,,Plasma,In vivo,A,,10984,,1969.0,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,13932,,
CHEMBL627045,50594,,Plasma,In vivo,A,,10985,10090.0,1969.0,Cmax in mouse plasma,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11637,,
CHEMBL627046,22224,,Plasma,In vivo,A,,10986,,1969.0,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,U,,0,,Autocuration,1,BAO_0000218,,,11637,,
CHEMBL627047,50597,,Plasma,In vivo,A,,10987,10116.0,1969.0,Maximal plasma concentration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13960,,
CHEMBL627048,50597,,Plasma,In vivo,A,,10988,10116.0,1969.0,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15905,,
CHEMBL627049,50597,,,In vivo,A,,10989,10116.0,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL627050,50597,,,In vivo,A,,10990,10116.0,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL627051,50597,,,In vivo,A,,10991,10116.0,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL627052,50597,,,In vivo,A,,10992,10116.0,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL627053,50597,,,In vivo,A,,10993,10116.0,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL627054,50597,,,In vivo,A,,10994,10116.0,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL627055,50594,,,In vivo,A,,10995,10090.0,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627056,50594,,,In vivo,A,,10996,10090.0,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627057,50594,,,In vivo,A,,10997,10090.0,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL627058,50594,,,In vivo,A,,10998,10090.0,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL626211,50594,,,In vivo,A,,10999,10090.0,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL626212,22224,,,In vivo,A,,11000,,,Maximum Concentration of the compound.,U,,0,,Autocuration,1,BAO_0000218,,,10291,,
CHEMBL626213,50588,,,In vivo,A,,11001,9615.0,,Maximum Concentration was measured after iv administration into Beagle dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL626214,50588,,,In vivo,A,,11002,9615.0,,Maximum Concentration was measured after iv administration into Beagle dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL626215,50588,,,In vivo,A,,11003,9615.0,,Maximum Concentration was measured after po administration into Beagle dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL626216,50588,,,In vivo,A,,11004,9615.0,,Maximum Concentration was measured after po administration into Beagle dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14599,,
CHEMBL626217,22224,,Blood,In vivo,A,,11005,,178.0,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL626218,22224,,Blood,In vivo,A,,11006,,178.0,Maximum blood level reached after an iv dose of 12.2 uM/kg,U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL626219,22224,,Blood,In vivo,A,,11007,,178.0,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL626220,22224,,Blood,In vivo,A,,11008,,178.0,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL626221,22224,,Blood,In vivo,A,,11009,,178.0,Maximum blood level reached after an oral dose of 5.0 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL626222,22224,,Blood,In vivo,A,,11010,,178.0,Maximum blood level reached at dose of 10.6 uM/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,12767,,
CHEMBL626223,50512,,,In vivo,A,,11011,10141.0,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14706,,
CHEMBL626224,50512,,,In vivo,A,,11012,10141.0,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14706,,
CHEMBL626225,50597,,Brain,In vivo,A,,11013,10116.0,955.0,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL626226,50597,,Brain,In vivo,A,,11014,10116.0,955.0,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL626227,50597,,Brain,In vivo,A,,11015,10116.0,955.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL626228,50597,,Brain,In vivo,A,,11016,10116.0,955.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL626229,50597,,,In vivo,A,,11017,10116.0,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL626921,50597,,,In vivo,A,,11018,10116.0,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL876793,50597,,,In vivo,A,,11019,10116.0,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL625309,50597,,,In vivo,A,,11020,10116.0,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL625310,50278,,,In vivo,A,,11021,1423.0,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Bacillus subtilis,10524,,
CHEMBL625311,22224,,,In vivo,A,,11022,314293.0,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,11871,,
CHEMBL625312,50597,,,In vivo,A,,11023,10116.0,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11871,,
CHEMBL625313,22224,,,In vivo,A,,11024,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,U,,0,,Autocuration,1,BAO_0000218,,,3437,,
CHEMBL625314,50594,,,In vivo,A,,11025,10090.0,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12038,,
CHEMBL625315,50597,,,In vivo,A,,11026,10116.0,,Maximum concentration in male rats after iv administration of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12038,,
CHEMBL625316,50597,,Liver,,A,,11027,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625317,50597,,Liver,,A,,11028,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625318,50597,,Liver,,A,,11029,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625319,50597,,Liver,,A,,11030,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625320,50597,,Liver,,A,,11031,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625321,50597,,Liver,,A,,11032,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625322,50597,,Liver,,A,,11033,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL876801,50597,,Liver,,A,,11034,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625323,50597,,Liver,,A,,11035,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625324,50597,,Liver,,A,,11036,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625325,50597,,Liver,,A,,11037,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625326,50597,,Liver,,A,,11038,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625327,50597,,Liver,,A,,11039,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625328,50597,,Liver,,A,,11040,10116.0,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625329,50597,,Lung,,A,,11041,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL625330,50597,,Lung,,A,,11042,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627774,50597,,Lung,,A,,11043,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627775,50597,,Lung,,A,,11044,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627949,50597,,Lung,,A,,11045,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627950,50597,,Lung,,A,,11046,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627951,50597,,Lung,,A,,11047,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627952,50597,,Lung,,A,,11048,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627953,50597,,Lung,,A,,11049,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627954,50597,,Lung,,A,,11050,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627955,50597,,Lung,,A,,11051,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627956,50597,,Lung,,A,,11052,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL876802,50597,,Lung,,A,,11053,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627957,50597,,Lung,,A,,11054,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627958,50597,,Lung,,A,,11055,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627959,50597,,Lung,,A,,11056,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627960,50597,,Lung,,A,,11057,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627961,50597,,Lung,,A,,11058,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627962,50597,,Lung,,A,,11059,10116.0,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL627963,50597,,,,A,,11060,10116.0,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624759,50597,,,,A,,11061,10116.0,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624760,50597,,,,A,,11062,10116.0,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624761,50597,,,,A,,11063,10116.0,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL877607,50597,,,,A,,11064,10116.0,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624762,50597,,Liver,,A,,11065,10116.0,2107.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624763,50597,,Liver,,A,,11066,10116.0,2107.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624764,50597,,Liver,,A,,11067,10116.0,2107.0,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624765,50597,,Liver,,A,,11068,10116.0,2107.0,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624766,50597,,Liver,,A,,11069,10116.0,2107.0,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL624767,50588,,,,A,,11070,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624768,50588,,,,A,,11071,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624769,50588,,,,A,,11072,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624770,50588,,,,A,,11073,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624771,50588,,,,A,,11074,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624772,50588,,,,A,,11075,9615.0,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624773,50597,,,,A,,11076,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624774,50597,,,,A,,11077,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624775,50597,,,,A,,11078,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624776,50597,,,,A,,11079,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624777,50597,,,,A,,11080,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624778,50597,,,,A,,11081,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624779,50597,,,,A,,11082,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624780,50597,,,,A,,11083,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624781,50597,,,,A,,11084,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL877608,50597,,,,A,,11085,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624782,50597,,,,A,,11086,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624783,50597,,,,A,,11087,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624784,50597,,,,A,,11088,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624785,50597,,,,A,,11089,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624786,50597,,,,A,,11090,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL624787,50597,,,,A,,11091,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL628676,50597,,,,A,,11092,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL621842,50597,,,,A,,11093,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL621843,50597,,,,A,,11094,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL623873,50597,,,,A,,11095,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL623874,50597,,,,A,,11096,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL623875,50597,,,,A,,11097,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL623876,50597,,,,A,,11098,10116.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL623877,50588,,,,A,,11099,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623878,50588,,,,A,,11100,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623879,50588,,,,A,,11101,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623880,50588,,,,A,,11102,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623881,50588,,,,A,,11103,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623957,50588,,,,A,,11104,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623958,50588,,,,A,,11105,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623959,50588,,,,A,,11106,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623960,50588,,,,A,,11107,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623961,50588,,,,A,,11108,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL623962,50588,,,,A,,11109,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624676,50588,,,,A,,11110,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624677,50588,,,,A,,11111,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624678,50588,,,,A,,11112,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624679,50588,,,,A,,11113,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624680,50588,,,,A,,11114,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624849,22224,,,In vivo,A,,11115,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL624850,22224,,,In vivo,A,,11116,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL874399,22224,,,In vivo,A,,11117,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL624851,22224,,,In vivo,A,,11118,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL624852,22224,,,In vivo,A,,11119,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,U,,0,,Autocuration,1,BAO_0000218,,,11732,,
CHEMBL624853,22224,,,In vivo,A,,11120,10116.0,,Oral bioavailability in rat (dose 10 mg/kg),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,13359,,
CHEMBL624854,22224,,,In vivo,A,,11121,10116.0,,Oral bioavailability in rat (Sprague-Dawley),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,16618,,
CHEMBL624855,22224,,,In vivo,A,,11122,10116.0,,Oral bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,13960,,
CHEMBL624856,22224,,,In vivo,A,,11123,10116.0,,Oral bioavailability in rats was determined in vivo,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,13917,,
CHEMBL882957,22224,,,In vivo,A,,11124,9615.0,,Oral bioavailability in dog,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,14266,,
CHEMBL624857,22224,,,In vivo,A,,11125,314293.0,,Oral bioavailability of compound in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12359,,
CHEMBL622202,50597,,,In vivo,A,,11126,10116.0,,Oral bioavailability of compound in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12359,,
CHEMBL622203,22224,,,In vivo,A,,11127,10116.0,,Bioavailability in rat of PMEA prodrug,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12359,,
CHEMBL625522,50597,,,In vivo,A,,11128,10116.0,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12359,,
CHEMBL622868,22224,,,In vivo,A,,11129,9544.0,,Serum conc at 3 hours following 25 mg/kg dose,U,,0,,Autocuration,1,BAO_0000218,,Macaca mulatta,10791,,
CHEMBL622869,22224,,Urine,In vivo,A,,11130,9544.0,1088.0,Urine conc 0-5 hours following 25 mg/kg dose,U,,0,,Autocuration,1,BAO_0000218,,Macaca mulatta,10791,,
CHEMBL622870,22224,,Urine,In vivo,A,,11131,9544.0,1088.0,Urine conc 0-24 hours following 25 mg/kg dose,U,,0,,Autocuration,1,BAO_0000218,,Macaca mulatta,10791,,
CHEMBL622871,22224,,,In vivo,A,,11132,9534.0,,Oral bioavailability in African green monkeys; 20-25,U,,0,,Autocuration,1,BAO_0000218,,Chlorocebus aethiops,138,,
CHEMBL620560,100710,,,In vivo,A,,11133,9541.0,,Oral bioavailability in cynomolgus monkey.,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14521,,
CHEMBL620561,22224,,,In vivo,A,,11134,9615.0,,Oral bioavailability in dog,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,13953,,
CHEMBL620562,50588,,,In vivo,A,,11135,9615.0,,Oral bioavailability in dog at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12836,,
CHEMBL620563,100712,,,In vivo,A,,11136,10026.0,,Oral bioavailability in hamster at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,12836,,
CHEMBL620564,50597,,,In vivo,A,,11137,10116.0,,Oral bioavailability in rat at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12836,,
CHEMBL872265,22224,,,In vivo,A,,11138,10116.0,,Oral bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,14521,,
CHEMBL620565,22224,,,In vivo,A,,11139,10116.0,,Oral bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,13953,,
CHEMBL620566,22224,,,In vivo,A,,11140,9347.0,,Oral bioavailability,U,,0,,Autocuration,1,BAO_0000218,,Eutheria,6799,,
CHEMBL620567,22224,,,In vivo,A,,11141,,,Oral bioavailability was determined; range 49-102%,U,,0,,Autocuration,1,BAO_0000218,,,11311,,
CHEMBL620568,50588,,,In vivo,A,,11142,9615.0,,Oral bioavailability was determined in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,4013,,
CHEMBL620569,22224,,,In vivo,A,,11143,10116.0,,Oral bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,4013,,
CHEMBL620570,22224,,,In vivo,A,,11144,9347.0,,Oral bioavailability,U,,0,,Autocuration,1,BAO_0000218,,Eutheria,17591,,
CHEMBL620571,22224,,,In vivo,A,,11145,,,Oral bioavailability was determined; Not orally available,U,,0,,Autocuration,1,BAO_0000218,,,17591,,
CHEMBL620572,50594,,,In vivo,A,,11146,10090.0,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL620573,22224,,,In vivo,A,,11147,10090.0,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),U,,0,,Autocuration,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL620574,22224,,,In vivo,A,,11148,10090.0,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Mus musculus,15011,,
CHEMBL620575,22224,,,In vivo,A,,11149,9544.0,,Oral bioavailability in Rhesus monkey,U,,0,,Autocuration,1,BAO_0000218,,Macaca mulatta,9552,,
CHEMBL620576,22224,,,In vivo,A,,11150,9615.0,,Oral bioavailability in dog (female mongrel),U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,9552,,
CHEMBL875846,22224,,,In vivo,A,,11151,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,U,,0,,Autocuration,1,BAO_0000218,,,3639,,
CHEMBL620577,22224,,,In vivo,A,,11152,9615.0,,Oral bioavailability in dog,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,13397,,
CHEMBL620578,22224,,,In vivo,A,,11153,,,Percentage Bioavailability was evaluated.,U,,0,,Autocuration,1,BAO_0000218,,,3031,,
CHEMBL620579,22224,,,In vivo,A,,11154,10116.0,,Bioavailability in rat administered i.d.,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12818,,
CHEMBL621248,22224,,,In vivo,A,,11155,9347.0,,Bioavailability,U,,0,,Autocuration,1,BAO_0000218,,Eutheria,4847,,
CHEMBL625390,22224,,,In vivo,A,,11156,9615.0,,Bioavailability in dog (male Beagle) i.v. administration,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,12421,,
CHEMBL625391,22224,,,In vivo,A,,11157,10116.0,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,11966,,
CHEMBL872266,22224,,,In vivo,A,,11158,9443.0,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),U,,0,,Autocuration,1,BAO_0000218,,Primates,11218,,
CHEMBL625392,22224,,,In vivo,A,,11159,10116.0,,Oral bioavailability in rat (Sprague-Dawley) (male),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,13129,,
CHEMBL625393,50597,,,In vivo,A,,11160,10116.0,,The oral bioavailability was measured on rats after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12350,,
CHEMBL625394,50597,,,In vivo,A,,11161,10116.0,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2231,,
CHEMBL625395,50797,,,In vivo,A,,11162,9544.0,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,2231,,
CHEMBL625396,22224,,,In vivo,A,,11163,10116.0,,Bioavailability in rat (dose 10 mg/kg i.d.),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL625397,22224,,,In vivo,A,,11164,9615.0,,Bioavailability in dog (male Beagle) i.v. administration,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,12421,,
CHEMBL625398,50594,,,In vivo,A,,11165,10090.0,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625399,50594,,Blood,In vivo,A,,11166,10090.0,178.0,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL626074,50594,,Cerebellum,In vivo,A,,11167,10090.0,2037.0,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL626075,50594,,,In vivo,A,,11168,10090.0,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL626076,50597,,Plasma,In vivo,A,,11169,10116.0,1969.0,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2231,,
CHEMBL626077,50797,,Plasma,In vivo,A,,11170,9544.0,1969.0,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,2231,,
CHEMBL626078,50597,,Blood,In vivo,A,,11171,10116.0,178.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12178,,
CHEMBL625846,22224,,Blood,In vivo,A,,11172,,178.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),U,,0,,Autocuration,1,BAO_0000218,,,12178,,
CHEMBL625847,22224,,Blood,In vivo,A,,11173,,178.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),U,,0,,Autocuration,1,BAO_0000218,,,12178,,
CHEMBL625848,50597,,,In vivo,A,,11174,10116.0,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,15633,,
CHEMBL625849,50597,,Plasma,In vivo,A,,11175,10116.0,1969.0,Maximum concentration of compound in plasma administered orally to rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14258,,
CHEMBL626023,50588,,Plasma,In vivo,A,,11176,9615.0,1969.0,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL626024,50588,,Plasma,In vivo,A,,11177,9615.0,1969.0,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL626025,50588,,Plasma,In vivo,A,,11178,9615.0,1969.0,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL626026,22224,,,In vivo,A,,11179,,,Maximum concentration after 10 mg/kg by oral administration,U,,0,,Autocuration,1,BAO_0000218,,,5566,,
CHEMBL626027,22224,,,In vivo,A,,11180,,,Maximum concentration at a dose of 1.5 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,16935,,
CHEMBL626028,22224,,,In vivo,A,,11181,,,Maximum concentration at a dose of 2.0 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,16935,,
CHEMBL626029,50588,,Plasma,In vivo,A,,11182,9615.0,1969.0,Maximum concentration in dog plasma,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL626030,22224,,Plasma,In vivo,A,,11183,,1969.0,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,U,,0,,Autocuration,1,BAO_0000218,,,12536,,
CHEMBL626031,22224,,Plasma,In vivo,A,,11184,,1969.0,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,U,,0,,Autocuration,1,BAO_0000218,,,12536,,
CHEMBL626032,22224,,Plasma,In vivo,A,,11185,,1969.0,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,U,,0,,Autocuration,1,BAO_0000218,,,12536,,
CHEMBL626033,22224,,Plasma,In vivo,A,,11186,,1969.0,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,U,,0,,Autocuration,1,BAO_0000218,,,12536,,
CHEMBL626034,22224,,Plasma,In vivo,A,,11187,,1969.0,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,U,,0,,Autocuration,1,BAO_0000218,,,12536,,
CHEMBL626035,50588,,Plasma,In vivo,A,,11188,9615.0,1969.0,Maximum concentration in plasma after oral administration in dog (25 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9994,,
CHEMBL626036,22224,,Plasma,In vivo,A,,11189,,1969.0,Maximum concentration in plasma at Tmax,U,,0,,Autocuration,1,BAO_0000218,,,1434,,
CHEMBL626037,50588,,Plasma,In vivo,A,,11190,9615.0,1969.0,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,N,,1,,Expert,1,BAO_0000218,,Canis lupus familiaris,12836,,
CHEMBL626038,100712,,Plasma,In vivo,A,,11191,10026.0,1969.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,12836,,
CHEMBL626039,50597,,Plasma,In vivo,A,,11192,10116.0,1969.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12836,,
CHEMBL626040,50597,,Plasma,In vivo,A,,11193,10116.0,1969.0,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12545,,
CHEMBL626041,50592,,Plasma,In vivo,A,,11194,9986.0,1969.0,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,13856,,
CHEMBL626042,22224,,,In vivo,A,,11195,,,Maximum concentration was calculated,U,,0,,Autocuration,1,BAO_0000218,,,3550,,
CHEMBL626043,22224,,,In vivo,A,,11196,,,Maximum concentration was calculated.,U,,0,,Autocuration,1,BAO_0000218,,,2632,,
CHEMBL626044,22224,,,In vivo,A,,11197,,,Maximum concentration at a peroral dose of 10 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,5566,,
CHEMBL626045,22224,,,In vivo,A,,11198,,,Maximum concentration of the drug at 10 uM/dg administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,11883,,
CHEMBL626046,22224,,,In vivo,A,,11199,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,11883,,
CHEMBL626047,50588,,Plasma,In vivo,A,,11200,9615.0,1969.0,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14122,,
CHEMBL626048,100712,,Plasma,In vivo,A,,11201,10026.0,1969.0,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,14122,,
CHEMBL626049,50597,,Plasma,In vivo,A,,11202,10116.0,1969.0,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14122,,
CHEMBL626050,50597,,Plasma,In vivo,A,,11203,10116.0,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12542,,
CHEMBL874541,50588,,Plasma,In vivo,A,,11204,9615.0,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12542,,
CHEMBL622826,100712,,Plasma,In vivo,A,,11205,10026.0,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,12542,,
CHEMBL622827,100712,,Plasma,In vivo,A,,11206,10026.0,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,12542,,
CHEMBL622828,50597,,Plasma,In vivo,A,,11207,10116.0,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12542,,
CHEMBL622829,50597,,Plasma,In vivo,A,,11208,10116.0,1969.0,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14080,,
CHEMBL876806,50597,,,In vivo,A,,11209,10116.0,,Maximum concentration reached following intravenous administration in male rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11911,,
CHEMBL622830,50588,,,In vivo,A,,11210,9615.0,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13204,,
CHEMBL622831,50597,,,In vivo,A,,11211,10116.0,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13204,,
CHEMBL626794,50588,,,In vivo,A,,11212,9615.0,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14346,,
CHEMBL626795,50597,,,In vivo,A,,11213,10116.0,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL626796,50597,,,In vivo,A,,11214,10116.0,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL626797,50597,,,In vivo,A,,11215,10116.0,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL626798,50597,,,In vivo,A,,11216,10116.0,,Maximum drug concentration is determined after oral dosing in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14127,,
CHEMBL626799,50588,,,In vivo,A,,11217,9615.0,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14339,,
CHEMBL626800,50588,,,In vivo,A,,11218,9615.0,,Maximum observed concentration in oral (5 mg/kg) fed dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14339,,
CHEMBL626801,22224,,Plasma,In vivo,A,,11219,,1969.0,Maximum plasma concentration,U,,0,,Autocuration,1,BAO_0000218,,,13494,,
CHEMBL876816,50597,,Plasma,In vivo,A,,11220,10116.0,1969.0,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14925,,
CHEMBL626802,50597,,Plasma,In vivo,A,,11221,10116.0,1969.0,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14474,,
CHEMBL626803,50588,,Plasma,In vivo,A,,11222,9615.0,1969.0,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14474,,
CHEMBL626804,22224,,Plasma,In vivo,A,,11223,,1969.0,Maximum plasma concentration following oral administration of 30 umol/kg,U,,0,,Autocuration,1,BAO_0000218,,,13917,,
CHEMBL626805,50597,,Plasma,,A,,11224,10116.0,1969.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626309,50597,,Plasma,,A,,11225,10116.0,1969.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626310,50597,,Plasma,,A,,11226,10116.0,1969.0,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626311,50597,,Plasma,,A,,11227,10116.0,1969.0,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626312,50597,,Plasma,,A,,11228,10116.0,1969.0,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626313,50597,,Uterus,,A,,11229,10116.0,995.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626314,50597,,Uterus,,A,,11230,10116.0,995.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626315,50597,,Uterus,,A,,11231,10116.0,995.0,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626316,50597,,Uterus,,A,,11232,10116.0,995.0,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626317,50597,,Uterus,,A,,11233,10116.0,995.0,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9796,,
CHEMBL626318,50597,,,,A,,11234,10116.0,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626319,50597,,,,A,,11235,10116.0,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626320,50597,,,,A,,11236,10116.0,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL875053,50597,,,,A,,11237,10116.0,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626321,50597,,,,A,,11238,10116.0,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626322,50597,,,,A,,11239,10116.0,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626323,50597,,,,A,,11240,10116.0,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626324,50597,,,,A,,11241,10116.0,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626325,50597,,,,A,,11242,10116.0,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626326,50597,,,,A,,11243,10116.0,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626327,50597,,,,A,,11244,10116.0,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626328,50597,,,,A,,11245,10116.0,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8363,,
CHEMBL626329,50597,,Blood,,A,,11246,10116.0,178.0,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL626330,50597,,Blood,,A,,11247,10116.0,178.0,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL626331,50597,,Blood,,A,,11248,10116.0,178.0,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL626332,50597,,Blood,,A,,11249,10116.0,178.0,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL626333,50597,,Blood,,A,,11250,10116.0,178.0,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL626334,50597,,Blood,,A,,11251,10116.0,178.0,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL626335,50597,,Blood,,A,,11252,10116.0,178.0,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624798,50597,,Blood,,A,,11253,10116.0,178.0,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624799,50597,,Brain,,A,,11254,10116.0,955.0,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624800,50597,,Brain,,A,,11255,10116.0,955.0,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624801,50597,,Brain,,A,,11256,10116.0,955.0,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624802,50597,,Brain,,A,,11257,10116.0,955.0,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624803,50597,,Brain,,A,,11258,10116.0,955.0,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624804,50597,,Brain,,A,,11259,10116.0,955.0,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624805,50597,,Brain,,A,,11260,10116.0,955.0,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624806,50597,,Brain,,A,,11261,10116.0,955.0,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624807,50597,,,,A,,11262,10116.0,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624808,50597,,,,A,,11263,10116.0,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624809,50597,,,,A,,11264,10116.0,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624810,50597,,,,A,,11265,10116.0,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL877618,50597,,,,A,,11266,10116.0,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624811,50597,,,,A,,11267,10116.0,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624812,50597,,,,A,,11268,10116.0,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624813,50597,,,,A,,11269,10116.0,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624814,50597,,,,A,,11270,10116.0,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624815,50597,,,,A,,11271,10116.0,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624816,50597,,,,A,,11272,10116.0,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624817,50597,,,,A,,11273,10116.0,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624818,50588,,,,A,,11274,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624819,50588,,,,A,,11275,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624820,50588,,,,A,,11276,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624821,50588,,,,A,,11277,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624822,50588,,,,A,,11278,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624823,50588,,,,A,,11279,9615.0,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624824,50212,,,,A,,11280,562.0,,Observed diffusion coefficient in organic solvent for Escherichia coli,N,,1,,Intermediate,1,BAO_0000218,,Escherichia coli,15599,,
CHEMBL624825,50597,,Blood,,A,,11281,10116.0,178.0,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624826,50597,,Blood,,A,,11282,10116.0,178.0,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL876817,50597,,Cardiac atrium,,A,,11283,10116.0,2081.0,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624827,50597,,Cardiac atrium,,A,,11284,10116.0,2081.0,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624828,50597,,,,A,,11285,10116.0,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624829,50597,,,,A,,11286,10116.0,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624830,50597,,Liver,,A,,11287,10116.0,2107.0,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624831,50597,,Liver,,A,,11288,10116.0,2107.0,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624832,50597,,Cardiac atrium,,A,,11289,10116.0,2081.0,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624833,50597,,Cardiac atrium,,A,,11290,10116.0,2081.0,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624834,50597,,,,A,,11291,10116.0,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624835,50597,,,,A,,11292,10116.0,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624836,50597,,Spleen,,A,,11293,10116.0,2106.0,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624837,50597,,Spleen,,A,,11294,10116.0,2106.0,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9614,,
CHEMBL624838,50597,,Blood,,A,,11295,10116.0,178.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL622188,50597,,Blood,,A,,11296,10116.0,178.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL622189,50597,,Heart,,A,,11297,10116.0,948.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL622190,50597,,Heart,,A,,11298,10116.0,948.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625170,50597,,Heart,,A,,11299,10116.0,948.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625171,50597,,Kidney,,A,,11300,10116.0,2113.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625172,50597,,Kidney,,A,,11301,10116.0,2113.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625173,50597,,Kidney,,A,,11302,10116.0,2113.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625174,50597,,Liver,,A,,11303,10116.0,2107.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625175,50597,,Liver,,A,,11304,10116.0,2107.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625176,50597,,Liver,,A,,11305,10116.0,2107.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625177,50597,,Lung,,A,,11306,10116.0,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625178,50597,,Lung,,A,,11307,10116.0,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625179,50597,,Lung,,A,,11308,10116.0,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625180,50597,,Lung,,A,,11309,10116.0,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9071,,
CHEMBL625181,22224,,,,A,,11310,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",U,,0,,Autocuration,1,BAO_0000218,,,10677,,
CHEMBL625182,50594,,Urine,,A,,11311,10090.0,1088.0,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9750,,
CHEMBL625183,50597,,,,A,,11312,10116.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL875848,50597,,,,A,,11313,10116.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL622260,50597,,,,A,,11314,10116.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL622261,50597,,,,A,,11315,10116.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL622262,50597,,,,A,,11316,10116.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL622263,50597,,Kidney,,A,,11317,10116.0,2113.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL622418,50597,,Kidney,,A,,11318,10116.0,2113.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL622419,50597,,Liver,,A,,11319,10116.0,2107.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623388,50594,,,In vivo,A,,11320,10090.0,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL623389,50594,,Liver,In vivo,A,,11321,10090.0,2107.0,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL623390,50594,,,In vivo,A,,11322,10090.0,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL623391,50594,,,In vivo,A,,11323,10090.0,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL623392,50594,,Blood,In vivo,A,,11324,10090.0,178.0,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL623393,50594,,Cerebellum,In vivo,A,,11325,10090.0,2037.0,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL623394,50594,,,In vivo,A,,11326,10090.0,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL618885,50594,,,In vivo,A,,11327,10090.0,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL618886,50594,,Liver,In vivo,A,,11328,10090.0,2107.0,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL618887,50594,,,In vivo,A,,11329,10090.0,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619535,50594,,,In vivo,A,,11330,10090.0,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619536,50594,,Blood,In vivo,A,,11331,10090.0,178.0,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619537,50594,,Cerebellum,In vivo,A,,11332,10090.0,2037.0,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619705,50594,,,In vivo,A,,11333,10090.0,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619706,50594,,,In vivo,A,,11334,10090.0,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619707,50594,,Liver,In vivo,A,,11335,10090.0,2107.0,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL619708,50594,,,In vivo,A,,11336,10090.0,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625219,50594,,,In vivo,A,,11337,10090.0,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625220,50594,,Blood,In vivo,A,,11338,10090.0,178.0,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625221,50594,,Cerebellum,In vivo,A,,11339,10090.0,2037.0,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625222,50594,,,In vivo,A,,11340,10090.0,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625223,50594,,,In vivo,A,,11341,10090.0,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625224,50594,,Liver,In vivo,A,,11342,10090.0,2107.0,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625225,50594,,,In vivo,A,,11343,10090.0,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13256,,
CHEMBL625226,50597,,Blood,In vivo,A,,11344,10116.0,178.0,Biodistribution in Rat blood after 24 hours of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625227,50597,,Blood,In vivo,A,,11345,10116.0,178.0,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625228,50597,,Blood,In vivo,A,,11346,10116.0,178.0,Biodistribution in Rat blood after 30 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL875354,50597,,Blood,In vivo,A,,11347,10116.0,178.0,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625229,50597,,Blood,In vivo,A,,11348,10116.0,178.0,Biodistribution in Rat blood after 5 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625230,50597,,Blood,In vivo,A,,11349,10116.0,178.0,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625231,50597,,Heart,In vivo,A,,11350,10116.0,948.0,Biodistribution in Rat heart after 24 hours of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625900,50597,,Heart,In vivo,A,,11351,10116.0,948.0,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625901,50597,,Heart,In vivo,A,,11352,10116.0,948.0,Biodistribution in Rat heart after 30 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625902,50597,,Heart,In vivo,A,,11353,10116.0,948.0,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625903,50597,,Heart,In vivo,A,,11354,10116.0,948.0,Biodistribution in Rat heart after 5 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625904,50597,,Heart,In vivo,A,,11355,10116.0,948.0,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625905,50597,,Liver,In vivo,A,,11356,10116.0,2107.0,Biodistribution in Rat liver after 24 hours of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL627861,50597,,Liver,In vivo,A,,11357,10116.0,2107.0,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL627862,50597,,Liver,In vivo,A,,11358,10116.0,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL627863,50597,,Liver,In vivo,A,,11359,10116.0,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL627769,50597,,Liver,In vivo,A,,11360,10116.0,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL627770,50588,,Plasma,In vivo,A,,11361,9615.0,1969.0,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13249,,
CHEMBL627771,100710,,,In vivo,A,,11362,9541.0,,Cmax in cynomolgus monkey (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,13622,,
CHEMBL627772,50597,,,In vivo,A,,11363,10116.0,,Cmax in rat (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13622,,
CHEMBL627773,50597,,,In vivo,A,,11364,10116.0,,Cmax in rat (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13622,,
CHEMBL621922,50597,,Plasma,In vivo,A,,11365,10116.0,1969.0,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13494,,
CHEMBL621923,50597,,Plasma,In vivo,A,,11366,10116.0,1969.0,Cmax in rat plasma after oral dose (10 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12170,,
CHEMBL621924,22224,,Plasma,In vivo,A,,11367,,1969.0,Cmax in plasma after oral dose (10 mg/kg),U,,0,,Autocuration,1,BAO_0000218,,,12170,,
CHEMBL621925,50588,,Plasma,In vivo,A,,11368,9615.0,1969.0,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17025,,
CHEMBL621926,22224,,Plasma,In vivo,A,,11369,314293.0,1969.0,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17025,,
CHEMBL621927,50592,,Plasma,In vivo,A,,11370,9986.0,1969.0,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL621928,50597,,Plasma,In vivo,A,,11371,10116.0,1969.0,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17025,,
CHEMBL621929,50597,,Plasma,In vivo,A,,11372,10116.0,1969.0,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14187,,
CHEMBL621930,50594,,Plasma,In vivo,A,,11373,10090.0,1969.0,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14816,,
CHEMBL621931,50597,,Plasma,In vivo,A,,11374,10116.0,1969.0,Maximum plasma concentration after oral dosing in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17820,,
CHEMBL621932,22224,,Plasma,In vivo,A,,11375,,1969.0,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL621933,22224,,Plasma,In vivo,A,,11376,,1969.0,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL621934,50588,,Plasma,In vivo,A,,11377,9615.0,1969.0,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14691,,
CHEMBL621935,50588,,Plasma,In vivo,A,,11378,9615.0,1969.0,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14691,,
CHEMBL621936,50597,,Plasma,In vivo,A,,11379,10116.0,1969.0,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13375,,
CHEMBL621937,22224,,Plasma,In vivo,A,,11380,,1969.0,Maximum plasma concentration was determined,U,,0,,Autocuration,1,BAO_0000218,,,6236,,
CHEMBL621938,22224,,Plasma,In vivo,A,,11381,,1969.0,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL621939,22224,,Plasma,In vivo,A,,11382,,1969.0,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL621940,22224,,Plasma,In vivo,A,,11383,,1969.0,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL621941,22224,,Plasma,In vivo,A,,11384,,1969.0,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL621942,22224,,Plasma,In vivo,A,,11385,,1969.0,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL626178,22224,,Plasma,In vivo,A,,11386,,1969.0,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL626179,22224,,Plasma,In vivo,A,,11387,,1969.0,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL626180,22224,,Plasma,In vivo,A,,11388,,1969.0,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL626181,50597,,Plasma,In vivo,A,,11389,10116.0,1969.0,Plasma Cmax in rat (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13622,,
CHEMBL626182,50597,,,In vivo,A,,11390,10116.0,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL626183,50597,,,In vivo,A,,11391,10116.0,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL626184,50597,,,In vivo,A,,11392,10116.0,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL626185,50597,,,In vivo,A,,11393,10116.0,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL626186,50588,,Plasma,In vivo,A,,11394,9615.0,1969.0,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14925,,
CHEMBL877589,50588,,Plasma,In vivo,A,,11395,9615.0,1969.0,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14925,,
CHEMBL626187,22224,,,In vivo,A,,11396,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,11883,,
CHEMBL626188,22224,,,In vivo,A,,11397,,,Maximum concentration of the drug at 20 uM/dg administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,11883,,
CHEMBL626189,22224,,,In vivo,A,,11398,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL626855,22224,,Blood,In vivo,A,,11399,,178.0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL623781,22224,,Blood,In vivo,A,,11400,,178.0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL623782,22224,,Blood,In vivo,A,,11401,,178.0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL623783,50597,,Plasma,In vivo,A,,11402,10116.0,1969.0,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16360,,
CHEMBL623784,50588,,Plasma,In vivo,A,,11403,9615.0,1969.0,Cmax in dog plasma after 1mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,3673,,
CHEMBL623785,50588,,Plasma,In vivo,A,,11404,9615.0,1969.0,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14431,,
CHEMBL623786,50597,,Plasma,In vivo,A,,11405,10116.0,1969.0,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14431,,
CHEMBL623787,50597,,,In vivo,A,,11406,10116.0,,Oral maximum concentration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14964,,
CHEMBL623788,50597,,,In vivo,A,,11407,10116.0,,Oral maximum concentration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14964,,
CHEMBL623789,50594,,Plasma,In vivo,A,,11408,10090.0,1969.0,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14209,,
CHEMBL623790,50594,,Blood,In vivo,A,,11409,10090.0,178.0,Peak concentration in blood after intravenous administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11355,,
CHEMBL623791,50594,,Blood,In vivo,A,,11410,10090.0,178.0,Peak concentration in blood after peroral administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11355,,
CHEMBL623792,50597,,Plasma,In vivo,A,,11411,10116.0,1969.0,Peak concentration in rat plasma was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11966,,
CHEMBL623793,22224,,Plasma,In vivo,A,,11412,314293.0,1969.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8918,,
CHEMBL623794,50594,,Plasma,In vivo,A,,11413,10090.0,1969.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8918,,
CHEMBL623795,50597,,Plasma,In vivo,A,,11414,10116.0,1969.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8918,,
CHEMBL623796,50597,,,,A,,11415,10116.0,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623797,50597,,,,A,,11416,10116.0,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623798,50597,,,,A,,11417,10116.0,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623799,50597,,,,A,,11418,10116.0,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624490,50597,,Intestine,,A,,11419,10116.0,160.0,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624491,50597,,Intestine,,A,,11420,10116.0,160.0,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624492,50597,,Intestine,,A,,11421,10116.0,160.0,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624493,50597,,Intestine,,A,,11422,10116.0,160.0,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL877595,50597,,Intestine,,A,,11423,10116.0,160.0,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624494,50597,,Intestine,,A,,11424,10116.0,160.0,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624495,50597,,Intestine,,A,,11425,10116.0,160.0,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624681,50597,,Intestine,,A,,11426,10116.0,160.0,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624682,50597,,,,A,,11427,10116.0,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624683,50597,,,,A,,11428,10116.0,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624684,50597,,,,A,,11429,10116.0,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624685,50597,,,,A,,11430,10116.0,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624686,50597,,,,A,,11431,10116.0,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624687,50597,,,,A,,11432,10116.0,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624688,50597,,,,A,,11433,10116.0,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL627161,50597,,,,A,,11434,10116.0,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL622127,50597,,,,A,,11435,10116.0,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL622128,50597,,,,A,,11436,10116.0,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL874384,50597,,,,A,,11437,10116.0,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624898,50597,,,,A,,11438,10116.0,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624899,50597,,,,A,,11439,10116.0,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624900,50597,,,,A,,11440,10116.0,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624901,50597,,,,A,,11441,10116.0,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624902,50597,,,,A,,11442,10116.0,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624903,50597,,,,A,,11443,10116.0,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624904,50597,,,,A,,11444,10116.0,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624905,50597,,,,A,,11445,10116.0,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624906,50597,,,,A,,11446,10116.0,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624907,50597,,,,A,,11447,10116.0,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624908,50597,,,,A,,11448,10116.0,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624909,50597,,,,A,,11449,10116.0,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624910,50597,,,,A,,11450,10116.0,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624911,50597,,Muscle tissue,,A,,11451,10116.0,2385.0,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL874388,50597,,Muscle tissue,,A,,11452,10116.0,2385.0,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL624912,50597,,Muscle tissue,,A,,11453,10116.0,2385.0,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL622930,50597,,Muscle tissue,,A,,11454,10116.0,2385.0,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623121,50597,,Muscle tissue,,A,,11455,10116.0,2385.0,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623122,50597,,Muscle tissue,,A,,11456,10116.0,2385.0,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623123,50597,,Muscle tissue,,A,,11457,10116.0,2385.0,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623124,50597,,Muscle tissue,,A,,11458,10116.0,2385.0,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623125,50597,,,,A,,11459,10116.0,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623126,50597,,,,A,,11460,10116.0,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623127,50597,,,,A,,11461,10116.0,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623128,50597,,,,A,,11462,10116.0,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623129,50597,,,,A,,11463,10116.0,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623130,50597,,,,A,,11464,10116.0,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623131,50597,,,,A,,11465,10116.0,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623132,50597,,,,A,,11466,10116.0,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL623133,50597,,Liver,,A,,11467,10116.0,2107.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623134,50597,,,,A,,11468,10116.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL874389,50597,,,,A,,11469,10116.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623135,50597,,,,A,,11470,10116.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623136,50597,,,,A,,11471,10116.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623137,50597,,,,A,,11472,10116.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623138,50597,,,,A,,11473,10116.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623139,50597,,Kidney,,A,,11474,10116.0,2113.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623140,50597,,Kidney,,A,,11475,10116.0,2113.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623141,50597,,Liver,,A,,11476,10116.0,2107.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623142,50597,,Liver,,A,,11477,10116.0,2107.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623143,50597,,,,A,,11478,10116.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL623144,50594,,Urine,,A,,11479,10090.0,1088.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14571,,
CHEMBL623405,50597,,Urine,,A,,11480,10116.0,1088.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14571,,
CHEMBL624074,50597,,,,A,,11481,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624075,50597,,,,A,,11482,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624076,50597,,,,A,,11483,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624077,50597,,,,A,,11484,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624078,50597,,,,A,,11485,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624079,50597,,Kidney,,A,,11486,10116.0,2113.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624261,50597,,Kidney,,A,,11487,10116.0,2113.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624262,50597,,,,A,,11488,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624263,50597,,,,A,,11489,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624264,50597,,,,A,,11490,10116.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624265,50597,,,,A,,11491,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624266,50597,,,,A,,11492,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624267,50597,,,,A,,11493,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624268,50597,,,,A,,11494,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL875227,50597,,,,A,,11495,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624269,50597,,Kidney,,A,,11496,10116.0,2113.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624270,50597,,Kidney,,A,,11497,10116.0,2113.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624271,50597,,,,A,,11498,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624272,50597,,,,A,,11499,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624273,50597,,,,A,,11500,10116.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8319,,
CHEMBL624274,50597,,Urine,,A,,11501,10116.0,1088.0,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12064,,
CHEMBL624275,50597,,Urine,,A,,11502,10116.0,1088.0,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12064,,
CHEMBL624276,50597,,Urine,,A,,11503,10116.0,1088.0,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12064,,
CHEMBL624277,50597,,Urine,,A,,11504,10116.0,1088.0,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12038,,
CHEMBL624278,22224,,,,A,,11505,,,% dose converted to 2-amino-5-chlorophenyl sulfate,U,,0,,Autocuration,1,BAO_0000019,,,14314,,
CHEMBL624279,22224,,,,A,,11506,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),U,,0,,Autocuration,1,BAO_0000019,,,14314,,
CHEMBL624280,50597,,Feces,,A,,11507,10116.0,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL624281,50597,,Feces,,A,,11508,10116.0,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL622933,50597,,Feces,,A,,11509,10116.0,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL622934,50597,,Feces,,A,,11510,10116.0,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL622935,50597,,Liver,In vivo,A,,11511,10116.0,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL622936,50597,,Liver,In vivo,A,,11512,10116.0,2107.0,Biodistribution in Rat liver after 5 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL875228,50597,,Liver,In vivo,A,,11513,10116.0,2107.0,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL622937,50597,,Lung,In vivo,A,,11514,10116.0,2048.0,Biodistribution in Rat lung after 24 hours of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL622938,50597,,Lung,In vivo,A,,11515,10116.0,2048.0,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL619736,50597,,Lung,In vivo,A,,11516,10116.0,2048.0,Biodistribution in Rat lung after 30 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625117,50597,,Lung,In vivo,A,,11517,10116.0,2048.0,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625118,50597,,Lung,In vivo,A,,11518,10116.0,2048.0,Biodistribution in Rat lung after 5 minutes of iv administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625119,50597,,Lung,In vivo,A,,11519,10116.0,2048.0,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8829,,
CHEMBL625120,50597,,Cerebellum,In vivo,A,,11520,10116.0,2037.0,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14972,,
CHEMBL625121,50597,,,In vivo,A,,11521,10116.0,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14972,,
CHEMBL625122,50597,,Thalamus,In vivo,A,,11522,10116.0,10000006.0,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14972,,
CHEMBL622204,50597,,Blood,In vivo,A,,11523,10116.0,178.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL877503,50597,,Blood,In vivo,A,,11524,10116.0,178.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627127,50597,,Blood,In vivo,A,,11525,10116.0,178.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627128,22224,,Hippocampus,In vivo,A,,11526,,10000000.0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,U,,0,,Autocuration,1,BAO_0000218,,,14608,,
CHEMBL627129,22224,,Hippocampus,In vivo,A,,11527,,10000000.0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,U,,0,,Autocuration,1,BAO_0000218,,,14608,,
CHEMBL627130,22224,,Hippocampus,In vivo,A,,11528,,10000000.0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,U,,0,,Autocuration,1,BAO_0000218,,,14608,,
CHEMBL627131,50597,,Brain,In vivo,A,,11529,10116.0,955.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627132,50597,,Brain,In vivo,A,,11530,10116.0,955.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627133,50597,,Brain,In vivo,A,,11531,10116.0,955.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627134,50597,,Cerebellum,In vivo,A,,11532,10116.0,2037.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627135,50597,,Cerebellum,In vivo,A,,11533,10116.0,2037.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL627136,50597,,Cerebellum,In vivo,A,,11534,10116.0,2037.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628435,50597,,,In vivo,A,,11535,10116.0,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628436,50597,,,In vivo,A,,11536,10116.0,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628437,50597,,,In vivo,A,,11537,10116.0,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628438,50597,,Heart,In vivo,A,,11538,10116.0,948.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628439,50597,,Heart,In vivo,A,,11539,10116.0,948.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628440,50597,,Heart,In vivo,A,,11540,10116.0,948.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628441,50597,,Hippocampus,In vivo,A,,11541,10116.0,10000000.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628442,50597,,Hippocampus,In vivo,A,,11542,10116.0,10000000.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628443,50597,,Hippocampus,In vivo,A,,11543,10116.0,10000000.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628444,50597,,Kidney,In vivo,A,,11544,10116.0,2113.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628445,50597,,Kidney,In vivo,A,,11545,10116.0,2113.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL877504,50597,,Kidney,In vivo,A,,11546,10116.0,2113.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL628446,50597,,Liver,In vivo,A,,11547,10116.0,2107.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626874,50597,,Liver,In vivo,A,,11548,10116.0,2107.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626875,50597,,Liver,In vivo,A,,11549,10116.0,2107.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626876,50597,,Lung,In vivo,A,,11550,10116.0,2048.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626877,50597,,Lung,In vivo,A,,11551,10116.0,2048.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626878,50597,,Lung,In vivo,A,,11552,10116.0,2048.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626879,50597,,Muscle tissue,In vivo,A,,11553,10116.0,2385.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL626880,22224,,Plasma,In vivo,A,,11554,314293.0,1969.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8918,,
CHEMBL626881,50594,,Plasma,In vivo,A,,11555,10090.0,1969.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8918,,
CHEMBL626882,50597,,Plasma,In vivo,A,,11556,10116.0,1969.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8918,,
CHEMBL626883,50588,,Plasma,In vivo,A,,11557,9615.0,1969.0,Peak plasma concentration was measured in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14470,,
CHEMBL626884,50597,,,In vivo,A,,11558,10116.0,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL626885,50597,,,In vivo,A,,11559,10116.0,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14886,,
CHEMBL626886,50597,,,In vivo,A,,11560,10116.0,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14886,,
CHEMBL626887,50597,,,In vivo,A,,11561,10116.0,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14886,,
CHEMBL626888,50597,,,In vivo,A,,11562,10116.0,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL626889,50588,,,In vivo,A,,11563,9615.0,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13465,,
CHEMBL626761,22224,,,In vivo,A,,11564,314293.0,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,13465,,
CHEMBL626762,50588,,,In vivo,A,,11565,9615.0,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13465,,
CHEMBL626763,50588,,,In vivo,A,,11566,9615.0,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13465,,
CHEMBL626764,50597,,,In vivo,A,,11567,10116.0,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13465,,
CHEMBL626765,50597,,,In vivo,A,,11568,10116.0,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13465,,
CHEMBL626766,50588,,,In vivo,A,,11569,9615.0,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13465,,
CHEMBL626767,50597,,,In vivo,A,,11570,10116.0,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13465,,
CHEMBL626768,50597,,,In vivo,A,,11571,10116.0,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13465,,
CHEMBL626769,50588,,,In vivo,A,,11572,9615.0,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13465,,
CHEMBL874463,50588,,,In vivo,A,,11573,9615.0,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13465,,
CHEMBL626770,22224,,,In vivo,A,,11574,314293.0,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,13465,,
CHEMBL626771,22224,,,In vivo,A,,11575,314293.0,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,13465,,
CHEMBL626772,50597,,,In vivo,A,,11576,10116.0,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13465,,
CHEMBL626773,100710,,,In vivo,A,,11577,9541.0,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14731,,
CHEMBL626774,50594,,,In vivo,A,,11578,10090.0,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14731,,
CHEMBL626775,50588,,,In vivo,A,,11579,9615.0,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13376,,
CHEMBL626776,50588,,,In vivo,A,,11580,9615.0,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13376,,
CHEMBL626777,50597,,,In vivo,A,,11581,10116.0,,Maximum concentration (Cmax) in rat when administered orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14443,,
CHEMBL626778,22224,,Plasma,In vivo,A,,11582,314293.0,1969.0,Maximal concentration in monkey plasma after 25 mg/kg oral dose,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,13465,,
CHEMBL626779,22224,,,In vivo,A,,11583,10116.0,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,16359,,
CHEMBL626780,22224,,,In vivo,A,,11584,10116.0,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,16359,,
CHEMBL626781,22224,,Plasma,In vivo,A,,11585,,1969.0,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,U,,0,,Autocuration,1,BAO_0000218,,,15618,,
CHEMBL632164,50597,,,In vivo,A,,11586,10116.0,,Pharmacokinetic profile Cmax was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14554,,
CHEMBL632165,50588,,,In vivo,A,,11587,9615.0,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,11537,,
CHEMBL632166,50594,,,In vivo,A,,11588,10090.0,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11537,,
CHEMBL632167,50588,,,In vivo,A,,11589,9615.0,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,11537,,
CHEMBL632168,50594,,,In vivo,A,,11590,10090.0,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11537,,
CHEMBL632169,22224,,Plasma,In vivo,A,,11591,10116.0,1969.0,Cmax in rat plasma,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,2021,,
CHEMBL632170,50588,,Plasma,In vivo,A,,11592,9615.0,1969.0,Cmax in dog plasma after 30mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,5932,,
CHEMBL632171,50597,,Plasma,In vivo,A,,11593,10116.0,1969.0,Cmax in rat plasma after 30mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5932,,
CHEMBL632172,50597,,Plasma,In vivo,A,,11594,10116.0,1969.0,Plasma level in rats at 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17320,,
CHEMBL632173,50594,,Plasma,In vivo,A,,11595,10090.0,1969.0,Tested for maximum plasma concentration in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15831,,
CHEMBL632174,50597,,,In vivo,A,,11596,10116.0,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL632175,50597,,,In vivo,A,,11597,10116.0,,The Cmax values in female wistar rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL632176,50588,,Plasma,In vivo,A,,11598,9615.0,1969.0,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15343,,
CHEMBL632177,50597,,Plasma,In vivo,A,,11599,10116.0,1969.0,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15343,,
CHEMBL632178,50597,,Plasma,In vivo,A,,11600,10116.0,1969.0,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14856,,
CHEMBL632179,50597,,,In vivo,A,,11601,10116.0,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13129,,
CHEMBL632180,50597,,Blood,In vivo,A,,11602,10116.0,178.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13098,,
CHEMBL632181,50597,,Blood,In vivo,A,,11603,10116.0,178.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13098,,
CHEMBL632182,50597,,Blood,In vivo,A,,11604,10116.0,178.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13098,,
CHEMBL632183,22224,,Blood,In vivo,A,,11605,10090.0,178.0,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,U,,0,,Autocuration,1,BAO_0000218,,Mus musculus,15478,,
CHEMBL632184,50588,,,In vivo,A,,11606,9615.0,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15341,,
CHEMBL874470,50597,,,In vivo,A,,11607,10116.0,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL631302,50597,,,,A,,11608,10116.0,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL631303,50597,,,,A,,11609,10116.0,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL631304,50597,,,,A,,11610,10116.0,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL631305,50597,,,,A,,11611,10116.0,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL631306,50597,,,,A,,11612,10116.0,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL631307,50597,,,,A,,11613,10116.0,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL631308,50597,,,,A,,11614,10116.0,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625557,50597,,,,A,,11615,10116.0,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625558,50597,,Spleen,,A,,11616,10116.0,2106.0,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625559,50597,,Spleen,,A,,11617,10116.0,2106.0,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625560,50597,,Spleen,,A,,11618,10116.0,2106.0,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625561,50597,,Spleen,,A,,11619,10116.0,2106.0,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625562,50597,,Spleen,,A,,11620,10116.0,2106.0,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL875320,50597,,Spleen,,A,,11621,10116.0,2106.0,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625563,50597,,Spleen,,A,,11622,10116.0,2106.0,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625564,50597,,Spleen,,A,,11623,10116.0,2106.0,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625565,50597,,Uterus,,A,,11624,10116.0,995.0,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625566,50597,,Uterus,,A,,11625,10116.0,995.0,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625567,50597,,Uterus,,A,,11626,10116.0,995.0,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL625568,50597,,Uterus,,A,,11627,10116.0,995.0,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL628217,50597,,Uterus,,A,,11628,10116.0,995.0,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL628218,50597,,Uterus,,A,,11629,10116.0,995.0,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL628219,50597,,Uterus,,A,,11630,10116.0,995.0,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL628220,50597,,Uterus,,A,,11631,10116.0,995.0,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8684,,
CHEMBL628221,22224,,,,A,,11632,,,Distribution in the blood after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628222,22224,,,,A,,11633,,,Distribution in the blood after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628223,22224,,,,A,,11634,,,Distribution in the blood after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628224,22224,,,,A,,11635,,,Distribution in the blood after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628225,22224,,,,A,,11636,,,Distribution in the blood after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628226,22224,,,,A,,11637,,,Distribution in the blood after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628227,22224,,,,A,,11638,,,Distribution in the bone after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL875481,22224,,,,A,,11639,,,Distribution in the bone after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628228,22224,,,,A,,11640,,,Distribution in the bone after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628229,22224,,,,A,,11641,,,Distribution in the bone after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628230,22224,,,,A,,11642,,,Distribution in the bone after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628231,22224,,,,A,,11643,,,Distribution in the bone after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628232,22224,,,,A,,11644,,,Distribution in the heart after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628233,22224,,,,A,,11645,,,Distribution in the heart after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628234,22224,,,,A,,11646,,,Distribution in the heart after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628235,22224,,,,A,,11647,,,Distribution in the heart after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628236,22224,,,,A,,11648,,,Distribution in the heart after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628237,22224,,,,A,,11649,,,Distribution in the heart after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628238,22224,,,,A,,11650,,,Distribution in the kidneys after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628239,22224,,,,A,,11651,,,Distribution in the kidneys after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628240,22224,,,,A,,11652,,,Distribution in the kidneys after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628241,22224,,,,A,,11653,,,Distribution in the kidneys after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628242,22224,,,,A,,11654,,,Distribution in the kidneys after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL875482,22224,,,,A,,11655,,,Distribution in the kidneys after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628243,22224,,,,A,,11656,,,Distribution in the liver after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628244,22224,,,,A,,11657,,,Distribution in the liver after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628245,22224,,,,A,,11658,,,Distribution in the liver after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628246,22224,,,,A,,11659,,,Distribution in the liver after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628247,22224,,,,A,,11660,,,Distribution in the liver after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628248,22224,,,,A,,11661,,,Distribution in the liver after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628249,22224,,,,A,,11662,,,Distribution in the lung after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL625452,50594,,,,A,,11663,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL625453,50594,,,,A,,11664,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL625454,50594,,,,A,,11665,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623844,50594,,,,A,,11666,10090.0,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14839,,
CHEMBL623845,50597,,,,A,,11667,10116.0,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12178,,
CHEMBL623846,50597,,,,A,,11668,10116.0,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12178,,
CHEMBL623847,22224,,,,A,,11669,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,U,,0,,Autocuration,1,BAO_0000218,,,12178,,
CHEMBL623848,100710,,,,A,,11670,9541.0,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL623849,100710,,,,A,,11671,9541.0,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL623850,100710,,,,A,,11672,9541.0,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL623851,100710,,,,A,,11673,9541.0,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL623852,22224,,,,A,,11674,314293.0,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL624551,50506,,,,A,,11675,9669.0,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,12187,,
CHEMBL624552,50506,,,,A,,11676,9669.0,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,12187,,
CHEMBL624553,22224,,,,A,,11677,314293.0,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL624554,22224,,,,A,,11678,314293.0,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL624555,50597,,,,A,,11679,10116.0,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL624741,50597,,,,A,,11680,10116.0,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL624742,50588,,,,A,,11681,9615.0,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14122,,
CHEMBL624743,100712,,,,A,,11682,10026.0,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,14122,,
CHEMBL877606,50597,,,,A,,11683,10116.0,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14122,,
CHEMBL624744,22224,,,,A,,11684,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL624745,22224,,Blood,,A,,11685,,178.0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL624746,22224,,Blood,,A,,11686,,178.0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL624747,22224,,Blood,,A,,11687,,178.0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,0,,Autocuration,1,BAO_0000218,,,13391,,
CHEMBL624748,22224,,,,A,,11688,,,Oral absorption expressed as Area under curve was determined,U,,0,,Autocuration,1,BAO_0000019,,,16360,,
CHEMBL622504,50588,,,,A,,11689,9615.0,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,3673,,
CHEMBL622505,50588,,,,A,,11690,9615.0,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14122,,
CHEMBL622506,100712,,,,A,,11691,10026.0,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,14122,,
CHEMBL622507,100712,,,,A,,11692,10026.0,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,14122,,
CHEMBL622508,50597,,,,A,,11693,10116.0,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14122,,
CHEMBL622509,22224,,,,A,,11694,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,U,,0,,Autocuration,1,BAO_0000019,,,13889,,
CHEMBL622510,50597,,,,A,,11695,10116.0,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL622511,50597,,,,A,,11696,10116.0,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17279,,
CHEMBL622512,100710,,,,A,,11697,9541.0,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14548,,
CHEMBL622513,100710,,,,A,,11698,9541.0,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14548,,
CHEMBL622514,100710,,,,A,,11699,9541.0,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14548,,
CHEMBL622515,50588,,,,A,,11700,9615.0,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14548,,
CHEMBL622516,50588,,,,A,,11701,9615.0,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14548,,
CHEMBL622517,50597,,,,A,,11702,10116.0,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14548,,
CHEMBL622518,50597,,,,A,,11703,10116.0,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14548,,
CHEMBL622519,50597,,,,A,,11704,10116.0,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14548,,
CHEMBL622520,50597,,Muscle tissue,In vivo,A,,11705,10116.0,2385.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL622521,50597,,Muscle tissue,In vivo,A,,11706,10116.0,2385.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL625113,50594,,Zone of skin,In vivo,A,,11707,10090.0,14.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14608,,
CHEMBL625114,50597,,Zone of skin,In vivo,A,,11708,10116.0,14.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL874397,50597,,Zone of skin,In vivo,A,,11709,10116.0,14.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL625115,50597,,Spleen,In vivo,A,,11710,10116.0,2106.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL625116,50597,,Spleen,In vivo,A,,11711,10116.0,2106.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623932,50597,,Spleen,In vivo,A,,11712,10116.0,2106.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623933,50597,,Striatum,In vivo,A,,11713,10116.0,2435.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623934,50597,,Striatum,In vivo,A,,11714,10116.0,2435.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623935,50597,,Striatum,In vivo,A,,11715,10116.0,2435.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623936,50597,,Thyroid gland,In vivo,A,,11716,10116.0,2046.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623937,50597,,Thyroid gland,In vivo,A,,11717,10116.0,2046.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623938,50597,,Thyroid gland,In vivo,A,,11718,10116.0,2046.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14608,,
CHEMBL623939,50594,,,,A,,11719,10090.0,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL623940,50594,,,,A,,11720,10090.0,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL623941,50594,,,,A,,11721,10090.0,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL627216,50594,,,,A,,11722,10090.0,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL623942,50594,,,,A,,11723,10090.0,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618793,50594,,Brain,,A,,11724,10090.0,955.0,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618794,50594,,Brain,,A,,11725,10090.0,955.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618795,50594,,Brain,,A,,11726,10090.0,955.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618796,50594,,,,A,,11727,10090.0,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618797,50594,,,,A,,11728,10090.0,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618798,50594,,Kidney,,A,,11729,10090.0,2113.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618799,50594,,Kidney,,A,,11730,10090.0,2113.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618800,50594,,Kidney,,A,,11731,10090.0,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618801,50594,,Kidney,,A,,11732,10090.0,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618802,50594,,Kidney,,A,,11733,10090.0,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618803,50594,,Kidney,,A,,11734,10090.0,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618804,50594,,Liver,,A,,11735,10090.0,2107.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618805,50594,,Liver,,A,,11736,10090.0,2107.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618806,50594,,Liver,,A,,11737,10090.0,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618807,50594,,Liver,,A,,11738,10090.0,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618808,50594,,Liver,,A,,11739,10090.0,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618809,50594,,Liver,,A,,11740,10090.0,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618810,50594,,Muscle tissue,,A,,11741,10090.0,2385.0,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618811,50594,,Muscle tissue,,A,,11742,10090.0,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL875844,50594,,Muscle tissue,,A,,11743,10090.0,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618812,50594,,Muscle tissue,,A,,11744,10090.0,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618813,50594,,Muscle tissue,,A,,11745,10090.0,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618814,50594,,,,A,,11746,10090.0,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618815,50594,,,,A,,11747,10090.0,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618816,50594,,,,A,,11748,10090.0,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL618817,50594,,,,A,,11749,10090.0,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL620544,50594,,,,A,,11750,10090.0,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL626230,50597,,,In vivo,A,,11751,10116.0,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL626231,50597,,,In vivo,A,,11752,10116.0,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL626232,50597,,,In vivo,A,,11753,10116.0,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL626233,50588,,Plasma,In vivo,A,,11754,9615.0,1969.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14906,,
CHEMBL626234,50597,,Plasma,In vivo,A,,11755,10116.0,1969.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14906,,
CHEMBL875341,50597,,Plasma,In vivo,A,,11756,10116.0,1969.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14906,,
CHEMBL626235,50587,,Plasma,In vivo,A,,11757,9606.0,1969.0,The maximum plasma concentration (100 mg/kg) administered orally in human,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL626236,22224,,Plasma,In vivo,A,,11758,9481.0,1969.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,U,,0,,Autocuration,1,BAO_0000218,,Callithrix,14215,,
CHEMBL626237,22224,,Plasma,In vivo,A,,11759,314293.0,1969.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,14215,,
CHEMBL626238,50588,,Plasma,In vivo,A,,11760,9615.0,1969.0,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14215,,
CHEMBL622412,50587,,Plasma,In vivo,A,,11761,9606.0,1969.0,The maximum plasma concentration (200 mg/kg) administered orally in human,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL623114,50597,,Plasma,In vivo,A,,11762,10116.0,1969.0,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14215,,
CHEMBL623115,22224,,Plasma,In vivo,A,,11763,9481.0,1969.0,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,U,,0,,Autocuration,1,BAO_0000218,,Callithrix,14215,,
CHEMBL623116,22224,,Plasma,In vivo,A,,11764,314293.0,1969.0,The maximum plasma concentration (25 mg/kg) administered orally in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,14215,,
CHEMBL623117,22224,,Plasma,In vivo,A,,11765,9615.0,1969.0,The maximum plasma concentration (30 mg/kg) administered orally in dog,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,14215,,
CHEMBL623118,50587,,Plasma,In vivo,A,,11766,9606.0,1969.0,The maximum plasma concentration (400 mg/kg) administered orally in human,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL623119,50597,,Plasma,In vivo,A,,11767,10116.0,1969.0,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14215,,
CHEMBL623120,50597,,Plasma,In vivo,A,,11768,10116.0,1969.0,The maximum plasma concentration (50 mg/kg) administered orally in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14215,,
CHEMBL623286,50587,,Plasma,In vivo,A,,11769,9606.0,1969.0,The maximum plasma concentration (800 mg/kg) administered orally in human,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL623287,50597,,Plasma,In vivo,A,,11770,10116.0,1969.0,The maximum plasma concentration was measured on rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14067,,
CHEMBL623288,50597,,Plasma,In vivo,A,,11771,10116.0,1969.0,The maximum plasma concentration was measured on rats after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12350,,
CHEMBL623289,50597,,Plasma,In vivo,A,,11772,10116.0,1969.0,Plasma drug Cmax in rat (PO dose),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14813,,
CHEMBL623290,22224,,,In vivo,A,,11773,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,U,,0,,Autocuration,1,BAO_0000218,,,12536,,
CHEMBL623291,50588,,Plasma,In vivo,A,,11774,9615.0,1969.0,maximum Plasma concentration in Dog was determined after Peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14169,,
CHEMBL623292,50597,,Plasma,In vivo,A,,11775,10116.0,1969.0,maximum Plasma concentration in Rats was determined after Peroral administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14169,,
CHEMBL623293,50588,,Plasma,In vivo,A,,11776,9615.0,1969.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15604,,
CHEMBL623294,22224,,Plasma,In vivo,A,,11777,314293.0,1969.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,15604,,
CHEMBL623295,50597,,Plasma,In vivo,A,,11778,10116.0,1969.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15604,,
CHEMBL623296,50594,,,In vivo,A,,11779,10090.0,,maximum concentration was measured when administered through oral route in mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14387,,
CHEMBL875349,50594,,,,A,,11780,10090.0,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15115,,
CHEMBL623297,22224,,,,A,,11781,314293.0,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,U,,0,,Autocuration,1,BAO_0000019,,Simiiformes,15115,,
CHEMBL623298,22224,,,,A,,11782,314293.0,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,U,,0,,Autocuration,1,BAO_0000019,,Simiiformes,15115,,
CHEMBL623299,22224,,,,A,,11783,314293.0,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,U,,0,,Autocuration,1,BAO_0000019,,Simiiformes,15115,,
CHEMBL623300,50597,,,,A,,11784,10116.0,,Pharmacokinetic parameter was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16359,,
CHEMBL623301,50594,,,,A,,11785,10090.0,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12829,,
CHEMBL623302,50594,,,,A,,11786,10090.0,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12829,,
CHEMBL623303,50594,,,,A,,11787,10090.0,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12829,,
CHEMBL623304,50594,,,,A,,11788,10090.0,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12829,,
CHEMBL623305,50594,,,,A,,11789,10090.0,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12829,,
CHEMBL623306,50597,,Plasma,,A,,11790,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL623307,50597,,Plasma,,A,,11791,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL623308,50597,,Plasma,,A,,11792,10116.0,1969.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15137,,
CHEMBL623309,50594,,Plasma,,A,,11793,10090.0,1969.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15137,,
CHEMBL623310,50594,,,,A,,11794,10090.0,,Plasma Concentration after 120 min of oral administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13509,,
CHEMBL623311,50594,,,,A,,11795,10090.0,,Plasma Concentration after 30 min of oral administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13509,,
CHEMBL623312,100710,,,,A,,11796,9541.0,,Plasma Concentration after 60 min of oral administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,13509,,
CHEMBL875350,50594,,,,A,,11797,10090.0,,Plasma Concentration after 60 min of oral administration to mice; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13509,,
CHEMBL628635,50594,,,,A,,11798,10090.0,,Plasma Concentration after 90 min of oral administration to mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13509,,
CHEMBL628636,50597,,,,A,,11799,10116.0,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12064,,
CHEMBL628637,50597,,,,A,,11800,10116.0,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12064,,
CHEMBL628058,50597,,,,A,,11801,10116.0,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12064,,
CHEMBL628059,50597,,,,A,,11802,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL628060,50597,,,,A,,11803,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL628061,22224,,,,A,,11804,,,Distribution in the lung after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628062,22224,,,,A,,11805,,,Distribution in the lung after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628063,22224,,,,A,,11806,,,Distribution in the lung after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628064,22224,,,,A,,11807,,,Distribution in the lung after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628065,22224,,,,A,,11808,,,Distribution in the lung after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628066,22224,,Muscle tissue,,A,,11809,,2385.0,Distribution in the muscle after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628067,22224,,Muscle tissue,,A,,11810,,2385.0,Distribution in the muscle after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL874646,50594,,Muscle tissue,,A,,11811,10090.0,2385.0,Distribution in the muscle after 30 min of intravenous administration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8926,,
CHEMBL628068,22224,,Muscle tissue,,A,,11812,,2385.0,Distribution in the muscle after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628069,22224,,Muscle tissue,,A,,11813,,2385.0,Distribution in the muscle after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628070,22224,,Muscle tissue,,A,,11814,,2385.0,Distribution in the muscle after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628071,22224,,Spleen,,A,,11815,,2106.0,Distribution in the spleen after 120 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628072,22224,,Spleen,,A,,11816,,2106.0,Distribution in the spleen after 15 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628073,22224,,Spleen,,A,,11817,,2106.0,Distribution in the spleen after 30 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628074,22224,,Spleen,,A,,11818,,2106.0,Distribution in the spleen after 5 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628075,22224,,Spleen,,A,,11819,,2106.0,Distribution in the spleen after 60 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628076,22224,,Spleen,,A,,11820,,2106.0,Distribution in the spleen after 90 min of intravenous administration,U,,0,,Autocuration,1,BAO_0000019,,,8926,,
CHEMBL628077,50597,,Adrenal cortex,,A,,11821,10116.0,1235.0,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL628078,50597,,Blood,,A,,11822,10116.0,178.0,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL628079,50597,,Liver,,A,,11823,10116.0,2107.0,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL628080,50597,,Female gonad,,A,,11824,10116.0,992.0,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL628081,50597,,Thyroid gland,,A,,11825,10116.0,2046.0,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL628082,50597,,Adrenal cortex,,A,,11826,10116.0,1235.0,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL874647,50597,,Blood,,A,,11827,10116.0,178.0,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL626406,50597,,Liver,,A,,11828,10116.0,2107.0,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL626407,50597,,Female gonad,,A,,11829,10116.0,992.0,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL626408,50597,,Thyroid gland,,A,,11830,10116.0,2046.0,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7570,,
CHEMBL626409,50597,,Blood,,A,,11831,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626410,50597,,Blood,,A,,11832,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626411,50597,,Blood,,A,,11833,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626412,50597,,Blood,,A,,11834,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626413,50597,,Blood,,A,,11835,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626414,50597,,Blood,,A,,11836,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626415,50597,,Blood,,A,,11837,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626416,50597,,Blood,,A,,11838,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627062,50597,,Blood,,A,,11839,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627063,50597,,Blood,,A,,11840,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627064,50597,,Blood,,A,,11841,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627227,50597,,Blood,,A,,11842,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627228,50597,,Blood,,A,,11843,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627229,50597,,Blood,,A,,11844,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL625792,50597,,Blood,,A,,11845,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL625793,50597,,Blood,,A,,11846,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL625794,50597,,Blood,,A,,11847,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL625795,50597,,Blood,,A,,11848,10116.0,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL625796,50594,,,,A,,11849,10090.0,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL625797,50588,,,,A,,11850,9615.0,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13376,,
CHEMBL625798,50588,,,,A,,11851,9615.0,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13376,,
CHEMBL875613,22224,,,,A,,11852,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL625799,22224,,,,A,,11853,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL625800,22224,,,,A,,11854,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL625801,22224,,,,A,,11855,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL625802,22224,,,,A,,11856,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL625803,22224,,,,A,,11857,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL625804,22224,,,,A,,11858,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,U,,0,,Autocuration,1,BAO_0000019,,,14380,,
CHEMBL622530,22224,,,,A,,11859,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,14380,,
CHEMBL622531,50594,,,,A,,11860,10090.0,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL622532,50594,,,,A,,11861,10090.0,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL623176,50594,,,,A,,11862,10090.0,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL623177,50594,,,,A,,11863,10090.0,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL623178,50594,,,,A,,11864,10090.0,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL623179,50594,,,,A,,11865,10090.0,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL623180,50594,,,,A,,11866,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL623181,50594,,,,A,,11867,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL624131,50594,,,,A,,11868,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL624132,50594,,,,A,,11869,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL624133,50594,,,,A,,11870,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL624846,50594,,,,A,,11871,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL624847,50594,,,,A,,11872,10090.0,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL624848,50594,,,,A,,11873,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625012,50594,,,,A,,11874,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625013,50594,,,,A,,11875,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625014,50594,,,,A,,11876,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625015,50594,,,,A,,11877,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625016,50594,,,,A,,11878,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625017,50594,,,,A,,11879,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625018,50594,,,,A,,11880,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625019,50594,,,,A,,11881,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625020,50594,,,,A,,11882,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625021,50594,,,,A,,11883,10090.0,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL625022,50597,,,,A,,11884,10116.0,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL625023,50594,,,,A,,11885,10090.0,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14731,,
CHEMBL625024,100710,,,,A,,11886,9541.0,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14731,,
CHEMBL627626,100710,,,,A,,11887,9541.0,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14731,,
CHEMBL627627,22224,,Brain,,A,,11888,,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,0,,Autocuration,1,BAO_0000218,,,13758,,
CHEMBL627628,22224,,Serum,,A,,11889,,1977.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,U,,0,,Autocuration,1,BAO_0000218,,,13758,,
CHEMBL627629,22224,,Brain,,A,,11890,,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,0,,Autocuration,1,BAO_0000218,,,13758,,
CHEMBL627630,22224,,Serum,,A,,11891,,1977.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,U,,0,,Autocuration,1,BAO_0000218,,,13758,,
CHEMBL627631,22224,,,,A,,11892,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),U,,0,,Autocuration,1,BAO_0000019,,,16359,,
CHEMBL629515,22224,,,,A,,11893,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),U,,0,,Autocuration,1,BAO_0000218,,,16359,,
CHEMBL629516,50594,,Spleen,,A,,11894,10090.0,2106.0,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL629517,50594,,Spleen,,A,,11895,10090.0,2106.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL629518,50594,,Spleen,,A,,11896,10090.0,2106.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL877499,50594,,,,A,,11897,10090.0,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL629519,50594,,,,A,,11898,10090.0,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL629520,50594,,,,A,,11899,10090.0,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL629521,50594,,,,A,,11900,10090.0,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15383,,
CHEMBL629522,50594,,,,A,,11901,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629523,50594,,,,A,,11902,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629524,50594,,,,A,,11903,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629525,50594,,,,A,,11904,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629526,50594,,,,A,,11905,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629527,50594,,,,A,,11906,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629528,50594,,,,A,,11907,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629529,50594,,,,A,,11908,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629530,50594,,,,A,,11909,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL629531,50594,,,,A,,11910,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628656,50594,,,,A,,11911,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628657,50594,,,,A,,11912,10090.0,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628658,50597,,,In vivo,A,,11913,10116.0,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628659,50597,,,In vivo,A,,11914,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL877500,50597,,,In vivo,A,,11915,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628660,50597,,,In vivo,A,,11916,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628661,50597,,,In vivo,A,,11917,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628662,50597,,,In vivo,A,,11918,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628663,50597,,,In vivo,A,,11919,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628664,50597,,,In vivo,A,,11920,10116.0,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628665,50597,,Blood,In vivo,A,,11921,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628666,50597,,Blood,In vivo,A,,11922,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628667,50597,,Blood,In vivo,A,,11923,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628668,50597,,Blood,In vivo,A,,11924,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628669,50597,,Blood,In vivo,A,,11925,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628670,50597,,Blood,In vivo,A,,11926,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628671,50597,,Blood,In vivo,A,,11927,10116.0,178.0,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL628672,50597,,Bone,In vivo,A,,11928,10116.0,10000001.0,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL630300,50597,,Bone,In vivo,A,,11929,10116.0,10000001.0,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629787,50597,,Bone,In vivo,A,,11930,10116.0,10000001.0,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629788,50597,,Bone,In vivo,A,,11931,10116.0,10000001.0,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629789,50597,,Brain,In vivo,A,,11932,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629790,50597,,Brain,In vivo,A,,11933,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629791,50597,,Brain,In vivo,A,,11934,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629792,50597,,Brain,In vivo,A,,11935,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629793,50597,,Brain,In vivo,A,,11936,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629794,50597,,Brain,In vivo,A,,11937,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL874459,50597,,,,A,,11938,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL629795,50597,,,,A,,11939,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL629796,50597,,,,A,,11940,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL629797,50597,,,,A,,11941,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL629798,50597,,,,A,,11942,10116.0,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10677,,
CHEMBL629799,50597,,Adrenal gland,In vivo,A,,11943,10116.0,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629800,50597,,Adrenal gland,In vivo,A,,11944,10116.0,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629801,50597,,Adrenal gland,In vivo,A,,11945,10116.0,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629802,50597,,Adrenal gland,In vivo,A,,11946,10116.0,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629803,50597,,Adrenal gland,In vivo,A,,11947,10116.0,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629804,50597,,Blood,In vivo,A,,11948,10116.0,178.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629805,50597,,Blood,In vivo,A,,11949,10116.0,178.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629806,50597,,Blood,In vivo,A,,11950,10116.0,178.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629807,50597,,Blood,In vivo,A,,11951,10116.0,178.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629808,50597,,Blood,In vivo,A,,11952,10116.0,178.0,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629809,50597,,Brain,In vivo,A,,11953,10116.0,955.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629810,50597,,Brain,In vivo,A,,11954,10116.0,955.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629811,50597,,Brain,In vivo,A,,11955,10116.0,955.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629812,50597,,Brain,In vivo,A,,11956,10116.0,955.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629813,50597,,Brain,In vivo,A,,11957,10116.0,955.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL874460,50597,,Brain,In vivo,A,,11958,10116.0,955.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629814,50597,,,In vivo,A,,11959,10116.0,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629815,50597,,,In vivo,A,,11960,10116.0,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629816,50597,,,In vivo,A,,11961,10116.0,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL629817,50597,,,In vivo,A,,11962,10116.0,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626643,50597,,Kidney,In vivo,A,,11963,10116.0,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626644,50597,,Kidney,In vivo,A,,11964,10116.0,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626806,50597,,Kidney,In vivo,A,,11965,10116.0,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626807,50597,,Kidney,In vivo,A,,11966,10116.0,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627261,50597,,Liver,In vivo,A,,11967,10116.0,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627262,50597,,Liver,In vivo,A,,11968,10116.0,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627263,50597,,Liver,In vivo,A,,11969,10116.0,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627264,50597,,Liver,In vivo,A,,11970,10116.0,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627265,50597,,Lung,In vivo,A,,11971,10116.0,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627266,50597,,Lung,In vivo,A,,11972,10116.0,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627267,50597,,Lung,In vivo,A,,11973,10116.0,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627268,50597,,Lung,In vivo,A,,11974,10116.0,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627269,50597,,Muscle tissue,In vivo,A,,11975,10116.0,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627270,50597,,Muscle tissue,In vivo,A,,11976,10116.0,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627271,50597,,,,A,,11977,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627946,50597,,,,A,,11978,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL875472,50597,,,,A,,11979,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627947,50597,,,,A,,11980,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627948,50597,,,,A,,11981,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628113,50597,,,,A,,11982,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628114,50597,,,,A,,11983,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628115,50597,,,,A,,11984,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628116,50597,,,,A,,11985,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628117,50597,,,,A,,11986,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628118,50597,,,,A,,11987,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628119,50597,,,,A,,11988,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628120,50597,,,,A,,11989,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628121,50597,,,,A,,11990,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628122,50597,,,,A,,11991,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627297,50597,,,,A,,11992,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627298,50597,,,,A,,11993,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627299,50597,,,,A,,11994,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627300,50597,,,,A,,11995,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627301,50597,,,,A,,11996,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627302,50597,,,,A,,11997,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627303,50597,,,,A,,11998,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627304,50597,,,,A,,11999,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627305,50597,,,,A,,12000,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627306,50597,,,,A,,12001,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623982,50597,,,,A,,12002,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623983,50597,,,,A,,12003,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623984,50597,,,,A,,12004,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623985,50597,,,,A,,12005,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623986,50597,,,,A,,12006,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623987,50597,,,,A,,12007,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623988,50597,,,,A,,12008,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623989,50597,,,,A,,12009,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL622215,50597,,,,A,,12010,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL622216,50597,,,,A,,12011,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL877481,50597,,,,A,,12012,10116.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL622217,22224,,,,A,,12013,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),U,,0,,Autocuration,1,BAO_0000218,,,16359,,
CHEMBL622218,50594,,,,A,,12014,10090.0,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13701,,
CHEMBL622219,50597,,,,A,,12015,10116.0,,Pharmacokinetic profile AUC was evaluated in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14554,,
CHEMBL622220,22224,,,,A,,12016,,,Pharmacokinetic property (Area under curve),U,,0,,Autocuration,1,BAO_0000019,,,6241,,
CHEMBL622221,50588,,,,A,,12017,9615.0,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,11537,,
CHEMBL622222,50594,,,,A,,12018,10090.0,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11537,,
CHEMBL622223,50588,,,,A,,12019,9615.0,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,11537,,
CHEMBL622224,50594,,,,A,,12020,10090.0,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11537,,
CHEMBL622225,22224,,,,A,,12021,,,Plasma concentration (AUC) was determined,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622226,22224,,,,A,,12022,,,Plasma concentration (AUC) was determined; Not detectable,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL624154,50512,,,,A,,12023,10141.0,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,9562,,
CHEMBL624155,50597,,,,A,,12024,10116.0,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10363,,
CHEMBL624156,50597,,,,A,,12025,10116.0,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10363,,
CHEMBL624157,50597,,,,A,,12026,10116.0,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10363,,
CHEMBL624158,50597,,,,A,,12027,10116.0,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10363,,
CHEMBL624159,50597,,,,A,,12028,10116.0,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL624160,50597,,,,A,,12029,10116.0,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL624161,50597,,,,A,,12030,10116.0,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL624162,50597,,,,A,,12031,10116.0,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL624163,50588,,,,A,,12032,9615.0,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13317,,
CHEMBL624164,50597,,,,A,,12033,10116.0,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL624165,50597,,,,A,,12034,10116.0,,The AUC(0-infinity) values in female wistar rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL624166,50597,,,,A,,12035,10116.0,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL624167,50597,,,,A,,12036,10116.0,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL624168,50597,,,,A,,12037,10116.0,,The AUC(0-t)values in female wistar rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL624169,50597,,,,A,,12038,10116.0,,The Area under the concentration time curve of compound was measured on rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14067,,
CHEMBL624170,50587,,,,A,,12039,9606.0,,The area under curve (100 mg/kg) administered orally in humans,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL624171,22224,,,,A,,12040,9481.0,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,U,,0,,Autocuration,1,BAO_0000218,,Callithrix,14215,,
CHEMBL624172,22224,,,,A,,12041,314293.0,,The area under curve (12.5 mg/kg) administered intravenously in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,14215,,
CHEMBL624173,50588,,,,A,,12042,9615.0,,The area under curve (15 mg/kg) administered intravenously in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14215,,
CHEMBL877488,50587,,,,A,,12043,9606.0,,The area under curve (200 mg/kg) administered orally in humans,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL624174,50597,,,,A,,12044,10116.0,,The area under curve (25 mg/kg) administered intravenously in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14215,,
CHEMBL624175,22224,,,,A,,12045,9481.0,,The area under curve (25 mg/kg) administered orally in marmoset,U,,0,,Autocuration,1,BAO_0000218,,Callithrix,14215,,
CHEMBL624176,22224,,,,A,,12046,314293.0,,The area under curve (25 mg/kg) administered orally in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,14215,,
CHEMBL624177,50588,,,,A,,12047,9615.0,,The area under curve (30 mg/kg) administered orally in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14215,,
CHEMBL624178,50587,,,,A,,12048,9606.0,,The area under curve (400 mg/kg) administered orally in humans,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL624179,50597,,,,A,,12049,10116.0,,The area under curve (50 mg/kg) administered orally in fasted rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14215,,
CHEMBL627689,50597,,,,A,,12050,10116.0,,The area under curve (50 mg/kg) administered orally in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14215,,
CHEMBL627690,50587,,,,A,,12051,9606.0,,The area under curve (800 mg/kg) administered orally in humans,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14215,,
CHEMBL627691,22224,,,,A,,12052,,,The compound was evaluated for area under the curve,U,,0,,Autocuration,1,BAO_0000019,,,11324,,
CHEMBL627692,22224,,,,A,,12053,9481.0,,The compound was evaluated for area under the curve in marmosets,U,,0,,Autocuration,1,BAO_0000019,,Callithrix,11324,,
CHEMBL627693,22224,,,,A,,12054,9481.0,,The compound was evaluated for area under the curve in marmosets,U,,0,,Autocuration,1,BAO_0000019,,Callithrix,11324,,
CHEMBL627694,50597,,,,A,,12055,10116.0,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13875,,
CHEMBL627695,50597,,,,A,,12056,10116.0,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13875,,
CHEMBL627696,22224,,,,A,,12057,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),U,,0,,Autocuration,1,BAO_0000218,,,13875,,
CHEMBL627697,50597,,,,A,,12058,10116.0,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13875,,
CHEMBL627698,50597,,,,A,,12059,10116.0,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13875,,
CHEMBL627699,50597,,,,A,,12060,10116.0,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13875,,
CHEMBL627700,50597,,,,A,,12061,10116.0,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13807,,
CHEMBL627701,50597,,,,A,,12062,10116.0,,Total drug exposure is determined after oral dosing in rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14127,,
CHEMBL627702,22224,,,,A,,12063,,,Total drug exposure (5 mg/kg) when administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,15116,,
CHEMBL627703,22224,,,,A,,12064,,,Total drug exposure (5 mg/kg) when administered orally,U,,0,,Autocuration,1,BAO_0000218,,,15116,,
CHEMBL626873,22224,,,,A,,12065,314293.0,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,15604,,
CHEMBL629583,50597,,,,A,,12066,10116.0,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15604,,
CHEMBL629584,50588,,,,A,,12067,9615.0,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15604,,
CHEMBL629585,50588,,,,A,,12068,9615.0,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15604,,
CHEMBL629586,50597,,Brain,In vivo,A,,12069,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629587,50597,,Brain,In vivo,A,,12070,10116.0,955.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629588,50597,,,In vivo,A,,12071,10116.0,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629589,50597,,,In vivo,A,,12072,10116.0,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629590,50597,,,In vivo,A,,12073,10116.0,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629591,50597,,,In vivo,A,,12074,10116.0,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629592,50597,,,In vivo,A,,12075,10116.0,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629593,50597,,,In vivo,A,,12076,10116.0,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629594,50597,,,In vivo,A,,12077,10116.0,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL629595,50597,,Heart,In vivo,A,,12078,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL630290,50597,,Heart,In vivo,A,,12079,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627137,50597,,Heart,In vivo,A,,12080,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627138,50597,,Heart,In vivo,A,,12081,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627139,50597,,Heart,In vivo,A,,12082,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627140,50597,,Heart,In vivo,A,,12083,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627141,50597,,Heart,In vivo,A,,12084,10116.0,948.0,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627142,50597,,Kidney,In vivo,A,,12085,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627143,50597,,Kidney,In vivo,A,,12086,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL874449,50597,,Kidney,In vivo,A,,12087,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627144,50597,,Kidney,In vivo,A,,12088,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627145,50597,,Kidney,In vivo,A,,12089,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627146,50597,,Kidney,In vivo,A,,12090,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627147,50597,,Kidney,In vivo,A,,12091,10116.0,2113.0,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627148,50597,,Liver,In vivo,A,,12092,10116.0,2107.0,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627149,50597,,Lung,In vivo,A,,12093,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL632160,50597,,Lung,In vivo,A,,12094,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL632161,50597,,Lung,In vivo,A,,12095,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL632162,50597,,Lung,In vivo,A,,12096,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL632163,50597,,Lung,In vivo,A,,12097,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL874469,50597,,Lung,In vivo,A,,12098,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627182,50597,,Lung,In vivo,A,,12099,10116.0,2048.0,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627183,50597,,Muscle tissue,In vivo,A,,12100,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627184,50597,,Muscle tissue,In vivo,A,,12101,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627185,50597,,Muscle tissue,In vivo,A,,12102,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627186,50597,,Muscle tissue,In vivo,A,,12103,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627187,50597,,Muscle tissue,In vivo,A,,12104,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627188,50597,,Muscle tissue,In vivo,A,,12105,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627189,50597,,Muscle tissue,In vivo,A,,12106,10116.0,2385.0,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627190,50597,,,In vivo,A,,12107,10116.0,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627191,50597,,Liver,In vivo,A,,12108,10116.0,2107.0,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627192,50597,,Liver,In vivo,A,,12109,10116.0,2107.0,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL627193,50597,,Liver,In vivo,A,,12110,10116.0,2107.0,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL874590,50597,,Muscle tissue,In vivo,A,,12111,10116.0,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627194,50597,,Muscle tissue,In vivo,A,,12112,10116.0,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627195,50597,,Muscle tissue,In vivo,A,,12113,10116.0,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627196,50597,,Female gonad,In vivo,A,,12114,10116.0,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627197,50597,,Female gonad,In vivo,A,,12115,10116.0,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627198,50597,,Female gonad,In vivo,A,,12116,10116.0,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627199,50597,,Female gonad,In vivo,A,,12117,10116.0,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627200,50597,,Female gonad,In vivo,A,,12118,10116.0,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627201,50597,,Plasma,In vivo,A,,12119,10116.0,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627202,50597,,Plasma,In vivo,A,,12120,10116.0,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627203,50597,,Plasma,In vivo,A,,12121,10116.0,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627204,50597,,Plasma,In vivo,A,,12122,10116.0,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627205,50597,,Spleen,In vivo,A,,12123,10116.0,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627206,50597,,Spleen,In vivo,A,,12124,10116.0,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627207,50597,,Spleen,In vivo,A,,12125,10116.0,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627208,50597,,Spleen,In vivo,A,,12126,10116.0,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627209,50597,,Thyroid gland,In vivo,A,,12127,10116.0,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627210,50597,,Thyroid gland,In vivo,A,,12128,10116.0,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627211,50597,,Thyroid gland,In vivo,A,,12129,10116.0,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627212,50597,,Thyroid gland,In vivo,A,,12130,10116.0,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627213,50597,,Uterus,In vivo,A,,12131,10116.0,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626599,50597,,Uterus,In vivo,A,,12132,10116.0,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626600,50597,,Uterus,In vivo,A,,12133,10116.0,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL626601,50597,,Uterus,In vivo,A,,12134,10116.0,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10911,,
CHEMBL627484,22224,,,,A,,12135,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,U,,0,,Autocuration,1,BAO_0000019,,,8081,,
CHEMBL627485,100710,,Plasma,,A,,12136,9541.0,1969.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,17248,,
CHEMBL628147,100710,,Plasma,,A,,12137,9541.0,1969.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,17248,,
CHEMBL628148,100710,,Plasma,,A,,12138,9541.0,1969.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,17248,,
CHEMBL628149,50588,,Plasma,,A,,12139,9615.0,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17248,,
CHEMBL628150,50588,,Plasma,,A,,12140,9615.0,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17248,,
CHEMBL628318,50588,,Plasma,,A,,12141,9615.0,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17248,,
CHEMBL628319,50588,,Plasma,,A,,12142,9615.0,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17248,,
CHEMBL875609,50588,,,,A,,12143,9615.0,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL628320,22224,,,,A,,12144,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628321,22224,,,,A,,12145,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628322,22224,,,,A,,12146,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628323,22224,,,,A,,12147,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628324,22224,,,,A,,12148,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628325,22224,,,,A,,12149,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628326,22224,,,,A,,12150,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,U,,0,,Autocuration,1,BAO_0000019,,,7040,,
CHEMBL628327,50588,,Adrenal medulla,,A,,12151,9615.0,1236.0,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL628328,50588,,Adrenal medulla,,A,,12152,9615.0,1236.0,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL628329,50588,,Blood,,A,,12153,9615.0,178.0,"Concentration of compound in blood of dog 1, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL628330,50597,,Liver,,A,,12154,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628331,50597,,Liver,,A,,12155,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628332,50597,,Liver,,A,,12156,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628333,50597,,Liver,,A,,12157,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628334,50597,,Liver,,A,,12158,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628335,50597,,Liver,,A,,12159,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628336,50597,,Liver,,A,,12160,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628337,50597,,Liver,,A,,12161,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628338,50597,,Liver,,A,,12162,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL875610,50597,,Liver,,A,,12163,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628339,50597,,Liver,,A,,12164,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628340,50597,,Liver,,A,,12165,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL628341,50597,,Liver,,A,,12166,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL622214,50597,,Liver,,A,,12167,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623167,50597,,Liver,,A,,12168,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623168,50597,,Liver,,A,,12169,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623169,50597,,Liver,,A,,12170,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL623170,50597,,Liver,,A,,12171,10116.0,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627224,50597,,Lung,,A,,12172,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL875634,50597,,Lung,,A,,12173,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627225,50597,,Lung,,A,,12174,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627226,50597,,Lung,,A,,12175,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626083,50597,,Lung,,A,,12176,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626084,50597,,Lung,,A,,12177,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626085,50597,,Lung,,A,,12178,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626086,50597,,Lung,,A,,12179,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626087,50597,,Lung,,A,,12180,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626088,50597,,Lung,,A,,12181,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626089,50597,,Lung,,A,,12182,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626090,50597,,Lung,,A,,12183,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626091,50597,,Lung,,A,,12184,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626092,50597,,Lung,,A,,12185,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626093,50597,,Lung,,A,,12186,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626094,50597,,Lung,,A,,12187,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626095,50597,,Lung,,A,,12188,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626096,50597,,Lung,,A,,12189,10116.0,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626097,22224,,,,A,,12190,314293.0,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,15604,,
CHEMBL626098,50597,,,,A,,12191,10116.0,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15604,,
CHEMBL626099,22224,,Plasma,,A,,12192,,1969.0,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,U,,0,,Autocuration,1,BAO_0000218,,,1806,,
CHEMBL626100,22224,,Plasma,,A,,12193,,1969.0,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,U,,0,,Autocuration,1,BAO_0000218,,,1806,,
CHEMBL626101,50588,,Plasma,,A,,12194,9615.0,1969.0,AUC 0-inf in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17237,,
CHEMBL626102,50512,,Plasma,,A,,12195,10141.0,1969.0,AUC 0-inf in guinea pig,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,17237,,
CHEMBL626103,50588,,Plasma,,A,,12196,9615.0,1969.0,AUC 0-t in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17237,,
CHEMBL628391,50512,,Plasma,,A,,12197,10141.0,1969.0,AUC 0-t in guinea pig,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,17237,,
CHEMBL628392,50597,,,,A,,12198,10116.0,,The compound was tested for brain to plasma partition in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15194,,
CHEMBL628393,50597,,,,A,,12199,10116.0,,The compound was tested for brain to plasma partition in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15194,,
CHEMBL628394,22224,,Blood,,A,,12200,,178.0,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,U,,0,,Autocuration,1,BAO_0000019,,,8787,,
CHEMBL628395,50588,,,,A,,12201,9615.0,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17025,,
CHEMBL628396,22224,,,,A,,12202,314293.0,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17025,,
CHEMBL628397,50592,,,,A,,12203,9986.0,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL628398,50597,,,,A,,12204,10116.0,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17025,,
CHEMBL628399,50797,,,,A,,12205,9544.0,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,4236,,
CHEMBL628400,50588,,,,A,,12206,9615.0,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15343,,
CHEMBL874907,50597,,,,A,,12207,10116.0,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15343,,
CHEMBL628401,22224,,,,A,,12208,,,Area under curve of the compound was determined,U,,0,,Autocuration,1,BAO_0000019,,,17720,,
CHEMBL628402,22224,,Plasma,,A,,12209,314293.0,1969.0,AUC in monkeys at a dose of 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17788,,
CHEMBL628403,50597,,Plasma,,A,,12210,10116.0,1969.0,AUC in rats at a dose of 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17788,,
CHEMBL628404,22224,,,,A,,12211,,,Compound was evaluated for the overall absorbance loss at pH of 2,U,,0,,Autocuration,1,BAO_0000019,,,8778,,
CHEMBL628405,22224,,,,A,,12212,,,Compound was evaluated for the overall absorbance loss at pH of 4,U,,0,,Autocuration,1,BAO_0000019,,,8778,,
CHEMBL628406,22224,,,,A,,12213,,,Compound was evaluated for the overall absorbance loss at pH of 7,U,,0,,Autocuration,1,BAO_0000019,,,8778,,
CHEMBL628407,50597,,,,A,,12214,10116.0,,Compound was evaluated for its absorption in the rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2249,,
CHEMBL628408,50597,,Urine,,A,,12215,10116.0,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8881,,
CHEMBL629171,50597,,Urine,,A,,12216,10116.0,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8881,,
CHEMBL629172,50597,,Urine,,A,,12217,10116.0,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8881,,
CHEMBL629173,50597,,Urine,,A,,12218,10116.0,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8881,,
CHEMBL629174,50597,,,,A,,12219,10116.0,,In vitro percent permeability into rat ileum,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL629175,50597,,,,A,,12220,10116.0,,In vitro percent permeability into rat ileum; Range is 10-17,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL629176,50597,,,,A,,12221,10116.0,,In vitro percent permeability into rat ileum; Range is 10-18,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL629177,50597,,,,A,,12222,10116.0,,In vitro percent permeability into rat ileum; Range is 10-19,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL629178,50597,,,,A,,12223,10116.0,,In vitro percent permeability into rat ileum; Range is 12-15,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631869,50597,,,,A,,12224,10116.0,,In vitro percent permeability into rat ileum; Range is 13-19,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631870,50597,,,,A,,12225,10116.0,,In vitro percent permeability into rat ileum; Range is 14-17,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631871,50597,,,,A,,12226,10116.0,,In vitro percent permeability into rat ileum; Range is 15-18,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631872,50597,,,,A,,12227,10116.0,,In vitro percent permeability into rat ileum; Range is 2-5,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL875775,22224,,Ileum,,A,,12228,,2116.0,In vitro percent permeability into rat ileum; Range is 23-42,U,,0,,Autocuration,1,BAO_0000221,,,15286,,
CHEMBL631873,50597,,,,A,,12229,10116.0,,In vitro percent permeability into rat ileum; Range is 28-36,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631874,50597,,,,A,,12230,10116.0,,In vitro percent permeability into rat ileum; Range is 29-35,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631875,50597,,,,A,,12231,10116.0,,In vitro percent permeability into rat ileum; Range is 46-66,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631876,50597,,,,A,,12232,10116.0,,In vitro percent permeability into rat ileum; Range is 50-68,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631877,50597,,,,A,,12233,10116.0,,In vitro percent permeability into rat ileum; Range is 78-81,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631878,50597,,,,A,,12234,10116.0,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631879,50597,,,,A,,12235,10116.0,,In vitro percent permeability into rat ileum; nd indicates not detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631880,50597,,,,A,,12236,10116.0,,In vitro percent permeability into rat ileum; nt indicates not detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631881,50597,,,,A,,12237,10116.0,,In vitro percent permeability into rat ileum; nt indicates not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15286,,
CHEMBL631882,50597,,,,A,,12238,10116.0,,Compound was tested for oral absorption in bile-duct cannulated rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13770,,
CHEMBL630749,50597,,,,A,,12239,10116.0,,Compound was tested for oral absorption in bile-duct cannulated rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13770,,
CHEMBL630750,50587,,,,A,,12240,9606.0,,Oral absorption using Caco-2 cell monolayers.,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,5202,,
CHEMBL630253,50587,,,,A,,12241,9606.0,,Percent of the drug absorbed after administration to humans was determined,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14920,,
CHEMBL630254,50597,,Plasma,,A,,12242,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL630255,50597,,Plasma,,A,,12243,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL630256,50597,,Plasma,,A,,12244,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL875781,50597,,Liver,In vivo,A,,12245,10116.0,2107.0,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL630257,50597,,Liver,In vivo,A,,12246,10116.0,2107.0,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL630258,50597,,Liver,In vivo,A,,12247,10116.0,2107.0,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13751,,
CHEMBL630259,50597,,,,A,,12248,10116.0,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15807,,
CHEMBL630260,50597,,Striatum,,A,,12249,10116.0,2435.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15807,,
CHEMBL630261,50597,,Striatum,,A,,12250,10116.0,2435.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15807,,
CHEMBL630262,50597,,,,A,,12251,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630263,50597,,,,A,,12252,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630264,50597,,,,A,,12253,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630265,50597,,,,A,,12254,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630266,50597,,,,A,,12255,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630267,50597,,Kidney,,A,,12256,10116.0,2113.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630268,50597,,Kidney,,A,,12257,10116.0,2113.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630269,50597,,,,A,,12258,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630270,50597,,,,A,,12259,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630141,50597,,Lung,,A,,12260,10116.0,2048.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630142,50597,,Lung,,A,,12261,10116.0,2048.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630143,50597,,Muscle tissue,,A,,12262,10116.0,2385.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630144,50597,,Muscle tissue,,A,,12263,10116.0,2385.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630145,50597,,Prostate gland,,A,,12264,10116.0,2367.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630146,50597,,Prostate gland,,A,,12265,10116.0,2367.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630147,50597,,,,A,,12266,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630148,50597,,,,A,,12267,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630149,50597,,,,A,,12268,10116.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630150,50597,,Spleen,,A,,12269,10116.0,2106.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL630151,50597,,Spleen,,A,,12270,10116.0,2106.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632031,50597,,Thyroid gland,,A,,12271,10116.0,2046.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632032,50597,,Thyroid gland,,A,,12272,10116.0,2046.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632033,50597,,,,A,,12273,10116.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632034,50597,,,,A,,12274,10116.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632035,50597,,Muscle tissue,,A,,12275,10116.0,2385.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632036,50597,,,,A,,12276,10116.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632037,50597,,Thyroid gland,,A,,12277,10116.0,2046.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14950,,
CHEMBL632038,50597,,Blood,,A,,12278,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL632039,50597,,Blood,,A,,12279,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL632040,50597,,Blood,,A,,12280,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL632041,50597,,Blood,,A,,12281,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL632042,50588,,Blood,,A,,12282,9615.0,178.0,"Concentration of compound in blood of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632043,50588,,,,A,,12283,9615.0,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632044,50588,,,,A,,12284,9615.0,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632045,50588,,Liver,,A,,12285,9615.0,2107.0,"Concentration of compound in liver of dog 1, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632046,50588,,Liver,,A,,12286,9615.0,2107.0,"Concentration of compound in liver of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632047,50588,,Lung,,A,,12287,9615.0,2048.0,"Concentration of compound in lung of dog 1, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632048,50588,,Lung,,A,,12288,9615.0,2048.0,"Concentration of compound in lung of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632049,50588,,Muscle tissue,,A,,12289,9615.0,2385.0,"Concentration of compound in muscle of dog 1, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL876418,50588,,Muscle tissue,,A,,12290,9615.0,2385.0,"Concentration of compound in muscle of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632050,50588,,Spleen,,A,,12291,9615.0,2106.0,"Concentration of compound in spleen of dog 1,after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632051,50588,,Spleen,,A,,12292,9615.0,2106.0,"Concentration of compound in spleen of dog 2, after administering intravenously",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9614,,
CHEMBL632052,22224,,,,F,,12293,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,U,,0,,Autocuration,1,BAO_0000218,,,10353,,
CHEMBL632053,22224,,,,F,,12294,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,U,,0,,Autocuration,1,BAO_0000218,,,10353,,
CHEMBL632054,22224,,,,A,,12295,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,0,,Autocuration,1,BAO_0000218,,,10353,,
CHEMBL632055,22224,,,,F,,12296,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,0,,Autocuration,1,BAO_0000218,,,10353,,
CHEMBL631181,22224,,,,F,,12297,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,U,,0,,Autocuration,1,BAO_0000218,,,10353,,
CHEMBL631182,22224,,,,A,,12298,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL631183,22224,,,,A,,12299,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL631184,22224,,,,A,,12300,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL629774,22224,,,,A,,12301,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL629775,22224,,,,A,,12302,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL876549,22224,,,,A,,12303,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628172,22224,,,,A,,12304,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628173,22224,,,,A,,12305,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628174,22224,,,,A,,12306,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628175,22224,,,,A,,12307,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628176,22224,,,,A,,12308,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628177,22224,,,,A,,12309,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628178,22224,,,,A,,12310,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628179,22224,,,,A,,12311,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628180,22224,,,,A,,12312,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628181,22224,,,,A,,12313,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628182,22224,,,,A,,12314,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628183,22224,,,,A,,12315,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628184,22224,,,,A,,12316,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628185,22224,,,,A,,12317,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL875617,22224,,,,A,,12318,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628186,22224,,,,A,,12319,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628187,22224,,,,A,,12320,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628188,22224,,,,A,,12321,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628189,22224,,,,A,,12322,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628190,22224,,,,A,,12323,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628191,22224,,,,A,,12324,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626513,22224,,,,A,,12325,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626514,50597,,Thyroid gland,,A,,12326,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626515,50597,,Thyroid gland,,A,,12327,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626516,50597,,Thyroid gland,,A,,12328,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626517,50597,,Thyroid gland,,A,,12329,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626518,50597,,Thyroid gland,,A,,12330,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626519,50597,,Thyroid gland,,A,,12331,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626520,50597,,Thyroid gland,,A,,12332,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626521,50597,,Thyroid gland,,A,,12333,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626522,50597,,Thyroid gland,,A,,12334,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626523,50597,,Thyroid gland,,A,,12335,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626524,50597,,Thyroid gland,,A,,12336,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626688,50597,,Thyroid gland,,A,,12337,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626689,50597,,Thyroid gland,,A,,12338,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626690,50597,,Thyroid gland,,A,,12339,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL626691,50597,,Thyroid gland,,A,,12340,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL627319,50597,,Thyroid gland,,A,,12341,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL624052,50597,,Thyroid gland,,A,,12342,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL624053,50597,,Thyroid gland,,A,,12343,10116.0,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8608,,
CHEMBL624054,50597,,,,A,,12344,10116.0,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL624055,50597,,,,A,,12345,10116.0,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL624056,50597,,,,A,,12346,10116.0,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL624057,50597,,Uterus,,A,,12347,10116.0,995.0,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622281,50597,,Uterus,,A,,12348,10116.0,995.0,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622282,50597,,Uterus,,A,,12349,10116.0,995.0,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622283,50597,,Uterus,,A,,12350,10116.0,995.0,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622284,50597,,Uterus,,A,,12351,10116.0,995.0,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622285,50597,,Uterus,,A,,12352,10116.0,995.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622286,50597,,Uterus,,A,,12353,10116.0,995.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8085,,
CHEMBL622287,22224,,,,P,,12354,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,U,,0,,Autocuration,1,BAO_0000100,,,7657,,
CHEMBL622288,50594,,,,A,,12355,10090.0,,Partition coefficient (logD7.4),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8935,,
CHEMBL622289,50594,,,,A,,12356,10090.0,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622290,50594,,Brain,,A,,12357,10090.0,955.0,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622291,50594,,,,A,,12358,10090.0,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622292,50594,,Brain,,A,,12359,10090.0,955.0,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622293,50594,,,,A,,12360,10090.0,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622294,50594,,Brain,,A,,12361,10090.0,955.0,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622295,50594,,,,A,,12362,10090.0,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL622296,50597,,Brain,,A,,12363,10116.0,955.0,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13792,,
CHEMBL874409,50597,,Plasma,,A,,12364,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622297,50597,,Plasma,,A,,12365,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622298,50597,,Plasma,,A,,12366,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622299,50597,,Plasma,,A,,12367,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622300,50597,,Plasma,,A,,12368,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622301,50597,,Plasma,,A,,12369,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622302,50597,,Plasma,,A,,12370,10116.0,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622303,50597,,Plasma,,A,,12371,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622304,50597,,Plasma,,A,,12372,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622305,50597,,Plasma,,A,,12373,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL622306,50597,,Plasma,,A,,12374,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626864,50597,,Plasma,,A,,12375,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626865,50597,,Plasma,,A,,12376,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626866,50597,,Plasma,,A,,12377,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626867,50597,,Plasma,,A,,12378,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626868,50597,,Plasma,,A,,12379,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626869,50597,,Plasma,,A,,12380,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626870,50597,,Plasma,,A,,12381,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626871,50597,,Plasma,,A,,12382,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL626872,50597,,Plasma,,A,,12383,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL632185,50597,,Plasma,,A,,12384,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL632186,50597,,Plasma,,A,,12385,10116.0,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14103,,
CHEMBL629310,22224,,,,A,,12386,,,Amount of acetic acid produced by the compound,U,,0,,Autocuration,1,BAO_0000019,,,12904,,
CHEMBL629311,22224,,,,A,,12387,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,U,,0,,Autocuration,1,BAO_0000019,,,12904,,
CHEMBL629312,50597,,,,A,,12388,10116.0,,Log of (Cbrain/Cblood) in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9663,,
CHEMBL629313,22224,,,,A,,12389,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000221,,,7652,,
CHEMBL629314,22224,,,,A,,12390,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000221,,,7652,,
CHEMBL629315,22224,,,,A,,12391,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000221,,,7652,,
CHEMBL629316,22224,,,,B,,12392,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000219,,,7652,,
CHEMBL629317,22224,,,,A,,12393,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000221,,,7652,,
CHEMBL629318,22224,,,,A,,12394,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL877497,22224,,,,A,,12395,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629319,22224,,,,A,,12396,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629320,22224,,,,A,,12397,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629496,22224,,,,A,,12398,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629497,22224,,,,A,,12399,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629498,22224,,,,A,,12400,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629499,22224,,,,A,,12401,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629500,22224,,,,A,,12402,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629501,22224,,,,A,,12403,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629502,22224,,,,A,,12404,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),U,,0,,Autocuration,1,BAO_0000019,,,7652,,
CHEMBL629503,22224,,,In vivo,F,,12405,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,U,,0,,Autocuration,1,BAO_0000218,,,8267,,
CHEMBL629504,50588,,,,A,,12406,9615.0,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8267,,
CHEMBL629505,22224,,,,A,,12407,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,U,,0,,Autocuration,1,BAO_0000019,,,14479,,
CHEMBL629506,22224,,,,A,,12408,,,Compound was evaluated for total body clearance,U,,0,,Autocuration,1,BAO_0000019,,,17515,,
CHEMBL629507,22224,,,,A,,12409,,,Compound was evaluated for volume of distribution at steady state,U,,0,,Autocuration,1,BAO_0000019,,,17515,,
CHEMBL877498,22224,,,,A,,12410,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,U,,0,,Autocuration,1,BAO_0000019,,,8142,,
CHEMBL629508,22224,,,,A,,12411,,,Percentage of the diamine which is monoprotonated at pH 7.4,U,,0,,Autocuration,1,BAO_0000019,,,14849,,
CHEMBL629509,22224,,,,A,,12412,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,U,,0,,Autocuration,1,BAO_0000019,,,7653,,
CHEMBL629510,50597,,Blood,,A,,12413,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL629511,50597,,Blood,,A,,12414,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL629512,50597,,Blood,,A,,12415,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL629513,50597,,Blood,,A,,12416,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL629514,50597,,Blood,,A,,12417,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL628447,50597,,Blood,,A,,12418,10116.0,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL628448,50597,,Blood,,A,,12419,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL628449,50597,,Blood,,A,,12420,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631119,50597,,Blood,,A,,12421,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631120,50597,,Blood,,A,,12422,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631121,50597,,Blood,,A,,12423,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL874458,50597,,Blood,,A,,12424,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631122,50597,,Blood,,A,,12425,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631123,50597,,Blood,,A,,12426,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631124,50597,,Blood,,A,,12427,10116.0,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631125,50597,,Blood,,A,,12428,10116.0,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631290,50597,,Blood,,A,,12429,10116.0,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631291,50597,,Blood,,A,,12430,10116.0,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631292,50597,,Blood,,A,,12431,10116.0,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631293,50597,,Blood,,A,,12432,10116.0,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631294,50597,,Blood,,A,,12433,10116.0,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631295,50597,,Blood,,A,,12434,10116.0,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631296,50597,,Blood,,A,,12435,10116.0,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631297,50597,,Blood,,A,,12436,10116.0,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8631,,
CHEMBL631298,22224,,,,A,,12437,,,Maximum biodistribution (Bmax) was determined.,U,,0,,Autocuration,1,BAO_0000218,,,10263,,
CHEMBL631299,50594,,,,A,,12438,10090.0,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12364,,
CHEMBL631300,50594,,,,A,,12439,10090.0,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12364,,
CHEMBL631301,50594,,,,A,,12440,10090.0,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12364,,
CHEMBL630291,50594,,,,A,,12441,10090.0,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12364,,
CHEMBL630292,22224,,,,A,,12442,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL630293,22224,,,,A,,12443,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL630294,22224,,,,A,,12444,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL630295,22224,,,,A,,12445,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL630296,22224,,,,A,,12446,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626782,22224,,,,A,,12447,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626783,22224,,,,A,,12448,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626784,22224,,,,A,,12449,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626785,22224,,,,A,,12450,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626786,22224,,,,A,,12451,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626787,22224,,,,A,,12452,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626788,22224,,,,A,,12453,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625927,22224,,,,A,,12454,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625928,50597,,Blood,,A,,12455,10116.0,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625929,50597,,Blood,,A,,12456,10116.0,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625930,50597,,Blood,,A,,12457,10116.0,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625931,50597,,Blood,,A,,12458,10116.0,178.0,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627230,50597,,Blood,,A,,12459,10116.0,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627231,50597,,Blood,,A,,12460,10116.0,178.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627232,50597,,Blood,,A,,12461,10116.0,178.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627233,50597,,Blood,,A,,12462,10116.0,178.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL875470,50597,,Blood,,A,,12463,10116.0,178.0,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627234,50597,,Blood,,A,,12464,10116.0,178.0,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627235,50597,,Blood,,A,,12465,10116.0,178.0,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627236,50597,,Blood,,A,,12466,10116.0,178.0,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627237,50597,,Blood,,A,,12467,10116.0,178.0,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627238,50597,,Blood,,A,,12468,10116.0,178.0,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627239,50597,,Blood,,A,,12469,10116.0,178.0,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627240,50597,,Blood,,A,,12470,10116.0,178.0,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627241,50597,,Blood,,A,,12471,10116.0,178.0,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627242,50597,,Blood,,A,,12472,10116.0,178.0,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627243,50597,,Blood,,A,,12473,10116.0,178.0,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627244,50597,,Blood,,A,,12474,10116.0,178.0,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627245,50597,,Blood,,A,,12475,10116.0,178.0,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627246,50597,,Blood,,A,,12476,10116.0,178.0,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627247,50597,,Blood,,A,,12477,10116.0,178.0,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627248,50597,,Blood,,A,,12478,10116.0,178.0,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627249,50597,,Blood,,A,,12479,10116.0,178.0,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625569,50597,,Blood,,A,,12480,10116.0,178.0,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625570,50597,,Blood,,A,,12481,10116.0,178.0,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625571,50597,,Blood,,A,,12482,10116.0,178.0,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625572,50597,,Blood,,A,,12483,10116.0,178.0,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625573,50597,,Blood,,A,,12484,10116.0,178.0,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL625574,50597,,Blood,,A,,12485,10116.0,178.0,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL626245,50597,,Blood,,A,,12486,10116.0,178.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL626246,50597,,Blood,,A,,12487,10116.0,178.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL626247,22224,,,,A,,12488,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626248,22224,,,,A,,12489,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626249,22224,,,,A,,12490,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626420,22224,,,,A,,12491,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626421,22224,,,,A,,12492,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626422,22224,,,,A,,12493,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626423,22224,,,,A,,12494,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626424,22224,,,,A,,12495,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626425,50588,,,,A,,12496,9615.0,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12023,,
CHEMBL875476,50597,,,,A,,12497,10116.0,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12023,,
CHEMBL626426,100710,,,,A,,12498,9541.0,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12023,,
CHEMBL626427,22224,,,,P,,12499,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,0,,Autocuration,1,BAO_0000100,,,10580,,
CHEMBL626428,22224,,,,P,,12500,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,0,,Autocuration,1,BAO_0000100,,,10580,,
CHEMBL626429,22224,,,,A,,12501,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,16032,,
CHEMBL625025,22224,,Urine,,A,,12502,,1088.0,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,U,,0,,Autocuration,1,BAO_0000019,,,16032,,
CHEMBL625026,50597,,Blood,,A,,12503,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625027,50597,,Blood,,A,,12504,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL874410,50597,,Blood,,A,,12505,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625028,50597,,Blood,,A,,12506,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625029,50597,,Blood,,A,,12507,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625030,50597,,Blood,,A,,12508,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625031,50597,,Blood,,A,,12509,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625032,50597,,Blood,,A,,12510,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625033,50597,,Blood,,A,,12511,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL625034,50597,,Blood,,A,,12512,10116.0,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624872,50597,,Heart,,A,,12513,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624873,50597,,Heart,,A,,12514,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624874,50597,,Heart,,A,,12515,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624875,50597,,Heart,,A,,12516,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624876,50597,,Heart,,A,,12517,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624877,50597,,Heart,,A,,12518,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624878,50597,,Heart,,A,,12519,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624879,50597,,Heart,,A,,12520,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624880,50597,,Heart,,A,,12521,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624881,50597,,Heart,,A,,12522,10116.0,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624882,50597,,Heart,,A,,12523,10116.0,948.0,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624883,50597,,Kidney,,A,,12524,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624884,50597,,Kidney,,A,,12525,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624885,50597,,Kidney,,A,,12526,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624886,50597,,Kidney,,A,,12527,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624887,50597,,Kidney,,A,,12528,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624888,50597,,Kidney,,A,,12529,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624889,50597,,Kidney,,A,,12530,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624890,50597,,Kidney,,A,,12531,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL621964,50597,,Kidney,,A,,12532,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL621965,50597,,Kidney,,A,,12533,10116.0,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL621966,50597,,Liver,,A,,12534,10116.0,2107.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL621967,50597,,Liver,,A,,12535,10116.0,2107.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL622164,50597,,Liver,,A,,12536,10116.0,2107.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL623097,22224,,,,A,,12537,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),U,,0,,Autocuration,1,BAO_0000019,,,7653,,
CHEMBL623098,22224,,,,A,,12538,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),U,,0,,Autocuration,1,BAO_0000019,,,7653,,
CHEMBL623099,22224,,,,A,,12539,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,U,,0,,Autocuration,1,BAO_0000019,,,7653,,
CHEMBL623100,22224,,,,A,,12540,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,U,,0,,Autocuration,1,BAO_0000019,,,7653,,
CHEMBL628673,50597,,,,A,,12541,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL628674,50597,,,,A,,12542,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL628675,50597,,,,A,,12543,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL627644,50597,,,,A,,12544,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL627645,50597,,,,A,,12545,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL627646,50597,,,,A,,12546,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL627647,50597,,,,A,,12547,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL627648,50597,,,,A,,12548,10116.0,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9104,,
CHEMBL627649,50597,,,,A,,12549,10116.0,,Free level in rat plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12902,,
CHEMBL628313,22224,,,,A,,12550,,,Level reaching in blood plasma of rat or human was determined,U,,0,,Autocuration,1,BAO_0000019,,,6614,,
CHEMBL628314,50597,,,,A,,12551,10116.0,,Log (Cbrain/Cblood) in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9663,,
CHEMBL628315,22224,,,,A,,12552,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,U,,0,,Autocuration,1,BAO_0000019,,,17658,,
CHEMBL628316,22224,,,,A,,12553,,,Mean percentage of compound transport through membrane; expressed as membrane transport,U,,0,,Autocuration,1,BAO_0000019,,,17658,,
CHEMBL628317,22224,,,,A,,12554,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,U,,0,,Autocuration,1,BAO_0000218,,,14314,,
CHEMBL628473,22224,,,,A,,12555,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,U,,0,,Autocuration,1,BAO_0000019,,,7385,,
CHEMBL628474,22224,,,,A,,12556,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",U,,0,,Autocuration,1,BAO_0000019,,,7385,,
CHEMBL628475,22224,,,,A,,12557,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,U,,0,,Autocuration,1,BAO_0000019,,,7385,,
CHEMBL628476,22224,,,,A,,12558,,,Net water uptake by a carrier mediated transport (%cm) mechanism,U,,0,,Autocuration,1,BAO_0000019,,,1329,,
CHEMBL628477,22224,,,,A,,12559,314293.0,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL628478,50506,,,,A,,12560,9669.0,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,12187,,
CHEMBL628479,50506,,,,A,,12561,9669.0,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,12187,,
CHEMBL628480,22224,,,,A,,12562,314293.0,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL628481,22224,,,,A,,12563,314293.0,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL628482,50597,,,,A,,12564,10116.0,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL628483,50597,,,,A,,12565,10116.0,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL628484,50597,,Plasma,,A,,12566,10116.0,1969.0,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL628485,50597,,Plasma,,A,,12567,10116.0,1969.0,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL628486,100710,,Plasma,,A,,12568,9541.0,1969.0,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,9278,,
CHEMBL628487,50587,,Plasma,,A,,12569,9606.0,1969.0,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,9278,,
CHEMBL628488,50597,,Plasma,,A,,12570,10116.0,1969.0,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL628489,50597,,Plasma,,A,,12571,10116.0,1969.0,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL628490,50597,,Plasma,,A,,12572,10116.0,1969.0,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL628491,100710,,,,A,,12573,9541.0,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL877507,100710,,,,A,,12574,9541.0,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL628492,22224,,,,A,,12575,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,U,,0,,Autocuration,1,BAO_0000218,,,12186,,
CHEMBL628493,22224,,,,A,,12576,314293.0,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),U,,0,,Autocuration,1,BAO_0000019,,Simiiformes,12041,,
CHEMBL628494,22224,,,,A,,12577,314293.0,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),U,,0,,Autocuration,1,BAO_0000019,,Simiiformes,12041,,
CHEMBL628495,22224,,,,A,,12578,314293.0,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),U,,0,,Autocuration,1,BAO_0000019,,Simiiformes,12041,,
CHEMBL628496,50587,,,,A,,12579,9606.0,,Permeability in Caco-2 assay at 10E-6,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,6737,,
CHEMBL628497,22224,,Brain,,A,,12580,,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,0,,Autocuration,1,BAO_0000218,,,13758,,
CHEMBL628498,22224,,Brain,,A,,12581,,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,0,,Autocuration,1,BAO_0000218,,,13758,,
CHEMBL628499,22224,,,,A,,12582,,,Plasma protein binding was determined,U,,0,,Autocuration,1,BAO_0000019,,,5676,,
CHEMBL627656,22224,,,,A,,12583,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL627657,22224,,,,A,,12584,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626808,22224,,,,A,,12585,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626809,22224,,,,A,,12586,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626810,22224,,,,A,,12587,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626811,22224,,,,A,,12588,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL874465,22224,,,,A,,12589,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626812,22224,,,,A,,12590,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626813,22224,,,,A,,12591,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626814,22224,,,,A,,12592,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,U,,0,,Autocuration,1,BAO_0000218,,,14793,,
CHEMBL626815,22224,,,,A,,12593,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,U,,0,,Autocuration,1,BAO_0000019,,,14000,,
CHEMBL628566,22224,,,,A,,12594,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,5948,,
CHEMBL628567,22229,,,,P,,12595,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,0,,Autocuration,1,BAO_0000100,,,13824,,
CHEMBL628568,22229,,,,P,,12596,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,10778,,
CHEMBL628569,50588,,,In vivo,A,,12597,9615.0,,C max in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17237,,
CHEMBL628570,50512,,,In vivo,A,,12598,10141.0,,C max in guinea pig,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,17237,,
CHEMBL628571,22224,,,In vivo,A,,12599,,,C max value was evaluated,U,,0,,Autocuration,1,BAO_0000218,,,2809,,
CHEMBL628572,22224,,,In vivo,A,,12600,,,Cmax value after oral dose of 0.1 mg//kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL628573,22224,,,In vivo,A,,12601,,,Cmax value after oral dose of 0.3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL628574,22224,,,In vivo,A,,12602,,,Cmax value after oral dose of 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL628575,22224,,,In vivo,A,,12603,,,Cmax value after oral dose of 10 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL628576,22224,,,In vivo,A,,12604,,,Cmax value after oral dose of 23.4 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL628577,22224,,,In vivo,A,,12605,,,Cmax value after oral dose of 3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL628578,22224,,,In vivo,A,,12606,,,Cmax value after oral dose of 3.87 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL874466,50588,,,In vivo,A,,12607,9615.0,,Cmax value in female Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12768,,
CHEMBL628579,50597,,,In vivo,A,,12608,10116.0,,Cmax value in male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12768,,
CHEMBL628580,50597,,Plasma,In vivo,A,,12609,10116.0,1969.0,Cmax value in rat plasma when administered 20 mg/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12780,,
CHEMBL628581,50588,,Plasma,In vivo,A,,12610,9615.0,1969.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL628582,50588,,Plasma,In vivo,A,,12611,9615.0,1969.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL628583,50588,,,,A,,12612,9615.0,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17025,,
CHEMBL625782,22224,,,,A,,12613,314293.0,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17025,,
CHEMBL625783,50592,,,,A,,12614,9986.0,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL625784,50597,,,,A,,12615,10116.0,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17025,,
CHEMBL625785,50797,,Plasma,,A,,12616,9544.0,1969.0,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,4236,,
CHEMBL625786,50597,,,,A,,12617,10116.0,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15791,,
CHEMBL874467,22224,,,,A,,12618,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,U,,0,,Autocuration,1,BAO_0000019,,,11149,,
CHEMBL625787,50588,,,,A,,12619,9615.0,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL625964,50677,,,,A,,12620,12721.0,,cytotoxicity against HIV protease enzyme.,N,,1,,Intermediate,1,BAO_0000218,,Human immunodeficiency virus,15778,,
CHEMBL625965,50594,,,,A,,12621,10090.0,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL625966,50594,,,,A,,12622,10090.0,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12745,,
CHEMBL625967,50588,,Plasma,In vivo,A,,12623,9615.0,1969.0,The plasma clearance in dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13941,,
CHEMBL625968,50597,,Plasma,In vivo,A,,12624,10116.0,1969.0,The plasma clearance in rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13941,,
CHEMBL625969,50597,,Plasma,In vivo,A,,12625,10116.0,1969.0,Clearance from plasma in male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16449,,
CHEMBL625970,100710,,Plasma,In vivo,A,,12626,9541.0,1969.0,Clearance from plasma in male cynomolgus monkeys,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,16449,,
CHEMBL625971,50588,,Plasma,In vivo,A,,12627,9615.0,1969.0,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL625972,50588,,Plasma,In vivo,A,,12628,9615.0,1969.0,Clearance of compound in dog plasma,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL625973,50587,,Plasma,In vivo,A,,12629,9606.0,1969.0,Clearance of compound in human plasma,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14224,,
CHEMBL625974,50588,,,In vivo,A,,12630,9615.0,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14317,,
CHEMBL625975,50588,,,In vivo,A,,12631,9615.0,,Clearance of compound when administered intravenously as an individual dose to a single dog.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14317,,
CHEMBL625976,50588,,Plasma,In vivo,A,,12632,9615.0,1969.0,"Clearance (10 mg/kg, intravenously) in dog plasma",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14224,,
CHEMBL625977,50588,,,In vivo,A,,12633,9615.0,,Clearance value in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17237,,
CHEMBL625978,50512,,,In vivo,A,,12634,10141.0,,Clearance value in guinea pig,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,17237,,
CHEMBL874468,50597,,,In vivo,A,,12635,10116.0,,Clearance values in rats after iv administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14187,,
CHEMBL625421,22224,,Plasma,In vivo,A,,12636,,1969.0,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,U,,0,,Autocuration,1,BAO_0000218,,,4806,,
CHEMBL625422,50592,,,In vivo,A,,12637,9986.0,,In vivo clearance (5 mg/kg) was determined in rabbits,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,15025,,
CHEMBL625423,50597,,,In vivo,A,,12638,10116.0,,Plasma Clearance rate was determined for the compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13197,,
CHEMBL625424,22224,,,In vivo,A,,12639,9520.0,,Plasma Clearance rate was determined for the compound in squirrel monkeys,U,,0,,Autocuration,1,BAO_0000218,,Saimiri,13197,,
CHEMBL625425,50597,,,In vivo,A,,12640,10116.0,,Plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13960,,
CHEMBL625426,22224,,,In vivo,A,,12641,,,Plasma clearance of the compound,U,,0,,Autocuration,1,BAO_0000218,,,17820,,
CHEMBL625427,50512,,,In vivo,A,,12642,10141.0,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14706,,
CHEMBL625428,50512,,,In vivo,A,,12643,10141.0,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,14706,,
CHEMBL625429,22224,,,In vivo,A,,12644,,,Plasma clearance was determined,U,,0,,Autocuration,1,BAO_0000218,,,6504,,
CHEMBL625430,50588,,,In vivo,A,,12645,9615.0,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14925,,
CHEMBL625431,50597,,,In vivo,A,,12646,10116.0,,Plasma clearance rate was determined for the compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13197,,
CHEMBL627307,22224,,,In vivo,A,,12647,9520.0,,Plasma clearance rate was determined for the compound in squirrel monkeys,U,,0,,Autocuration,1,BAO_0000218,,Saimiri,13197,,
CHEMBL627308,22224,,,In vivo,A,,12648,,,Slow clearance (CL) was determined,U,,0,,Autocuration,1,BAO_0000218,,,3437,,
CHEMBL627309,22224,,,,A,,12649,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627310,22224,,,,A,,12650,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627311,22224,,,,A,,12651,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627312,22224,,,,A,,12652,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627313,22224,,,,A,,12653,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627314,22224,,,,A,,12654,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627315,22224,,,,A,,12655,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627316,22224,,,,A,,12656,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627317,22224,,,,A,,12657,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627318,22224,,,,A,,12658,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL627999,22224,,,,A,,12659,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628000,22224,,,,A,,12660,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628001,22224,,,,A,,12661,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL628002,22224,,,,A,,12662,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625610,22224,,,,A,,12663,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625611,22224,,,,A,,12664,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625612,22224,,,,A,,12665,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625613,22224,,,,A,,12666,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL875479,22224,,,,A,,12667,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625614,22224,,,,A,,12668,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL625615,22224,,,,A,,12669,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626302,22224,,,,A,,12670,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,0,,Autocuration,1,BAO_0000218,,,9196,,
CHEMBL626303,50597,,Blood,,A,,12671,10116.0,178.0,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627420,50597,,Blood,,A,,12672,10116.0,178.0,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8374,,
CHEMBL627421,50597,,,,A,,12673,10116.0,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL625695,50597,,,,A,,12674,10116.0,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL625696,50597,,,,A,,12675,10116.0,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL875606,50594,,Brain,,A,,12676,10090.0,955.0,Distribution of compound in mice brain was measured after 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625697,50594,,Brain,,A,,12677,10090.0,955.0,Distribution of compound in mice brain was measured after 24 hr r,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625698,50594,,Brain,,A,,12678,10090.0,955.0,Distribution of compound in mice brain was measured after 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625699,50594,,Brain,,A,,12679,10090.0,955.0,Distribution of compound in mice brain was measured after 3 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625700,50594,,Brain,,A,,12680,10090.0,955.0,Distribution of compound in mice brain was measured after 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625701,50594,,,,A,,12681,10090.0,,Distribution of compound in mice liver was measured after 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625702,50594,,,,A,,12682,10090.0,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625703,50594,,,,A,,12683,10090.0,,Distribution of compound in mice liver was measured after 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625704,50594,,,,A,,12684,10090.0,,Distribution of compound in mice liver was measured after 3 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625705,50594,,,,A,,12685,10090.0,,Distribution of compound in mice liver was measured after 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625706,50588,,Adrenal medulla,,A,,12686,9615.0,1236.0,Distribution in dog adrenal medulla 30 min after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL625707,50588,,Adrenal medulla,,A,,12687,9615.0,1236.0,Distribution in dog adrenal medulla 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL625708,50588,,,,A,,12688,9615.0,,Distribution in female dog Ovary 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL625709,50588,,,,A,,12689,9615.0,,Distribution in female dog Ovary 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624180,50588,,,,A,,12690,9615.0,,Distribution in female dog adipose 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624181,50588,,,,A,,12691,9615.0,,Distribution in female dog adipose 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624182,50588,,Adrenal cortex,,A,,12692,9615.0,1235.0,Distribution in female dog adrenal cortex 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624183,50588,,Adrenal cortex,,A,,12693,9615.0,1235.0,Distribution in female dog adrenal cortex 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624184,50597,,Liver,,A,,12694,10116.0,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL877489,50597,,Liver,,A,,12695,10116.0,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624185,50597,,Liver,,A,,12696,10116.0,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624186,50597,,Liver,,A,,12697,10116.0,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624187,50597,,Liver,,A,,12698,10116.0,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624188,50597,,Liver,,A,,12699,10116.0,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624189,50597,,Lung,,A,,12700,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624190,50597,,Lung,,A,,12701,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624191,50597,,Lung,,A,,12702,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624192,50597,,Lung,,A,,12703,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624193,50597,,Lung,,A,,12704,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624194,50597,,Lung,,A,,12705,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624891,50597,,Lung,,A,,12706,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624892,50597,,Lung,,A,,12707,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL624893,50597,,Lung,,A,,12708,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627632,50597,,Lung,,A,,12709,10116.0,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627633,50597,,,,A,,12710,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627634,50597,,,,A,,12711,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627635,50597,,,,A,,12712,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627636,50597,,,,A,,12713,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626816,50597,,,,A,,12714,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626817,50597,,,,A,,12715,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626818,50597,,,,A,,12716,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626819,50597,,,,A,,12717,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626820,50597,,,,A,,12718,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626821,50597,,,,A,,12719,10116.0,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626822,50597,,Thyroid gland,,A,,12720,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626823,50597,,Thyroid gland,,A,,12721,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626824,50597,,Thyroid gland,,A,,12722,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626825,50597,,Thyroid gland,,A,,12723,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626826,50597,,Thyroid gland,,A,,12724,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626827,50597,,Thyroid gland,,A,,12725,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626828,50597,,Thyroid gland,,A,,12726,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626829,50597,,Thyroid gland,,A,,12727,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626830,50597,,Thyroid gland,,A,,12728,10116.0,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627150,50597,,,,A,,12729,10116.0,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627151,50597,,,,A,,12730,10116.0,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627152,50597,,,,A,,12731,10116.0,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627153,50597,,,,A,,12732,10116.0,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL627154,22224,,,,A,,12733,,,Rate of acetate production by the compound was determined,U,,0,,Autocuration,1,BAO_0000019,,,12904,,
CHEMBL627155,22224,,,,A,,12734,,,Rate of acetate production by the compound was determined; Not determined,U,,0,,Autocuration,1,BAO_0000019,,,12904,,
CHEMBL627156,22224,,,,A,,12735,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,U,,0,,Autocuration,1,BAO_0000019,,,3730,,
CHEMBL627157,22224,,,,A,,12736,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,U,,0,,Autocuration,1,BAO_0000019,,,3627,,
CHEMBL627158,50592,,,,A,,12737,9986.0,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,13799,,
CHEMBL627159,50592,,Plasma,,A,,12738,9986.0,1969.0,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,13799,,
CHEMBL627160,50594,,,,A,,12739,10090.0,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13799,,
CHEMBL628540,50597,,,,A,,12740,10116.0,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13799,,
CHEMBL628541,50597,,Plasma,,A,,12741,10116.0,1969.0,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13799,,
CHEMBL628542,50597,,Plasma,,A,,12742,10116.0,1969.0,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13799,,
CHEMBL628543,22229,,,,P,,12743,,,Solubility after at a pH 1.2,U,,0,,Autocuration,1,BAO_0000100,,,6629,,
CHEMBL628544,22229,,,,P,,12744,,,Solubility after at pH 1.2,U,,0,,Autocuration,1,BAO_0000100,,,6629,,
CHEMBL628545,22229,,,,P,,12745,,,Solubility after injection of water,U,,0,,Autocuration,1,BAO_0000100,,,6629,,
CHEMBL628546,22224,,,,A,,12746,,,Statistical significance of IC 50 values; Expressed as R value,U,,0,,Autocuration,1,BAO_0000019,,,14000,,
CHEMBL874455,22224,,,,A,,12747,,,Systemic availability with respect to methyldopa was determined,U,,0,,Autocuration,1,BAO_0000019,,,8267,,
CHEMBL628547,50597,,,,A,,12748,10116.0,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13799,,
CHEMBL628548,50597,,Plasma,,A,,12749,10116.0,1969.0,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13799,,
CHEMBL628549,50592,,Feces,,A,,12750,9986.0,1988.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628550,50592,,Feces,,A,,12751,9986.0,1988.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628551,50592,,Feces,,A,,12752,9986.0,1988.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628552,50592,,Urine,,A,,12753,9986.0,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628553,50592,,Urine,,A,,12754,9986.0,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628554,50592,,Urine,,A,,12755,9986.0,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628555,50592,,Urine,,A,,12756,9986.0,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628556,50592,,Urine,,A,,12757,9986.0,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628557,50592,,Kidney,,A,,12758,9986.0,2113.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628558,50592,,Feces,,A,,12759,9986.0,1988.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628559,50592,,Feces,,A,,12760,9986.0,1988.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628560,50592,,Feces,,A,,12761,9986.0,1988.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL874456,50592,,Urine,,A,,12762,9986.0,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628561,50592,,Feces,,A,,12763,9986.0,1988.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628562,50592,,Feces,,A,,12764,9986.0,1988.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628563,50592,,Urine,,A,,12765,9986.0,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628564,50592,,Urine,,A,,12766,9986.0,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL628565,50592,,Urine,,A,,12767,9986.0,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL631248,50592,,Urine,,A,,12768,9986.0,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL631249,50592,,Urine,,A,,12769,9986.0,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627214,50592,,Kidney,,A,,12770,9986.0,2113.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL874591,50592,,Feces,,A,,12771,9986.0,1988.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627215,50592,,Feces,,A,,12772,9986.0,1988.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625471,50592,,Feces,,A,,12773,9986.0,1988.0,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625472,50592,,,,A,,12774,9986.0,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625473,50592,,,,A,,12775,9986.0,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625474,50588,,,In vivo,A,,12776,9615.0,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13317,,
CHEMBL625475,50588,,,In vivo,A,,12777,9615.0,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15341,,
CHEMBL625476,50597,,,In vivo,A,,12778,10116.0,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL625477,50597,,,In vivo,A,,12779,10116.0,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL625478,50597,,,In vivo,A,,12780,10116.0,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15341,,
CHEMBL625479,50597,,esophageal tunica muscularis mucosae,In vitro,A,,12781,10116.0,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12801,,
CHEMBL625480,50597,,esophageal tunica muscularis mucosae,In vitro,A,,12782,10116.0,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12801,,
CHEMBL625481,50597,,Plasma,In vivo,A,,12783,10116.0,1969.0,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14856,,
CHEMBL625482,50597,,,In vivo,A,,12784,10116.0,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL625483,50597,,,In vivo,A,,12785,10116.0,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL625484,50597,,,In vivo,A,,12786,10116.0,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL625485,50597,,,In vivo,A,,12787,10116.0,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14062,,
CHEMBL625486,50588,,Plasma,In vivo,A,,12788,9615.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14346,,
CHEMBL625487,50597,,Plasma,In vivo,A,,12789,10116.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL625488,50597,,Plasma,In vivo,A,,12790,10116.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL625489,50597,,Plasma,In vivo,A,,12791,10116.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL625490,50597,,Plasma,In vivo,A,,12792,10116.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL625491,50588,,Plasma,In vivo,A,,12793,9615.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14346,,
CHEMBL625492,50597,,Plasma,In vivo,A,,12794,10116.0,1969.0,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14346,,
CHEMBL625493,50587,,Plasma,In vivo,A,,12795,9606.0,1969.0,plasma clearance in human,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,15711,,
CHEMBL625494,50597,,,In vivo,A,,12796,10116.0,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14886,,
CHEMBL625495,50597,,,In vivo,A,,12797,10116.0,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14886,,
CHEMBL625496,50597,,,In vivo,A,,12798,10116.0,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14886,,
CHEMBL625497,22229,,,,P,,12799,,,1-Octanol/water partition coefficient measured at 7.4,U,,0,,Autocuration,1,BAO_0000100,,,4115,,
CHEMBL625498,22229,,,,P,,12800,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13733,,
CHEMBL625499,22224,,,,A,,12801,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,12102,,
CHEMBL625500,22229,,,,P,,12802,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12676,,
CHEMBL625501,22229,,,,P,,12803,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13733,,
CHEMBL625502,22229,,,,P,,12804,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13740,,
CHEMBL625503,22229,,,,P,,12805,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),U,,0,,Autocuration,1,BAO_0000100,,,12766,,
CHEMBL625504,22229,,,,P,,12806,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,2764,,
CHEMBL625505,22229,,,,P,,12807,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12355,,
CHEMBL625506,22229,,,,P,,12808,,,Calculated partition coefficient of the compound,U,,0,,Autocuration,1,BAO_0000100,,,11314,,
CHEMBL625507,22224,,,,A,,12809,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,12706,,
CHEMBL625508,22229,,,,P,,12810,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12645,,
CHEMBL625509,22229,,,,P,,12811,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13668,,
CHEMBL625510,22229,,,,P,,12812,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12819,,
CHEMBL883125,22229,,,,P,,12813,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13668,,
CHEMBL625511,22229,,,,P,,12814,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13017,,
CHEMBL874650,22224,,,,A,,12815,,,Partition coefficient of the compound,U,,0,,Autocuration,1,BAO_0000019,,,2448,,
CHEMBL625512,22224,,,,A,,12816,,,Partition coefficient of the compound,U,,0,,Autocuration,1,BAO_0000019,,,11526,,
CHEMBL625513,22224,,,,A,,12817,,,Partition coefficient of compound was determined,U,,0,,Autocuration,1,BAO_0000019,,,12426,,
CHEMBL625514,22224,,,,A,,12818,,,Partition coefficient was determined,U,,0,,Autocuration,1,BAO_0000019,,,2448,,
CHEMBL625515,22229,,,,P,,12819,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12001,,
CHEMBL625516,22229,,,,P,,12820,,,partition coefficient of compound was determined,U,,0,,Autocuration,1,BAO_0000100,,,12426,,
CHEMBL625517,50588,,,In vivo,A,,12821,9615.0,,The total body administered intravenously in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13204,,
CHEMBL625518,50597,,,In vivo,A,,12822,10116.0,,The total body administered intravenously in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13204,,
CHEMBL625519,50594,,,,A,,12823,10090.0,,Time taken for the administration to female NIH mice weighing 25-30 g.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13889,,
CHEMBL625520,22224,,,,A,,12824,,,Time taken for the administration,U,,0,,Autocuration,1,BAO_0000019,,,13889,,
CHEMBL874651,50588,,,In vivo,A,,12825,9615.0,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,17025,,
CHEMBL625521,22224,,,In vivo,A,,12826,314293.0,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,17025,,
CHEMBL623171,50592,,,In vivo,A,,12827,9986.0,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL623853,50597,,,In vivo,A,,12828,10116.0,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,17025,,
CHEMBL623854,22224,,,,A,,12829,,,Plasma clearance for the compound was determined.,U,,0,,Autocuration,1,BAO_0000019,,,15067,,
CHEMBL874405,22224,,,,P,,12830,,,CLog P value of the compound,U,,0,,Autocuration,1,BAO_0000100,,,3091,,
CHEMBL623855,22229,,,,P,,12831,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,15592,,
CHEMBL623856,22229,,,,P,,12832,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,14738,,
CHEMBL623857,22224,,,,P,,12833,,,ClogP value of the compound; nd ='no data',U,,0,,Autocuration,1,BAO_0000100,,,14738,,
CHEMBL623858,22224,,,,P,,12834,,,ClogP value of the compound; nd ='not determined',U,,0,,Autocuration,1,BAO_0000100,,,14738,,
CHEMBL623859,22224,,,,P,,12835,,,CLog P was determined,U,,0,,Autocuration,1,BAO_0000100,,,6076,,
CHEMBL839829,22229,,,,P,,12836,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,17840,,
CHEMBL623860,22224,,,,A,,12837,,,CLogP was calculated,U,,0,,Autocuration,1,BAO_0000019,,,13589,,
CHEMBL623861,22224,,,,A,,12838,,,CLogP value was determined,U,,0,,Autocuration,1,BAO_0000019,,,17655,,
CHEMBL623862,22224,,,,A,,12839,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,U,,0,,Autocuration,1,BAO_0000019,,,5867,,
CHEMBL874406,22229,,,,P,,12840,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,5867,,
CHEMBL623863,22229,,,,P,,12841,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,10783,,
CHEMBL624021,22229,,,,P,,12842,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,14849,,
CHEMBL624022,50588,,Adrenal medulla,,A,,12843,9615.0,1236.0,Distribution in female dog adrenal medulla 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624023,50588,,Adrenal medulla,,A,,12844,9615.0,1236.0,Distribution in female dog adrenal medulla 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624024,50588,,,,A,,12845,9615.0,,Distribution in female dog bile 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624025,50588,,,,A,,12846,9615.0,,Distribution in female dog bile 72 hr after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624026,50588,,,,A,,12847,9615.0,,Distribution in female dog blood 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624027,50588,,,,A,,12848,9615.0,,Distribution in female dog blood 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624028,50588,,,,A,,12849,9615.0,,Distribution in female dog heart 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624029,50588,,,,A,,12850,9615.0,,Distribution in female dog heart 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624030,50588,,,,A,,12851,9615.0,,Distribution in female dog kidney 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624031,50588,,,,A,,12852,9615.0,,Distribution in female dog kidney 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624032,50588,,Intestine,,A,,12853,9615.0,160.0,Distribution in female dog large intestine 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL874407,50588,,Intestine,,A,,12854,9615.0,160.0,Distribution in female dog large intestine 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624033,50588,,,,A,,12855,9615.0,,Distribution in female dog liver 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624034,50588,,,,A,,12856,9615.0,,Distribution in female dog liver 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624035,50588,,,,A,,12857,9615.0,,Distribution in female dog lung 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624036,50588,,,,A,,12858,9615.0,,Distribution in female dog lung 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624037,50588,,Muscle tissue,,A,,12859,9615.0,2385.0,Distribution in female dog muscle 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624038,50588,,Muscle tissue,,A,,12860,9615.0,2385.0,Distribution in female dog muscle 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624039,50588,,,,A,,12861,9615.0,,Distribution in female dog pancreas 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624040,50588,,,,A,,12862,9615.0,,Distribution in female dog pancreas 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624041,50588,,Intestine,,A,,12863,9615.0,160.0,Distribution in female dog small intestine 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624042,50588,,Intestine,,A,,12864,9615.0,160.0,Distribution in female dog small intestine 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624043,50588,,Spleen,,A,,12865,9615.0,2106.0,Distribution in female dog spleen 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624044,50588,,Spleen,,A,,12866,9615.0,2106.0,Distribution in female dog spleen 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624045,50588,,Stomach,,A,,12867,9615.0,945.0,Distribution in female dog stomach 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624046,50588,,Stomach,,A,,12868,9615.0,945.0,Distribution in female dog stomach 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624047,50588,,Thyroid gland,,A,,12869,9615.0,2046.0,Distribution in female dog thyroid 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624048,50588,,Thyroid gland,,A,,12870,9615.0,2046.0,Distribution in female dog thyroid 72 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL874408,50588,,Urine,,A,,12871,9615.0,1088.0,Distribution in female dog urine 24 hours after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624049,50588,,Urine,,A,,12872,9615.0,1088.0,Distribution in female dog urine 72 hr after administration.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8170,,
CHEMBL624050,22224,,Plasma,,A,,12873,,1969.0,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,14283,,
CHEMBL624051,22224,,,,A,,12874,,,Plasma concentration at 7 hr after intravenous dosing,U,,0,,Autocuration,1,BAO_0000019,,,5623,,
CHEMBL623278,50597,,,,A,,12875,10116.0,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623279,50597,,,,A,,12876,10116.0,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623280,50597,,,,A,,12877,10116.0,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623963,50597,,,,A,,12878,10116.0,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623964,50597,,,,A,,12879,10116.0,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623965,50597,,,,A,,12880,10116.0,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623966,50597,,,,A,,12881,10116.0,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL874415,50597,,,,A,,12882,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623967,50597,,,,A,,12883,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623968,50597,,,,A,,12884,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL623969,50597,,,,A,,12885,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL628409,50597,,,,A,,12886,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL628410,50597,,,,A,,12887,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL628411,50597,,,,A,,12888,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL628412,50597,,,,A,,12889,10116.0,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL628413,22224,,,,A,,12890,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,U,,0,,Autocuration,1,BAO_0000019,,,12553,,
CHEMBL628414,22224,,Plasma,,A,,12891,,1969.0,The concentration in plasmat; Not determined,U,,0,,Autocuration,1,BAO_0000019,,,14548,,
CHEMBL628415,50597,,,,A,,12892,10116.0,,Tissue level at 10 mg/kg/po in wistar rats in blood,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL628416,50597,,,,A,,12893,10116.0,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL628417,50597,,,,A,,12894,10116.0,,Tissue level at 10 mg/kg/po in wistar rats in heart,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL874908,50597,,Liver,,A,,12895,10116.0,2107.0,Tissue level at 10 mg/kg/po in wistar rats in liver,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL628418,50597,,,,A,,12896,10116.0,,Tissue level at 10 mg/kg/po in wistar rats in plasma,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL628419,50597,,Muscle tissue,,A,,12897,10116.0,2385.0,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL628420,50597,,,,A,,12898,10116.0,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL628421,22224,,,,A,,12899,,,Water solubility at 37 degree C.,U,,0,,Autocuration,1,BAO_0000019,,,1629,,
CHEMBL626726,22229,,,,P,,12900,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626727,22229,,,,P,,12901,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626728,50597,,Blood,,A,,12902,10116.0,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626729,50597,,Blood,,A,,12903,10116.0,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626730,50597,,Blood,,A,,12904,10116.0,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626731,50597,,Blood,,A,,12905,10116.0,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626732,50597,,Blood,,A,,12906,10116.0,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626733,50597,,Heart,,A,,12907,10116.0,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626734,50597,,Heart,,A,,12908,10116.0,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626735,50597,,Heart,,A,,12909,10116.0,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL874909,50597,,Heart,,A,,12910,10116.0,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626736,50597,,Heart,,A,,12911,10116.0,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL626737,50597,,Kidney,,A,,12912,10116.0,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630999,50597,,Kidney,,A,,12913,10116.0,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631000,50597,,Kidney,,A,,12914,10116.0,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631001,50597,,Kidney,,A,,12915,10116.0,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631002,50597,,Kidney,,A,,12916,10116.0,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631003,50597,,Liver,,A,,12917,10116.0,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631004,50597,,Liver,,A,,12918,10116.0,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631005,50597,,Liver,,A,,12919,10116.0,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631006,50597,,Liver,,A,,12920,10116.0,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631007,50597,,Liver,,A,,12921,10116.0,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631008,50597,,Lung,,A,,12922,10116.0,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631009,50597,,Lung,,A,,12923,10116.0,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631010,50597,,Lung,,A,,12924,10116.0,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631011,50597,,Lung,,A,,12925,10116.0,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL631012,50597,,Lung,,A,,12926,10116.0,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630271,50597,,Thyroid gland,,A,,12927,10116.0,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630272,50597,,Thyroid gland,,A,,12928,10116.0,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630273,50597,,Thyroid gland,,A,,12929,10116.0,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630274,50597,,Thyroid gland,,A,,12930,10116.0,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630275,50597,,Thyroid gland,,A,,12931,10116.0,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL875782,50597,,,,A,,12932,10116.0,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630276,50597,,,,A,,12933,10116.0,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630277,50597,,,,A,,12934,10116.0,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630278,50597,,,,A,,12935,10116.0,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630279,50597,,,,A,,12936,10116.0,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8594,,
CHEMBL630280,22224,,,,A,,12937,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL630281,22224,,,,A,,12938,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL630282,50592,,,,A,,12939,9986.0,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630283,50592,,,,A,,12940,9986.0,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630284,22224,,,,A,,12941,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),U,,0,,Autocuration,1,BAO_0000019,,,5797,,
CHEMBL630285,22224,,,,A,,12942,,,Alkylating activity was determined,U,,0,,Autocuration,1,BAO_0000019,,,7849,,
CHEMBL630286,22224,,,,A,,12943,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),U,Microsomes,0,,Autocuration,1,BAO_0000251,,,14220,,
CHEMBL630069,50592,,,,A,,12944,9986.0,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,8650,,
CHEMBL630070,50592,,,,A,,12945,9986.0,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,8650,,
CHEMBL630071,50592,,,,A,,12946,9986.0,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,8650,,
CHEMBL630072,50592,,,,A,,12947,9986.0,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,8650,,
CHEMBL875110,50592,,,,A,,12948,9986.0,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,8650,,
CHEMBL630073,50597,,,,A,,12949,10116.0,,Compound was tested for antidiuretic activity in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7116,,
CHEMBL630074,22224,,,,A,,12950,,,Compound was tested for inactivation kinetic values,U,,0,,Autocuration,1,BAO_0000019,,,14131,,
CHEMBL630075,22224,,,In vivo,A,,12951,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,U,,0,,Autocuration,1,BAO_0000218,,,7415,,
CHEMBL630076,22224,,,,A,,12952,,,Dissociation rate calculated from the first-order equation using the t1/2 value,U,,0,,Autocuration,1,BAO_0000019,,,13178,,
CHEMBL630077,22229,,,,P,,12953,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,U,,0,,Autocuration,1,BAO_0000100,,,8815,,
CHEMBL630078,22229,,,,P,,12954,,,Aqueous solubility was measured,U,,0,,Autocuration,1,BAO_0000100,,,1450,,
CHEMBL630079,22229,,,,P,,12955,,,Aqueous solubility was measured at a pH 4,U,,0,,Autocuration,1,BAO_0000100,,,1450,,
CHEMBL630080,22229,,,,P,,12956,,,Aqueous solubility (pH 7),U,,0,,Autocuration,1,BAO_0000100,,,1450,,
CHEMBL630081,22229,,,,P,,12957,,,Aqueous solubility was measured at a pH 9,U,,0,,Autocuration,1,BAO_0000100,,,1450,,
CHEMBL630082,22224,,,,A,,12958,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",U,,0,,Autocuration,1,BAO_0000019,,,12711,,
CHEMBL630083,22224,,,,A,,12959,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,0,,Autocuration,1,BAO_0000019,,,12711,,
CHEMBL630084,22224,,,,A,,12960,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,0,,Autocuration,1,BAO_0000019,,,12711,,
CHEMBL629198,22229,,,,P,,12961,,,Aqueous solubility of the compound,U,,0,,Autocuration,1,BAO_0000100,,,15032,,
CHEMBL629199,22229,,,,P,,12962,,,Aqueous solubility at 37 degree Celsius at pH 7.38,U,,0,,Autocuration,1,BAO_0000100,,,9964,,
CHEMBL629200,22229,,,,P,,12963,,,Aqueous solubility in pH 7.4 phosphate buffer,U,,0,,Autocuration,1,BAO_0000100,,,14962,,
CHEMBL629201,50588,,,,A,,12964,9615.0,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12487,,
CHEMBL629202,50588,,,,A,,12965,9615.0,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12487,,
CHEMBL875111,50587,,,,A,,12966,9606.0,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10026,,
CHEMBL629203,50587,,,,A,,12967,9606.0,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10026,,
CHEMBL629204,50587,,,,A,,12968,9606.0,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10026,,
CHEMBL629205,50587,,,,A,,12969,9606.0,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10026,,
CHEMBL629206,50587,,,,A,,12970,9606.0,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10026,,
CHEMBL631185,22224,,,,A,,12971,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,U,,0,,Autocuration,1,BAO_0000019,,,10026,,
CHEMBL631186,50597,,,,A,,12972,10116.0,,Compound was evaluated for the average bile flow rat in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL631187,50592,,,,A,,12973,9986.0,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL631188,50592,,,,A,,12974,9986.0,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,17025,,
CHEMBL876419,22224,,,,A,,12975,,,Average half life period was determined,U,,0,,Autocuration,1,BAO_0000019,,,10184,,
CHEMBL631189,22224,,,,A,,12976,,,Average half life period was determined,U,,0,,Autocuration,1,BAO_0000019,,,10184,,
CHEMBL631190,50602,,,,A,,12977,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL631191,50602,,,,A,,12978,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL631192,50602,,,,A,,12979,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL632400,50602,,,,A,,12980,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL630564,50602,,,,A,,12981,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL630565,50602,,,,A,,12982,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL630566,50602,,,,A,,12983,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL631229,50602,,,,A,,12984,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL631230,50602,,,,A,,12985,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL876428,22229,,,,P,,12986,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6030,,
CHEMBL631231,22229,,,,P,,12987,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6147,,
CHEMBL631232,22229,,,,P,,12988,,,Calculated partition coefficient (clogP) (MacLogP),U,,0,,Autocuration,1,BAO_0000100,,,14556,,
CHEMBL631233,22224,,,,A,,12989,,,Hydrophilicity was determined,U,,0,,Autocuration,1,BAO_0000019,,,768,,
CHEMBL631234,22229,,,,P,,12990,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,14452,,
CHEMBL883126,22224,,,,A,,12991,,,Increased absorption was determined,U,,0,,Autocuration,1,BAO_0000019,,,5237,,
CHEMBL631235,22224,,,,P,,12992,,,Lipophilicity value was evaluated,U,,0,,Autocuration,1,BAO_0000100,,,14378,,
CHEMBL631236,22224,,,,P,,12993,,,Log P value of the compound.,U,,0,,Autocuration,1,BAO_0000100,,,14418,,
CHEMBL631237,22224,,,,A,,12994,,,Partition coefficient of compound was determined,U,,0,,Autocuration,1,BAO_0000019,,,5249,,
CHEMBL631238,22229,,,,P,,12995,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,14621,,
CHEMBL876429,22229,,,,P,,12996,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12542,,
CHEMBL631414,22224,,,,A,,12997,,,Partition coefficient was measured by medchem software; Not calculated,U,,0,,Autocuration,1,BAO_0000019,,,12542,,
CHEMBL631415,22224,,,,P,,12998,,,Partition coefficient was measured by octanol-water using standard shake-flask method,U,,0,,Autocuration,1,BAO_0000100,,,12542,,
CHEMBL631416,22229,,,,P,,12999,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,15462,,
CHEMBL631417,22224,,,,A,,13000,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,14884,,
CHEMBL631418,22229,,,,P,,13001,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,16526,,
CHEMBL631419,22229,,,,P,,13002,,,The Octanol/Water partition coefficient CLogP,U,,0,,Autocuration,1,BAO_0000100,,,13693,,
CHEMBL631420,22224,,,,A,,13003,,,The pharmacokinetic parameter C Log p was reported,U,,0,,Autocuration,1,BAO_0000019,,,13693,,
CHEMBL631421,22229,,,,P,,13004,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13779,,
CHEMBL631422,22229,,,,P,,13005,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,14772,,
CHEMBL631423,22229,,,,P,,13006,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,14393,,
CHEMBL876430,50597,,Plasma,In vivo,A,,13007,10116.0,1969.0,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL631424,50597,,Plasma,In vivo,A,,13008,10116.0,1969.0,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL631425,50588,,Plasma,In vivo,A,,13009,9615.0,1969.0,Compound was administered intravenously in dog to evaluate plasma clearance values,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13744,,
CHEMBL631426,22224,,Plasma,In vivo,A,,13010,314293.0,1969.0,Compound was administered intravenously in monkey to evaluate plasma clearance values,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,13744,,
CHEMBL631427,50594,,Plasma,In vivo,A,,13011,10090.0,1969.0,Compound was administered intravenously in mouse to evaluate plasma clearance values,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13744,,
CHEMBL631428,50588,,Plasma,In vivo,A,,13012,9615.0,1969.0,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13207,,
CHEMBL631429,50797,,Liver,In vitro,A,,13013,9544.0,2107.0,Intrinsic clearance in Rhesus liver microsome,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,5669,,
CHEMBL631430,50588,,Liver,In vitro,A,,13014,9615.0,2107.0,Intrinsic clearance in dog liver microsome,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,5669,,
CHEMBL631431,50597,,Liver,In vitro,A,,13015,10116.0,2107.0,Intrinsic clearance in rat liver microsome,N,Microsomes,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL631432,50797,,Plasma,In vivo,A,,13016,9544.0,1969.0,Low plasma clearance was calculated in rhesus monkey,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,4853,,
CHEMBL631433,50588,,,In vivo,A,,13017,9615.0,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,16452,,
CHEMBL631434,22224,,,In vivo,A,,13018,,,Plasma clearance after intravenous dose of 0.3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL631435,22224,,,In vivo,A,,13019,,,Plasma clearance after intravenous dose of 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL631436,22224,,,In vivo,A,,13020,,,Plasma clearance after intravenous dose of 3 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL631437,22224,,,In vivo,A,,13021,,,Plasma clearance after intravenous dose of 3.87 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,11954,,
CHEMBL631438,50597,,,In vivo,A,,13022,10116.0,,Plasma clearance after peroral administration at 10 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL876431,50797,,,In vivo,A,,13023,9544.0,,Plasma clearance after peroral administration at 10 mpk in Rhesus,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,5669,,
CHEMBL631439,50588,,,In vivo,A,,13024,9615.0,,Plasma clearance after peroral administration at 10 mpk in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,5669,,
CHEMBL631440,50597,,,In vivo,A,,13025,10116.0,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13662,,
CHEMBL631441,22224,,,,A,,13026,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),U,,0,,Autocuration,1,BAO_0000019,,,8272,,
CHEMBL631442,22224,,,,A,,13027,,,Critical Micellar concentration was determined,U,,0,,Autocuration,1,BAO_0000019,,,13410,,
CHEMBL626525,22224,,,,A,,13028,,,Critical Micellar concentration of the compound. was determined,U,,0,,Autocuration,1,BAO_0000019,,,13410,,
CHEMBL627168,22224,,,,A,,13029,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,U,,0,,Autocuration,1,BAO_0000019,,,12628,,
CHEMBL875618,22224,,,,A,,13030,,,Critical micellar concentration was measured in water by the dye solubilization method,U,,0,,Autocuration,1,BAO_0000019,,,9675,,
CHEMBL626612,22224,,,,B,,13031,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,U,,0,,Autocuration,1,BAO_0000019,,,12628,,
CHEMBL626613,22224,,,,A,,13032,,,CMR value (relative to BAY K 8644),U,,0,,Autocuration,1,BAO_0000019,,,12766,,
CHEMBL626614,22224,,,,A,,13033,,,Carbamoylating activity was determined,U,,0,,Autocuration,1,BAO_0000019,,,7849,,
CHEMBL626615,22224,,,,A,,13034,314293.0,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL626616,22224,,,,A,,13035,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,U,,0,,Autocuration,1,BAO_0000019,,,2040,,
CHEMBL626617,22224,,,,A,,13036,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,U,,0,,Autocuration,1,BAO_0000019,,,2040,,
CHEMBL626618,50588,,Plasma,In vivo,A,,13037,9615.0,1969.0,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14180,,
CHEMBL626619,50597,,Plasma,In vivo,A,,13038,10116.0,1969.0,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14180,,
CHEMBL626620,50588,,,In vivo,A,,13039,9615.0,,"Clearance rate at 0.46 mg/kg, iv, in dogs",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14474,,
CHEMBL626621,50597,,,In vivo,A,,13040,10116.0,,"Clearance rate at 5.5 mg/kg, iv, in rat",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14474,,
CHEMBL626622,100710,,,In vivo,A,,13041,9541.0,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14548,,
CHEMBL626623,100710,,,In vivo,A,,13042,9541.0,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14548,,
CHEMBL626624,50588,,,In vivo,A,,13043,9615.0,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,14548,,
CHEMBL626625,50597,,,In vivo,A,,13044,10116.0,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14548,,
CHEMBL626626,50597,,Liver,Ex vivo,A,,13045,10116.0,2107.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6125,,
CHEMBL626627,22224,,,In vivo,A,,13046,,,Tested for the total clearance of the compound,U,,0,,Autocuration,1,BAO_0000218,,,6874,,
CHEMBL626628,50588,,,In vivo,A,,13047,9615.0,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15343,,
CHEMBL626629,22224,,,In vivo,A,,13048,,,Total body clearance was determined,U,,0,,Autocuration,1,BAO_0000218,,,6236,,
CHEMBL626630,50597,,,,A,,13049,10116.0,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626631,50597,,,,A,,13050,10116.0,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626632,22229,,,,P,,13051,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626633,22229,,,,P,,13052,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626634,22229,,,,P,,13053,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626635,22229,,,,P,,13054,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626636,22229,,,,P,,13055,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626637,22229,,,,P,,13056,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,0,,Autocuration,1,BAO_0000100,,,8194,,
CHEMBL626638,50339,,,,A,,13057,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL626639,50339,,,,A,,13058,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL626640,50339,,,,A,,13059,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL626641,50339,,,,A,,13060,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL627272,50339,,,,A,,13061,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL627273,50339,,,,A,,13062,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL627441,50339,,,,A,,13063,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL628355,50339,,,,A,,13064,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL628356,50339,,,,A,,13065,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL628357,50339,,,,A,,13066,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL628358,50339,,,,A,,13067,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL622307,50339,,,,A,,13068,4754.0,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),N,,1,,Intermediate,1,BAO_0000218,,Pneumocystis carinii,13273,,
CHEMBL622527,22224,,,,A,,13069,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622528,22224,,,,A,,13070,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622529,22224,,,,A,,13071,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622992,22224,,,,A,,13072,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622993,22224,,,,A,,13073,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622994,22224,,,,A,,13074,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,U,,0,,Autocuration,1,BAO_0000019,,,13118,,
CHEMBL622995,50597,,,,A,,13075,10116.0,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10633,,
CHEMBL622996,50597,,,,A,,13076,10116.0,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10633,,
CHEMBL622997,50597,,,,A,,13077,10116.0,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10633,,
CHEMBL622998,50597,,,,A,,13078,10116.0,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10633,,
CHEMBL622999,22224,,,,A,,13079,,,Cp max following ip administration at 1 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,5767,,
CHEMBL623000,22224,,Plasma,In vivo,A,,13080,,1969.0,Maximum concentration in plasma was reported at 0.5 hour,U,,0,,Autocuration,1,BAO_0000218,,,3302,,
CHEMBL623001,22224,,Plasma,In vivo,A,,13081,,1969.0,Maximum concentration in plasma was reported at 2 hour,U,,0,,Autocuration,1,BAO_0000218,,,3302,,
CHEMBL623002,50594,,,,A,,13082,10090.0,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12467,,
CHEMBL623003,22229,,,,P,,13083,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),U,,0,,Autocuration,1,BAO_0000100,,,11778,,
CHEMBL623004,22224,,,,A,,13084,,,Steady state concentration was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,4321,,
CHEMBL623005,22224,,,,A,,13085,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,14884,,
CHEMBL623006,22224,,,,A,,13086,,,Partition coefficient (logD7.4),U,,0,,Autocuration,1,BAO_0000019,,,15234,,
CHEMBL623007,50597,,Liver,In vivo,A,,13087,10116.0,2107.0,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623008,50597,,Bone,In vivo,A,,13088,10116.0,10000001.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL876654,50597,,Cerebellum,In vivo,A,,13089,10116.0,2037.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623009,50597,,,In vivo,A,,13090,10116.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623010,50597,,,In vivo,A,,13091,10116.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623011,50597,,Heart,In vivo,A,,13092,10116.0,948.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623012,50597,,Intestine,In vivo,A,,13093,10116.0,160.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623013,22224,,,,A,,13094,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL623014,22224,,,,A,,13095,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL623015,22224,,Urine,,A,,13096,,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL623016,22224,,Urine,,A,,13097,,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL624858,22224,,Urine,,A,,13098,,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,U,,0,,Autocuration,1,BAO_0000019,,,8151,,
CHEMBL624859,50597,,,,A,,13099,10116.0,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL624860,50597,,,,A,,13100,10116.0,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL624861,50597,,,,A,,13101,10116.0,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL624862,50597,,,,A,,13102,10116.0,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL624863,50597,,,,A,,13103,10116.0,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL876655,50597,,,,A,,13104,10116.0,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8151,,
CHEMBL624864,50588,,,,A,,13105,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624865,50588,,,,A,,13106,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624866,50588,,,,A,,13107,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624867,50588,,,,F,,13108,9615.0,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,N,,1,,Expert,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL624868,50588,,,,A,,13109,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628450,50588,,,,A,,13110,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628451,50588,,,,A,,13111,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628452,50588,,,,A,,13112,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628453,50588,,,,A,,13113,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628454,50588,,,,A,,13114,9615.0,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628455,50588,,,,A,,13115,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628456,50588,,,,A,,13116,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628457,50588,,,,A,,13117,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL877505,50588,,,,A,,13118,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628458,50588,,,,A,,13119,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628459,50588,,,,A,,13120,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628460,50588,,,,A,,13121,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628461,50588,,,,A,,13122,9615.0,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL628462,22224,,,,B,,13123,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",U,,0,,Autocuration,1,BAO_0000218,,,6996,,
CHEMBL628463,50588,,,,A,,13124,9615.0,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL625666,50597,,,,F,,13125,10116.0,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625667,22224,,,,B,,13126,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,U,,0,,Autocuration,1,BAO_0000218,,,6996,,
CHEMBL625668,50597,,,,A,,13127,10116.0,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,1,,Expert,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625669,50597,,,,A,,13128,10116.0,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL625670,22224,,,,A,,13129,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,U,,0,,Autocuration,1,BAO_0000019,,,7114,,
CHEMBL625671,50597,,,,A,,13130,10116.0,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7114,,
CHEMBL625672,50602,,,,A,,13131,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL625673,50602,,,,A,,13132,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL625674,50602,,,,A,,13133,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL625675,50602,,,,A,,13134,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627637,50602,,,,A,,13135,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627638,50602,,,,A,,13136,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627639,50602,,,,A,,13137,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627640,50602,,,,A,,13138,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627641,50602,,,,A,,13139,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627642,50602,,,,A,,13140,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL877506,50602,,,,A,,13141,10298.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL627275,50594,,,,A,,13142,10090.0,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8613,,
CHEMBL627643,50506,,,,A,,13143,9669.0,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL631246,50506,,,,A,,13144,9669.0,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL631247,50506,,,,A,,13145,9669.0,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL629532,50506,,,,A,,13146,9669.0,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL629533,50506,,,,A,,13147,9669.0,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL629534,50506,,,,A,,13148,9669.0,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL629535,50506,,,,A,,13149,9669.0,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,N,,1,,Intermediate,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL625932,22224,,,,A,,13150,,,Pharmacokinetic parameter :drug bound to plasma was reported,U,,0,,Autocuration,1,BAO_0000019,,,14837,,
CHEMBL625933,22224,,,,A,,13151,,,compound was evaluated for drug bound in plasma,U,,0,,Autocuration,1,BAO_0000019,,,14837,,
CHEMBL625934,50597,,,,A,,13152,10116.0,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15343,,
CHEMBL625935,22224,,,,A,,13153,9347.0,,Bioavailability,U,,0,,Autocuration,1,BAO_0000218,,Eutheria,13761,,
CHEMBL625936,50597,,,,A,,13154,10116.0,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14810,,
CHEMBL625937,50597,,,,A,,13155,10116.0,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14810,,
CHEMBL625938,50588,,,,A,,13156,9615.0,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13249,,
CHEMBL625939,50597,,Bile,,A,,13157,10116.0,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9267,,
CHEMBL625940,50597,,Bile,,A,,13158,10116.0,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9267,,
CHEMBL874464,50597,,Bile,,A,,13159,10116.0,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9267,,
CHEMBL625941,50597,,Bile,,A,,13160,10116.0,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9267,,
CHEMBL625942,50597,,Bile,,A,,13161,10116.0,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9267,,
CHEMBL625943,50597,,Bile,,A,,13162,10116.0,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9267,,
CHEMBL625944,50587,,Serum,,A,,13163,9606.0,1977.0,In vitro protein binding in human serum at 5 ug/ml,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,15549,,
CHEMBL625945,22224,,,,A,,13164,,,Serum protein binding ability was measured,U,,0,,Autocuration,1,BAO_0000019,,,10929,,
CHEMBL625946,22224,,,,A,,13165,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),U,,0,,Autocuration,1,BAO_0000019,,,15444,,
CHEMBL625947,22224,,,In vivo,A,,13166,9615.0,,Oral bioavailability in dog,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,12860,,
CHEMBL625948,50597,,,In vivo,A,,13167,10116.0,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12170,,
CHEMBL625949,22224,,,In vivo,A,,13168,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL625950,22224,,,In vivo,A,,13169,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL625951,22224,,,In vivo,A,,13170,9347.0,,Oral bioavailability (dose 15 mg/kg i.v.),U,,0,,Autocuration,1,BAO_0000218,,Eutheria,15173,,
CHEMBL625952,22224,,,In vivo,A,,13171,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL625953,22224,,,In vivo,A,,13172,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL625954,22224,,,In vivo,A,,13173,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL882959,22224,,,In vivo,A,,13174,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL625955,50588,,,In vivo,A,,13175,9615.0,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,11767,,
CHEMBL625956,22224,,,In vivo,A,,13176,9669.0,,Bioavailability in ferret,U,,0,,Autocuration,1,BAO_0000218,,Mustela putorius furo,11219,,
CHEMBL625957,100710,,,In vivo,A,,13177,9541.0,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,12186,,
CHEMBL625958,50597,,,,A,,13178,10116.0,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL625959,50597,,,,A,,13179,10116.0,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626642,50597,,,,A,,13180,10116.0,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL631330,50597,,,,A,,13181,10116.0,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL631331,50597,,,,A,,13182,10116.0,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL631332,50597,,,,A,,13183,10116.0,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL631333,50597,,,,A,,13184,10116.0,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632018,50597,,,,A,,13185,10116.0,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632019,50597,,,,A,,13186,10116.0,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632020,50597,,,,A,,13187,10116.0,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632021,50597,,,,A,,13188,10116.0,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632022,50597,,,,A,,13189,10116.0,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632023,50597,,,,A,,13190,10116.0,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632024,50597,,,,A,,13191,10116.0,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL874472,50597,,,,A,,13192,10116.0,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632025,50597,,,,A,,13193,10116.0,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632026,50597,,,,A,,13194,10116.0,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632027,50597,,,,A,,13195,10116.0,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL632028,50597,,,,A,,13196,10116.0,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626430,50597,,,,A,,13197,10116.0,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626431,50597,,,,A,,13198,10116.0,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626432,50597,,,,A,,13199,10116.0,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626433,50597,,,,A,,13200,10116.0,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626434,50597,,,,A,,13201,10116.0,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627280,50597,,,,A,,13202,10116.0,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627281,50597,,,,A,,13203,10116.0,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627282,50597,,,,A,,13204,10116.0,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627283,22224,,,,A,,13205,,,Total body clearance was measured at given dose,U,,0,,Autocuration,1,BAO_0000019,,,7199,,
CHEMBL627284,22224,,,,A,,13206,,,Total body clearance was measured at given dose.,U,,0,,Autocuration,1,BAO_0000218,,,7199,,
CHEMBL627285,50597,,,,A,,13207,10116.0,,Metabolic clearance from the body in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7095,,
CHEMBL627286,22224,,,In vivo,A,,13208,,,Renal clearance from the body,U,,0,,Autocuration,1,BAO_0000218,,,7095,,
CHEMBL875477,50597,,,In vivo,A,,13209,10116.0,,Renal clearance from the body in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7095,,
CHEMBL627287,50597,,,In vivo,A,,13210,10116.0,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12528,,
CHEMBL627288,50588,,,In vivo,A,,13211,9615.0,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12528,,
CHEMBL627289,50597,,,,A,,13212,10116.0,,Total clearance from the body in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7095,,
CHEMBL627290,50597,,Plasma,In vivo,A,,13213,10116.0,1969.0,Clearance into cortex from rat plasma or PBS,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14223,,
CHEMBL627291,22224,,,In vivo,A,,13214,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,U,,0,,Autocuration,1,BAO_0000218,,,13569,,
CHEMBL627292,22224,,,In vivo,A,,13215,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,U,,0,,Autocuration,1,BAO_0000218,,,13569,,
CHEMBL627293,22224,,,In vivo,A,,13216,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,U,,0,,Autocuration,1,BAO_0000218,,,13569,,
CHEMBL627294,22224,,,In vivo,A,,13217,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,U,,0,,Autocuration,1,BAO_0000218,,,13569,,
CHEMBL875478,22224,,,In vivo,A,,13218,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,U,,0,,Autocuration,1,BAO_0000218,,,13569,,
CHEMBL627295,22224,,,In vivo,A,,13219,,,Clearance was determined,U,,0,,Autocuration,1,BAO_0000218,,,13979,,
CHEMBL627296,50594,,,In vivo,A,,13220,10090.0,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14315,,
CHEMBL626119,50592,,,In vivo,A,,13221,9986.0,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,14315,,
CHEMBL626120,50597,,,In vivo,A,,13222,10116.0,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14315,,
CHEMBL626121,50597,,,In vivo,A,,13223,10116.0,,Clearance in rat after iv dose (100 ug/kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12174,,
CHEMBL626122,22224,,,In vivo,A,,13224,10141.0,,Clearance in guinea pig,U,,0,,Autocuration,1,BAO_0000218,,Cavia porcellus,12797,,
CHEMBL626123,50597,,,In vivo,A,,13225,10116.0,,Compound was evaluated for clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12797,,
CHEMBL623456,50588,,,In vivo,A,,13226,9615.0,,Compound was evaluated for the clearance in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12797,,
CHEMBL623457,50597,,,In vivo,A,,13227,10116.0,,Compound was evaluated for the clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12797,,
CHEMBL623458,50597,,,In vivo,A,,13228,10116.0,,Compound was tested in vivo for clearance after iv administration in the rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11500,,
CHEMBL623459,22224,,,In vivo,A,,13229,,,IV clearance determined at an iv dose of 14 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL875484,22224,,,In vivo,A,,13230,,,IV clearance determined at an iv dose of 15.2 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL623460,22224,,,In vivo,A,,13231,,,IV clearance determined at an iv dose of 15 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL623461,22224,,,In vivo,A,,13232,,,IV clearance determined at an peroral dose of 30 mg/kg.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL623462,22224,,,In vivo,A,,13233,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL627386,22224,,,In vivo,A,,13234,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL627387,50597,,Kidney,In vivo,A,,13235,10116.0,2113.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627388,50597,,Liver,In vivo,A,,13236,10116.0,2107.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627389,50597,,Lung,In vivo,A,,13237,10116.0,2048.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627390,50597,,Muscle tissue,In vivo,A,,13238,10116.0,2385.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627391,50597,,Plasma,In vivo,A,,13239,10116.0,1969.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627392,50597,,,In vivo,A,,13240,10116.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627393,50597,,Spleen,In vivo,A,,13241,10116.0,2106.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627394,50597,,Trachea,In vivo,A,,13242,10116.0,3126.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627395,50597,,Bone,In vivo,A,,13243,10116.0,10000001.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL875485,50597,,Cerebellum,In vivo,A,,13244,10116.0,2037.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627396,50597,,,In vivo,A,,13245,10116.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627397,50597,,,In vivo,A,,13246,10116.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627398,50597,,Heart,In vivo,A,,13247,10116.0,948.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627399,50597,,Bone,In vivo,A,,13248,10116.0,10000001.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627400,50597,,Kidney,In vivo,A,,13249,10116.0,2113.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627401,50597,,Liver,In vivo,A,,13250,10116.0,2107.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627402,50597,,Lung,In vivo,A,,13251,10116.0,2048.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627403,50597,,Muscle tissue,In vivo,A,,13252,10116.0,2385.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL627404,50597,,Plasma,In vivo,A,,13253,10116.0,1969.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623101,50597,,,In vivo,A,,13254,10116.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL877480,50597,,Spleen,In vivo,A,,13255,10116.0,2106.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623102,50597,,Trachea,In vivo,A,,13256,10116.0,3126.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623103,50597,,Bone,In vivo,A,,13257,10116.0,10000001.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623104,50597,,Cerebellum,In vivo,A,,13258,10116.0,2037.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623105,50597,,,In vivo,A,,13259,10116.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623106,50597,,,In vivo,A,,13260,10116.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623107,50597,,Heart,In vivo,A,,13261,10116.0,948.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623108,50597,,Intestine,In vivo,A,,13262,10116.0,160.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623109,50597,,Kidney,In vivo,A,,13263,10116.0,2113.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623110,50597,,Liver,In vivo,A,,13264,10116.0,2107.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL623111,50597,,Lung,In vivo,A,,13265,10116.0,2048.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625060,50597,,Muscle tissue,In vivo,A,,13266,10116.0,2385.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625061,50597,,Plasma,In vivo,A,,13267,10116.0,1969.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625062,50597,,,In vivo,A,,13268,10116.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625063,50597,,Spleen,In vivo,A,,13269,10116.0,2106.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625064,50597,,Trachea,In vivo,A,,13270,10116.0,3126.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625065,50597,,Bone,In vivo,A,,13271,10116.0,10000001.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625066,50597,,Cerebellum,In vivo,A,,13272,10116.0,2037.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625067,50597,,,In vivo,A,,13273,10116.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL625068,50597,,,In vivo,A,,13274,10116.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622159,50597,,Heart,In vivo,A,,13275,10116.0,948.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622160,50597,,Intestine,In vivo,A,,13276,10116.0,160.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622161,50597,,Kidney,In vivo,A,,13277,10116.0,2113.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622162,50597,,Lung,In vivo,A,,13278,10116.0,2048.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622163,50597,,Muscle tissue,In vivo,A,,13279,10116.0,2385.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622313,50597,,Plasma,In vivo,A,,13280,10116.0,1969.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622314,50597,,,In vivo,A,,13281,10116.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622315,50597,,Spleen,In vivo,A,,13282,10116.0,2106.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL622316,50597,,Trachea,In vivo,A,,13283,10116.0,3126.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14198,,
CHEMBL877486,50212,,,,A,,13284,562.0,,Normal diffusion coefficient in water for Escherichia coli,N,,1,,Intermediate,1,BAO_0000218,,Escherichia coli,15599,,
CHEMBL622317,22224,,,,A,,13285,,,Average max percent decrease in RVR (renal vascular resistance) was determined,U,,0,,Autocuration,1,BAO_0000019,,,8204,,
CHEMBL622318,22224,,,,A,,13286,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,U,,0,,Autocuration,1,BAO_0000019,,,8204,,
CHEMBL622319,22224,,,,A,,13287,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL622320,22224,,,,A,,13288,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL622321,22224,,,,A,,13289,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL622322,22224,,,,A,,13290,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL622323,22224,,,,A,,13291,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,U,,0,,Autocuration,1,BAO_0000019,,,7114,,
CHEMBL622324,50597,,,,A,,13292,10116.0,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7114,,
CHEMBL622325,50588,,Urine,,A,,13293,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622326,50588,,Urine,,A,,13294,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL877487,50588,,Urine,,A,,13295,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622327,50588,,Urine,,A,,13296,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622328,50588,,Urine,,A,,13297,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622329,50588,,Urine,,A,,13298,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622330,50588,,Urine,,A,,13299,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622331,50588,,Urine,,A,,13300,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622332,50588,,Urine,,A,,13301,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL622333,50588,,Urine,,A,,13302,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL627658,22224,,Urine,,A,,13303,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL630428,22224,,Urine,,A,,13304,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL630429,22224,,Urine,,A,,13305,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL630430,22224,,Urine,,A,,13306,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL630431,22224,,Urine,,A,,13307,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL630432,50597,,Urine,,A,,13308,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL630433,50597,,Urine,,A,,13309,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL630434,50597,,Urine,,A,,13310,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629372,50597,,Urine,,A,,13311,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629553,50597,,Urine,,A,,13312,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629554,50597,,Urine,,A,,13313,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL874447,50597,,Urine,,A,,13314,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629555,50597,,Urine,,A,,13315,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629556,50597,,Urine,,A,,13316,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629557,50597,,Urine,,A,,13317,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629558,50597,,Urine,,A,,13318,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629559,50597,,Urine,,A,,13319,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629560,50597,,Urine,,A,,13320,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629561,50588,,Urine,,A,,13321,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629562,50588,,Urine,,A,,13322,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629563,50588,,Urine,,A,,13323,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629564,50588,,Urine,,A,,13324,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629565,50588,,Urine,,A,,13325,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629566,50588,,Urine,,A,,13326,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629567,50588,,Urine,,A,,13327,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629568,50588,,Urine,,A,,13328,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629569,50588,,Urine,,A,,13329,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629570,50588,,Urine,,A,,13330,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL629571,22224,,Urine,,A,,13331,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL629572,22224,,,In vivo,A,,13332,10116.0,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12170,,
CHEMBL629573,22224,,,In vivo,A,,13333,10116.0,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12170,,
CHEMBL629574,22224,,,In vivo,A,,13334,9347.0,,Bioavailability (dose 20 mg/kg),U,,0,,Autocuration,1,BAO_0000218,,Eutheria,4985,,
CHEMBL629575,22224,,,In vivo,A,,13335,9615.0,,Bioavailability in dog,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,15145,,
CHEMBL874448,22224,,,In vivo,A,,13336,10116.0,,Bioavailability in rat (Sprague-Dawley) (male),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,14080,,
CHEMBL629576,22224,,,In vivo,A,,13337,9443.0,,Bioavailability in monkey (dose 10 mg/kg i.d.),U,,0,,Autocuration,1,BAO_0000218,,Primates,11219,,
CHEMBL629577,22224,,,In vivo,A,,13338,10116.0,,Bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,15145,,
CHEMBL629578,22224,,,In vivo,A,,13339,10116.0,,Bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,15145,,
CHEMBL629579,22224,,,In vivo,A,,13340,9615.0,,Bioavailability in dog (dose 3.0 mg/kg p.o.),U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,1202,,
CHEMBL882958,22224,,,In vivo,A,,13341,9615.0,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,1202,,
CHEMBL629580,50505,,,In vivo,A,,13342,9598.0,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,N,,1,,Intermediate,1,BAO_0000218,,Pan troglodytes,1202,,
CHEMBL629581,22224,,,In vivo,A,,13343,9347.0,,Bioavailability,U,,0,,Autocuration,1,BAO_0000218,,Eutheria,4026,,
CHEMBL629582,22224,,,In vivo,A,,13344,9520.0,,Bioavailability in squirrel monkey,U,,0,,Autocuration,1,BAO_0000218,,Saimiri,1492,,
CHEMBL628522,50588,,,In vivo,A,,13345,9615.0,,Bioavailability was evaluated in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12793,,
CHEMBL625432,100712,,,In vivo,A,,13346,10026.0,,Bioavailability was evaluated in hamster,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,12793,,
CHEMBL625433,22224,,,In vivo,A,,13347,10116.0,,Bioavailability in rat,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12793,,
CHEMBL625434,50597,,Plasma,In vivo,A,,13348,10116.0,1969.0,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL625435,50597,,Plasma,In vivo,A,,13349,10116.0,1969.0,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL625436,22224,,,In vivo,A,,13350,10116.0,,Bioavailability in rat (dose 10 mg/kg p.o.),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,14793,,
CHEMBL874588,100710,,,In vivo,A,,13351,9541.0,,Bioavailability was measured in cynomolgus monkeys.,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,14731,,
CHEMBL625437,50594,,,In vivo,A,,13352,10090.0,,Bioavailability was measured in nude mice.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14731,,
CHEMBL625438,22224,,,In vivo,A,,13353,9669.0,,Bioavailability in ferret (dose 10 mg/kg i.d.),U,,0,,Autocuration,1,BAO_0000218,,Mustela putorius furo,12187,,
CHEMBL625439,22224,,,In vivo,A,,13354,314293.0,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL625440,22224,,,In vivo,A,,13355,314293.0,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL625441,22224,,,In vivo,A,,13356,314293.0,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,12187,,
CHEMBL625442,22224,,,In vivo,A,,13357,10116.0,,Bioavailability in rat (dose 10 mg/kg i.d.),U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL625443,50597,,,In vivo,A,,13358,10116.0,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12187,,
CHEMBL625444,22224,,,In vivo,A,,13359,,,Bioavailability was determined; extremely poor,U,,0,,Autocuration,1,BAO_0000218,,,17431,,
CHEMBL625445,50594,,,In vivo,A,,13360,10090.0,,% bioavailability in mice after oral administration of prodrug,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13318,,
CHEMBL625446,50588,,,In vivo,A,,13361,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL882960,50588,,,In vivo,A,,13362,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625447,50588,,,In vivo,A,,13363,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625448,50588,,,In vivo,A,,13364,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625449,50588,,,In vivo,A,,13365,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL874589,50588,,,In vivo,A,,13366,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625450,50588,,,In vivo,A,,13367,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625451,50588,,,In vivo,A,,13368,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626584,50588,,,In vivo,A,,13369,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626585,50588,,,In vivo,A,,13370,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626586,50588,,,In vivo,A,,13371,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626587,50588,,,In vivo,A,,13372,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626588,50588,,,In vivo,A,,13373,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626589,50588,,,In vivo,A,,13374,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626590,50588,,,In vivo,A,,13375,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626591,50588,,,In vivo,A,,13376,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL627181,50588,,,In vivo,A,,13377,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628083,50588,,,In vivo,A,,13378,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628084,22224,,,In vivo,A,,13379,,,IV clearance determined at an peroral dose of 15 mg/kg.,U,,0,,Autocuration,1,BAO_0000218,,,15173,,
CHEMBL628085,50064,,,In vivo,F,,13380,102285.0,,Mouse oral clearance was measured against Hymenolepiasis nana.,N,,1,,Expert,1,BAO_0000218,,Hymenolepis nana,7732,,
CHEMBL628086,50545,,,In vivo,F,,13381,6339.0,,Mouse oral clearance was measured against Nematospiroides dubius,N,,1,,Expert,1,BAO_0000218,,Heligmosomoides polygyrus,7732,,
CHEMBL628087,22224,,,In vivo,F,,13382,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,U,,0,,Autocuration,1,BAO_0000218,,,7732,,
CHEMBL628088,50594,,,In vivo,A,,13383,10090.0,,Mouse oral clearance was measured against N. nana; NT is Not Tested,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,7732,,
CHEMBL628089,22224,,,In vivo,B,,13384,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,U,,0,,Autocuration,1,BAO_0000218,,,7732,,
CHEMBL628090,22224,,,In vivo,A,,13385,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL628091,22224,,,In vivo,A,,13386,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL628092,22224,,,In vivo,A,,13387,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL628093,22224,,,In vivo,A,,13388,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL875607,22224,,,In vivo,A,,13389,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL625710,22224,,,In vivo,A,,13390,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL625711,22224,,,In vivo,A,,13391,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL625712,22224,,,In vivo,A,,13392,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL625713,22224,,,In vivo,A,,13393,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,U,,0,,Autocuration,1,BAO_0000218,,,8328,,
CHEMBL625714,50588,,,In vivo,A,,13394,9615.0,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,13376,,
CHEMBL625715,50797,,,In vivo,A,,13395,9544.0,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,13477,,
CHEMBL625716,50597,,,In vivo,A,,13396,10116.0,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL625717,50597,,,In vivo,A,,13397,10116.0,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13477,,
CHEMBL625718,50597,,,In vivo,A,,13398,10116.0,,Plasma clearance was determined for the compound in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13313,,
CHEMBL625719,50597,,,In vivo,A,,13399,10116.0,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL625720,50597,,,In vivo,A,,13400,10116.0,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL625721,50597,,,In vivo,A,,13401,10116.0,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL625722,50597,,,In vivo,A,,13402,10116.0,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12504,,
CHEMBL625723,50597,,,In vivo,A,,13403,10116.0,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13129,,
CHEMBL625724,50545,,,In vivo,A,,13404,6339.0,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,N,,1,,Intermediate,1,BAO_0000218,,Heligmosomoides polygyrus,7732,,
CHEMBL625725,50545,,,In vivo,A,,13405,6339.0,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,N,,1,,Intermediate,1,BAO_0000218,,Heligmosomoides polygyrus,7732,,
CHEMBL625726,50545,,,In vivo,A,,13406,6339.0,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,N,,1,,Intermediate,1,BAO_0000218,,Heligmosomoides polygyrus,7732,,
CHEMBL875608,50545,,,In vivo,A,,13407,6339.0,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,N,,1,,Intermediate,1,BAO_0000218,,Heligmosomoides polygyrus,7732,,
CHEMBL625727,50545,,,In vivo,A,,13408,6339.0,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,N,,1,,Intermediate,1,BAO_0000218,,Heligmosomoides polygyrus,7732,,
CHEMBL625728,22224,,Urine,In vivo,A,,13409,10116.0,1088.0,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL625729,22224,,,In vivo,A,,13410,10116.0,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL625730,22224,,,In vivo,A,,13411,10116.0,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL625731,22224,,Urine,In vivo,A,,13412,10116.0,1088.0,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL626417,22224,,Urine,In vivo,A,,13413,10116.0,1088.0,Urinary clearance was determined in rat at 25 mg/kg os dosage,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,9278,,
CHEMBL626418,50587,,Urine,In vivo,A,,13414,9606.0,1088.0,Urinary clearance was determined at 100 mg/kg oral dosage in human,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,9278,,
CHEMBL626419,50588,,Urine,In vivo,A,,13415,9615.0,1088.0,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9278,,
CHEMBL626592,50588,,Plasma,In vivo,A,,13416,9615.0,1969.0,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,5932,,
CHEMBL626593,50597,,Plasma,In vivo,A,,13417,10116.0,1969.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5932,,
CHEMBL626594,50597,,,In vivo,A,,13418,10116.0,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5182,,
CHEMBL625035,50588,,,In vivo,A,,13419,9615.0,,Clearance rate in dogs,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,10499,,
CHEMBL625036,22224,,,In vitro,A,,13420,,,Compound was measured for intrinsic clearance,U,,0,,Autocuration,1,BAO_0000019,,,6051,,
CHEMBL625037,22229,,,,P,,13421,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,17508,,
CHEMBL625038,22229,,,,P,,13422,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6228,,
CHEMBL625039,22229,,,,P,,13423,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6231,,
CHEMBL625040,22229,,,,P,,13424,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,17740,,
CHEMBL625041,22229,,,,P,,13425,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6495,,
CHEMBL625042,22229,,,,P,,13426,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,2171,,
CHEMBL874411,22224,,,,A,,13427,,,Partition coefficient of the compound,U,,0,,Autocuration,1,BAO_0000019,,,3255,,
CHEMBL625043,22224,,,,A,,13428,,,Permeability,U,,0,,Autocuration,1,BAO_0000019,,,6821,,
CHEMBL625044,22229,,,,P,,13429,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,2685,,
CHEMBL625045,22224,,,,A,,13430,,,Partition coefficient (logD),U,,0,,Autocuration,1,BAO_0000019,,,17584,,
CHEMBL625046,22229,,,,P,,13431,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,0,,Autocuration,1,BAO_0000100,,,13824,,
CHEMBL625047,22229,,,,P,,13432,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,0,,Autocuration,1,BAO_0000100,,,13824,,
CHEMBL625048,22229,,,,P,,13433,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,16479,,
CHEMBL625049,22229,,,,P,,13434,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,11997,,
CHEMBL625050,22229,,,,P,,13435,,,Calculated logarithm of partition coefficient (P) was determined,U,,0,,Autocuration,1,BAO_0000100,,,2988,,
CHEMBL625051,22229,,,,P,,13436,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,931,,
CHEMBL874412,22229,,,,P,,13437,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,4381,,
CHEMBL625052,22229,,,,P,,13438,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,4397,,
CHEMBL625053,22229,,,,P,,13439,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,5889,,
CHEMBL623250,22224,,,,A,,13440,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL623251,22224,,,,A,,13441,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL623252,22224,,,,A,,13442,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL623253,22224,,,,A,,13443,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL623254,22224,,,,A,,13444,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL623255,22224,,,,A,,13445,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,U,,0,,Autocuration,1,BAO_0000019,,,6154,,
CHEMBL626831,22224,,,,A,,13446,,,Percent degradation of compound at a pH of 1 over a 18 hr period,U,,0,,Autocuration,1,BAO_0000019,,,6887,,
CHEMBL877494,22224,,,,A,,13447,,,Percent degradation of compound at pH of 1 over an 18 hr period,U,,0,,Autocuration,1,BAO_0000019,,,6887,,
CHEMBL626832,22224,,,,A,,13448,,,Delta Logarithm of Partition Coefficient value was determined.,U,,0,,Autocuration,1,BAO_0000019,,,14116,,
CHEMBL626833,22224,,,,A,,13449,,,Delta logPoct-cyc,U,,0,,Autocuration,1,BAO_0000019,,,11137,,
CHEMBL626834,22224,,,,P,,13450,,,Lipophilicity estimated on reversed phase TLC,U,,0,,Autocuration,1,BAO_0000100,,,7230,,
CHEMBL626835,22224,,,,A,,13451,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,U,,0,,Autocuration,1,BAO_0000019,,,15741,,
CHEMBL626836,22224,,,,A,,13452,,,Delta logPoct-cyc,U,,0,,Autocuration,1,BAO_0000019,,,9663,,
CHEMBL626837,22229,,,,P,,13453,,,Change in logarithm of partition coefficient of the compound,U,,0,,Autocuration,1,BAO_0000100,,,9663,,
CHEMBL626838,22224,,,,A,,13454,,,Delta logD (pH 6.5),U,,0,,Autocuration,1,BAO_0000019,,,13807,,
CHEMBL626839,22224,,,,P,,13455,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",U,,0,,Autocuration,1,BAO_0000100,,,13807,,
CHEMBL626840,22224,,,,A,,13456,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,U,,0,,Autocuration,1,BAO_0000019,,,17425,,
CHEMBL626841,22224,,,,A,,13457,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),U,,0,,Autocuration,1,BAO_0000019,,,12143,,
CHEMBL626842,22224,,,,A,,13458,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,U,,0,,Autocuration,1,BAO_0000219,,,12608,,
CHEMBL626843,22224,,,,A,,13459,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,U,,0,,Autocuration,1,BAO_0000219,,,12608,,
CHEMBL626844,50597,,,,A,,13460,10116.0,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL877495,50597,,,,A,,13461,10116.0,,Amount of deuterium retained was reported after normal workup in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL626845,50597,,,,A,,13462,10116.0,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL626846,50597,,,,A,,13463,10116.0,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL626847,50597,,,,A,,13464,10116.0,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL628677,50597,,,,A,,13465,10116.0,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL628678,50597,,,,A,,13466,10116.0,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8649,,
CHEMBL628679,22224,,,,A,,13467,,,Compound was subjected to electrochemical oxidation,U,,0,,Autocuration,1,BAO_0000019,,,9659,,
CHEMBL628680,22224,,,,A,,13468,,,Compound was subjected to photochemical oxidation,U,,0,,Autocuration,1,BAO_0000019,,,9659,,
CHEMBL628681,22224,,,,A,,13469,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,U,,0,,Autocuration,1,BAO_0000019,,,9659,,
CHEMBL628682,22224,,,,A,,13470,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,U,,0,,Autocuration,1,BAO_0000019,,,9659,,
CHEMBL628683,22224,,,,A,,13471,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,U,,0,,Autocuration,1,BAO_0000019,,,9659,,
CHEMBL628684,50597,,,,A,,13472,10116.0,,Percent diffusion through fuzzy rat skin after 48 h of incubation,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9607,,
CHEMBL877501,22229,,,,P,,13473,,,Dissociation constant (pKa),U,,0,,Autocuration,1,BAO_0000100,,,7057,,
CHEMBL628685,22224,,,,P,,13474,,,Dissociation constant value of the compound; ND means not determined.,U,,0,,Autocuration,1,BAO_0000100,,,7057,,
CHEMBL628686,50597,,Blood,,A,,13475,10116.0,178.0,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL628687,50597,,Blood,,A,,13476,10116.0,178.0,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL628688,50597,,,,A,,13477,10116.0,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL628689,50597,,,,A,,13478,10116.0,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL628690,50597,,Liver,,A,,13479,10116.0,2107.0,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629363,50597,,Liver,,A,,13480,10116.0,2107.0,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629364,50597,,Spleen,,A,,13481,10116.0,2106.0,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629365,50597,,Spleen,,A,,13482,10116.0,2106.0,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629366,50597,,,,A,,13483,10116.0,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629367,50597,,Urine,,A,,13484,10116.0,1088.0,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629368,50597,,Feces,,A,,13485,10116.0,1988.0,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL877502,50597,,Urine,,A,,13486,10116.0,1088.0,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7911,,
CHEMBL629369,50594,,Cerebellum,,A,,13487,10090.0,2037.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL629370,50594,,Brain,,A,,13488,10090.0,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL629371,22224,,Urine,,A,,13489,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL626276,22224,,Urine,,A,,13490,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL626277,22224,,Urine,,A,,13491,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL631250,22224,,Urine,,A,,13492,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL631251,50597,,Urine,,A,,13493,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL631252,50597,,Urine,,A,,13494,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL631253,50597,,Urine,,A,,13495,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL631254,50597,,Urine,,A,,13496,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL631255,50597,,Urine,,A,,13497,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL631256,50597,,Urine,,A,,13498,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL631257,50597,,Urine,,A,,13499,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628009,50597,,Urine,,A,,13500,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628010,50597,,Urine,,A,,13501,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628011,50597,,Urine,,A,,13502,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628012,50597,,Urine,,A,,13503,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628013,50597,,Urine,,A,,13504,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628014,50597,,Urine,,A,,13505,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628015,50588,,Urine,,A,,13506,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628016,50588,,Urine,,A,,13507,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL874461,50588,,Urine,,A,,13508,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628017,50588,,Urine,,A,,13509,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628018,50588,,Urine,,A,,13510,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628019,50588,,Urine,,A,,13511,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628020,50588,,Urine,,A,,13512,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628021,50588,,Urine,,A,,13513,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628022,50588,,Urine,,A,,13514,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628023,50588,,Urine,,A,,13515,9615.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8133,,
CHEMBL628024,22224,,Urine,,A,,13516,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL628025,22224,,Urine,,A,,13517,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL628026,22224,,Urine,,A,,13518,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL628027,22224,,Urine,,A,,13519,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL628028,22224,,Urine,,A,,13520,314293.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,8133,,
CHEMBL628029,50597,,Urine,,A,,13521,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628030,50597,,Urine,,A,,13522,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628031,50597,,Urine,,A,,13523,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628032,50597,,Urine,,A,,13524,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628033,50597,,Urine,,A,,13525,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628034,50597,,Urine,,A,,13526,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628035,50597,,Urine,,A,,13527,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628036,50597,,Urine,,A,,13528,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL874462,50597,,Urine,,A,,13529,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL628037,50588,,,In vivo,A,,13530,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628123,50588,,,In vivo,A,,13531,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628124,50588,,,In vivo,A,,13532,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628125,50588,,,In vivo,A,,13533,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628126,50588,,,In vivo,A,,13534,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628127,50588,,,In vivo,A,,13535,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628128,50588,,,In vivo,A,,13536,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628129,50588,,,In vivo,A,,13537,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628130,50588,,,In vivo,A,,13538,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628131,50588,,,In vivo,A,,13539,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628132,50588,,,In vivo,A,,13540,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628133,50588,,,In vivo,A,,13541,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628134,50588,,,In vivo,A,,13542,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628135,50588,,,In vivo,A,,13543,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628136,50588,,,In vivo,A,,13544,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628137,50588,,,In vivo,A,,13545,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628138,50588,,,In vivo,A,,13546,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628139,50588,,,In vivo,A,,13547,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628140,50588,,,In vivo,A,,13548,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628141,50588,,,In vivo,A,,13549,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628142,50588,,,In vivo,A,,13550,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628143,50588,,,In vivo,A,,13551,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628144,50588,,,In vivo,A,,13552,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628145,50588,,,In vivo,A,,13553,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL628146,50588,,,In vivo,A,,13554,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625355,50588,,,In vivo,A,,13555,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625356,50588,,,In vivo,A,,13556,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625357,50588,,,In vivo,A,,13557,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625527,50588,,,In vivo,A,,13558,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL875473,50588,,,In vivo,A,,13559,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL625528,50588,,,In vivo,A,,13560,9615.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL626304,50597,,,In vivo,A,,13561,10116.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9025,,
CHEMBL624138,50588,,Artery,In vivo,A,,13562,9615.0,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,9025,,
CHEMBL624139,22229,,,,P,,13563,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6448,,
CHEMBL624140,22229,,,,P,,13564,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,17221,,
CHEMBL624141,22229,,,,P,,13565,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6545,,
CHEMBL624142,22229,,,,P,,13566,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,577,,
CHEMBL624143,22229,,,,P,,13567,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6285,,
CHEMBL624144,22229,,,,P,,13568,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6500,,
CHEMBL624145,22229,,,,P,,13569,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6716,,
CHEMBL624146,22229,,,,P,,13570,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,13658,,
CHEMBL624147,22229,,,,P,,13571,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6549,,
CHEMBL883123,22229,,,,P,,13572,,,Calculated partition coefficient (clogP) (MacLogP),U,,0,,Autocuration,1,BAO_0000100,,,14685,,
CHEMBL624148,22224,,,,A,,13573,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,6893,,
CHEMBL874416,22224,,,,A,,13574,,,Kinetic parameter was determined,U,,0,,Autocuration,1,BAO_0000019,,,3687,,
CHEMBL624149,22229,,,,P,,13575,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,4207,,
CHEMBL624150,22229,,,,P,,13576,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,4626,,
CHEMBL624151,22224,,,,P,,13577,,,Lipophilicity was determined,U,,0,,Autocuration,1,BAO_0000100,,,1021,,
CHEMBL624152,22224,,,,P,,13578,,,Lipophilicity was determined,U,,0,,Autocuration,1,BAO_0000100,,,3777,,
CHEMBL622139,22224,,,,P,,13579,,,Lipophilicity was determined,U,,0,,Autocuration,1,BAO_0000100,,,17533,,
CHEMBL622140,22229,,,,P,,13580,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,6524,,
CHEMBL622141,22224,,,,P,,13581,,,Lipophilicity was determined,U,,0,,Autocuration,1,BAO_0000100,,,17533,,
CHEMBL622142,22224,,,,P,,13582,,,Lipophilicity in octanol-water,U,,0,,Autocuration,1,BAO_0000100,,,6480,,
CHEMBL622143,22229,,,,P,,13583,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,17606,,
CHEMBL622144,22229,,,,P,,13584,,,Octanol-water partition coefficient was determined,U,,0,,Autocuration,1,BAO_0000100,,,6863,,
CHEMBL877473,22224,,,,A,,13585,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,1356,,
CHEMBL622145,22229,,,,P,,13586,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,3326,,
CHEMBL622146,22224,,,,A,,13587,,,Partition coefficient was determined; ND means not determined,U,,0,,Autocuration,1,BAO_0000019,,,1356,,
CHEMBL622147,22229,,,,P,,13588,,,Calculated partition coefficient (clogP),U,,0,,Autocuration,1,BAO_0000100,,,12984,,
CHEMBL622148,22224,,,,A,,13589,,,Partition coefficient of the compound,U,,0,,Autocuration,1,BAO_0000019,,,17363,,
CHEMBL883124,22224,,,,A,,13590,,,Permeability was determined,U,,0,,Autocuration,1,BAO_0000019,,,6827,,
CHEMBL622149,22229,,,,P,,13591,,,The compound was evaluated for the partition coefficient,U,,0,,Autocuration,1,BAO_0000100,,,261,,
CHEMBL622150,22224,,,,A,,13592,,,Partition coefficient (logP),U,,0,,Autocuration,1,BAO_0000019,,,2685,,
CHEMBL622151,22224,,,,P,,13593,,,The lipophilicity was reported,U,,0,,Autocuration,1,BAO_0000100,,,414,,
CHEMBL622152,22229,,,,P,,13594,,,logarithm of the octanol-water partition coefficient for the compound,U,,0,,Autocuration,1,BAO_0000100,,,15769,,
CHEMBL622153,22224,,,,A,,13595,,,Clogp value was determined,U,,0,,Autocuration,1,BAO_0000019,,,17248,,
CHEMBL877474,22224,,,In vivo,A,,13596,,,Clp at a dose of 1.5 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,16935,,
CHEMBL622154,22224,,,In vivo,A,,13597,,,Clp at a dose of 2.0 mg/kg,U,,0,,Autocuration,1,BAO_0000218,,,16935,,
CHEMBL622155,22224,,Plasma,In vivo,A,,13598,,1969.0,"Clp, plasma clearance at a dose of 10 mg/kg",U,,0,,Autocuration,1,BAO_0000218,,,14832,,
CHEMBL622156,22224,,Plasma,In vivo,A,,13599,,1969.0,"Clp, plasma clearance at a dose of 50 mg/kg",U,,0,,Autocuration,1,BAO_0000218,,,14832,,
CHEMBL622157,50597,,Plasma,In vivo,A,,13600,10116.0,1969.0,Compound was tested for plasma clearance in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2399,,
CHEMBL622158,50597,,Plasma,In vivo,A,,13601,10116.0,1969.0,Compound was tested for plasma clearance in rat; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,2399,,
CHEMBL622807,50597,,,In vivo,A,,13602,10116.0,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6227,,
CHEMBL622808,50797,,,In vivo,A,,13603,9544.0,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,6227,,
CHEMBL622809,22224,,,In vivo,A,,13604,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,U,,0,,Autocuration,1,BAO_0000218,,,5623,,
CHEMBL622810,22224,,,In vivo,A,,13605,,,Plasma clearance determined,U,,0,,Autocuration,1,BAO_0000218,,,4854,,
CHEMBL876653,100712,,,In vivo,A,,13606,10026.0,,Plasma clearance after iv administration at 3 mg/kg in hamster,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,4493,,
CHEMBL622811,100712,,,In vivo,A,,13607,10026.0,,Plasma clearance after iv administration at 4 mg/kg in hamster,N,,1,,Intermediate,1,BAO_0000218,,Cricetinae,4493,,
CHEMBL622986,50597,,,In vivo,A,,13608,10116.0,,Rate of clearance in rat was determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14956,,
CHEMBL622987,50597,,Plasma,In vivo,A,,13609,10116.0,1969.0,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL622988,50597,,Plasma,In vivo,A,,13610,10116.0,1969.0,Total plasma clearance after iv dose of 5.10 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL622989,50597,,Plasma,In vivo,A,,13611,10116.0,1969.0,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL622990,50597,,Plasma,In vivo,A,,13612,10116.0,1969.0,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15372,,
CHEMBL622991,22224,,Plasma,In vivo,A,,13613,314293.0,1969.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,,0,,Autocuration,1,BAO_0000218,,Simiiformes,15604,,
CHEMBL622227,50597,,Plasma,In vivo,A,,13614,10116.0,1969.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15604,,
CHEMBL622228,50588,,Plasma,In vivo,A,,13615,9615.0,1969.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15604,,
CHEMBL622229,50597,,,In vivo,A,,13616,10116.0,,Clpl value in rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14964,,
CHEMBL622230,50512,,,In vivo,A,,13617,10141.0,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,15240,,
CHEMBL622231,50597,,,In vivo,A,,13618,10116.0,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16449,,
CHEMBL622232,100710,,,In vivo,A,,13619,9541.0,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,N,,1,,Intermediate,1,BAO_0000218,,Macaca fascicularis,16449,,
CHEMBL622233,22224,,,In vivo,A,,13620,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622234,22224,,,In vivo,A,,13621,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622235,22224,,,In vivo,A,,13622,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622236,22224,,,In vivo,A,,13623,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622237,22224,,,In vivo,A,,13624,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL877482,22224,,,In vivo,A,,13625,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622238,22224,,,In vivo,A,,13626,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622239,22224,,,In vivo,A,,13627,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,U,,0,,Autocuration,1,BAO_0000218,,,12902,,
CHEMBL622240,22224,,Blood,In vivo,A,,13628,,178.0,Cmax was calculated as maximum concentration reached in the blood,U,,0,,Autocuration,1,BAO_0000218,,,11149,,
CHEMBL622241,22224,,Blood,In vivo,A,,13629,,178.0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,U,,0,,Autocuration,1,BAO_0000218,,,11149,,
CHEMBL631013,50597,,,In vivo,A,,13630,10116.0,,Cmax was determine after peroral administration at 10 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL631014,50797,,,In vivo,A,,13631,9544.0,,Cmax was determine after peroral administration at 10 mpk in Rhesus,N,,1,,Intermediate,1,BAO_0000218,,Macaca mulatta,5669,,
CHEMBL631015,50588,,,In vivo,A,,13632,9615.0,,Cmax was determine after peroral administration at 10 mpk in dog,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,5669,,
CHEMBL631016,50597,,,In vivo,A,,13633,10116.0,,Cmax was determine after peroral administration at 160 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL631017,50597,,,In vivo,A,,13634,10116.0,,Cmax was determine after peroral administration at 20 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL631018,50597,,,In vivo,A,,13635,10116.0,,Cmax was determine after peroral administration at 50 mpk in Rat,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,5669,,
CHEMBL631019,22224,,,In vivo,A,,13636,,,Cmax was determined,U,,0,,Autocuration,1,BAO_0000218,,,4236,,
CHEMBL875761,50594,,Brain,,A,,13637,10090.0,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL631020,50594,,Brain,,A,,13638,10090.0,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL631669,50594,,Brain,,A,,13639,10090.0,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL631670,50594,,Brain,,A,,13640,10090.0,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL631671,50594,,Striatum,,A,,13641,10090.0,2435.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13792,,
CHEMBL631672,50597,,Blood,,A,,13642,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631673,50597,,Blood,,A,,13643,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631856,50597,,Blood,,A,,13644,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631857,50597,,Blood,,A,,13645,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631858,50597,,Blood,,A,,13646,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631859,50597,,Blood,,A,,13647,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631860,50597,,Blood,,A,,13648,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631861,50597,,Blood,,A,,13649,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631862,50597,,Blood,,A,,13650,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631863,50597,,Blood,,A,,13651,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631864,50597,,Blood,,A,,13652,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631865,50597,,Blood,,A,,13653,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL631866,50597,,Blood,,A,,13654,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629360,50597,,Blood,,A,,13655,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629361,50597,,Blood,,A,,13656,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629362,50597,,Blood,,A,,13657,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630740,50597,,Blood,,A,,13658,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630741,50597,,Blood,,A,,13659,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630742,50597,,Blood,,A,,13660,10116.0,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630743,50597,,,,A,,13661,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630744,50597,,,,A,,13662,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630745,50597,,,,A,,13663,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630746,50597,,,,A,,13664,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630747,50597,,,,A,,13665,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL630748,50597,,,,A,,13666,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL632056,50597,,,,A,,13667,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL632057,50597,,,,A,,13668,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL632058,50597,,,,A,,13669,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL632059,50597,,,,A,,13670,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL632060,50597,,,,A,,13671,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL632061,50597,,,,A,,13672,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629207,50597,,,,A,,13673,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629208,50597,,,,A,,13674,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629209,50597,,,,A,,13675,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629210,50597,,,,A,,13676,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629211,50597,,,,A,,13677,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629212,50597,,,,A,,13678,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629213,50597,,,,A,,13679,10116.0,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8418,,
CHEMBL629214,50597,,Urine,,A,,13680,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629215,50597,,Urine,,A,,13681,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL635154,50597,,Urine,,A,,13682,10116.0,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8133,,
CHEMBL629216,50597,,,,A,,13683,10116.0,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL629217,50597,,,,A,,13684,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL629218,50597,,,,A,,13685,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL629219,50597,,,,A,,13686,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL629220,50597,,,,A,,13687,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL629221,50597,,,,A,,13688,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631127,50597,,,,A,,13689,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631128,50597,,,,A,,13690,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631129,50597,,,,A,,13691,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631130,50597,,,,A,,13692,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631131,50597,,,,A,,13693,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631132,50597,,,,A,,13694,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631133,50597,,,,A,,13695,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631134,50597,,,,A,,13696,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL875120,50597,,,,A,,13697,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631135,50597,,,,A,,13698,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631136,50597,,,,A,,13699,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631137,50597,,,,A,,13700,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631138,50597,,,,A,,13701,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631139,50597,,,,A,,13702,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631140,50597,,,,A,,13703,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631141,50597,,,,A,,13704,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631142,50597,,,,A,,13705,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631143,50597,,,,A,,13706,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631144,50597,,,,A,,13707,10116.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6996,,
CHEMBL631145,50588,,,,A,,13708,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631146,50588,,,,A,,13709,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631147,50588,,,,A,,13710,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631148,50588,,,,A,,13711,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631149,50588,,,,A,,13712,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631150,50588,,,,A,,13713,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631151,50588,,,,A,,13714,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631152,50588,,,,A,,13715,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631443,50588,,,,A,,13716,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631444,50588,,,,A,,13717,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631445,50588,,,,A,,13718,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631446,50588,,,,A,,13719,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631447,50588,,,,A,,13720,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631448,50588,,,,A,,13721,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631449,50588,,,,A,,13722,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL631450,50588,,,,A,,13723,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL629724,50588,,,,A,,13724,9615.0,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,6996,,
CHEMBL629725,50594,,Zone of skin,In vivo,A,,13725,10090.0,14.0,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL629726,50594,,Zone of skin,In vivo,A,,13726,10090.0,14.0,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL629727,50594,,Spleen,In vivo,A,,13727,10090.0,2106.0,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630404,50594,,Spleen,In vivo,A,,13728,10090.0,2106.0,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630405,50594,,Spleen,In vivo,A,,13729,10090.0,2106.0,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630406,50594,,Spleen,In vivo,A,,13730,10090.0,2106.0,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630407,50594,,Stomach,In vivo,A,,13731,10090.0,945.0,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630573,50594,,Stomach,In vivo,A,,13732,10090.0,945.0,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630574,50594,,Stomach,In vivo,A,,13733,10090.0,945.0,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630575,50594,,Stomach,In vivo,A,,13734,10090.0,945.0,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630576,50594,,,In vivo,A,,13735,10090.0,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630577,50594,,,In vivo,A,,13736,10090.0,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630578,50594,,,In vivo,A,,13737,10090.0,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630579,50594,,,In vivo,A,,13738,10090.0,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,9716,,
CHEMBL630580,50594,,Kidney,,A,,13739,10090.0,2113.0,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630581,50594,,Kidney,,A,,13740,10090.0,2113.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630582,50594,,Kidney,,A,,13741,10090.0,2113.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630583,50594,,,,A,,13742,10090.0,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630584,50594,,,,A,,13743,10090.0,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630585,50594,,,,A,,13744,10090.0,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630586,50594,,,,A,,13745,10090.0,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630587,50594,,,,A,,13746,10090.0,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630588,50594,,,,A,,13747,10090.0,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630589,50594,,,,A,,13748,10090.0,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630590,50594,,,,A,,13749,10090.0,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,12192,,
CHEMBL630591,22224,,Feces,,A,,13750,,1988.0,Removal of 238-Plutonium(IV) in feces at 24 h,U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630592,22224,,Feces,,A,,13751,,1988.0,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630593,22224,,,,A,,13752,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630594,22224,,,,A,,13753,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630595,22224,,Urine,,A,,13754,,1088.0,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630596,22224,,Urine,,A,,13755,,1088.0,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630597,22224,,Urine,,A,,13756,,1088.0,Removal of 238-Plutonium(IV) in urine after 0-24 h,U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630598,22224,,Urine,,A,,13757,,1088.0,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630599,22224,,Urine,,A,,13758,,1088.0,Removal of 238-Plutonium(IV) in urine after 0-4 h,U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630600,22224,,Urine,,A,,13759,,1088.0,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630601,22224,,Urine,,A,,13760,,1088.0,Removal of 238-Plutonium(IV) in urine after 4-24 h,U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630602,22224,,Urine,,A,,13761,,1088.0,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630603,22224,,Urine,,A,,13762,,1088.0,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL630604,22224,,Urine,,A,,13763,,1088.0,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),U,,0,,Autocuration,1,BAO_0000019,,,12192,,
CHEMBL624869,50597,,Blood,In vivo,A,,13764,10116.0,178.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL624870,50597,,Blood,In vivo,A,,13765,10116.0,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623189,50597,,Blood,In vivo,A,,13766,10116.0,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623190,50597,,Blood,In vivo,A,,13767,10116.0,178.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623191,50597,,Blood,In vivo,A,,13768,10116.0,178.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623192,50597,,,In vivo,A,,13769,10116.0,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623193,50597,,,In vivo,A,,13770,10116.0,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623194,50597,,,In vivo,A,,13771,10116.0,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623195,50597,,,In vivo,A,,13772,10116.0,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623196,50597,,,In vivo,A,,13773,10116.0,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623197,50597,,,,A,,13774,10116.0,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623198,50597,,,,A,,13775,10116.0,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623199,50597,,,,A,,13776,10116.0,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623200,50597,,Muscle tissue,,A,,13777,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623201,50597,,Muscle tissue,,A,,13778,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623202,50597,,Muscle tissue,,A,,13779,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623203,50597,,Muscle tissue,,A,,13780,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623204,50597,,Muscle tissue,,A,,13781,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623205,50597,,Muscle tissue,,A,,13782,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623206,50597,,Muscle tissue,,A,,13783,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623207,50597,,Muscle tissue,,A,,13784,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623208,50597,,Muscle tissue,,A,,13785,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623209,50597,,Muscle tissue,,A,,13786,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623210,50597,,Muscle tissue,,A,,13787,10116.0,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623211,50597,,,,A,,13788,10116.0,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623212,50597,,Uterus,,A,,13789,10116.0,995.0,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11836,,
CHEMBL623213,22224,,,,A,,13790,,,Tested in vitro for intrinsic activity relative to quinpirole,U,,0,,Autocuration,1,BAO_0000019,,,12640,,
CHEMBL623214,22224,,,,A,,13791,,,"Relative ion enhancement, determined in pulsed ultrafiltration",U,,0,,Autocuration,1,BAO_0000019,,,14218,,
CHEMBL623215,22224,,,,A,,13792,,,% ionization at the pH 7.4 at 37 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,11296,,
CHEMBL623216,22224,,,,A,,13793,,,Percentage ionization was measured,U,,0,,Autocuration,1,BAO_0000019,,,10929,,
CHEMBL623217,50591,,,,A,,13794,9913.0,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,N,,1,,Intermediate,1,BAO_0000218,,Bos taurus,13841,,
CHEMBL623218,22224,,,,A,,13795,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,U,,0,,Autocuration,1,BAO_0000019,,,10431,,
CHEMBL623913,22224,,,,A,,13796,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,U,,0,,Autocuration,1,BAO_0000019,,,10431,,
CHEMBL623914,22224,,,,A,,13797,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,U,,0,,Autocuration,1,BAO_0000019,,,10431,,
CHEMBL623915,22229,,,,P,,13798,,,Compound was evaluated for the partition coefficient in octanol/water,U,,0,,Autocuration,1,BAO_0000100,,,8826,,
CHEMBL624080,22229,,,,P,,13799,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),U,,0,,Autocuration,1,BAO_0000100,,,8826,,
CHEMBL624081,22224,,,,A,,13800,,,Equilibrium constant measured by the pulse radiolysis at pH 7,U,,0,,Autocuration,1,BAO_0000019,,,9884,,
CHEMBL624082,50587,,,,A,,13801,9606.0,,In vitro hydrolytic rate constant determined in human blood,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,9827,,
CHEMBL625054,50587,,,,A,,13802,9606.0,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10009,,
CHEMBL877485,22224,,,,A,,13803,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,U,,0,,Autocuration,1,BAO_0000019,,,10009,,
CHEMBL625055,50594,,,,A,,13804,10090.0,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625056,50594,,,,A,,13805,10090.0,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL625057,50587,,,,A,,13806,9606.0,,In vitro oxidation of compound in presence of human plasma,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,10009,,
CHEMBL625058,22224,,,,A,,13807,,,In vitro oxidation of compound in presence of hydrogen peroxide,U,,0,,Autocuration,1,BAO_0000019,,,10009,,
CHEMBL625059,50594,,,,A,,13808,10090.0,,In vitro oxidation of compound in presence of mouse brain homogenate,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL629536,50594,,,,A,,13809,10090.0,,In vitro oxidation of compound in presence of mouse liver homogenate,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,10009,,
CHEMBL629537,50597,,,,A,,13810,10116.0,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629538,50597,,,,A,,13811,10116.0,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629539,50597,,,,A,,13812,10116.0,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL874445,50597,,,,A,,13813,10116.0,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629540,50597,,,,A,,13814,10116.0,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629541,50597,,,,A,,13815,10116.0,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629542,50597,,,,A,,13816,10116.0,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630243,50597,,,,A,,13817,10116.0,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630244,50597,,,,A,,13818,10116.0,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630245,50597,,,,A,,13819,10116.0,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630246,50597,,,,A,,13820,10116.0,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630247,50597,,,,A,,13821,10116.0,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630248,50597,,,,A,,13822,10116.0,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630249,50597,,Blood,In vivo,A,,13823,10116.0,178.0,Biodistribution in rat blood at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630250,50597,,Blood,In vivo,A,,13824,10116.0,178.0,Biodistribution in rat blood at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630251,50597,,Blood,In vivo,A,,13825,10116.0,178.0,Biodistribution in rat blood at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630252,50597,,Blood,In vivo,A,,13826,10116.0,178.0,Biodistribution in rat blood at 3 hr after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630408,50597,,Blood,In vivo,A,,13827,10116.0,178.0,Biodistribution in rat blood at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630409,50597,,Cerebellum,In vivo,A,,13828,10116.0,2037.0,Biodistribution in rat cerebellum at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL874446,50597,,Cerebellum,In vivo,A,,13829,10116.0,2037.0,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630410,50597,,Cerebellum,In vivo,A,,13830,10116.0,2037.0,Biodistribution in rat cerebellum at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630411,50597,,Cerebellum,In vivo,A,,13831,10116.0,2037.0,Biodistribution in rat cerebellum at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630412,50597,,Cerebellum,In vivo,A,,13832,10116.0,2037.0,Biodistribution in rat cerebellum at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630413,50597,,Cerebellum,In vivo,A,,13833,10116.0,2037.0,Biodistribution in rat cerebellum at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630414,50597,,Cerebellum,In vivo,A,,13834,10116.0,2037.0,Biodistribution in rat cerebellum at 3 hr after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630415,50597,,Cerebellum,In vivo,A,,13835,10116.0,2037.0,Biodistribution in rat cerebellum at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630416,50597,,,In vivo,A,,13836,10116.0,,Biodistribution in rat cortex at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630417,50597,,,In vivo,A,,13837,10116.0,,Biodistribution in rat cortex at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630418,50597,,,In vivo,A,,13838,10116.0,,Biodistribution in rat cortex at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630419,50597,,,In vivo,A,,13839,10116.0,,Biodistribution in rat cortex at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630420,50597,,,In vivo,A,,13840,10116.0,,Biodistribution in rat cortex at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630421,50597,,,In vivo,A,,13841,10116.0,,Biodistribution in rat cortex at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630422,50597,,,In vivo,A,,13842,10116.0,,Biodistribution in rat cortex at 3 hr after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630423,50597,,,In vivo,A,,13843,10116.0,,Biodistribution in rat cortex at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630424,50597,,Heart,In vivo,A,,13844,10116.0,948.0,Biodistribution in rat heart at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630425,50597,,Heart,In vivo,A,,13845,10116.0,948.0,Biodistribution in rat heart at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL629462,50597,,Heart,In vivo,A,,13846,10116.0,948.0,Biodistribution in rat heart at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630426,50597,,Heart,In vivo,A,,13847,10116.0,948.0,Biodistribution in rat heart at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630427,50597,,Heart,In vivo,A,,13848,10116.0,948.0,Biodistribution in rat heart at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625877,50597,,Heart,In vivo,A,,13849,10116.0,948.0,Biodistribution in rat heart at 3 hr after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625878,50597,,Heart,In vivo,A,,13850,10116.0,948.0,Biodistribution in rat heart at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625879,50597,,Hippocampus,In vivo,A,,13851,10116.0,10000000.0,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625880,50597,,Hippocampus,In vivo,A,,13852,10116.0,10000000.0,Biodistribution in rat hippocampus at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625881,50597,,Hippocampus,In vivo,A,,13853,10116.0,10000000.0,Biodistribution in rat hippocampus at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625882,50597,,Hippocampus,In vivo,A,,13854,10116.0,10000000.0,Biodistribution in rat hippocampus at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625883,50597,,Hippocampus,In vivo,A,,13855,10116.0,10000000.0,Biodistribution in rat hippocampus at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625884,50597,,Kidney,In vivo,A,,13856,10116.0,2113.0,Biodistribution in rat kidney at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625885,50597,,Kidney,In vivo,A,,13857,10116.0,2113.0,Biodistribution in rat kidney at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628649,50597,,Kidney,In vivo,A,,13858,10116.0,2113.0,Biodistribution in rat kidney at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628650,50597,,Kidney,In vivo,A,,13859,10116.0,2113.0,Biodistribution in rat kidney at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628651,50597,,Kidney,In vivo,A,,13860,10116.0,2113.0,Biodistribution in rat kidney at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628652,50597,,Kidney,In vivo,A,,13861,10116.0,2113.0,Biodistribution in rat kidney at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628653,50597,,Kidney,In vivo,A,,13862,10116.0,2113.0,Biodistribution in rat kidney at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628654,50597,,Liver,In vivo,A,,13863,10116.0,2107.0,Biodistribution in rat liver at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628655,50597,,Liver,In vivo,A,,13864,10116.0,2107.0,Biodistribution in rat liver at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625238,50597,,Liver,In vivo,A,,13865,10116.0,2107.0,Biodistribution in rat liver at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625239,50597,,Liver,In vivo,A,,13866,10116.0,2107.0,Biodistribution in rat liver at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625240,50597,,Liver,In vivo,A,,13867,10116.0,2107.0,Biodistribution in rat liver at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625241,50597,,Liver,In vivo,A,,13868,10116.0,2107.0,Biodistribution in rat liver at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625242,50597,,Liver,In vivo,A,,13869,10116.0,2107.0,Biodistribution in rat liver at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL874587,50597,,Lung,In vivo,A,,13870,10116.0,2048.0,Biodistribution in rat lung at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625405,50597,,Lung,In vivo,A,,13871,10116.0,2048.0,Biodistribution in rat lung at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625406,50597,,Lung,In vivo,A,,13872,10116.0,2048.0,Biodistribution in rat lung at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625407,50597,,Lung,In vivo,A,,13873,10116.0,2048.0,Biodistribution in rat lung at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625408,50597,,Lung,In vivo,A,,13874,10116.0,2048.0,Biodistribution in rat lung at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625409,50597,,Lung,In vivo,A,,13875,10116.0,2048.0,Biodistribution in rat lung at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL625410,50597,,Thoracic aorta,,A,,13876,10116.0,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625411,50597,,Thoracic aorta,,A,,13877,10116.0,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625412,50597,,Thoracic aorta,,A,,13878,10116.0,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625413,50597,,Thoracic aorta,,A,,13879,10116.0,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625414,50597,,Thoracic aorta,,A,,13880,10116.0,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips v,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625415,50597,,Thoracic aorta,,A,,13881,10116.0,1515.0,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625416,50597,,Thoracic aorta,,A,,13882,10116.0,1515.0,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12361,,
CHEMBL625417,50597,,Urine,,A,,13883,10116.0,1088.0,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12712,,
CHEMBL625418,50597,,Feces,,A,,13884,10116.0,1988.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL625419,50597,,Urine,,A,,13885,10116.0,1088.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL625420,50597,,,,A,,13886,10116.0,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL626996,50597,,,,A,,13887,10116.0,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL626997,50597,,Feces,,A,,13888,10116.0,1988.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL626998,50597,,Urine,,A,,13889,10116.0,1088.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL626999,50597,,,,A,,13890,10116.0,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL627000,50594,,,,A,,13891,10090.0,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627001,50594,,,,A,,13892,10090.0,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627002,50594,,,,A,,13893,10090.0,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627003,50594,,,,A,,13894,10090.0,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627004,50594,,Urine,,A,,13895,10090.0,1088.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627005,50594,,Urine,,A,,13896,10090.0,1088.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL874594,50594,,Urine,,A,,13897,10090.0,1088.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627006,50594,,Urine,,A,,13898,10090.0,1088.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627007,50594,,Urine,,A,,13899,10090.0,1088.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627884,50594,,Urine,,A,,13900,10090.0,1088.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627885,50594,,Urine,,A,,13901,10090.0,1088.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627886,50594,,Urine,,A,,13902,10090.0,1088.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627887,50594,,Urine,,A,,13903,10090.0,1088.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627888,50594,,Urine,,A,,13904,10090.0,1088.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL628057,50594,,Urine,,A,,13905,10090.0,1088.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627405,50594,,Urine,,A,,13906,10090.0,1088.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8050,,
CHEMBL627406,50588,,Urine,,A,,13907,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627407,50588,,Urine,,A,,13908,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627408,50588,,Urine,,A,,13909,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627409,50588,,Urine,,A,,13910,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL875486,50588,,Urine,,A,,13911,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627410,50588,,Urine,,A,,13912,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627411,50588,,Urine,,A,,13913,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627412,50588,,Urine,,A,,13914,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627413,50588,,Urine,,A,,13915,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627414,50588,,Urine,,A,,13916,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627415,50588,,Urine,,A,,13917,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627416,50588,,Urine,,A,,13918,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627417,50588,,Urine,,A,,13919,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627418,50588,,Urine,,A,,13920,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627419,50588,,Urine,,A,,13921,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627320,50588,,Urine,,A,,13922,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627321,50588,,Urine,,A,,13923,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627322,50597,,Kidney,In vivo,A,,13924,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627323,50597,,Kidney,In vivo,A,,13925,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627491,50597,,Kidney,In vivo,A,,13926,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627492,50597,,Kidney,In vivo,A,,13927,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627493,50597,,Kidney,In vivo,A,,13928,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627494,50597,,Liver,In vivo,A,,13929,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627495,50597,,Liver,In vivo,A,,13930,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627496,50597,,Liver,In vivo,A,,13931,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627497,50597,,Liver,In vivo,A,,13932,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627498,50597,,Liver,In vivo,A,,13933,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627499,50597,,Lung,In vivo,A,,13934,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627500,50597,,Lung,In vivo,A,,13935,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627501,50597,,Lung,In vivo,A,,13936,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625616,50597,,Lung,In vivo,A,,13937,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625617,50597,,Lung,In vivo,A,,13938,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625618,50597,,Muscle tissue,In vivo,A,,13939,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625619,50597,,Muscle tissue,In vivo,A,,13940,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625620,50597,,Muscle tissue,In vivo,A,,13941,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625621,50597,,Muscle tissue,In vivo,A,,13942,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625622,50597,,Muscle tissue,In vivo,A,,13943,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625788,50597,,Spleen,In vivo,A,,13944,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625789,50597,,Spleen,In vivo,A,,13945,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625790,50597,,Spleen,In vivo,A,,13946,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL625791,50597,,Spleen,In vivo,A,,13947,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL622334,50597,,Spleen,In vivo,A,,13948,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL622335,50597,,Thyroid gland,In vivo,A,,13949,10116.0,2046.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL622336,50597,,Thyroid gland,In vivo,A,,13950,10116.0,2046.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL622337,50597,,Thyroid gland,In vivo,A,,13951,10116.0,2046.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL622338,50597,,Thyroid gland,In vivo,A,,13952,10116.0,2046.0,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL622339,50597,,Thyroid gland,In vivo,A,,13953,10116.0,2046.0,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL624153,50597,,,In vivo,A,,13954,10116.0,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL628430,50597,,,In vivo,A,,13955,10116.0,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL628431,50597,,,In vivo,A,,13956,10116.0,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL628432,50597,,,In vivo,A,,13957,10116.0,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL628433,50597,,,In vivo,A,,13958,10116.0,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL628434,50597,,Spleen,In vivo,A,,13959,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL626789,50597,,Spleen,In vivo,A,,13960,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL626790,50597,,Spleen,In vivo,A,,13961,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL626791,50597,,Spleen,In vivo,A,,13962,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL626792,50597,,Spleen,In vivo,A,,13963,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL626793,50597,,Spleen,In vivo,A,,13964,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL627436,50597,,,,A,,13965,10116.0,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627437,50597,,,,A,,13966,10116.0,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627438,50597,,,,A,,13967,10116.0,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627439,50597,,,,A,,13968,10116.0,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627440,50597,,,,A,,13969,10116.0,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627602,50597,,,,A,,13970,10116.0,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627603,50597,,,,A,,13971,10116.0,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627604,50597,,,,A,,13972,10116.0,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627605,50597,,,,A,,13973,10116.0,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627606,50597,,,,A,,13974,10116.0,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627607,50597,,,,A,,13975,10116.0,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627608,50597,,,,A,,13976,10116.0,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627609,50597,,,,A,,13977,10116.0,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627610,50597,,,,A,,13978,10116.0,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627611,50597,,,,A,,13979,10116.0,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627612,50597,,,,A,,13980,10116.0,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL627613,22229,,,,P,,13981,,,Octanol:water partition coefficient is evaluated,U,,0,,Autocuration,1,BAO_0000100,,,8362,,
CHEMBL627614,22224,,,,P,,13982,,,Partition coefficient in 1-octanol/water system,U,,0,,Autocuration,1,BAO_0000100,,,8257,,
CHEMBL627615,22224,,,,P,,13983,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,U,,0,,Autocuration,1,BAO_0000100,,,8257,,
CHEMBL627616,22224,,,,P,,13984,,,Partition coefficient in octanol/water system was determined,U,,0,,Autocuration,1,BAO_0000100,,,9468,,
CHEMBL627617,22224,,,,P,,13985,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,U,,0,,Autocuration,1,BAO_0000100,,,9468,,
CHEMBL627618,22224,,,,A,,13986,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,10568,,
CHEMBL627619,22224,,,,A,,13987,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,10568,,
CHEMBL627620,22224,,,,A,,13988,,,Pseudo-first-order rate constant of the compound,U,,0,,Autocuration,1,BAO_0000019,,,15359,,
CHEMBL627621,22224,,,,A,,13989,,,Pseudo-first-order rate constant with 1-min time point,U,,0,,Autocuration,1,BAO_0000019,,,15359,,
CHEMBL627622,22224,,,,A,,13990,,,Pseudo-first-order rate constant without 1-min time point,U,,0,,Autocuration,1,BAO_0000019,,,15359,,
CHEMBL627623,22224,,,,A,,13991,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,U,,0,,Autocuration,1,BAO_0000019,,,10431,,
CHEMBL627624,22224,,,,A,,13992,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,U,,0,,Autocuration,1,BAO_0000019,,,10431,,
CHEMBL627625,22224,,,,A,,13993,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,U,,0,,Autocuration,1,BAO_0000019,,,10431,,
CHEMBL628523,22224,,,,A,,13994,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,15704,,
CHEMBL628524,22224,,,,A,,13995,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,U,,0,,Autocuration,1,BAO_0000019,,,15287,,
CHEMBL628525,22224,,,,A,,13996,,,The efflux rate constant of the compound,U,,0,,Autocuration,1,BAO_0000019,,,7516,,
CHEMBL625732,22224,,,,A,,13997,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,0,,Autocuration,1,BAO_0000019,,,12973,,
CHEMBL625733,22224,,,,A,,13998,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,0,,Autocuration,1,BAO_0000019,,,12973,,
CHEMBL625734,22224,,,,F,,13999,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,0,,Autocuration,1,BAO_0000019,,,12973,,
CHEMBL625913,22224,,,,A,,14000,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,U,,0,,Autocuration,1,BAO_0000019,,,12973,,
CHEMBL625914,22224,,,,A,,14001,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,U,,0,,Autocuration,1,BAO_0000019,,,8696,,
CHEMBL625915,22224,,,,A,,14002,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,U,,0,,Autocuration,1,BAO_0000019,,,15052,,
CHEMBL625916,22224,,,,A,,14003,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,U,,0,,Autocuration,1,BAO_0000019,,,15052,,
CHEMBL625917,22224,,,,A,,14004,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),U,,0,,Autocuration,1,BAO_0000019,,,10503,,
CHEMBL625918,22224,,,,A,,14005,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625919,22224,,,,A,,14006,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625920,22224,,,,A,,14007,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL874453,22224,,,,A,,14008,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625921,22224,,,,A,,14009,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625922,22224,,,,A,,14010,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,U,,0,,Autocuration,1,BAO_0000019,,,10503,,
CHEMBL625923,22224,,,,A,,14011,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625924,22224,,,,A,,14012,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625925,22224,,,,A,,14013,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL625926,22224,,,,A,,14014,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL627704,50597,,Lung,In vivo,A,,14015,10116.0,2048.0,Biodistribution in rat lung at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL627705,50597,,,In vivo,A,,14016,10116.0,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL627706,50597,,,In vivo,A,,14017,10116.0,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL627707,50597,,,In vivo,A,,14018,10116.0,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL627708,50597,,,In vivo,A,,14019,10116.0,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628361,50597,,,In vivo,A,,14020,10116.0,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628362,50597,,,In vivo,A,,14021,10116.0,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628363,50597,,Striatum,In vivo,A,,14022,10116.0,2435.0,Biodistribution in rat striatum at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628364,50597,,Striatum,In vivo,A,,14023,10116.0,2435.0,Biodistribution in rat striatum at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628365,50597,,Striatum,In vivo,A,,14024,10116.0,2435.0,Biodistribution in rat striatum at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL874454,50597,,Striatum,In vivo,A,,14025,10116.0,2435.0,Biodistribution in rat striatum at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628531,50597,,Striatum,In vivo,A,,14026,10116.0,2435.0,Biodistribution in rat striatum at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628532,50597,,Striatum,In vivo,A,,14027,10116.0,2435.0,Biodistribution in rat striatum at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628533,50597,,Striatum,In vivo,A,,14028,10116.0,2435.0,Biodistribution in rat striatum at 3 hr after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628534,50597,,Striatum,In vivo,A,,14029,10116.0,2435.0,Biodistribution in rat striatum at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628535,50597,,Thyroid gland,In vivo,A,,14030,10116.0,2046.0,Biodistribution in rat thyroid at 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628536,50597,,Thyroid gland,In vivo,A,,14031,10116.0,2046.0,Biodistribution in rat thyroid at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628537,50597,,Thyroid gland,In vivo,A,,14032,10116.0,2046.0,Biodistribution in rat thyroid at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628538,50597,,Thyroid gland,In vivo,A,,14033,10116.0,2046.0,Biodistribution in rat thyroid at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628539,50597,,Thyroid gland,In vivo,A,,14034,10116.0,2046.0,Biodistribution in rat thyroid at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630297,50597,,Thyroid gland,In vivo,A,,14035,10116.0,2046.0,Biodistribution in rat thyroid at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630298,50597,,Thyroid gland,In vivo,A,,14036,10116.0,2046.0,Biodistribution in rat thyroid at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL630299,50597,,Brain,In vivo,A,,14037,10116.0,955.0,Biodistribution in rest of brain of rat 120 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628094,50597,,Brain,In vivo,A,,14038,10116.0,955.0,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628095,50597,,Brain,In vivo,A,,14039,10116.0,955.0,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL874648,50597,,Brain,In vivo,A,,14040,10116.0,955.0,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628096,50597,,Brain,In vivo,A,,14041,10116.0,955.0,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628097,50597,,Brain,In vivo,A,,14042,10116.0,955.0,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628098,50597,,Brain,In vivo,A,,14043,10116.0,955.0,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13100,,
CHEMBL628099,22224,,,,A,,14044,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628100,22224,,,,A,,14045,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628101,22224,,,,A,,14046,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628102,22224,,,,A,,14047,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628103,22224,,,,A,,14048,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628104,22224,,,,A,,14049,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628105,22224,,,,A,,14050,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628106,22224,,,,A,,14051,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",U,,0,,Autocuration,1,BAO_0000019,,,13331,,
CHEMBL628107,50597,,Urine,,A,,14052,10116.0,1088.0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10086,,
CHEMBL628108,22224,,Urine,,F,,14053,,1088.0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,U,,0,,Autocuration,1,BAO_0000218,,,10086,,
CHEMBL628109,50597,,Urine,,A,,14054,10116.0,1088.0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10086,,
CHEMBL625299,22224,,Urine,,F,,14055,,1088.0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,U,,0,,Autocuration,1,BAO_0000218,,,10086,,
CHEMBL625300,50597,,Urine,,A,,14056,10116.0,1088.0,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10086,,
CHEMBL625301,50597,,Urine,,A,,14057,10116.0,1088.0,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10086,,
CHEMBL625302,50597,,Urine,,A,,14058,10116.0,1088.0,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10086,,
CHEMBL874649,50597,,Urine,,A,,14059,10116.0,1088.0,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10086,,
CHEMBL625303,50597,,,,A,,14060,10116.0,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13248,,
CHEMBL625463,50597,,,,A,,14061,10116.0,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13248,,
CHEMBL625464,50587,,Liver,,A,,14062,9606.0,2107.0,In vitro metabolism in human liver microsomes,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14527,,
CHEMBL625465,50587,,,,A,,14063,9606.0,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,3008,,
CHEMBL625466,50588,,Urine,,A,,14064,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625467,50588,,Urine,,A,,14065,9615.0,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625468,50597,,Urine,,A,,14066,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625469,50597,,Urine,,A,,14067,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625470,50597,,Urine,,A,,14068,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL632418,50597,,Urine,,A,,14069,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627250,50597,,Urine,,A,,14070,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627251,50597,,Urine,,A,,14071,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627252,50597,,Urine,,A,,14072,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627253,50597,,Urine,,A,,14073,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627254,50597,,Urine,,A,,14074,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL875471,50597,,Urine,,A,,14075,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627255,50597,,Urine,,A,,14076,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627256,50597,,Urine,,A,,14077,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627257,50597,,Urine,,A,,14078,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627258,50597,,Urine,,A,,14079,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627259,50597,,Urine,,A,,14080,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627260,50597,,Urine,,A,,14081,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623256,50597,,Urine,,A,,14082,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL874413,50597,,Urine,,A,,14083,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623257,50597,,Urine,,A,,14084,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623258,50597,,Urine,,A,,14085,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623259,50597,,Urine,,A,,14086,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623260,50597,,Urine,,A,,14087,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623261,50597,,Urine,,A,,14088,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623262,50597,,Urine,,A,,14089,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623263,50597,,Urine,,A,,14090,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623264,50597,,Urine,,A,,14091,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623265,50597,,Urine,,A,,14092,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623266,50597,,Urine,,A,,14093,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623267,50597,,Urine,,A,,14094,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623268,50597,,Urine,,A,,14095,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623269,50597,,Urine,,A,,14096,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623270,50597,,Urine,,A,,14097,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623271,50597,,Urine,,A,,14098,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623272,50597,,Urine,,A,,14099,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623273,50597,,Urine,,A,,14100,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623274,50597,,Urine,,A,,14101,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL874414,50597,,Urine,,A,,14102,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623275,50597,,Urine,,A,,14103,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL629150,50597,,Urine,,A,,14104,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623276,50597,,Urine,,A,,14105,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623277,50597,,Urine,,A,,14106,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623112,50597,,Urine,,A,,14107,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623113,50597,,Urine,,A,,14108,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623800,50597,,Urine,,A,,14109,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623801,50597,,Urine,,A,,14110,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623802,50597,,Spleen,In vivo,A,,14111,10116.0,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623803,50597,,Uterus,In vivo,A,,14112,10116.0,995.0,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623970,50597,,Uterus,In vivo,A,,14113,10116.0,995.0,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623971,50597,,Uterus,In vivo,A,,14114,10116.0,995.0,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL623972,50597,,Blood,In vivo,A,,14115,10116.0,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623973,50597,,Blood,In vivo,A,,14116,10116.0,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623974,50597,,Blood,In vivo,A,,14117,10116.0,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623975,50597,,Blood,In vivo,A,,14118,10116.0,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623976,50597,,Brain,In vivo,A,,14119,10116.0,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623977,50597,,Brain,In vivo,A,,14120,10116.0,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623978,50597,,Brain,In vivo,A,,14121,10116.0,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623979,50597,,Brain,In vivo,A,,14122,10116.0,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623980,50597,,,In vivo,A,,14123,10116.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL623981,50597,,,In vivo,A,,14124,10116.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL626278,50597,,,In vivo,A,,14125,10116.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL626279,50597,,,In vivo,A,,14126,10116.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14045,,
CHEMBL626280,50594,,,In vivo,A,,14127,10090.0,,Biodistribution in mice bladder plus excreted urine was determined,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626281,50594,,,,A,,14128,10090.0,,"Percentage biodistribution in mouse blood, 10 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626282,50594,,,,A,,14129,10090.0,,"Percentage biodistribution in mouse blood, 30 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626283,50594,,,,A,,14130,10090.0,,"Percentage biodistribution in mouse blood, 5 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626284,50594,,,,A,,14131,10090.0,,"Percentage biodistribution in mouse blood, 60 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626285,50594,,Brain,,A,,14132,10090.0,955.0,"Percentage biodistribution in mouse brain, 10 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626286,50594,,Brain,,A,,14133,10090.0,955.0,"Percentage biodistribution in mouse brain, 30 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626287,50594,,Brain,,A,,14134,10090.0,955.0,"Percentage biodistribution in mouse brain, 5 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626288,50594,,Brain,,A,,14135,10090.0,955.0,"Percentage biodistribution in mouse brain, 60 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626289,50594,,,,A,,14136,10090.0,,"Percentage biodistribution in mouse heart, 10 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626290,50594,,,,A,,14137,10090.0,,"Percentage biodistribution in mouse heart, 30 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626291,50594,,,,A,,14138,10090.0,,"Percentage biodistribution in mouse heart, 5 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL839888,50594,,,,A,,14139,10090.0,,"Percentage biodistribution in mouse heart, 60 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626292,50594,,Intestine,,A,,14140,10090.0,160.0,"Percentage biodistribution in mouse intestine, 10 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626293,50594,,Intestine,,A,,14141,10090.0,160.0,"Percentage biodistribution in mouse intestine, 30 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626294,50594,,Intestine,,A,,14142,10090.0,160.0,"Percentage biodistribution in mouse intestine, 5 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL626295,50594,,Intestine,,A,,14143,10090.0,160.0,"Percentage biodistribution in mouse intestine, 60 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627659,50594,,Liver,,A,,14144,10090.0,2107.0,"Percentage biodistribution in mouse liver, 10 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627660,50594,,Liver,,A,,14145,10090.0,2107.0,"Percentage biodistribution in mouse liver, 30 minutes of post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627661,50594,,Liver,,A,,14146,10090.0,2107.0,"Percentage biodistribution in mouse liver, 5 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627662,50594,,Liver,In vivo,A,,14147,10090.0,2107.0,Biodistribution in mice liver at 60 minutes of post injection,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627663,50594,,Lung,In vivo,A,,14148,10090.0,2048.0,Biodistribution in mice lungs at 10 min of post injection,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627664,50594,,,,A,,14149,10090.0,,"Percentage biodistribution in mouse lung, 30 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627665,50594,,,,A,,14150,10090.0,,"Percentage biodistribution in mousee lung, 5 minutes post injection",N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627666,50594,,Lung,In vivo,A,,14151,10090.0,2048.0,Biodistribution in mice lungs at 60 min of post injection,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627667,50594,,Spleen,,A,,14152,10090.0,2106.0,Percentage biodistribution in mouse spleen,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627668,50594,,Stomach,,A,,14153,10090.0,945.0,Percentage biodistribution in mouse stomach,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14045,,
CHEMBL627669,50594,,Urine,,A,,14154,10090.0,1088.0,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,11745,,
CHEMBL627670,22224,,Urinary bladder,In vivo,A,,14155,,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627671,22224,,Blood,In vivo,A,,14156,,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627672,22224,,Bone element,In vivo,A,,14157,,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627673,22224,,,In vivo,A,,14158,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627674,22224,,Kidney,In vivo,A,,14159,,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627675,22224,,Liver,In vivo,A,,14160,,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627676,22224,,Lung,In vivo,A,,14161,,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627677,22224,,Muscle tissue,In vivo,A,,14162,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627678,22224,,,,A,,14163,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL627679,50597,,Serum,,A,,14164,10116.0,1977.0,Affinity for protein binding expressed as association constant in fresh rat serum,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7095,,
CHEMBL627680,22224,,,,A,,14165,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,0,,Autocuration,1,BAO_0000019,,,12185,,
CHEMBL627681,22224,,,,A,,14166,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,0,,Autocuration,1,BAO_0000019,,,12185,,
CHEMBL627682,22224,,,,A,,14167,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,0,,Autocuration,1,BAO_0000019,,,12185,,
CHEMBL627683,22224,,,,A,,14168,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,0,,Autocuration,1,BAO_0000019,,,12185,,
CHEMBL627684,22224,,,,A,,14169,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,U,,0,,Autocuration,1,BAO_0000019,,,12686,,
CHEMBL874441,22224,,,,A,,14170,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,0,,Autocuration,1,BAO_0000019,,,12686,,
CHEMBL627685,22224,,,,A,,14171,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,U,,0,,Autocuration,1,BAO_0000019,,,12686,,
CHEMBL627686,22224,,,,A,,14172,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,0,,Autocuration,1,BAO_0000019,,,12686,,
CHEMBL627687,22224,,,,A,,14173,,,Apparent rate constant Koff for inactivation of dTMP synthase.,U,,0,,Autocuration,1,BAO_0000019,,,8057,,
CHEMBL627688,22224,,,,A,,14174,,,The irreversible inhibitor activity by second order rate equation.,U,,0,,Autocuration,1,BAO_0000019,,,15778,,
CHEMBL628038,50597,,,,A,,14175,10116.0,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12375,,
CHEMBL628039,50597,,,,A,,14176,10116.0,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12375,,
CHEMBL628040,50597,,,,A,,14177,10116.0,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12375,,
CHEMBL628041,22224,,,,A,,14178,,,Dissociation rate calculated from the first-order equation using t1/2 value,U,,0,,Autocuration,1,BAO_0000019,,,13588,,
CHEMBL630226,22224,,,,A,,14179,,,The compound was tested for Binding constant against DNA,U,,0,,Autocuration,1,BAO_0000019,,,15039,,
CHEMBL628042,22224,,,,A,,14180,,,First order rate constant for cyclization of the compound,U,,0,,Autocuration,1,BAO_0000019,,,9500,,
CHEMBL625232,22224,,,,A,,14181,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,0,,Autocuration,1,BAO_0000019,,,10014,,
CHEMBL625233,22224,,,,A,,14182,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,0,,Autocuration,1,BAO_0000019,,,10014,,
CHEMBL625979,22224,,,,A,,14183,,,Hydrolysis rate constant was determined,U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL625980,22224,,,,A,,14184,,,Observed first order rate constant,U,,0,,Autocuration,1,BAO_0000019,,,10026,,
CHEMBL625981,22224,,,,A,,14185,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,0,,Autocuration,1,BAO_0000019,,,10281,,
CHEMBL625982,22224,,,,A,,14186,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,0,,Autocuration,1,BAO_0000019,,,10281,,
CHEMBL625983,22224,,,,A,,14187,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL625984,22224,,,,A,,14188,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625985,22224,,,,A,,14189,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625986,22224,,,,A,,14190,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625987,22224,,,,A,,14191,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625988,22224,,,,A,,14192,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625989,22224,,,,A,,14193,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625990,22224,,,,A,,14194,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625991,22224,,,,A,,14195,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625992,22224,,,,A,,14196,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL625993,22224,,,,A,,14197,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL631973,22224,,,,A,,14198,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632143,22224,,,,A,,14199,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632144,22224,,,,A,,14200,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632145,22224,,,,A,,14201,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632146,22224,,,,A,,14202,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632147,22224,,,,A,,14203,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632148,22224,,,,A,,14204,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632149,22224,,,,A,,14205,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632150,22224,,,,A,,14206,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632151,22224,,,,A,,14207,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL632152,50587,,,,A,,14208,9606.0,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,3008,,
CHEMBL632153,50587,,,,A,,14209,9606.0,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,4509,,
CHEMBL632154,50587,,,,A,,14210,9606.0,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,4509,,
CHEMBL632155,50602,,,,A,,14211,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL632156,50602,,,,A,,14212,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL632157,50602,,,,A,,14213,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL632158,50602,,,,A,,14214,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL632159,50602,,,,A,,14215,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626305,50602,,,,A,,14216,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626306,50602,,,,A,,14217,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626307,50602,,,,A,,14218,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626308,50602,,,,A,,14219,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626479,50602,,,,A,,14220,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626480,50602,,,,A,,14221,10298.0,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,N,,1,,Intermediate,1,BAO_0000218,,Human herpesvirus 1,8613,,
CHEMBL626481,22229,,,,P,,14222,,,Calculated partition coefficient (clogP) (MlogP),U,,0,,Autocuration,1,BAO_0000100,,,6021,,
CHEMBL626482,22224,,,,A,,14223,,,Equipotent potent ratio relative to carbachol (nicotinic activity),U,,0,,Autocuration,1,BAO_0000019,,,9348,,
CHEMBL626483,50588,,,,A,,14224,9615.0,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL626484,50588,,,,A,,14225,9615.0,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL626485,22229,,,,P,,14226,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,U,,0,,Autocuration,1,BAO_0000100,,,15592,,
CHEMBL626486,22229,,,,P,,14227,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,U,,0,,Autocuration,1,BAO_0000100,,,15592,,
CHEMBL626487,22229,,,,P,,14228,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,U,,0,,Autocuration,1,BAO_0000100,,,15592,,
CHEMBL626488,50588,,Plasma,In vivo,A,,14229,9615.0,1969.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,15592,,
CHEMBL626489,50597,,Serum,,A,,14230,10116.0,1977.0,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7095,,
CHEMBL626490,22224,,,,A,,14231,,,Area under the MAP curve measured over 5 min; ND means Not determined,U,,0,,Autocuration,1,BAO_0000019,,,16618,,
CHEMBL626491,22224,,,,P,,14232,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,U,,0,,Autocuration,1,BAO_0000100,,,16835,,
CHEMBL626492,22229,,,,P,,14233,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,U,,0,,Autocuration,1,BAO_0000100,,,15284,,
CHEMBL626493,22224,,,,A,,14234,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,U,,0,,Autocuration,1,BAO_0000019,,,15750,,
CHEMBL626494,50597,,,In vivo,A,,14235,10116.0,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16618,,
CHEMBL626495,22224,,,In vivo,A,,14236,,,Half life after oral tested,U,,0,,Autocuration,1,BAO_0000218,,,16618,,
CHEMBL626496,50597,,Plasma,,A,,14237,10116.0,1969.0,Half life was determined in plasma of rat; NT indicates not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15812,,
CHEMBL626497,50597,,,In vivo,A,,14238,10116.0,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,16618,,
CHEMBL626498,22224,,,In vivo,A,,14239,,,Oral bioavailability after oral tested,U,,0,,Autocuration,1,BAO_0000218,,,16618,,
CHEMBL626499,50597,,,,A,,14240,10116.0,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13098,,
CHEMBL626500,50597,,,,A,,14241,10116.0,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13098,,
CHEMBL626501,50597,,Plasma,,A,,14242,10116.0,1969.0,half life was determined in plasma of rat; NT indicates not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15812,,
CHEMBL626502,50597,,Plasma,,A,,14243,10116.0,1969.0,half life was determined in plasma of rat; NT means not tested,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15812,,
CHEMBL626503,50597,,,,A,,14244,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626504,50597,,,,A,,14245,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626505,50597,,,,A,,14246,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626506,50597,,,,A,,14247,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626507,50597,,,,A,,14248,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626508,50597,,,,A,,14249,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626509,50597,,,,A,,14250,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL875480,50597,,,,A,,14251,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626510,50597,,,,A,,14252,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626511,50597,,,,A,,14253,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL626512,50597,,,,A,,14254,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628208,50597,,,,A,,14255,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628209,50597,,,,A,,14256,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628210,50597,,,,A,,14257,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628211,50597,,,,A,,14258,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628212,50597,,,,A,,14259,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628213,50597,,,,A,,14260,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL628214,50597,,Urine,,A,,14261,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628215,50597,,Urine,,A,,14262,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628216,50597,,Urine,,A,,14263,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626595,50597,,Urine,,A,,14264,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626596,50597,,Urine,,A,,14265,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626597,50597,,Urine,,A,,14266,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626598,50597,,Urine,,A,,14267,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622242,50597,,Urine,,A,,14268,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622243,50597,,Urine,,A,,14269,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622244,50597,,Urine,,A,,14270,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622245,50597,,Urine,,A,,14271,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622246,50597,,Urine,,A,,14272,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622247,50597,,Urine,,A,,14273,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622248,50597,,Urine,,A,,14274,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL877483,50597,,Urine,,A,,14275,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622249,50597,,Urine,,A,,14276,10116.0,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL622250,50588,,Urine,,A,,14277,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622251,50588,,Urine,,A,,14278,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622252,50588,,Urine,,A,,14279,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622253,50588,,Urine,,A,,14280,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622254,50588,,Urine,,A,,14281,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622255,50588,,Urine,,A,,14282,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622256,50588,,Urine,,A,,14283,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622257,50588,,Urine,,A,,14284,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622258,50588,,Urine,,A,,14285,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622259,50588,,Urine,,A,,14286,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622927,50588,,Urine,,A,,14287,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622928,50588,,Urine,,A,,14288,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL622929,50588,,Urine,,A,,14289,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL623182,50588,,Urine,,A,,14290,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL623183,50588,,Urine,,A,,14291,9615.0,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL623184,50597,,Urine,,A,,14292,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623185,50597,,Urine,,A,,14293,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL877484,50597,,Urine,,A,,14294,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL627274,50597,,Urine,,A,,14295,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623186,50597,,Urine,,A,,14296,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623187,50597,,Urine,,A,,14297,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL623188,50597,,Urine,,A,,14298,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628055,50597,,Urine,,A,,14299,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628056,50597,,Urine,,A,,14300,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628200,50597,,Urine,,A,,14301,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628201,50597,,Urine,,A,,14302,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628202,50597,,Urine,,A,,14303,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628203,50597,,Urine,,A,,14304,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628204,50597,,Urine,,A,,14305,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628205,50597,,Urine,,A,,14306,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628206,50597,,Urine,,A,,14307,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628207,22224,,Prostate gland,In vivo,A,,14308,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627220,22224,,Prostate gland,In vivo,A,,14309,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627221,22224,,Muscle tissue,In vivo,A,,14310,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627222,22224,,Prostate gland,In vivo,A,,14311,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627223,22224,,,In vivo,A,,14312,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL632062,22224,,Muscle tissue,In vivo,A,,14313,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL632063,22224,,Spleen,In vivo,A,,14314,,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL632064,22224,,Urinary bladder,In vivo,A,,14315,,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL632065,22224,,Blood,In vivo,A,,14316,,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL632066,22224,,Bone element,In vivo,A,,14317,,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL632067,22224,,,In vivo,A,,14318,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629188,22224,,Kidney,In vivo,A,,14319,,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629189,22224,,Liver,In vivo,A,,14320,,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629190,22224,,Lung,In vivo,A,,14321,,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629191,22224,,Muscle tissue,In vivo,A,,14322,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629192,22224,,Prostate gland,In vivo,A,,14323,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629193,22224,,Muscle tissue,In vivo,A,,14324,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629194,22224,,Prostate gland,In vivo,A,,14325,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629195,22224,,,In vivo,A,,14326,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629373,22224,,Muscle tissue,In vivo,A,,14327,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629374,22224,,Spleen,In vivo,A,,14328,,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629375,22224,,Prostate gland,In vivo,A,,14329,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629376,22224,,Urinary bladder,In vivo,A,,14330,,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629377,22224,,Blood,In vivo,A,,14331,,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629378,22224,,Bone element,In vivo,A,,14332,,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629379,22224,,,In vivo,A,,14333,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629151,22224,,Kidney,In vivo,A,,14334,,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629152,22224,,Liver,In vivo,A,,14335,,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629153,22224,,Lung,In vivo,A,,14336,,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629154,22224,,Muscle tissue,In vivo,A,,14337,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629155,22224,,Prostate gland,In vivo,A,,14338,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629156,22224,,Prostate gland,In vivo,A,,14339,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629157,22224,,Muscle tissue,In vivo,A,,14340,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629158,22224,,Prostate gland,In vivo,A,,14341,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629159,22224,,,In vivo,A,,14342,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629160,22224,,Muscle tissue,In vivo,A,,14343,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629161,22224,,Spleen,In vivo,A,,14344,,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629162,22224,,Urinary bladder,In vivo,A,,14345,,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629163,22224,,Blood,In vivo,A,,14346,,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629164,22224,,Bone element,In vivo,A,,14347,,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629165,22224,,,In vivo,A,,14348,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629166,22224,,Liver,In vivo,A,,14349,,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629167,22224,,Lung,In vivo,A,,14350,,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629168,22224,,Muscle tissue,In vivo,A,,14351,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL629169,22224,,,,A,,14352,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,U,,0,,Autocuration,1,BAO_0000019,,,2193,,
CHEMBL629170,22224,,,,A,,14353,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,U,,0,,Autocuration,1,BAO_0000019,,,2193,,
CHEMBL631153,22224,,,,A,,14354,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,U,,0,,Autocuration,1,BAO_0000019,,,2193,,
CHEMBL875121,22224,,,,A,,14355,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,U,,0,,Autocuration,1,BAO_0000019,,,2193,,
CHEMBL631154,22224,,,,A,,14356,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,U,,0,,Autocuration,1,BAO_0000019,,,2193,,
CHEMBL631155,22224,,,,A,,14357,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,U,,0,,Autocuration,1,BAO_0000019,,,2193,,
CHEMBL631156,22224,,,,A,,14358,,,Hydrolysis rate constant was determined,U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL631157,22224,,,,A,,14359,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL631158,22224,,,,A,,14360,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL631159,22224,,,,A,,14361,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL631160,22224,,,,A,,14362,,,Observed second order rate constant,U,,0,,Autocuration,1,BAO_0000019,,,10026,,
CHEMBL631161,22224,,,,A,,14363,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,0,,Autocuration,1,BAO_0000019,,,10281,,
CHEMBL631162,22224,,,,A,,14364,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,0,,Autocuration,1,BAO_0000019,,,10014,,
CHEMBL630313,22224,,,,A,,14365,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,0,,Autocuration,1,BAO_0000019,,,10014,,
CHEMBL630314,22224,,,,A,,14366,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL630315,22224,,,,A,,14367,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL630316,22224,,,,A,,14368,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630986,22224,,,,A,,14369,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630987,22224,,,,A,,14370,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630988,22224,,,,A,,14371,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630989,22224,,,,A,,14372,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630990,22224,,,,A,,14373,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630991,22224,,,,A,,14374,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630992,22224,,,,A,,14375,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630993,22224,,,,A,,14376,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630994,22224,,,,A,,14377,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,0,,Autocuration,1,BAO_0000019,,,13028,,
CHEMBL630995,50597,,,,A,,14378,10116.0,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10014,,
CHEMBL629252,22224,,,,A,,14379,,,Association constant for compound at 31 degree C was determined,U,,0,,Autocuration,1,BAO_0000019,,,9962,,
CHEMBL629253,22224,,,,A,,14380,,,Calculated antagonist equilibrium dissociation constant of the compound,U,,0,,Autocuration,1,BAO_0000019,,,12029,,
CHEMBL629944,22224,,,,A,,14381,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,U,,0,,Autocuration,1,BAO_0000019,,,12029,,
CHEMBL629945,50512,,Trachea,,A,,14382,10141.0,3126.0,Dissociation constants vs LTE4 on guinea pig trachea,N,,1,,Intermediate,1,BAO_0000218,,Cavia porcellus,10583,,
CHEMBL629946,22224,,,,A,,14383,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL629947,22224,,,,A,,14384,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL629948,22224,,,,A,,14385,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL856024,22224,,,,A,,14386,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL629949,22224,,,,A,,14387,,,Affinity constant KD value was derived from TMP,U,,0,,Autocuration,1,BAO_0000019,,,7493,,
CHEMBL629950,22224,,,,A,,14388,,,Apparent dissociation (binding) rate constant was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,8371,,
CHEMBL630127,22224,,,,P,,14389,,,Dissociation constant (KD) of the compound,U,,0,,Autocuration,1,BAO_0000100,,,13114,,
CHEMBL630128,22224,,,,P,,14390,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,U,,0,,Autocuration,1,BAO_0000100,,,15515,,
CHEMBL630129,22224,,,,P,,14391,,,Dissociation constant from ESR titration experiments,U,,0,,Autocuration,1,BAO_0000100,,,522,,
CHEMBL630130,22224,,,,,,14392,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),U,,0,,Autocuration,1,BAO_0000019,,,13888,,
CHEMBL875234,22224,,,,P,,14393,,,Dissociation constant was evaluated.,U,,0,,Autocuration,1,BAO_0000100,,,2616,,
CHEMBL630131,22224,,,,P,,14394,,,Dissociation constant was reported,U,,0,,Autocuration,1,BAO_0000100,,,3798,,
CHEMBL630132,50597,,,,A,,14395,10116.0,,Dissociation constant was determined in rat pituitary cells.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,8731,,
CHEMBL630133,22224,,,,A,,14396,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,U,,0,,Autocuration,1,BAO_0000019,,,11892,,
CHEMBL630134,22224,,,,A,,14397,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,U,,0,,Autocuration,1,BAO_0000019,,,11892,,
CHEMBL630135,22224,,,,A,,14398,,,Equilibrium dissociation constant of the compound,U,,0,,Autocuration,1,BAO_0000019,,,2582,,
CHEMBL630136,22224,,,,A,,14399,,,Equilibrium dissociation constant was determined,U,,0,,Autocuration,1,BAO_0000019,,,11892,,
CHEMBL630137,22224,,,,A,,14400,,,Kinetic constant KD was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,13396,,
CHEMBL630138,22224,,,,A,,14401,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,U,,0,,Autocuration,1,BAO_0000019,,,603,,
CHEMBL630139,22224,,,,A,,14402,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,U,,0,,Autocuration,1,BAO_0000019,,,15673,,
CHEMBL630140,22224,,,,A,,14403,,,Rate constant for hydrolysis in aqueous acetone.,U,,0,,Autocuration,1,BAO_0000019,,,10368,,
CHEMBL875235,22224,,,,A,,14404,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,U,,0,,Autocuration,1,BAO_0000019,,,14228,,
CHEMBL876439,50597,,,,A,,14405,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630605,50597,,,,A,,14406,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630606,50597,,,,A,,14407,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630607,50597,,,,A,,14408,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630608,50597,,,,A,,14409,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630609,50597,,,,A,,14410,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630610,50597,,,,A,,14411,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL630611,50597,,,,A,,14412,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629552,50597,,,,A,,14413,10116.0,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629733,50597,,,,A,,14414,10116.0,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629734,50597,,,,A,,14415,10116.0,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629735,50597,,,,A,,14416,10116.0,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629736,50597,,,,A,,14417,10116.0,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629737,50597,,,,A,,14418,10116.0,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629738,50597,,,,A,,14419,10116.0,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629739,50597,,,,A,,14420,10116.0,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629740,50597,,,,A,,14421,10116.0,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629741,50597,,,,A,,14422,10116.0,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629742,50597,,,,A,,14423,10116.0,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629743,50597,,,,A,,14424,10116.0,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629744,50597,,,,A,,14425,10116.0,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629745,50597,,,,A,,14426,10116.0,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629746,50597,,,,A,,14427,10116.0,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629747,50597,,,,A,,14428,10116.0,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629748,50597,,,,A,,14429,10116.0,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629749,50597,,,,A,,14430,10116.0,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629750,50597,,,,A,,14431,10116.0,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629751,50597,,,,A,,14432,10116.0,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629752,50597,,,,A,,14433,10116.0,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629753,50597,,,,A,,14434,10116.0,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629754,50597,,,,A,,14435,10116.0,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629755,50597,,,,A,,14436,10116.0,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629756,50597,,,,A,,14437,10116.0,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629757,50597,,,,A,,14438,10116.0,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629758,50597,,,,A,,14439,10116.0,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629759,50597,,,,A,,14440,10116.0,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629760,50597,,,,A,,14441,10116.0,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL876443,50597,,,,A,,14442,10116.0,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11510,,
CHEMBL629761,50588,,,,A,,14443,9615.0,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8310,,
CHEMBL629762,50588,,,,A,,14444,9615.0,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8310,,
CHEMBL629763,50594,,,,A,,14445,10090.0,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629764,50594,,,,A,,14446,10090.0,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629765,50594,,,,A,,14447,10090.0,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629766,50594,,,,A,,14448,10090.0,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629767,50594,,,,A,,14449,10090.0,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629768,50588,,,,A,,14450,9615.0,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8310,,
CHEMBL629769,50594,,,,A,,14451,10090.0,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629770,50588,,,,A,,14452,9615.0,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8310,,
CHEMBL629771,50588,,,,A,,14453,9615.0,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,8310,,
CHEMBL629772,50594,,,,A,,14454,10090.0,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL629773,50594,,,,A,,14455,10090.0,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL625455,50594,,,,A,,14456,10090.0,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL625456,50594,,,,A,,14457,10090.0,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL625457,50594,,,,A,,14458,10090.0,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,8310,,
CHEMBL625458,50597,,Urine,,A,,14459,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625459,50597,,Urine,,A,,14460,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL875483,50597,,Urine,,A,,14461,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL634779,50597,,Urine,,A,,14462,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625460,50597,,Urine,,A,,14463,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626117,50597,,Urine,,A,,14464,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626118,50597,,Urine,,A,,14465,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628342,50597,,Urine,,A,,14466,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628343,50597,,Urine,,A,,14467,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628344,50597,,Urine,,A,,14468,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628345,50597,,Urine,,A,,14469,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628346,50597,,Urine,,A,,14470,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628347,50597,,Urine,,A,,14471,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628348,50597,,Urine,,A,,14472,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628349,50597,,Urine,,A,,14473,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL875611,50597,,Urine,,A,,14474,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628350,50597,,Urine,,A,,14475,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628351,50597,,Urine,,A,,14476,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628352,50597,,Urine,,A,,14477,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628353,50597,,Urine,,A,,14478,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628354,50597,,Urine,,A,,14479,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626667,50597,,Urine,,A,,14480,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626668,50597,,Urine,,A,,14481,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626669,50597,,Urine,,A,,14482,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626670,50597,,Urine,,A,,14483,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626671,50597,,Urine,,A,,14484,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626672,50597,,Urine,,A,,14485,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626673,50597,,Urine,,A,,14486,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626674,50597,,Urine,,A,,14487,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626675,50597,,Urine,,A,,14488,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626676,50597,,Urine,,A,,14489,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626677,50597,,Urine,,A,,14490,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626678,50597,,Urine,,A,,14491,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626679,50597,,Urine,,A,,14492,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL875612,50597,,Urine,,A,,14493,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626680,50597,,Urine,,A,,14494,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626681,50597,,Urine,,A,,14495,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626682,50597,,Urine,,A,,14496,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626683,50597,,Urine,,A,,14497,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626684,50597,,Urine,,A,,14498,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626685,50597,,Urine,,A,,14499,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626686,50597,,Urine,,A,,14500,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626687,50597,,Urine,,A,,14501,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL624978,50597,,Urine,,A,,14502,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL624979,50597,,Urine,,A,,14503,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL624980,50597,,Urine,,A,,14504,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL624981,50597,,Urine,,A,,14505,10116.0,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL624982,50588,,Urine,,A,,14506,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627564,22224,,Prostate gland,In vivo,A,,14507,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627565,22224,,Prostate gland,In vivo,A,,14508,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627566,22224,,,In vivo,A,,14509,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627567,22224,,Muscle tissue,In vivo,A,,14510,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627568,22224,,Spleen,In vivo,A,,14511,,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627569,22224,,Kidney,In vivo,A,,14512,,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627570,22224,,Urinary bladder,In vivo,A,,14513,,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627571,22224,,Blood,In vivo,A,,14514,,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627572,22224,,Bone element,In vivo,A,,14515,,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627573,22224,,,In vivo,A,,14516,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627574,22224,,Kidney,In vivo,A,,14517,,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627575,22224,,Liver,In vivo,A,,14518,,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627576,22224,,Lung,In vivo,A,,14519,,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627577,22224,,Muscle tissue,In vivo,A,,14520,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627578,22224,,Prostate gland,In vivo,A,,14521,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627579,22224,,Prostate gland,In vivo,A,,14522,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627580,22224,,Muscle tissue,In vivo,A,,14523,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627581,22224,,Prostate gland,In vivo,A,,14524,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627582,22224,,,In vivo,A,,14525,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627583,22224,,Muscle tissue,In vivo,A,,14526,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627584,22224,,Spleen,In vivo,A,,14527,,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627585,22224,,Prostate gland,In vivo,A,,14528,,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627586,22224,,Muscle tissue,In vivo,A,,14529,,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,U,,0,,Autocuration,1,BAO_0000218,,,13257,,
CHEMBL627587,50597,,,In vivo,A,,14530,10116.0,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL627588,50597,,,In vivo,A,,14531,10116.0,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628250,50597,,,In vivo,A,,14532,10116.0,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628251,50597,,,In vivo,A,,14533,10116.0,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628252,50597,,Hippocampus,In vivo,A,,14534,10116.0,10000000.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628253,50597,,Hippocampus,In vivo,A,,14535,10116.0,10000000.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628254,50597,,Hypothalamus,In vivo,A,,14536,10116.0,1898.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL877493,50597,,Hypothalamus,In vivo,A,,14537,10116.0,1898.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628255,50597,,,In vivo,A,,14538,10116.0,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628256,50597,,,In vivo,A,,14539,10116.0,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628257,50597,,Hippocampus,In vivo,A,,14540,10116.0,10000000.0,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628258,50597,,Hypothalamus,In vivo,A,,14541,10116.0,1898.0,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628259,50597,,,In vivo,A,,14542,10116.0,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL628429,50597,,,In vivo,A,,14543,10116.0,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL626862,50597,,Hippocampus,In vivo,A,,14544,10116.0,10000000.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL626863,50597,,Hypothalamus,In vivo,A,,14545,10116.0,1898.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625886,50597,,Cerebellum,In vivo,A,,14546,10116.0,2037.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625887,50597,,Cerebellum,In vivo,A,,14547,10116.0,2037.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625888,50597,,,In vivo,A,,14548,10116.0,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625889,50597,,,In vivo,A,,14549,10116.0,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625890,50597,,Hippocampus,In vivo,A,,14550,10116.0,10000000.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625891,50597,,Hippocampus,In vivo,A,,14551,10116.0,10000000.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625892,50597,,Hypothalamus,In vivo,A,,14552,10116.0,1898.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625893,50597,,Hypothalamus,In vivo,A,,14553,10116.0,1898.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625894,50597,,Cerebellum,In vivo,A,,14554,10116.0,2037.0,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625895,50597,,,In vivo,A,,14555,10116.0,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL625896,22224,,,,A,,14556,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,0,,Autocuration,1,BAO_0000019,,,12404,,
CHEMBL625897,22224,,,,A,,14557,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL625898,22224,,,,A,,14558,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL625899,22224,,,,A,,14559,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,0,,Autocuration,1,BAO_0000019,,,568,,
CHEMBL626124,22224,,,,A,,14560,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,0,,Autocuration,1,BAO_0000019,,,12404,,
CHEMBL628500,50212,,,,A,,14561,562.0,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,N,,1,,Intermediate,1,BAO_0000218,,Escherichia coli,7624,,
CHEMBL857856,50597,,,,A,,14562,10116.0,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7624,,
CHEMBL628501,50597,,,,A,,14563,10116.0,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7624,,
CHEMBL628502,22224,,,,A,,14564,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",U,,0,,Autocuration,1,BAO_0000019,,,4643,,
CHEMBL628503,22224,,,,A,,14565,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,U,,0,,Autocuration,1,BAO_0000019,,,11532,,
CHEMBL628504,22224,,,,A,,14566,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,11018,,
CHEMBL628505,22224,,,,A,,14567,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL874452,22224,,,,A,,14568,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL628506,22224,,,,A,,14569,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL628507,22224,,,,A,,14570,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL628508,22224,,,,A,,14571,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL628509,22224,,,,A,,14572,,,Michaelis constant (KM) was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,8949,,
CHEMBL628510,22224,,,,A,,14573,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,0,,Autocuration,1,BAO_0000019,,,12404,,
CHEMBL628511,22224,,,,B,,14574,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,U,,0,,Autocuration,1,BAO_0000019,,,7625,,
CHEMBL628512,22224,,,,B,,14575,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,U,,0,,Autocuration,1,BAO_0000019,,,7625,,
CHEMBL628513,22224,,,,B,,14576,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,U,,0,,Autocuration,1,BAO_0000019,,,7625,,
CHEMBL628514,22224,,,,B,,14577,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,U,,0,,Autocuration,1,BAO_0000019,,,7625,,
CHEMBL628515,22224,,,,A,,14578,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,U,,0,,Autocuration,1,BAO_0000019,,,12908,,
CHEMBL628516,22224,,,,A,,14579,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,U,,0,,Autocuration,1,BAO_0000019,,,10368,,
CHEMBL628517,22224,,,,A,,14580,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,0,,Autocuration,1,BAO_0000019,,,13108,,
CHEMBL628518,22224,,,,A,,14581,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,0,,Autocuration,1,BAO_0000019,,,13108,,
CHEMBL628519,22224,,,,A,,14582,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,U,,0,,Autocuration,1,BAO_0000019,,,15217,,
CHEMBL628520,22224,,,,A,,14583,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,U,,0,,Autocuration,1,BAO_0000019,,,15217,,
CHEMBL628521,22224,,,,A,,14584,,,Binding constant was determined,U,,0,,Autocuration,1,BAO_0000019,,,10933,,
CHEMBL630443,22224,,,,A,,14585,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,2363,,
CHEMBL630444,22224,,,,A,,14586,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,U,,0,,Autocuration,1,BAO_0000019,,,2363,,
CHEMBL857732,22224,,,,A,,14587,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL630445,22224,,,,P,,14588,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,U,,0,,Autocuration,1,BAO_0000100,,,14915,,
CHEMBL630446,22224,,,,A,,14589,,,Catalytic rate constant of the compound,U,,0,,Autocuration,1,BAO_0000019,,,8847,,
CHEMBL630447,22224,,,,B,,14590,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,U,,0,,Autocuration,1,BAO_0000019,,,15357,,
CHEMBL630448,22224,,,,A,,14591,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),U,,0,,Autocuration,1,BAO_0000019,,,2869,,
CHEMBL630449,22224,,,,A,,14592,,,Catalytic rate constant against phospholipase A2 was determined,U,,0,,Autocuration,1,BAO_0000019,,,3484,,
CHEMBL630450,22224,,,,A,,14593,,,"Compound was evaluated for catalytic constant, Kcat",U,,0,,Autocuration,1,BAO_0000019,,,1373,,
CHEMBL630451,22224,,,,A,,14594,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,U,,0,,Autocuration,1,BAO_0000019,,,8142,,
CHEMBL630452,22224,,,,A,,14595,,,Kcat calculated from 0.693/T1/2,U,,0,,Autocuration,1,BAO_0000019,,,14131,,
CHEMBL630453,22224,,,,A,,14596,,,Kcat was determined,U,,0,,Autocuration,1,BAO_0000019,,,17269,,
CHEMBL630454,22224,,,,A,,14597,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,U,,0,,Autocuration,1,BAO_0000019,,,3485,,
CHEMBL630455,22224,,,,A,,14598,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,U,,0,,Autocuration,1,BAO_0000019,,,3485,,
CHEMBL631487,22224,,,,A,,14599,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,U,,0,,Autocuration,1,BAO_0000019,,,3485,,
CHEMBL631488,22224,,,,A,,14600,,,Kcat value was determined,U,,0,,Autocuration,1,BAO_0000019,,,5962,,
CHEMBL876440,22224,,,,A,,14601,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,3133,,
CHEMBL631489,22224,,,,A,,14602,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,3133,,
CHEMBL857742,22224,,,,A,,14603,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL631490,22224,,,,A,,14604,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL631491,22224,,,,A,,14605,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL631492,22224,,,,A,,14606,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL631493,22224,,,,A,,14607,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL631494,22224,,,,A,,14608,,,Kinetic parameter for rate of conversion to PABA was determined,U,,0,,Autocuration,1,BAO_0000019,,,4892,,
CHEMBL631495,22224,,,,A,,14609,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,3133,,
CHEMBL631496,50597,,Feces,,A,,14610,10116.0,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL631497,50597,,Urine,,A,,14611,10116.0,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL631498,50597,,Urine,,A,,14612,10116.0,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL629776,50597,,Urine,,A,,14613,10116.0,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL629777,50597,,Urine,,A,,14614,10116.0,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL629778,50597,,Urine,,A,,14615,10116.0,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630456,50597,,,,A,,14616,10116.0,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630457,50597,,,,A,,14617,10116.0,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630458,50597,,,,A,,14618,10116.0,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630459,50597,,,,A,,14619,10116.0,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630460,50597,,,,A,,14620,10116.0,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL876550,50597,,,,A,,14621,10116.0,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630461,50597,,,,A,,14622,10116.0,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630462,50597,,,,A,,14623,10116.0,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630463,50597,,,,A,,14624,10116.0,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630464,50597,,,,A,,14625,10116.0,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630465,50597,,,,A,,14626,10116.0,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630466,50597,,,,A,,14627,10116.0,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630467,50597,,,,A,,14628,10116.0,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630633,50597,,,,A,,14629,10116.0,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630634,50597,,,,A,,14630,10116.0,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630635,50597,,,,A,,14631,10116.0,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630636,50597,,,,A,,14632,10116.0,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630637,50597,,,,A,,14633,10116.0,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,11488,,
CHEMBL630638,50592,,Feces,,A,,14634,9986.0,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630639,50592,,Feces,,A,,14635,9986.0,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630640,50592,,Feces,,A,,14636,9986.0,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL876551,50592,,Feces,,A,,14637,9986.0,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630641,50592,,Urine,,A,,14638,9986.0,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630642,50592,,Urine,,A,,14639,9986.0,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630643,50592,,Urine,,A,,14640,9986.0,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630644,50592,,Urine,,A,,14641,9986.0,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL630645,50592,,Urine,,A,,14642,9986.0,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625599,50592,,Feces,,A,,14643,9986.0,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625600,50592,,Feces,,A,,14644,9986.0,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625601,50592,,Feces,,A,,14645,9986.0,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL625602,50592,,Feces,,A,,14646,9986.0,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627470,50592,,Urine,,A,,14647,9986.0,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627471,50592,,Urine,,A,,14648,9986.0,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627472,50592,,Urine,,A,,14649,9986.0,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627473,50592,,Urine,,A,,14650,9986.0,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627474,50592,,Urine,,A,,14651,9986.0,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,7132,,
CHEMBL627475,50597,,Blood,In vivo,A,,14652,10116.0,178.0,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL627476,50597,,Blood,In vivo,A,,14653,10116.0,178.0,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL627477,50588,,Urine,,A,,14654,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627478,50588,,Urine,,A,,14655,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627479,50588,,Urine,,A,,14656,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627480,50588,,Urine,,A,,14657,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627481,50588,,Urine,,A,,14658,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627482,50588,,Urine,,A,,14659,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL627483,50588,,Urine,,A,,14660,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL875636,50588,,Urine,,A,,14661,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625764,50588,,Urine,,A,,14662,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625765,50588,,Urine,,A,,14663,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625766,50588,,Urine,,A,,14664,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625767,50588,,Urine,,A,,14665,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625768,50588,,Urine,,A,,14666,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625769,50588,,Urine,,A,,14667,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625770,50588,,Urine,,A,,14668,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625771,50588,,Urine,,A,,14669,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625772,50588,,Urine,,A,,14670,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625773,50588,,Urine,,A,,14671,9615.0,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Canis lupus familiaris,12582,,
CHEMBL625774,50597,,Urine,,A,,14672,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625775,50597,,Urine,,A,,14673,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625776,50597,,Urine,,A,,14674,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625777,50597,,Urine,,A,,14675,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625778,50597,,Urine,,A,,14676,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625779,50597,,Urine,,A,,14677,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625780,50597,,Urine,,A,,14678,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL625781,50597,,Urine,,A,,14679,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL875637,50597,,Urine,,A,,14680,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626473,50597,,Urine,,A,,14681,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626474,50597,,Urine,,A,,14682,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626475,50597,,Urine,,A,,14683,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626476,50597,,Urine,,A,,14684,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL634397,50597,,Urine,,A,,14685,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL626477,50597,,Urine,,A,,14686,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631069,50597,,Urine,,A,,14687,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631070,50597,,Urine,,A,,14688,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631071,50597,,Urine,,A,,14689,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631072,50597,,Urine,,A,,14690,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631073,50597,,Urine,,A,,14691,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631074,50597,,Urine,,A,,14692,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631075,50597,,Urine,,A,,14693,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631725,50597,,Urine,,A,,14694,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631726,50597,,Urine,,A,,14695,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631727,50597,,Urine,,A,,14696,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631728,50597,,Urine,,A,,14697,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631729,50597,,Urine,,A,,14698,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631730,50597,,Urine,,A,,14699,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631731,50597,,Urine,,A,,14700,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631910,50597,,Urine,,A,,14701,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631911,50597,,Hippocampus,In vivo,A,,14702,10116.0,10000000.0,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL631912,50597,,Hypothalamus,In vivo,A,,14703,10116.0,1898.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL631913,50597,,Hypothalamus,In vivo,A,,14704,10116.0,1898.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15413,,
CHEMBL631914,50597,,Blood,In vivo,A,,14705,10116.0,178.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631915,50597,,Blood,In vivo,A,,14706,10116.0,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL875778,50597,,Blood,In vivo,A,,14707,10116.0,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631916,50597,,Blood,In vivo,A,,14708,10116.0,178.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631917,50597,,Blood,In vivo,A,,14709,10116.0,178.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631918,50597,,Blood,In vivo,A,,14710,10116.0,178.0,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631919,50597,,Blood,In vivo,A,,14711,10116.0,178.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631920,50597,,Blood,In vivo,A,,14712,10116.0,178.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631921,50597,,Blood,In vivo,A,,14713,10116.0,178.0,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631922,50597,,Blood,In vivo,A,,14714,10116.0,178.0,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631923,50597,,Blood,In vivo,A,,14715,10116.0,178.0,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631924,50597,,,In vivo,A,,14716,10116.0,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630234,50597,,,In vivo,A,,14717,10116.0,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630235,50597,,,In vivo,A,,14718,10116.0,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630236,50597,,,In vivo,A,,14719,10116.0,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630237,50597,,,In vivo,A,,14720,10116.0,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630238,50597,,,In vivo,A,,14721,10116.0,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630239,50597,,,In vivo,A,,14722,10116.0,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630303,50597,,,In vivo,A,,14723,10116.0,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630304,50597,,,In vivo,A,,14724,10116.0,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630305,50597,,,In vivo,A,,14725,10116.0,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630306,50597,,Kidney,In vivo,A,,14726,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630307,50597,,Kidney,In vivo,A,,14727,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630308,50597,,Kidney,In vivo,A,,14728,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630309,50597,,Kidney,In vivo,A,,14729,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL629309,50597,,Kidney,In vivo,A,,14730,10116.0,2113.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL629993,50597,,Kidney,In vivo,A,,14731,10116.0,2113.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL629994,50597,,Kidney,In vivo,A,,14732,10116.0,2113.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL629995,50597,,Kidney,In vivo,A,,14733,10116.0,2113.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631993,50597,,Kidney,In vivo,A,,14734,10116.0,2113.0,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631994,50597,,Kidney,In vivo,A,,14735,10116.0,2113.0,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631995,50597,,Kidney,In vivo,A,,14736,10116.0,2113.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631996,50597,,Liver,In vivo,A,,14737,10116.0,2107.0,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631997,50597,,Liver,In vivo,A,,14738,10116.0,2107.0,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631998,50597,,Liver,In vivo,A,,14739,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631999,50597,,Liver,In vivo,A,,14740,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL632000,50597,,Liver,In vivo,A,,14741,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL632001,50597,,Liver,In vivo,A,,14742,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL874424,50597,,Liver,In vivo,A,,14743,10116.0,2107.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL632002,50597,,Liver,In vivo,A,,14744,10116.0,2107.0,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL632003,50597,,Liver,In vivo,A,,14745,10116.0,2107.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL632004,22224,,,,A,,14746,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,3133,,
CHEMBL632005,22224,,,,A,,14747,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632006,22224,,,,A,,14748,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632007,22224,,,,A,,14749,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632008,22224,,,,A,,14750,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632009,22224,,,,A,,14751,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632010,22224,,,,A,,14752,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL857750,22224,,,,A,,14753,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632011,22224,,,,A,,14754,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,U,,0,,Autocuration,1,BAO_0000019,,,2742,,
CHEMBL632012,22224,,,,A,,14755,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL632013,22224,,,,A,,14756,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL632014,22224,,,,A,,14757,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL629622,22224,,,,A,,14758,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL629623,22224,,,,A,,14759,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL629624,22224,,,,A,,14760,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL629625,22224,,,,A,,14761,,,Ratio of Kcat to that of Km was determined,U,,0,,Autocuration,1,BAO_0000019,,,17269,,
CHEMBL629626,22224,,,,A,,14762,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL629627,22224,,,,A,,14763,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,0,,Autocuration,1,BAO_0000019,,,2276,,
CHEMBL629628,22224,,,,A,,14764,,,"Compound was evaluated for constant, Kd",U,,0,,Autocuration,1,BAO_0000019,,,15917,,
CHEMBL629629,22224,,,,A,,14765,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,U,,0,,Autocuration,1,BAO_0000019,,,10933,,
CHEMBL629630,22224,,,,A,,14766,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,U,,0,,Autocuration,1,BAO_0000019,,,10933,,
CHEMBL856030,22224,,,,A,,14767,,,Dissociation Constant of compound determined,U,,0,,Autocuration,1,BAO_0000019,,,14293,,
CHEMBL629631,22224,,,,B,,14768,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,U,,0,,Autocuration,1,BAO_0000019,,,6698,,
CHEMBL629632,22224,,,,B,,14769,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,U,,0,,Autocuration,1,BAO_0000019,,,6698,,
CHEMBL629633,22224,,,,P,,14770,,,Dissociation constant of compound with Fructose was determined,U,,0,,Autocuration,1,BAO_0000100,,,4318,,
CHEMBL629634,22224,,,,P,,14771,,,Dissociation constant of compound with Fructose was determined; Not determined,U,,0,,Autocuration,1,BAO_0000100,,,4318,,
CHEMBL629635,22224,,,,P,,14772,,,Dissociation constant of compound with Lactulose was determined,U,,0,,Autocuration,1,BAO_0000100,,,4318,,
CHEMBL629636,22224,,,,P,,14773,,,Dissociation constant of compound with Lactulose was determined; Not determined,U,,0,,Autocuration,1,BAO_0000100,,,4318,,
CHEMBL629637,22224,,,,P,,14774,,,Dissociation constant of the Compound,U,,0,,Autocuration,1,BAO_0000100,,,14959,,
CHEMBL629638,22224,,,,P,,14775,,,Dissociation constant by non-linear regression analysis,U,,0,,Autocuration,1,BAO_0000100,,,5913,,
CHEMBL629639,22224,,,,P,,14776,,,Dissociation constant was determined,U,,0,,Autocuration,1,BAO_0000100,,,14218,,
CHEMBL629640,22224,,,,P,,14777,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,U,,0,,Autocuration,1,BAO_0000100,,,10689,,
CHEMBL629641,22224,,,,P,,14778,,,Dissociation constant was determined,U,,0,,Autocuration,1,BAO_0000100,,,13925,,
CHEMBL631344,22224,,,,P,,14779,,,Dissociation constant was determined,U,,0,,Autocuration,1,BAO_0000100,,,16359,,
CHEMBL631345,50597,,Muscle tissue,,A,,14780,10116.0,2385.0,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10944,,
CHEMBL631346,22224,,,,A,,14781,,,The dissociation constant determined by fluorescence displacement assay,U,,0,,Autocuration,1,BAO_0000019,,,11080,,
CHEMBL631524,22224,,,,A,,14782,,,kd value surface plasmon resonance (SPR) method,U,,0,,Autocuration,1,BAO_0000019,,,17805,,
CHEMBL631525,50597,,Muscle tissue,,A,,14783,10116.0,2385.0,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,10944,,
CHEMBL631526,22224,,,,F,,14784,,,First dissociation constant of the binding of compound to V30M TTR,U,,0,,Autocuration,1,BAO_0000019,,,16645,,
CHEMBL631527,22224,,,,F,,14785,,,Second dissociation constant of the binding of compound to V30M TTR,U,,0,,Autocuration,1,BAO_0000019,,,16645,,
CHEMBL631528,22224,,,,A,,14786,,,"Compound was evaluated for equilibrium constant, Ke",U,,0,,Autocuration,1,BAO_0000019,,,7793,,
CHEMBL631529,22224,,Hypothalamus,,A,,14787,,1898.0,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,U,,0,,Autocuration,1,BAO_0000019,,,12199,,
CHEMBL631530,22224,,Hypothalamus,,A,,14788,,1898.0,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,U,,0,,Autocuration,1,BAO_0000019,,,12199,,
CHEMBL631531,22224,,,,A,,14789,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL631532,22224,,,,A,,14790,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL631533,22224,,,,A,,14791,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,9680,,
CHEMBL876552,50594,,,,A,,14792,10090.0,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631534,50594,,,,A,,14793,10090.0,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631535,50594,,,,A,,14794,10090.0,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631536,50594,,,,A,,14795,10090.0,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631537,50594,,,,A,,14796,10090.0,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631538,50594,,,,A,,14797,10090.0,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631539,50594,,,,A,,14798,10090.0,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL631540,50594,,,,A,,14799,10090.0,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,13758,,
CHEMBL625637,50597,,,,A,,14800,10116.0,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL625638,50597,,,,A,,14801,10116.0,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14393,,
CHEMBL625639,50597,,,,A,,14802,10116.0,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,15078,,
CHEMBL625640,50597,,Brain,In vivo,A,,14803,10116.0,955.0,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625641,50597,,Brain,In vivo,A,,14804,10116.0,955.0,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625642,50597,,Heart,In vivo,A,,14805,10116.0,948.0,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625643,50597,,Heart,In vivo,A,,14806,10116.0,948.0,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625644,50597,,Kidney,In vivo,A,,14807,10116.0,2113.0,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625645,50597,,Kidney,In vivo,A,,14808,10116.0,2113.0,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625646,50597,,Liver,In vivo,A,,14809,10116.0,2107.0,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625647,50597,,Liver,In vivo,A,,14810,10116.0,2107.0,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625648,50597,,Lung,In vivo,A,,14811,10116.0,2048.0,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625649,50597,,Lung,In vivo,A,,14812,10116.0,2048.0,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625650,50597,,Muscle tissue,In vivo,A,,14813,10116.0,2385.0,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625651,50597,,Muscle tissue,In vivo,A,,14814,10116.0,2385.0,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625652,50597,,Zone of skin,In vivo,A,,14815,10116.0,14.0,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625653,50597,,Zone of skin,In vivo,A,,14816,10116.0,14.0,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625654,50597,,Spleen,In vivo,A,,14817,10116.0,2106.0,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625655,50597,,Spleen,In vivo,A,,14818,10116.0,2106.0,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL625656,50597,,Blood,In vivo,A,,14819,10116.0,178.0,Biodistribution of Compound in rat blood after 15 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625657,50597,,Blood,In vivo,A,,14820,10116.0,178.0,Biodistribution of Compound in rat blood after 2 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625658,50597,,Brain,In vivo,A,,14821,10116.0,955.0,Biodistribution of Compound in rat brain after 15 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625659,50597,,Brain,In vivo,A,,14822,10116.0,955.0,Biodistribution of Compound in rat brain after 2 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625660,50597,,Heart,In vivo,A,,14823,10116.0,948.0,Biodistribution of Compound in rat heart after 15 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625661,50597,,Heart,In vivo,A,,14824,10116.0,948.0,Biodistribution of Compound in rat heart after 2 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625662,50597,,Liver,In vivo,A,,14825,10116.0,2107.0,Biodistribution of Compound in rat liver after 15 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL625663,50597,,Liver,In vivo,A,,14826,10116.0,2107.0,Biodistribution of Compound in rat liver after 2 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL875621,50597,,Lung,In vivo,A,,14827,10116.0,2048.0,Biodistribution of Compound in rat lung after 15 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL628382,50597,,Lung,In vivo,A,,14828,10116.0,2048.0,Biodistribution of Compound in rat lung after 2 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL628383,50597,,Muscle tissue,In vivo,A,,14829,10116.0,2385.0,Biodistribution of Compound in rat muscle after 15 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL628384,50597,,Muscle tissue,In vivo,A,,14830,10116.0,2385.0,Biodistribution of Compound in rat muscle after 2 minutes of administration,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,9712,,
CHEMBL628385,50597,,,,A,,14831,10116.0,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL875753,50597,,,,A,,14832,10116.0,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL628386,50597,,,,A,,14833,10116.0,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,13925,,
CHEMBL628387,50597,,,,A,,14834,10116.0,,Organ distribution in rat blood 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL628388,50597,,,,A,,14835,10116.0,,Organ distribution in rat blood 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL628389,50597,,,,A,,14836,10116.0,,Organ distribution in rat blood 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL632756,50597,,,,A,,14837,10116.0,,Organ distribution in rat blood 30 min after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL628390,50597,,,,A,,14838,10116.0,,Organ distribution in rat brain 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631811,50597,,,,A,,14839,10116.0,,Organ distribution in rat brain 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631812,50597,,,,A,,14840,10116.0,,Organ distribution in rat brain 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631813,50597,,,,A,,14841,10116.0,,Organ distribution in rat heart 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631814,50597,,,,A,,14842,10116.0,,Organ distribution in rat heart 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631815,50597,,,,A,,14843,10116.0,,Organ distribution in rat heart 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631816,50597,,,,A,,14844,10116.0,,Organ distribution in rat kidney 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL875758,50597,,,,A,,14845,10116.0,,Organ distribution in rat kidney 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631817,50597,,,,A,,14846,10116.0,,Organ distribution in rat kidney 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631818,50597,,Liver,,A,,14847,10116.0,2107.0,Organ distribution in rat liver 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631819,50597,,Liver,,A,,14848,10116.0,2107.0,Organ distribution in rat liver 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631820,50597,,Liver,,A,,14849,10116.0,2107.0,Organ distribution in rat liver 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631821,50597,,,,A,,14850,10116.0,,Organ distribution in rat lung 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631822,50597,,,,A,,14851,10116.0,,Organ distribution in rat lung 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631823,50597,,,,A,,14852,10116.0,,Organ distribution in rat lung 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631824,50597,,Muscle tissue,,A,,14853,10116.0,2385.0,Organ distribution in rat muscle 2 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631825,50597,,Muscle tissue,,A,,14854,10116.0,2385.0,Organ distribution in rat muscle 2 hr after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631826,50597,,Muscle tissue,,A,,14855,10116.0,2385.0,Organ distribution in rat muscle 30 minutes after intravenous injection,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,6941,,
CHEMBL631827,50594,,,In vivo,A,,14856,10090.0,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL631828,50594,,,In vivo,A,,14857,10090.0,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL631829,50594,,,In vivo,A,,14858,10090.0,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL875759,50597,,Urine,,A,,14859,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631830,50597,,Urine,,A,,14860,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631831,50597,,Urine,,A,,14861,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631832,50597,,Urine,,A,,14862,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631833,50597,,Urine,,A,,14863,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631834,50597,,Urine,,A,,14864,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631835,50597,,Urine,,A,,14865,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631836,50597,,Urine,,A,,14866,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631837,50597,,Urine,,A,,14867,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631838,50597,,Urine,,A,,14868,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631839,50597,,Urine,,A,,14869,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631840,50597,,Urine,,A,,14870,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631841,50597,,Urine,,A,,14871,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631842,50597,,Urine,,A,,14872,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631843,50597,,Urine,,A,,14873,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631844,50597,,Urine,,A,,14874,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631845,50597,,Urine,,A,,14875,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631846,50597,,Urine,,A,,14876,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL875760,50597,,Urine,,A,,14877,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL632199,50597,,Urine,,A,,14878,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631847,50597,,Urine,,A,,14879,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL631848,50597,,Urine,,A,,14880,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628707,50597,,Urine,,A,,14881,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628708,50597,,Urine,,A,,14882,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628709,50597,,Urine,,A,,14883,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628710,50597,,Urine,,A,,14884,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628711,50597,,Urine,,A,,14885,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628712,50597,,Urine,,A,,14886,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628713,50597,,Urine,,A,,14887,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628714,50597,,Urine,,A,,14888,10116.0,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12582,,
CHEMBL628715,50597,,,,A,,14889,10116.0,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,7415,,
CHEMBL629179,22224,,,,A,,14890,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,U,,0,,Autocuration,1,BAO_0000019,,,7313,,
CHEMBL629180,22224,,,,A,,14891,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,U,,0,,Autocuration,1,BAO_0000019,,,7313,,
CHEMBL875108,22224,,,,A,,14892,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,U,,0,,Autocuration,1,BAO_0000019,,,7313,,
CHEMBL629181,22224,,Adrenal cortex,,A,,14893,,1235.0,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629182,22224,,Adrenal cortex,,A,,14894,,1235.0,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629183,22224,,,,A,,14895,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629184,22224,,,,A,,14896,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629185,22224,,Adrenal cortex,,A,,14897,,1235.0,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629186,22224,,Adrenal cortex,,A,,14898,,1235.0,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629187,22224,,,,A,,14899,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629887,22224,,,,A,,14900,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629888,22224,,,,A,,14901,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629889,22224,,,,A,,14902,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629890,22224,,Adrenal cortex,,A,,14903,,1235.0,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629891,22224,,,,A,,14904,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629892,22224,,,,A,,14905,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629893,22224,,Adrenal cortex,,A,,14906,,1235.0,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629894,22224,,,,A,,14907,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL629895,22224,,,,A,,14908,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,0,,Autocuration,1,BAO_0000019,,,7570,,
CHEMBL875109,22224,,,In vivo,A,,14909,9615.0,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",U,,0,,Autocuration,1,BAO_0000218,,Canis lupus familiaris,14122,,
CHEMBL629896,22224,,,In vivo,A,,14910,9541.0,,Absolute bioavailability in male cynomolgus monkeys,U,,0,,Autocuration,1,BAO_0000218,,Macaca fascicularis,16449,,
CHEMBL629897,22224,,,In vivo,A,,14911,10116.0,,Absolute bioavailability in maleSprague-Dawley rats,U,,0,,Autocuration,1,BAO_0000218,,Rattus norvegicus,16449,,
CHEMBL629898,50597,,Liver,In vivo,A,,14912,10116.0,2107.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630057,50597,,Liver,In vivo,A,,14913,10116.0,2107.0,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630058,50597,,Liver,In vivo,A,,14914,10116.0,2107.0,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630059,50597,,Lung,In vivo,A,,14915,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630060,50597,,Lung,In vivo,A,,14916,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630061,50597,,Lung,In vivo,A,,14917,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630062,50597,,Lung,In vivo,A,,14918,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630063,50597,,Lung,In vivo,A,,14919,10116.0,2048.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630064,50597,,Lung,In vivo,A,,14920,10116.0,2048.0,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630065,50597,,Lung,In vivo,A,,14921,10116.0,2048.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630066,50597,,Lung,In vivo,A,,14922,10116.0,2048.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630067,50597,,Lung,In vivo,A,,14923,10116.0,2048.0,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630068,50597,,Lung,In vivo,A,,14924,10116.0,2048.0,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631113,50597,,Muscle tissue,In vivo,A,,14925,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631114,50597,,Muscle tissue,In vivo,A,,14926,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631115,50597,,Muscle tissue,In vivo,A,,14927,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL631116,50597,,Muscle tissue,In vivo,A,,14928,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630528,50597,,Muscle tissue,In vivo,A,,14929,10116.0,2385.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630529,50597,,Muscle tissue,In vivo,A,,14930,10116.0,2385.0,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630530,50597,,Muscle tissue,In vivo,A,,14931,10116.0,2385.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630531,50597,,Muscle tissue,In vivo,A,,14932,10116.0,2385.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630532,50597,,Muscle tissue,In vivo,A,,14933,10116.0,2385.0,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630533,50597,,Muscle tissue,In vivo,A,,14934,10116.0,2385.0,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630534,50594,,Blood,In vivo,A,,14935,10090.0,178.0,Biodistribution in normal mice blood after 120 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630535,50594,,Blood,In vivo,A,,14936,10090.0,178.0,Biodistribution in normal mice blood after 24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630536,50594,,Blood,In vivo,A,,14937,10090.0,178.0,Biodistribution in normal mice blood after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630537,50594,,Bone,In vivo,A,,14938,10090.0,10000001.0,Biodistribution in normal mice bone after 120 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630538,50594,,Bone,In vivo,A,,14939,10090.0,10000001.0,Biodistribution in normal mice bone after 24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630539,50594,,Bone,In vivo,A,,14940,10090.0,10000001.0,Biodistribution in normal mice bone after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630540,50594,,Heart,In vivo,A,,14941,10090.0,948.0,Biodistribution in normal mice heart after 120 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630541,50594,,Heart,In vivo,A,,14942,10090.0,948.0,Biodistribution in normal mice heart after 24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630542,50594,,Heart,In vivo,A,,14943,10090.0,948.0,Biodistribution in normal mice heart after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630543,50594,,Kidney,In vivo,A,,14944,10090.0,2113.0,Biodistribution in normal mice kidney after 120 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630544,50594,,Kidney,In vivo,A,,14945,10090.0,2113.0,Biodistribution in normal mice kidney after 24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630545,50594,,Kidney,In vivo,A,,14946,10090.0,2113.0,Biodistribution in normal mice kidney after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630546,50594,,Liver,In vivo,A,,14947,10090.0,2107.0,Biodistribution in normal mice liver after 120 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630547,50594,,Liver,In vivo,A,,14948,10090.0,2107.0,Biodistribution in normal mice liver after 24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630548,50594,,Liver,In vivo,A,,14949,10090.0,2107.0,Biodistribution in normal mice liver after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630549,50594,,Spleen,In vivo,A,,14950,10090.0,2106.0,Biodistribution in normal mice spleen after 120 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630550,50594,,Spleen,In vivo,A,,14951,10090.0,2106.0,Biodistribution in normal mice spleen after 24 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL876426,50594,,Spleen,In vivo,A,,14952,10090.0,2106.0,Biodistribution in normal mice spleen after 4 hr,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,15045,,
CHEMBL630551,50597,,Spleen,In vivo,A,,14953,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630552,50597,,Spleen,In vivo,A,,14954,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630553,50597,,Spleen,In vivo,A,,14955,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630554,50597,,Spleen,In vivo,A,,14956,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630555,50597,,Spleen,In vivo,A,,14957,10116.0,2106.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630556,50597,,Spleen,In vivo,A,,14958,10116.0,2106.0,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630557,50597,,Spleen,In vivo,A,,14959,10116.0,2106.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630558,50597,,Spleen,In vivo,A,,14960,10116.0,2106.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630559,50597,,Spleen,In vivo,A,,14961,10116.0,2106.0,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630560,50597,,Spleen,In vivo,A,,14962,10116.0,2106.0,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL876427,50597,,Thyroid gland,In vivo,A,,14963,10116.0,2046.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,12017,,
CHEMBL630561,50597,,,,A,,14964,10116.0,,The Kel values in female wistar rats.,N,,1,,Intermediate,1,BAO_0000218,,Rattus norvegicus,14941,,
CHEMBL630562,22224,,,,A,,14965,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,4646,,
CHEMBL630563,22224,,,,A,,14966,,,Hydrolysis rate constant of the compound,U,,0,,Autocuration,1,BAO_0000019,,,8847,,
CHEMBL629673,22229,,,,P,,14967,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,U,,0,,Autocuration,1,BAO_0000100,,,11778,,
CHEMBL629674,22224,,,,A,,14968,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,2363,,
CHEMBL629675,22224,,,,A,,14969,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",U,,0,,Autocuration,1,BAO_0000019,,,2363,,
CHEMBL629676,22224,,,,A,,14970,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",U,,0,,Autocuration,1,BAO_0000019,,,2363,,
CHEMBL629677,22224,,,,A,,14971,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",U,,0,,Autocuration,1,BAO_0000019,,,2363,,
CHEMBL629678,22224,,,,A,,14972,,,Apparent inactivation rate constant was evaluated,U,,0,,Autocuration,1,BAO_0000019,,,8371,,
CHEMBL629679,22224,,,,A,,14973,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,U,,0,,Autocuration,1,BAO_0000019,,,14883,,
CHEMBL629680,22224,,,,A,,14974,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,U,,0,,Autocuration,1,BAO_0000019,,,14883,,
CHEMBL629681,22224,,,,A,,14975,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,U,,0,,Autocuration,1,BAO_0000019,,,4643,,
CHEMBL629682,22224,,,,A,,14976,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,U,,0,,Autocuration,1,BAO_0000019,,,3519,,
CHEMBL629683,22224,,,,A,,14977,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,U,,0,,Autocuration,1,BAO_0000019,,,10600,,
CHEMBL629684,22224,,,,F,,14978,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,U,,0,,Autocuration,1,BAO_0000019,,,8501,,
CHEMBL629685,22224,,,,P,,14979,,,Dissociation constant was determined,U,,0,,Autocuration,1,BAO_0000100,,,8505,,
CHEMBL629686,22224,,,,P,,14980,,,Dissociation constant was determined,U,,0,,Autocuration,1,BAO_0000100,,,9778,,
CHEMBL872932,22224,,,,P,,14981,,,Dissociation constant at pH 7.4,U,,0,,Autocuration,1,BAO_0000100,,,9778,,
CHEMBL629687,22224,,,,P,,14982,,,Dissociation constant in presence of 1 mM dithiothreitol,U,,0,,Autocuration,1,BAO_0000100,,,9778,,
CHEMBL872931,22224,,,,A,,14983,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,0,,Autocuration,1,BAO_0000019,,,13007,,
CHEMBL628151,22224,,,,A,,14984,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,0,,Autocuration,1,BAO_0000019,,,13007,,
CHEMBL628152,22224,,,,A,,14985,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,0,,Autocuration,1,BAO_0000019,,,13007,,
CHEMBL628153,22224,,,,A,,14986,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,0,,Autocuration,1,BAO_0000019,,,13007,,
CHEMBL628154,22224,,,,A,,14987,,,Kinetic constant for aromatization of androstenedione,U,,0,,Autocuration,1,BAO_0000019,,,11482,,
CHEMBL628155,22224,,,,A,,14988,,,Kinetic constant for aromatization of testosterone,U,,0,,Autocuration,1,BAO_0000019,,,11482,,
CHEMBL628156,22224,,,,A,,14989,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,U,,0,,Autocuration,1,BAO_0000019,,,2303,,
CHEMBL628157,22224,,,,A,,14990,,,Local inhibition constant was determined,U,,0,,Autocuration,1,BAO_0000019,,,11964,,
CHEMBL857533,50347,,,,A,,14991,4932.0,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,N,,1,,Intermediate,1,BAO_0000218,,Saccharomyces cerevisiae,3140,,
CHEMBL628158,22224,,,,P,,14992,,,Dissociation constant value of the compound,U,,0,,Autocuration,1,BAO_0000100,,,10650,,
CHEMBL628159,22224,,Cornea,,A,,14993,,964.0,In vitro permeability through cornea without epithelium,U,,0,,Autocuration,1,BAO_0000019,,,4667,,
CHEMBL875616,22224,,Cornea,,A,,14994,,964.0,In vitro permeability through intact cornea,U,,0,,Autocuration,1,BAO_0000019,,,4667,,
CHEMBL628160,50592,,Cornea,,A,,14995,9986.0,964.0,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,N,,1,,Intermediate,1,BAO_0000218,,Oryctolagus cuniculus,9199,,
CHEMBL628161,22224,,,,A,,14996,,,Rate of enzyme inactivation for the compound was determined,U,,0,,Autocuration,1,BAO_0000019,,,11966,,
CHEMBL628162,22224,,Cornea,,A,,14997,,964.0,In vitro permeability through cornea without epithelium,U,,0,,Autocuration,1,BAO_0000019,,,4667,,
CHEMBL628163,22224,,Cornea,,A,,14998,,964.0,In vitro permeability through intact cornea,U,,0,,Autocuration,1,BAO_0000019,,,4667,,
CHEMBL628164,22224,,,,A,,14999,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628165,22224,,,,A,,15000,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628166,22224,,,,A,,15001,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628167,22224,,,,A,,15002,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628168,22224,,,,A,,15003,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628169,22224,,,,A,,15004,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628170,22224,,,,A,,15005,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628171,22224,,,,A,,15006,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL627434,22224,,,,A,,15007,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL627435,22224,,,,A,,15008,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628110,22224,,,,A,,15009,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628111,22224,,,,A,,15010,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628112,22224,,,,A,,15011,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628260,22224,,,,A,,15012,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628261,22224,,,,A,,15013,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,0,,Autocuration,1,BAO_0000019,,,8354,,
CHEMBL628262,50594,,,In vivo,A,,15014,10090.0,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628263,50587,,,In vivo,A,,15015,9606.0,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,N,,1,,Intermediate,1,BAO_0000218,,Homo sapiens,14439,,
CHEMBL628264,50594,,,In vivo,A,,15016,10090.0,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628265,50594,,,In vivo,A,,15017,10090.0,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628266,50594,,,In vivo,A,,15018,10090.0,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628267,50594,,,In vivo,A,,15019,10090.0,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628268,50594,,,In vivo,A,,15020,10090.0,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628269,50594,,,In vivo,A,,15021,10090.0,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628270,50594,,,In vivo,A,,15022,10090.0,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628271,50594,,,In vivo,A,,15023,10090.0,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
CHEMBL628272,50594,,,In vivo,A,,15024,10090.0,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),N,,1,,Intermediate,1,BAO_0000218,,Mus musculus,14439,,
